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Koraljka Gall Trošelj
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was proposer and co-ordinator of the European COST Action B35 on Lipid Peroxidation Associated
Disorders and was a member of the CMST (Chemistry, Molecular Sciences and Technologies) Domain
of COST (European Cooperation in Science and Technology) and of the Board of Governors of
EARTO (European Association of Research and Technology Organizations), while he acts now as
Study Director of the Interdisciplinary Ph.D. Study Program in Molecular Biosciences and as Visiting
Professor of the Medical University in Bialystok. He is college professor of economy/management
and holds university professorships in biology and in medicine at the University of Osijek. In 1985,
he received national award for research in pathology, while in 2007 he got the national award for





Roles and Functions of ROS and RNS in Cellular
Physiology and Pathology
Neven Zarkovic
Rudjer Boskovic Institute, Laboratory for Oxidative Stress (LabOS), Bijenička 54, HR-1000 Zagreb, Croatia;
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Abstract: Our common knowledge on oxidative stress has evolved substantially over the years,
being focused mostly on the fundamental chemical reactions and the most relevant chemical species
involved in human pathophysiology of oxidative stress-associated diseases. Thus, reactive oxygen
species and reactive nitrogen species (ROS and RNS) were identified as key players in initiating,
mediating, and regulating the cellular and biochemical complexity of oxidative stress either as
physiological (acting pro-hormetic) or as pathogenic (causing destructive vicious circles) processes.
The papers published in this particular Special Issue of Cells show an impressive range on the
pathophysiological relevance of ROS and RNS, including the relevance of second messengers of free
radicals like 4-hydroxynonenal, allowing us to assume that the future will reveal even more detailed
mechanisms of their positive and negative effects that might improve the monitoring of major modern
diseases, and aid the development of advanced integrative biomedical treatments.
Keywords: free radicals; redox balance; cell signaling; growth; toxicity; antioxidants; oxidative
homeostasis; oxidative metabolism of the cells; pathophysiology of oxidative stress
For decades, free radicals were mostly considered as harmful molecules that contribute to the toxic,
mutagenic, and carcinogenic bioactivities of different chemical and physical stressors. However, after
hydrogen peroxide and nitric oxide were found to have multiple, often cell-type and dose-dependent
effects, the new era of interdisciplinary molecular biosciences and translation medicine made significant
progress in studies on the pathophysiology of oxidative stress and associated disorders. Therefore, the
major goal of this Special Issue of Cells is to cover broad aspects of these important scientific areas, still
focusing on the cellular level. However, since many disorders are based on altered cellular functions
involving interactions of reactive oxygen species (ROS) and reactive nitrogen species (RNS) with
macromolecules, in this Special Issue we also try to tackle physiological and pathological aspects of
cellular ROS and RNS related to specific cellular processes affecting the entire organism.
While ROS have plenty of physiological activities, particularly in redox signaling and growth
regulation, the most aggressive oxygen free radical, which is attributed to the majority of the negative
effects of oxidative stress, is hydroxyl radical (HO.), known for its ability to damage almost any
biomolecule, induce lipid peroxidation, and cause DNA strand breaks [1,2]. Hence, C. Chatgilialoglu
et al. presented the chemical, analytical, biological, and diagnostic significance of cyclopurine lesions
(cPu) in DNA damage caused by HO., and also alternative damage by UV irradiation [3]. They
found the use of cPu lesions as candidate biomarkers of DNA damage, since they are relatively stable
and not associated with frequent artifacts like other oxidatively generated DNA lesions. Although
rather demanding, LC–MS/MS seems to be the most convenient analytical method for the cPu. C.
Chatgilialoglu et al. reveal cPu as a cellular DNA damage biomarker, which is convenient to study in
carcinogenesis, aging, and xeroderma pigmentosum.
The very recent review paper of A. Cherkas et al. [4] offered new perspectives to evaluate the
importance of glucose not only for the overall cellular oxidative metabolism but also for the overall
regulation of the cellular adaptation to stressors, especially to oxidative stress. Going in a similar
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direction, the K. Gall Trošelj’s group evaluated nutritional stress disturbing the cellular redox-status,
increasing the ROS production. In particular, they studied the NRF2-NQO1 axis, which represents
a protective mechanism against oxidative stress. Their study involved different cancer cell lines
(FaDu, Cal 27, and Detroit 562), which have different basal NQO1 activity and were exposed to the
absence of glucose and glutamine, or solely to the low levels of either glucose or glutamine [5]. While
all the cells lines analyzed showed sensitivity to glucose deprivation, their differential activation
of the NRF2-NQO1 axis resulted in a differently increased expression of NQO1. Therefore, further
exploration of such stress response in complex biological systems, focusing in particular on NQO1*2/*2
polymorphism (rs1800566), is required.
A. Methner’s group studied in vitro mitochondrial structure and function, including ATP content
as well as mitochondrial quality control to study mild oxidative stress in a model of Charcot–Marie
tooth disease, which is a hereditary polyneuropathy caused by mutations in Mitofusin-2 (MFN2), a
GTPase in the outer mitochondrial membrane involved in the regulation of mitochondrial fusion and
bioenergetics [6]. By using MFN2-deficient fibroblasts stably expressing wildtype or R94Q MFN2
they found that the mutation R94Q in MFN2 decreases ATP production but increases mitochondrial
respiration under conditions of mild oxidative stress. This was associated with an increase of glucose
uptake and an upregulation of hexokinase 1 and pyruvate kinase M2, suggesting increased pyruvate
shuttling into mitochondria, resulting in mitophagy due to the less efficient mitochondrial quality
control in mitochondria of R94Q cells.
Increased sensitivity to oxidative stress was also reported for the human neuroblastoma SH-SY5Y
cells upon increased TRPM2 channel expression, as reported by X. An et al. [7]. Namely, SH-SY5Y
cells are used as in vitro study models for neurodegenerative diseases, as recent finding showed that
the 1-methyl-4-phenylpyridine ion (MPP), which selectively causes dopaminergic neuronal death
leading to Parkinson’s disease-like symptoms, can reduce SH-SY5Y cell viability by inducing H2O2
generation and subsequent TRPM2 channel activation. After establishing the stable SH-SY5Y cell line
overexpressing the human TRPM2 channel, the authors observed augmented H2O2-induced cell death
rates and a reduction in cell viability, which were prevented either by 2-APB, a TRPM2 inhibitor, or
by PJ34 and DPQ, poly(ADP-ribose) polymerase (PARP) inhibitors. Therefore, they concluded that
TRPM2 channel plays a critical role in conferring the ROS-induced death of SH-SY5Y cells.
The relevance of oxidative stress and advantages/disadvantages of different experimental models
used, especially in vitro, to study human pathophysiology was further stressed by O. Alamu et al.,
who analyzed the relevance of differential sensitivity of different endothelial cell lines to hydrogen
peroxide used for in vitro studies of the blood–brain barrier (BBB) [8]. The authors found that even
standardized and well-known cell lines can substantially differ in their antioxidant characteristics.
In accordance, they recommend caution in making comparisons across BBB models utilizing distinctly
different cell lines that require further prerequisites to ensure that in vitro BBB models involving these
cell lines are reliable and reproducible.
In the review on the roles of toll-like receptors (TLRs) in nitroxidative stress, Y. Li et al. focus
mostly on the TLR2 and TLR4 in the innate immunity cells to conclude that TLRs trigger a signaling
cascade, resulting in the generation of ROS and RNS [9]. Namely, TLRs stimulate immune competent
cells to produce pro-inflammatory factors upon pathogen invasion, which can induce oxidative
stress. Moreover, TLRs can also affect antioxidant mechanisms that attenuate regulate oxidative stress.
Hence, the signaling pathways of TLRs can upregulate the expression of cytokines and RSO and RNS
production through inflammatory cells.
Going a step further, M. Jaganjac et al. described the important roles of the lipid peroxidation
product acrolein and NADPH oxidase in the granulocyte-mediated growth-inhibition of tumor
cells [10]. Namely, in a series of research papers published several years ago, these authors dealt with
the phenomenon of spontaneous cancer regression using mostly murine tumors, W256, EAT, and
melanoma B16 [11,12]. Eventually, they revealed that the oxidative burst of granulocytes is responsible
for spontaneous regression of these neoplasms, while the crucial element for the achieved cancer
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regression is cytotoxic reactive aldehydes generated by lipid peroxidation and myeloperoxidase, in
particular 4-hydroxynonenal (4-HNE) and acrolein. In their study, they analyzed the involvement of
reactive aldehydes in cellular redox homeostasis and surface TLR4 expression. They found acrolein
to act as an inducer of the granulocyte TLR4 expression, while granulocyte-mediated antitumor
effects were shown to be mediated via HOCl intracellular pathway by the action of NADPH oxidase.
Thus, they confirmed the interference of intracellular inflammatory signaling pathways of TLRs
and oxidative stress, which require further studies to understand the interaction between TLR4 and
granulocyte-tumor cell intercellular signaling pathways.
The interference of oxidative stress and cellular inflammatory pathways were also studied by A.
Jastrab et al., who produced a study on the expression of inflammatory proteins in keratinocytes [13].
Namely, exposure to UV light is a known causative factor in acute skin photodamage, chronic
photoaging, and skin carcinogenesis, although it can also be beneficial for the treatment of chronic
inflammatory diseases, such as psoriasis [14]. Due to frequent exposure of almost any person to solar
UV irradiation and the ongoing increase in skin cancer incidence (especially of melanoma) there is a
lot of interest to define convenient protective/antioxidant substances that could prevent undesirable
effects of UV light on skin cells. Hence, the authors analyzed, in vitro, the potentially beneficial effects
of cannabidiol (CBD), a natural phytocannabinoid without psychoactive effects, which is a well-known
anti-inflammatory and antioxidant substance. They found CBD to significantly enhance antioxidant
enzymes such as superoxide dismutase and thioredoxin reductase in UV irradiated keratinocytes,
while it reduced the levels of glutathione. CBD also reduced lipid peroxidation, as observed by
decreased levels of 4-HNE and 15d-PGJ2. Moreover, CBD influenced interactions of transcription
factors Nrf2-NFκB by inhibiting the NFκB pathway, increasing the expression of Nrf2 activators. Thus,
the antioxidant activity of CBD through Nrf2 activation as well as its anti-inflammatory properties as
an inhibitor of NFκB suggests that CBD could be a useful skin protective agent.
The association of inflammatory factors, such as histamine, and the onset of
oxidative stress affecting the blood vessels was studied by P. Avdonin et al. [15].
In particular, the authors studied effects of NAD(P)H oxidase (NOX) inhibitor VAS2870
(3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine) on the histamine-induced elevation
of free cytoplasmic calcium concentration ([Ca2+]i) and the secretion of vonWillebrand factor (vWF) in
human umbilical vein endothelial cells (HUVECs), and on the relaxation of rat aorta in response to
histamine. They found that VAS2870 attenuated histamine-induced secretion of vWF, although it did
not inhibit its basal secretion. However, VAS2870 did not change the degree of histamine-induced
relaxation of rat aortic rings constricted by norepinephrine. In accordance, the authors suggest that
NOX inhibitors might be useful as a tool for preventing deep vein thrombosis induced by histamine
release from mast cells without affecting vasorelaxation, which, of course, requires intense additional
studies, both in vitro and in vivo.
The association between oxidative stress and the functional activities of blood vessels is usually
addressed in terms of tackling the onset and progression of atherosclerosis. Therefore, S. Fiorelli et al.
analyzed the oxidative stress from the aspects of the Nrf2/HO-1 axis in monocyte-derived macrophages
(MDMs) obtained from healthy subjects and from patients with coronary artery disease (CAD), in
relation to coronary plaque features evaluated in vivo by optical coherence tomography (OCT) [16].
They found that the MDMs of healthy subjects exhibited a lower oxidative stress status, lower Nrf2,
and HO-1 levels as compared to CAD patients. High HO-1 levels in MDMs were associated with the
presence of a higher macrophage content, a thinner fibrous cap, and a ruptured plaque with thrombus
formation, as detected by OCT analysis. Thus, by revealing the activation of Nrf2/HO-1 pathways as
an antioxidant response mechanism in MDMs in CAD patients, the authors suggest that HO-1 levels
may reflect coronary plaque vulnerability. They assume that evaluating this association could help in
the identification of patients with rupture-prone plaque and suggest Nrf2/HO-1 pathways as a new
potential therapeutic targets to counteract plaque progression.
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The frequent consequences of atherosclerotic changes affecting coronary blood vessels are ischemia
and reperfusion of the heart, i.e., induced oxidative stress of the cardiac muscle cells. However, there
are indices suggesting that short-term intermittent hypoxia (IH), similar to ischemia preconditioning,
could be beneficiary, and even cardioprotective. This phenomenon was focused on in the research
produced by K.T. Young’s group [17]. Aiming to find out if IH exposure can enhance the antioxidant
capacity of the heart muscle cells, acting as a cardioprotective mechanism against oxidative stress
and ischemia/reperfusion (I/R) injury in vitro, they cultured primary rat neonatal cardiomyocytes
under IH condition with an oscillating O2 concentration between 20% and 5% every 30 min. They
found that IH protected cardiomyocytes against H2O2- and I/R-induced cell death, most likely because
H2O2-induced Ca2+ imbalance and mitochondrial membrane depolarization was attenuated by IH,
which also reduced the I/R-induced Ca2+ overload. Moreover, IH increased the expression of superoxide
dismutase (SOD), notably of Cu/Zn SOD and Mn SOD, the total antioxidant capacity, and the activity
of catalase, suggesting that IH may indeed protect the cardiomyocytes against H2O2- and I/R-induced
oxidative stress, maintaining Ca2+ homeostasis as well as the mitochondrial membrane potential and
upregulation of antioxidant enzymes.
The last paper of this Special Issue of Cells deals with novel and challenging topic of oxidative
stress modulation as an option to regulate the healing of soft-tissue wounds or even bone fractures [18].
Thus, E. Skrzydlewska’s group described the beneficial effects of vitamins K and D3 on the redox
homeostasis of human osteoblasts if cultured in the presence of hydroxyapatite-based biomaterials [19].
The authors observed that hydroxyapatite-based biomaterials induce oxidative stress manifested by
the increased production of reactive oxygen species and decreased glutathione levels and glutathione
peroxidase activity, causing lipid peroxidation manifested by an increase of 4-HNE levels, which is
known to influence the growth of bone cells [20]. Thus, they confirmed previous findings on the
importance of 4-HNE as a regulatory factor that affects bioactivities of the biomaterials in vitro, and
might eventually explain at least some of the activity principles of enhanced fracture healing upon
insertion of bioactive glass [21]. In the study presented by E. Ambrozewicz et al., vitamins D3 and K
were shown to help maintain redox balance and prevent lipid peroxidation in osteoblasts cultured
with hydroxyapatite-based biomaterials promoting the growth of the osteoblasts [19].
Conclusions
Observed together, the papers published in this particular Special Issue of Cells show an impressive
range on the pathophysiological relevance of ROS and RNS, including the relevance of second
messengers of free radicals like 4-HNE, allowing us to assume that the future will reveal even more
detailed mechanisms of their positive and negative effects that might improve the monitoring of major
modern diseases and the development of advanced integrative biomedicine treatments.
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Biocompatibility of implantable materials: An oxidative stress viewpoint. Biomaterials 2016, 109, 55–68.
[CrossRef] [PubMed]
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Abstract: Purine 5′,8-cyclo-2′-deoxynucleosides (cPu) are tandem-type lesions observed among the
DNA purine modifications and identified in mammalian cellular DNA in vivo. These lesions can be
present in two diasteroisomeric forms, 5′R and 5′S, for each 2′-deoxyadenosine and 2′-deoxyguanosine
moiety. They are generated exclusively by hydroxyl radical attack to 2′-deoxyribose units generating
C5′ radicals, followed by cyclization with the C8 position of the purine base. This review describes
the main recent achievements in the preparation of the cPu molecular library for analytical and
DNA synthesis applications for the studies of the enzymatic recognition and repair mechanisms,
their impact on transcription and genetic instability, quantitative determination of the levels of
lesions in various types of cells and animal model systems, and relationships between the levels of
lesions and human health, disease, and aging, as well as the defining of the detection limits and
quantification protocols.
Keywords: reactive oxygen species; free radicals; DNA damage; cyclopurines; DNA and RNA
polymerases; nucleotide excision repair; LC-MS/MS; xeroderma pigmentosum; cancer
1. Introduction
1.1. Reactive Oxygen Species (ROS)
Since the start of life on Earth, the human body has lived in an oxidative atmosphere due to the
presence of molecular oxygen (dioxygen in its ground triplet state), which plays an immense role in
biological processes [1,2]. Each individual consumes ca. 3.5 kg of molecular oxygen every day and 2.8%
of it is utilized to generate free radicals. Superoxide dismutase (SOD) and nitric oxide synthase (NOS)
are two classes of enzymes that control the production of superoxide radical anions (O2•–) and induce
the formation of nitric oxide (•NO) [2]. These two radicals are the progenitors of endogenous reactive
oxygen species (ROS) and reactive nitrogen species (RNS). The ROS/RNS network includes molecules
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such as hydrogen peroxide (H2O2), hypochlorous acid (HOCl), and peroxynitrite (ONOO–), as well
as radicals such as hydroxyl radicals (HO•), nitrogen dioxide (•NO2), and carbonate radical anions
(CO3•–). However, the ROS/RNS network also functions as an efficient cellular defense mechanism,
being involved in the elimination of viral and microbial infections. The overproduction of ROS/RNS
has been linked with the etiology of many diseases. The main processes that generate HO• radicals are
depicted in reactions (1)–(3): the Fenton reaction of H2O2, the reduction of HOCl by the superoxide
radical anion, and the spontaneous decomposition of protonated ONOO–, respectively [2,3].
H2O2 + Fe2+→ Fe3+ + HO− + HO• (1)
HOCl + O2•− → O2 + Cl− + HO• (2)
ONOO− + H+ ONOOH→ •NO2 + HO• (3)
1.2. Reactivity of Hydroxyl Radicals with DNA
Hydroxyl radicals (HO•) are known for their reactivity and ability to cause DNA strand breaks
and chemical modifications of nucleobase. In addition to the induction of DNA damage through
the metabolism of oxygen, DNA damage may be induced through other environmentally originated
insults such as ionizing radiation, UV light, and chemical mutagens. Although the majority of DNA
damage induced through oxidative metabolism are single lesions, there are also types of multiple
lesions, such as tandem or clustered lesions and DNA/DNA or DNA/protein crosslinking, that may
challenge the repair machinery of the cell. Indeed, enzymatic systems such as base excision repair (BER)
and nucleotide excision repair (NER) are known to remove the majority of DNA lesions and safeguard
the integrity of the genome [4]. However, the lesions may accumulate in tissues, mainly due to the
progressive loss of protective systems and consequent poor repair, as it occurs in the aging process [5].
Also, enzymatic deficiencies can give rise to the accumulation of damage to cellular components that
are linked to certain pathologies.
As far as the chemical mechanisms are concerned, the site of DNA attack by diffusible HO•
radicals are known to be either the hydrogen atom abstraction from the 2-deoxyribose units or the
addition to the base moieties, the latter being the predominant one (accounting for 85–90% of sites
attacked) [6]. Moreover, experimental evidence on direct strand scission suggests the transfer of the
radical center from the base moieties to the sugar backbone [6]. The order of reactivity of HO• radicals
towards the various hydrogen atoms of the 2-deoxyribose moiety is generally accepted to follow that
of the hydrogen atom exposure to solvent (i.e., H5′ > H4’ > H3′  H2′  H1’) [7,8]. The proportion of
attacks at H5′ of DNA by HO• radicals is estimated to be 55% for all possible sugar positions [9]. After
abstraction of a hydrogen atom from 2-deoxyribose, the fate of the carbon-centered radical depends
upon the environment. There are several studies focused on the selective generation of these species to
obtain quantitative data [10–12]. The C5′ radical has a very peculiar behavior with respect to the other
positions of 2-deoxyribose, since its corresponding peroxyl radical does not generate an abasic site and
leads to the formation of unique cyclic base–sugar adducts, the purine 5′,8-cyclo-2′-deoxynucleosides
(cPu). These tandem-type lesions can be observed in models of DNA modifications and have also been
identified in mammalian cellular DNA in vivo [13].
1.3. Historical Background of ‘Cyclopurines’
The chemistry of purine 5′,8-cyclo-2′-deoxynucleosides (cPu) has its origin in the literature of
ionizing radiation [14] and goes back to 1968, when Keck discovered that the attack of HO• radicals
to adenosine-5′-monophosphate leads, among other products, to the production of 5′S and 5′R
diastereoisomers of 5′,8-cycloadenosine-5′-monophosphate [15]. The abstraction of the H5′ atom of the
2-deoxyribose moiety by the HO• radical was suggested as the initiating step of this reaction, followed
by intramolecular cyclization of the C5′ radical onto C8, leading to the formation of a new covalent
bond, C5′–C8 (Figure 1).
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Figure 1. Purine 2′-deoxynucleotide reacts with a hydroxyl radical (HO•), yielding the purine
5′,8-cyclo-2′-deoxynucleotide via cyclization of the C5′ radical followed by oxidation.
In the late 1980s, Dizdaroglu and coworkers demonstrated that 5′,8-cyclo-2′-deoxyadenosine
(cdA) and 5′,8-cyclo-2′-deoxyguanosine (cdG) exist in 5′R and 5′S diastereoisomeric forms (Figure 2A)
and are generated by the reaction of HO• radicals with the genetic material via C5′ radical chemistry
of purine moieties (Figure 1) [16,17]. The induction by ionizing radiation and identification of R-cdG
and S-cdG in living cells were also reported in 1987 [18].
 
Figure 2. Libraries of purine 5′,8-cyclo-2′-deoxynucleosides (cPu).
The increasing interest in cPu lesions prompted research activity by several groups on DNA
damage to investigate different areas of interest, including: nucleoside level, biomimetic models,
DNA repair systems, structural investigations, biological effects, and relevance to human disease.
Remarkable efforts have been made to improve the detection and quantification of the lesions in order
to evaluate them in vivo and in vitro [13,19,20]. They are considered the ‘smallest’ tandem lesions and
are the substrates of nucleotide excision repair (NER).
2. Synthesis of the cPu Library
Continuous efforts of the research community deepened our understanding of complex biological
processes. When research efforts identify the structural features of specific small molecules that
participate in these biological phenomena, it is of significant importance to develop synthetic procedures
for generating large amounts of such molecules of interest for in-depth studies. The synthesis of
molecules found in nature is also a challenge, compared to their natural synthesis, and bear important
information for synthetic chemists concerning their physicochemical properties and reactivities.
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Bioinspired synthetic strategies are indeed being applied and have been successful in providing
novel insights.
2.1. 5′,8-Cyclo-2′-Deoxyadenosine (cdA) and 5′,8-Cyclo-2′-Deoxyguanosine (cdG)
The existence of cdA and cdG lesions in biological systems is due to the reactions of hydroxyl
radicals with the natural DNA nucleotides. A full chemical understanding of the mechanisms of
formation of these lesions has been obtained by extensive exploration of the fate of the C5′ purine
nucleoside radicals.
The simplest models are well understood and are based on the scenarios of reactions of
2′-deoxyadenosine (dA) and 2′-deoxyguanosine (dG) with HO• radicals in the absence or presence of
molecular oxygen. The two diastereomeric forms, S-cdG and R-cdG, were identified as the products of
γ-irradiation of a N2O-saturated aqueous solution of dG; the overall reaction yields were 8–10% and
the R/S product ratios were 8.3:1 (Figure 2A) [21]. In a similar experiment using dA instead of dG,
two diastereomeric forms, S-cdA and R-cdA, were identified, with an R/S ratio of 6:1 and an overall yield
of 10–11% [22,23]. The diastereomeric outcome is rationalized in terms of favorable hydrogen-bonded
structures in the pro-(5′R) conformation. In both cases, in the presence of 2.7 × 10–4 M O2, hydrated
5′-aldehydes were formed instead of the cyclopurines, indicating that the reactions of C5′ radicals
occurred with oxygen instead of cyclization [24]. The rate constants of C5′ radical cyclization at the
nucleoside level were determined by pulse radiolysis studies and found to be 1.6× 105 and 6.9 × 105 s−1
at room temperature for dA and dG, respectively [22,23,25].
Synthetic procedures of four cPu (Figure 2A) were developed, starting from 8-bromopurine
derivatives under continuous radiolysis or photolysis [21,23]. These procedures involved a radical
cascade reaction that mimics the DNA damage that results in the formation of cdA and cdG lesions
(Figure 3). The γ-radiolysis of aqueous solutions of 8-bromo-2′-deoxyadenosine (8-Br-2′-dA) in the
presence of the K4Fe(CN)6 gives rise to the formation of cdA with an ratio R/S ratio of 6:1 and a yield of
67% (based on the starting material conversion) [22,23]. After ultraviolet light irradiation in acetonitrile,
the yield of formation attained 65%, but with a diastereomeric ratio R/S of 1.7:1 [26]. The photolysis
of 8-Br-2′-dG solution with ultraviolet light gave rise to cdG with a yield of 26% and an R/S ratio of
8:1 [21]. A study of the factors that influence the stability of the pro-5′R and pro-5′S conformers during
the radical cyclization also revealed that the pro-5′R is stabilized in aqueous conditions when the 3′OH
and 5′OH groups are free. The opposite behavior was observed in aprotic solvents where the pro-5′S
conformer is favored when the 3′OH and 5′OH are coupled with relatively bulky lipophilic groups
such as the TBDMS group [27,28].
 
Figure 3. Bioinspired radical transformations for the synthesis of 5′,8-cyclopurines.
The abovementioned results regarding the chemical generation and fates of the C5′ radicals in
purine nucleosides led to the development of shorter procedures that afforded the four diastereoisomers
of cPu in good to very good yields. Overall, starting from 8-Br-2′-dA, both R-cdA and S-cdA were
obtained in good yields when the reaction was performed in aprotic solvents in the absence of oxygen
using ultraviolet light irradiation. Starting with 8-Br-2′-dG, the selective protection of the free hydroxyl
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groups with bulky lipophilic groups such as the TBDMS group was found to improve the radical
cascade of cyclization yield in aprotic solvents and shifted the R/S ratio in favor of the S diastereoisomer.
One-step deprotection afforded both lesions in good yield. The 8-bromo derivatives are accessible
following standard bromination conditions that have been reported in the literature. Thus, the C5′
radicals can be easily generated in situ by a variety of radical methodologies affording the products in
good to very good yields [27,28].
2.2. Isotopically Labeled Derivatives
The relatively low abundance of the cPu in cellular DNA demands the development of highly
sensitive analytical methods for their identification and quantification in biological samples. One of
the sensitive and reliable techniques utilized by various laboratories in the field is based on liquid
chromatography isotope dilution tandem mass spectrometry (see below). The synthesis of the
stable 15N5 isotopes of the R-cdA, S-cdA, R-cdG, and S-cdG (Figure 2B) by the above-described
methodologies for the synthesis of the natural lesions has been reported in the literature. In particular,
photoirradiation of 15N5-labeled 8-Br-2′-dA in acetonitrile with UV light at λ = 254 nm was shown
to yield the 15N5-labeled R-cdA and S-cdA products. The same procedure under similar conditions
was also reported to give access to the 15N5-labeled R-cdG and S-cdG products, starting from the
corresponding 15N5-labeled 8-Br-2′-dG [29,30]. Another synthetic strategy that involves two steps
utilizes 15N5-labeled 2′-deoxyadenosine and 15N5-labeled 2′-deoxyguanosine triphosphate aqueous
solutions, under γ-radiolysis conditions in the presence of nitrous oxide, to form the triphosphate
5′,8-cyclopurine intermediates. The latter are then subjected to enzymatic dephosphorylation, affording
the 15N5-labeled cdA and cdG lesions [31]. A more straightforward methodology has been utilized for
generating both R and S 15N5-labeled cdA lesions after γ-radiolysis of aqueous solution of 15N5-labeled
dA in the presence of nitrous oxide [30].
2.3. Phosphoramidite Synthones
Further studies of the biological characteristics of the cPu lesions require the design of more
complex model systems that mimic biomaterials in their natural environments. Biochemical and
biological experiments that can unveil important information regarding the formation of lesions and
their repair in cells are based on synthetic DNA oligonucleotides that contain lesions incorporated at
specific positions in the DNA sequences according to the requirements of the experimental design. These
oligonucleotide strands can be synthesized according to standard automated DNA synthesis methods.
The phosphoramidite synthones of the cPu that are compatible with standard automated DNA
synthesis conditions can be synthesized by multistep procedures [32]. In order to achieve the synthesis
of protected phosphoramidites in an appropriate manner, the 3′OH and 5′OH protecting groups should
be differentiated prior to cyclization. The four phosphoramidites of S-cdA, R-cdA, S-cdG, and R-cdG
(Figure 2C) were obtained in a nine-step synthesis procedure starting from the 8-Br-2′-dA or 8-Br-2′-dG,
respectively, in good overall yields. In the case of the cdA series, the bromo-derivative under UV-light
irradiation cyclized to give the mixture of the two diastereoisomers in 55% yield (Figure 4a). The two
diastereoisomers were separated by chromatography on silica and each of them was converted to the
final products following standard procedures. In the cdG series, two different protecting groups were
produced for 3′OH and 5′OH moieties using deprotection with the TBDMS group, monodeprotection,
and reprotection with Et3SiCl. This “key” derivative, cyclized under radical cascade conditions in the
presence of Bu3SnH and AIBN as radical initiators, affords a mixture of the two diastereoisomers in
good yields (Figure 4b). The two diastereoisomers were separated by chromatography on silica gel
and each of these steps was followed by the necessary steps to yield the final products.
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Figure 4. Synthesis of (A) 5′,8-cyclo-2′-deoxyadenosine (cdA) and (B) 5′,8-cyclo-2′-deoxyguanosine
(cdG) in both diastereoisomeric forms, differentiating the two secondary 3′OH and 5′OH groups, by the
radical cascade protocol. (m.p.: medium pressure).
The earlier syntheses of cPu phosphoramidites based on the protocol reported by
Matsuda et al. [33] for the synthesis of the S diastereoisomer and the subsequent inversion of the C5′
configuration were characterized by lower overall yields [34,35]. At the present time, the companies
Glen Research (Sterling, VA, USA) and Berry & Associates Inc. (Dexter, MI) produce phosphoramidites
of S-cdA and S-cdG. These companies commercialize S-cdG protected with a 5′-tetrahydropyranyl
(THP) group instead of the widely used dimethoxytrityl (DMT) group. Worth noting is that the
procedure used to remove the THP group is more aggressive than the one used to remove the
DMT group.
3. Synthesis of Oligonucleotides Containing Site-Specifically Inserted cPu
The phosphoramidite derivatives were incorporated (following standard procedures, in the 3′→5′
direction [34,35]) into specific sequences of oligodeoxynucleotides (ODNs). These site-specifically
modified ODNs can serve as the simplest biomimetic models of oxidized DNA lesions for studies
of DNA repair pathways of cPu lesions, their biological impact, insights into structure–function
relationships, and relevance of repair to the onset of human diseases. These model systems are
less complex than DNA in its natural environment, but nevertheless provide valuable insights
into the biological characteristics of these DNA lesions. It is worth mentioning that ODNs
can also be synthesized via the automated solid DNA synthesis approach following a 5′→3′
direction by using 3′-O-DMTr-5′-O-(β-cyanoethyl)-N,N,-diisopropylamino-2′-deoxyribonucleoside
phosphoramidites [36].
Figure 5 shows the results of the synthetic procedures for the same oligonucleotide sequences
containing the four cPu lesions [32]. The total yields of the ODNs containing S-cdA or S-cdG were always
greater than those of the ODNs containing the corresponding R diastereoisomers. The stereochemistry
of the cPu lesions were found to influence the coupling yield and thus the total yield of the full-length
modified oligonucleotides.
It is well known that the double strands have a lower molar extinction coefficient at λ = 260 nm
than the corresponding mixture of single strands because the absorbance of the aromatic base system
is diminished due to base–base stacking interactions in the double helix (hypochromicity). When the
temperature of the sample is raised above a temperature specific for the examined length and sequence,
the duplexes dissociate into single strands and the intensity of UV absorbance increases. The melting
point (Tm) of an oligonucleotide duplex is defined as the midpoint of the duplex-to-single-strand
transition at λ = 260 nm. In order to evaluate the structural destabilization induced by the presence
11
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of each of the four diastereomeric lesions in different oligonucleotide sequences, melting studies
were carried out, in the absence and presence of cPu lesions, by several research groups (Table 1).
The thermodynamic destabilization of the duplexes containing the lesion was observed by the decrease
of the melting points of modified duplex sequences with respect to unmodified ones. In the case of
17-mer double-stranded (ds) oligonucleotides (Table 1), it was demonstrated that all four cPu lesions
destabilize identical duplex sequences, with cdA producing more destabilization than cdG. Shorter
DNA duplexes are more easily destabilized by the lesions than longer ones.
Figure 5. Comparison of the total yields of the 17-mer: 5′-d(CCA CCA ACX CTA CCA CC)-3′, where X
= S-cdA, R-cdA, S-cdG, or R-cdG.
Table 1. Melting points (Tm) of a series of double-stranded (ds) oligonucleotide sequences.
Length Sequence Tm, ◦C Reference
11-mer
5′-d(CGT ACX CAT GC)-3′
[37]3
′-d(GCA TGY GTA CG)-5′
X = dA, Y = T 49.5
X = S-cdA, Y = T 42.0
12-mer
5′-d(GTG CXT GTT TGT)-3′
[38]3
′-d(CAC GYA CAA ACA)-5′
X = dG, Y = C 55.0
X = S-cdG, Y = C 46 ± 1
14-mer
5′-d(ATC GTG XCT GAT CT)-3′
[24]3
′-d(TAG CAC YGA CTA GA)-5′
X = dA, Y = T 54 ± 1
X = S-cdA, Y = T 48 ± 1
17-mer
5′-d(CCA CCA ACX CTA CCA CC)-3′
[39]
3′-d(GGT GGT TGY GAT GGT GG)-5′
X = dA, Y = T 65.2 ± 0.6
X = R-cdA, Y = T 58.9 ± 0.6
X = S-cdA, Y = T 60.5 ± 0.6
X = dG, Y = C 66.2 ± 0.7
X = R-cdG, Y = C 63.4 ± 1.0
X = S-cdG, Y = C 63.5 ± 0.6
23-mer
5′-d(GCA GAC ATA TCC TAG AGX CAT AT)-3′
[40]
3′-d(CGT CTG TAT AGG ATC TCY GTA TA)-3′
X = dA, Y = T 60.0 ± 0.3
X = R-cdA, Y = T 59.0 ± 0.2
X = S-cdA, Y = T 58.0 ± 0.3
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The presence of the C5′–C8 bond in cPu lesions causes substantial structural changes in DNA.
These structural changes include displacement of the purine base, an unusual sugar pucker, deformation
of the sugar–phosphate backbone, and alterations in the base stacking with adjacent nucleotides in
DNA, especially the 5′ side relative to the lesion [37–39,41,42]. Molecular dynamics simulations were
also used by several groups to evaluate the structural distortions and dynamics induced by cPu lesions
in comparison with unmodified DNA. It was found that the R diastereomers cause a greater backbone
distortion and base stacking impairment than the S diastereomers [37–39,43]. The differences in the
structural perturbation effects, as caused by the presence of the R and S diastereoisomers, provide
some rationale for the observation that the R isomers are more efficiently recognized by the nucleotide
excision repair (NER) system [37,39,44].
4. Base Excision Repair (BER) and Nucleotide Excision Repair (NER) Pathways
The stability of the human genome subjected to oxidative stress is maintained by the repair of
oxidatively generated DNA lesions in cellular DNA [45]. Non-bulky oxidatively generated DNA
lesions are typically repaired by BER mechanisms [46] that are highly conserved in all three domains
of life: Bacteria, Archaea, and Eukarya [47,48]. The BER proteins bind to the damaged nucleotide
and induce cleavage of the N-glycosyl bond, thus forming abasic sites. In the case of monofunctional
glycosylases, abasic sites are cleaved by an apurinic (AP) human endonuclease (APE1) that results
in the formation of fragments with 3′-OH and 5′-deoxyribose phosphate (5′-dRP) at the ends [49].
In turn, bifunctional glycosylases cleave abasic sites by AP lyase activities that result in the formation of
single-strand breaks containing either a phosphate (P) group (β, δ-elimination), or an α,β-unsaturated
aldehyde (PUA, β-elimination) at the 3′-end [50,51]. Thus, the BER mechanism results in the excision
of the damaged nucleotide and the formation of single-strand breaks that can be detected by gel
electrophoresis methods [52]. Brooks et al. [36] have shown that cdA lesions are not repaired by BER
pathways in adult rat brain nuclear extracts [53], although other known BER substrates [54] were
efficiently removed. Furthermore, none of the cPu lesions R-cdA, S-cdA, or S-cdG were found to be
substrates of DNA glycosylases in HeLa cell extracts [44]. Pande et al. [55] also reported that the seven
purified BER proteins (E. coli Fpg, Endo III, Endo V, and Endo VIII; human OGG1; human NEIL1; and
NEIL2) neither bind to nor excise S-cdA or S-cdG lesions from double-stranded (ds) oligonucleotide
duplexes. In summary, these results clearly demonstrate that the cPu lesions are not substrates of
BER pathways.
The human NER machinery typically excises bulky DNA lesions, such as those derived from the
binding of metabolically activated polycyclic aromatic hydrocarbons (PAH) to DNA [56]. Bulky DNA
lesions are recognized by the DNA damage sensor and NER factor XPC-RAD23B, a heterodimeric
protein complex. After binding to the DNA lesion, the ten-protein NER factor TFIIH, XPA, and the
endonucleases XPF-ERCC1 and XPG are recruited to the XPC–TFIIH–DNA lesion complex. The two
endonucleases incise the damaged strand on the two sides of the bulky DNA lesion, thus excising
the characteristic ~24–30 nucleotide (nt) dual incision products that contain the lesion and are the
hallmarks of successful NER [57,58].
More recently, it was demonstrated that certain non-bulky DNA lesions, such as the oxidatively
generated diastereomeric spiroiminodihydantoin (Sp) and 5-guanidinohydantoin (Gh), are the
substrates of both BER and NER pathways in human cell extracts [59] and in intact human cells [60].
In contrast, cPu lesions are repaired exclusively by the NER pathway [13,19,61].
Employing the host cell reactivation assay, Brooks et al. [36] found that the S-cdA lesions
strongly block gene expression in Chinese hamster ovary (CHO) cells and in SV40-transformed human
fibroblasts. Furthermore, the repair of cdA lesions was significantly suppressed in NER-deficient
CHO cells and in human cells from patients who are carriers of XP complementation group A (XPA)
mutations that are associated with neurodegeneration [36]. NER dual incision products were also
detected after incubation of plasmid DNA harboring R-cdA or S-cdA lesions in HeLa cell extracts [44].
The NER incision of R-cdA was more efficient than in the case of S-cdA. In cell extracts supplemented
13
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with antiserum against XPA, the NER dual incision efficiency was significantly reduced; in turn,
NER activity was restored by the addition of purified XPA protein [44]. The time course of dual
incisions from 136 bp DNA duplexes harboring S-cdA and S-cdG lesions in HeLa cell extracts was
compared to the rate of excision of cis-anti-B[a]PDE-dG adducts (an excellent substrate of human
NER [62]) embedded in an identical sequence context in HeLa cell extracts; it was shown that the
cis-anti-B[a]PDE-dG adduct (where B[a]PDE-dG denotes the product of reaction of the B[a]P diol
epoxide metabolite (+)-7R,8S-dihydrodiol, 9S,10R-epoxy-tetrahydrobenzo[a]pyrene, BPDE) with the
exocyclic amino group of guanine in double-stranded DNA was repaired more efficiently than the
S-cdG lesion. In turn, the latter was a better NER substrate than the S-cdA lesion embedded in the
same sequence context under identical conditions [55].
The relative NER efficiencies of all four cPu in the same sequence context were measured and
compared in human HeLa cell extracts for the first time under identical conditions [39]. The cdA and
cdG lesions were excised with similar efficiencies, but the NER excision rates measured for both R
diastereoisomers were greater by a factor of ~2 than in the case of the S lesions. Molecular modeling
and molecular dynamics simulations revealed the structural and energetic origins of this difference in
NER-incision efficiencies. The characteristic C5′–C8 bond in both kinds of diastereoisomeric cPu lesions
causes a greater local distortion of the DNA backbone and a greater disruption of local van der Waals
stacking interactions in the case of the R than the S diastereoisomeric cdA and cdG lesions. Molecular
dynamic simulations indicate that the local structural dynamic fluctuations are more pronounced in the
case of the diastereoisomeric R than the S cPu lesions [39]. Therefore, the greater local dynamics and
destabilization of stacking interactions associated with the R diastereoisomers appear to be correlated
with their higher susceptibilities to NER compared to the S-cdA and S-cdG lesions.
The relative NER efficiencies at the level of chromatin or nucleosomes, the primary subunits of
chromatin, can be significantly reduced to those of free or naked DNA because DNA lesions embedded
in nucleosomes are less accessible to NER repair protein factors [63–65]. To explore the effects of
nucleosome environments on the relative NER efficiencies, all four cPu were embedded at the In or
Out rotational setting near the dyad axis in nucleosome core particles reconstituted either with native
histones extracted from HeLa cells (HeLa-NCP) or with recombinant histones (Rec-NCP), as shown in
Figure 6 [66]. These experiments showed that while the cPu and B[a]PDE-dG lesions in free DNA are
good NER substrates, the non-bulky cdA and cdG lesions embedded at either the In or Out rotational
setting of native HeLa histone-derived nucleosomes are completely resistant to NER in human cell
extracts (Figure 7).
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Figure 6. (A) Schematic illustrations of the placements of the DNA lesions and the Cy3 donor and
Cy5 acceptor molecules at the “Out” and “In” rotational settings in the 147-mer 601 DNA duplexes
used in the Förster Resonance Energy Transfer (FRET) experiments. (B) The crystal structure of the
601 nucleosome core particles (PDB 3LZ0) [67]. The dyad axis is indicated by the red line. (C) Positions
of the Cy3 donor and Cy5 acceptor molecules in the nucleosome FRET experiments. The lesions were
positioned at the 66th or 70th nucleotide (nt) counted from the 5′-end of the 147-mer, corresponding to
the Out or In rotational settings. The internal Cy3 and Cy5 labels were positioned at nucleotides 43 and
39 counted from the dyad axis in opposite strands. Reproduced from reference [66].
By contrast, the relative excision rates of the trans- and cis-B[a]PDE-dG adducts that are excised at
different rates in free DNA are reduced by the same factor of ~2.2 in HeLa nucleosomes and by the much
greater factor of ~11 in recombinant histone nucleosomes. Molecular dynamics simulations showed
that the cis-anti-B[a]PDE-dG adduct is more dynamic and more destabilizing than the smaller and more
constrained cdG lesions, suggesting more facile access to the bulkier cis-anti-B[a]PDE-dG lesion [68].
By contrast to the bulky B[a]PDE-dG adducts, the cPu lesions embedded in the same sequence contexts
in either post-translationally modified HeLa histone-derived nucleosomes or unmodified recombinant
histone nucleosome core particles are fully resistant to NER in human cell extracts.
The NER response of the B[a]PDE-dG adducts in HeLa-NCPs is not directly correlated with the
observed differences in the thermodynamic destabilization of HeLa NCPs, the Förster resonance energy
transfer (FRET) values, or hydroxyl radical footprint patterns and is weakly dependent on the rotational
settings [66]. These and other observations suggest that NER is initiated and limited by the binding of
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the DNA damage-sensing NER factor XPC-RAD23B to a transiently opened B[a]PDE-dG-modified
DNA sequence in HeLa histone nucleosome particles that corresponds to the known footprint of
XPC–DNA–RAD23B complexes (≥30 base pairs). These observations are consistent with the hypothesis
that post-translation modifications and the dimensions and properties of the DNA lesions are the
major factors that have an impact on the dynamics and initiation of NER in nucleosomes. These results
further suggested the hypothesis that the non-bulky cPu DNA lesions do not sufficiently perturb the
dynamics of nucleosomes and are therefore resistant to NER in human cell extracts [66].
 
Figure 7. Representative autoradiographs of denaturing gels of the results of nucleotide excision
experiment assays in HeLa cell extracts. (A) The substrates were either free 147-mer 601cP DNA
sequences containing single cPu lesions or nucleosomes assembled with histone octamers derived from
recombinant (Rec) histones or native, post-translationally modified histones extracted from HeLa cells.
(B) Analogous nucleotide excision repair (NER) experiments with cis- and trans-B[a]PDE-dG adducts
positioned at the same In and Out superhelical locations. Three separate gels are depicted in panels A
and B. Reproduced from reference [66].
It remains unknown whether these observations carried out with post-translationally modified
and recombinant histone-derived nucleosome particles in vitro are also relevant to the same lesions
embedded in chromatin in intact human cells and tissues. It is therefore important to extend such
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studies to the more challenging in vivo environments in order to determine whether the physically
smaller cPu lesions are also more resistant to repair in their natural chromatin settings than lesions
derived from the binding of metabolites of bulky polycyclic compounds to native DNA in vivo.
5. Bypassing of cPu Lesions by DNA and RNA Polymerases and the Resulting
Biological Consequences
As already discussed, unlike other oxidized DNA base lesions, cPu lesions cannot be repaired by
the BER pathway. This results in the accumulation of the lesions in the genomic DNA and distorts
the DNA backbone, initiating the NER pathway. On the other hand, NER repairs cPu lesions at low
efficiency compared to its repair of other bulky DNA lesions, thereby resulting in the accumulation of
cPu lesions in DNA. When DNA and RNA polymerases encounter the lesions during DNA replication
and repair and gene transcription, they have to bypass the lesions to complete the biological processes
(Figure 8). Studies have shown that repair DNA polymerases such as DNA polymerase β (pol β) and
translesion DNA polymerases, including pol η and ι, and ζ, can bypass cdA [69–71]. Also, cdA lesions
can be bypassed by an RNA polymerase [36,72]. A study from the Kuraoka group has found that
E. coli polymerase I (pol I) can incorporate R-cdA and S-cdA into DNA [73].
Figure 8. Accumulation of cPu disrupts DNA replication, repair, and gene transcription, leading to
lesion bypass, mutations, and genome instability.
5.1. cPu Incorporation by a Replicative DNA Polymerase
The Kuraoka group found that the E. coli DNA polymerase I (pol I) large protein fragment,
the Klenow fragment, which lacks 5′–3′ exonuclease activity [74], can incorporate 5′R and 5′S
diastereoisomers of cdATP at different efficiencies [73]. The incorporation of R-cdATP and S-cdATP
into a base pair with a dTMP by the pol I fragment is about 17,000-fold and 750-fold less efficient than
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that of dATP, respectively. The rate of the incorporation of S-cdATP and R-cdATP opposite to a dTMP
by the Klenow fragment is 25.6 μM−1 min−1 and 1.13 μM−1 min−1, respectively. The extension of a
cdA by the pol I fragment is only slightly inhibited by the two isomers of cdA, although S-cdATP is
more readily incorporated and extended by the Klenow fragment [73]. The pol I Klenow fragment
incorporates S-cdATP more efficiently than R-cdATP. This is because the active site of the Klenow
fragment binds to R-cdA and S-cdA with a different affinity due to the stereospecific difference between
the two isomers. By superimposing R-cdATP and S-cdATP on the incoming dATP, the interaction
between the Klenow fragment and the cdA lesions is revealed. It is found that the 5′-phosphate group
of the R-cdA is turned away from the active site of the polymerase. In contrast, the 5′-phosphate
of the S-cdA turns toward the active site [73]. Thus, compared to S-cdATP, the R-cdATP can barely
form a hydrogen bond with dTMP through the transition from an opened to a closed conformation in
the active site of the polymerase, thereby leading to low efficiency of its incorporation. Interestingly,
both stereoisomers of cdATP can also be incorporated by the polymerase to base-pair with dCMP.
However, R-cdATP preferentially base-pairs with dCMP rather than dTMP, suggesting that R-cdATP is
more error-prone than S-cdATP.
5.2. Inhibition of Gene Transcription by a cPu Lesion and Its Bypass by an RNA Polymerase
A cdA lesion can also inhibit the binding of TATA box binding protein (TBP) [75] and RNA
polymerase II to the CMV promoter that regulates the luciferase reporter gene [36], resulting in reduced
synthesis of RNA that further decreases the luciferase reporter gene expression [36,72,75]. It has been
shown that XP cells transfected with plasmids containing a single S-cdA lesion located at the second
A in the TATA box of the CMV promoter exhibit 75% reduced luciferase gene expression [75]. In a
study that has also tested the effects of S-cdA on the transcriptional activity of RNA polymerase II, XP
cells were transfected with a plasmid carrying a single S-cdA lesion in the transcribed region of the
luciferase reporter gene. The results show that XP cells transfected with plasmids containing the lesion
still exhibit 20–30% of the luciferase activity of the XP cells transfected with the plasmids without a
lesion [36]. This indicates that the presence of an S-cdA does not entirely abolish the activity of RNA
polymerase II, further suggesting that RNA polymerase can partially bypass an S-cdA in the template,
and the bypass of a cdA by RNA pol II can result in full-length transcribed products. It has been found
that yeast RNA pol II bypasses a cdA by preferentially incorporating UTP that base-pairs with a cdA,
although it also misincorporates rA, rG, and rC to base-pair with the lesion with low efficiency [72].
In the presence of ATP alone, yeast RNA pol II can efficiently incorporate it to base-pair with a cdA,
but with a much lower rate than its incorporation of UTP. To continue to extend the nucleotide that
base-pairs with a cdA, RNA pol II can incorporate an rA opposite a dA next to the lesion. Besides,
the transcription initiation/elongation factor TFIIF can stimulate the activity of RNA pol II of bypassing
a cdA lesion without affecting its fidelity, indicating that the cis and trans factors can also affect the
efficiency of the bypassing of a cPu lesion by RNA pol II [72].
5.3. Inhibition of DNA Polymerase Activities by a cPu Lesion and Its Bypass by DNA Polymerases
A cPu lesion can alter the activity of DNA polymerases. It has been reported that the DNA
synthesis activities of calf thymus replicative DNA polymerases, such as pol δ, and the bacterial phage
DNA polymerase T7 DNA polymerase are inhibited completely by R-cdA and S-cdA lesions, resulting
in replication fork stalling [44]. The primer extension activity of calf thymus pol δ is abolished at an
R-cdA or S-cdA lesion site in the template strand, whereas T7 DNA polymerase can manage to extend
the primer at the cPu lesions [44]. This indicates that the DNA synthesis of the pol δ ceases before the
cPu lesions, while T7 DNA polymerase can bypass R-cdA or S-cdA by incorporating an additional
nucleotide. T7 DNA polymerase bypasses an R-cdA more efficiently than an S-cdA. The results indicate
that cPu lesions can lead to DNA replication stalling by inhibiting the activities of replication DNA
polymerases, further suggesting that the lesions have to be bypassed by translesion DNA synthesis in
cells to resolve the stalled replication fork and restart DNA replication.
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An S-cdA lesion located in double-stranded DNA can also inhibit pol β DNA synthesis and BER
in cell extracts during the repair of an abasic (AP) site at the complementary strand [76]. The inhibitory
effect on the DNA synthesis activity is determined by the location of the AP site relative to the S-cdA
lesion. The DNA synthesis at the AP site located at the 5th or 8th nucleotide upstream (−8 or −5) or
downstream (+5 or +8) of S-cdA is not significantly affected [76]. However, the polymerase only can
exhibit minimal incorporation of a nucleotide at the AP site located at the 1 nucleotide upstream (−1)
and downstream (+1) of and opposite to (0) the S-cdA [76]. These indicate that an S-cdA lesion close to
an abasic site can inhibit the DNA synthesis by the DNA polymerase during BER, whereas the lesion
located at ≥5 nt away from an AP site does not affect its DNA synthesis. It is suggested that an S-cdA
induces a geometric alteration of the DNA surrounding the AP site, and this may inhibit the binding of
pol β to the DNA, thereby inhibiting its DNA synthesis.
The Basu group has further identified a translesion DNA polymerase that can bypass a cPu
lesion in E. coli. They demonstrate that S-cdA and S-cdG strongly block E. coli replicative and repair
DNA polymerases, including pol II, Klenow fragment, pol IV, and pol V, as well as S. solfataricus P2
DNA polymerase IV (Dpo4) [77,78]. Through the gene knockout of pol II, pol IV, and pol V in the
SOS-induced or uninduced E. coli strains, the group has found that pol V is the one that is responsible
for bypassing of S-cdA or S-cdG inserted in a plasmid through translesion DNA synthesis in E. coli,
whereas pol II and pol IV do not play a role in bypassing of the lesions. This is further supported by
the results showing that the E. coli strain with pol V deficiency that bears the plasmids containing an
S-cdA or S-cdG cannot survive [77,78]. This demonstrates that pol V is required for the bypass of
S-cdA or S-cdG in E. coli. However, in vitro biochemical characterization has shown that the E. coli
Klenow fragment, pol IV, and Dpo4 can incorporate nucleotides to base-pair with S-cdA or S-cdG [78].
Specifically, the Klenow fragment preferentially incorporates dTTP and dCTG to base-pair with S-cdA
or S-cdG, respectively. On the other hand, biochemical characterization indicates that pol IV can
incorporate dTTP and dCTP to base-pair with S-cdA and dCTP to base-pair with S-cdG. Dpo4 can
insert dTTP and dGTP to base-pair with S-cdA. However, it preferentially inserts dTTP over dCTP to
base-pair with S-cdG. This may be due to a more opened and less rigid active site in Dpo4 polymerase
that can tolerate distorted and bulky DNA lesions. A study conducted by Xu et al. has also shown that
the bypass of S-cdG by S. solfataricus Dpo1 and Dpo4 is decreased by 140- and 65-fold compared to their
bypass of dG [79]. The authors further demonstrate that Dpo1 and Dpo4 preferentially incorporate
dCTP opposite to S-cdG. In addition, the polymerases can misincorporate dATP and dTTP opposite to
the lesion [79]. The results of Dpo4 differ from those reported by Basu’s group, which showed that
Dpo4 preferentially incorporates dTTP opposite to S-cdG [78]. The inefficient bypass of S-cdG by
Dpo1 and Dpo4 appears to result from their poor DNA synthesis at the lesion, with the nucleotide
incorporation reduced by 200- and 3000-fold [79]. On the other hand, the binding affinity of Dpo1 and
Dpo4 to a substrate containing S-cdG is either not affected or moderately reduced by only 6-fold [79].
The structural base of the DNA polymerases has been revealed by the results from a crystal structure
containing a Dpo4:S-cdG:dCTP complex and showing that S-cdG is shifted to the major groove of the
DNA substrate. This separates the α-phosphate dCTP from the C3′ atom of the primer terminal dideoxy
C (Cdd) by 9.2 Å, thereby preventing nucleotidyl transfer activity of the polymerase for catalyzing the
DNA synthesis [79]. In a crystal structure of the Dpo4:S-cdG:dTTP complex, the formation of a looped
template has been also identified. This suggests that Dpo1 and Dpo4 can skip the lesion by looping out
the template strand. This may further lead to sequence deletion, thus providing the structural evidence
for the findings about a cPu-induced repeat sequence instability reported by the Liu laboratory [69].
These results indicate that the Klenow fragment, pol IV, Dpo1, and Dpo4 can manage to bypass cPu
lesions. The results further indicate that pol IV, Dpo1, and Dpo4 are more error-prone than the Klenow
fragment by performing nucleotide misincorporation to bypass a cPu lesion.
In eukaryotic cells, cPu lesions can also be readily bypassed by several human and yeast translesion
DNA polymerases, pol η, pol ι, and pol ζ, but not pol κ. These DNA polymerases can incorporate
different nucleotides to base-pair with an S-cdA and S-cdG [70]. For example, pol ι can incorporate
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dTTP, dGTP, and dATP to base-pair with S-cdA, whereas it incorporates dCTG, dATP, and dGTP to
base-pair with S-cdG. In contrast, human pol η usually incorporates a correct nucleotide to base-pair
with S-cdA or S-cdG, whereas yeast pol η can also misincorporate dTTP opposite to S-cdG [80]. Among
these DNA polymerases, pol η and pol ζ can extend the nucleotides incorporated opposite an S-cdA or
S-cdG lesion [70,80]. Human pol η can only extend a matched nucleotide that base-pairs with a cPu
lesion. However, yeast pol η can extend both matched and mismatched nucleotides that base-pair with
the lesions [80]. It is proposed that human pol η, pol ι, and pol ζ cooperate to bypass cPu lesions during
DNA replication and repair. Cell-based mutation analysis has further demonstrated that the bypass
of cPu lesions through these translesion DNA polymerase results in a wide spectrum of mutations,
indicating the misincorporation of nucleotides through the bypass of cPu lesions in cells [70].
A recent study from the Yang group has further revealed the molecular basis underlying the
bypass of an S-cdA by human pol η using the cocrystals of pol η and the DNA substrates containing
an S-cdA lesion [81]. The crystal structures indicate that the C5′–C8 covalent bond of cdA distorts the
backbone of the DNA template by shifting the sugar toward the minor groove. This further results in
the change of the width of duplex DNA and pushes the adenine of the cdA to be tilted toward the
5′–direction, leading to the disruption of the base stacking between the damaged nucleotide and the
adjacent base. The structural study further reveals that ~60% of adenines from the damaged nucleotide
are shifted into the major groove, thereby preventing the formation of a hydrogen bond between the
damaged nucleotide and dTTP. In addition, the presence of different type of metal ions can also alter the
configuration of the active site, either facilitating the incorporation of dTTP opposite cdA or preventing
the formation of the hydrogen bonds between cdA and dTTP. The effect is also mediated through the
opening of the finger domain of pol η to accommodate the DNA backbone distortion. Since cdA is
shifted to the major groove, this protects it from forming the hydrogen bonds with dT at the 3′-end.
Instead, this allows cdA to make only van der Waals interaction with the dT, preventing the formation
of a new base pair with the incoming nucleotide and primer extension. Thus, as a result, pol η fails
to extend the dT opposite the cdA lesion. The study provides novel insights into the structural basis
underlying the nucleotide incorporation by pol η in bypassing a cdA lesion [81].
Similar to the Y family translesion DNA polymerases, DNA polymerase β (pol β), a central
component of BER [82,83], can also bypass a cdA lesion [84]. Pol β can readily bypass both R-cdA and
S-cdA located in the substrates mimicking DNA replication and BER intermediates [84]. It has been
shown that pol β wild-type mouse embryonic fibroblast (MEF) cell extracts can generate a significant
amount of DNA synthesis products resulting from the bypass of an R-cdA and S-cdA lesion located
in an open template, i.e., a DNA substrate containing a 1-nt gap or 1-nt gap with a sugar–phosphate
residue [84]. However, pol β-knockout MEF cell extracts generate only a small amount of the lesion
bypass products on all the substrates [84]. The results suggest that pol β also plays an important role
in bypassing a cPu lesion during DNA replication and repair in mammalian cells. Further biochemical
analysis has shown that pol β mainly incorporates a dT to base-pair with a R-cdA, but can also
misincorporate dA, dG, and dC to base-pair with the damaged nucleotide at low efficiency. Pol β only
inserts a dT opposite an S-cdA lesion. Moreover, the polymerase can readily extend the dT opposite an
R-cdA, but fails to extend the dT opposite an S-cdA, indicating that pol β stalls at an S-cdA following its
incorporation of a dT. This further inhibits the ligation of the nick by DNA ligase I (LIG I), allowing flap
endonuclease 1 (FEN1) to cleave nucleotides. Subsequently, this results in the gaps and accumulation
of single-strand DNA break intermediates [84]. Thus, pol β bypass of an R-cdA can lead to nucleotide
misincorporation causing mutations, whereas its bypass of an S-cdA can cause the accumulation of
DNA strand break intermediates that in turn results in recombination and genome instability [84].
5.4. Repeat Sequence Instability Through the Bypass of cdA by Pol β
Interestingly, although pol β stalls at an S-cdA that is located in the random sequences [84], it can
efficiently extend a dT opposite to an S-cdA located in trinucleotide repeats, such as CAG repeats.
This further results in CTG repeat deletion through BER [69]. It has been found that this is because both
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R and S diasteroisomers of cdA located on the template strand induce the formation of a CAG repeat
loop in the template that mimics the intermediates formed during maturation of the lagging strand
and BER [69]. This is likely due to the distortion of the backbone of the repeats, which subsequently
induces the G:C self-base pair in the CAG repeats. Since pol β preferentially skips over a hairpin or
loop structure [85,86], the loop structure in CAG repeats induced by a cdA lesion can also be readily
bypassed by pol β, thereby leading to the displacement of the downstream repeat strand into a flap
during DNA lagging strand maturation and BER [69]. Subsequently, the flap is captured and cleaved
efficiently by FEN1, resulting in CTG repeat deletion (Figure 9). This is further supported by the fact
that the locations of a gap relative to that of a cdA lesion in the CAG repeat template can govern the
deletion of CTG repeats. A gap that is located upstream of or opposite to the lesion can result in CTG
repeat deletion through the pol β bypass of a CAG repeat loop structure. However, a gap located
downstream of the cdA that does not involve pol β loop bypass fails to cause repeat deletion [69].
These findings further demonstrate the essential role of pol β bypass of a loop structure containing a
cPu lesion in mediating trinucleotide repeat deletion.
Figure 9. A cdA located at DNA repeat sequences induces repeat instability through pol β bypass of a
loop structure. Pol β: DNA polymerase β; LIG I: DNA ligase I; FEN1: flap endonuclease 1.
Although a study provides a mechanistic insight into the incorporation of cdATP by the Klenow
fragment using superimposing modeling, crystallography-based structural studies on the Klenow
fragment and other replication and repair polymerases and translesion DNA polymerases, especially
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eukaryotic DNA polymerases, are needed to understand the molecular mechanisms underlying cPu
incorporation in DNA. Because DNA replication and repair polymerases often coordinate with their
cofactors during DNA replication and repair, the effects of the coordination on the bypass of a cPu lesion
and their impact on cellular function remain to be elucidated. Moreover, the effects of cPu lesions on
the instability of repeated DNA sequences, including mono-, di-, tri-, tetra- and hexanucleotide repeats,
through DNA replication and repair and the crosstalk among different DNA metabolic pathways and
the underlying mechanisms need to be explored.
6. Quantification of cPu Lesions in DNA Samples
6.1. 32P-Postlabeling and Enzyme-Linked Immunosorbent Assays
A variety of analytical techniques for the quantification of oxidative DNA lesions in material
derived from various types of cells and organisms have been developed, including radiolabeling
approaches, enzyme-linked immunosorbent assays (ELISA), and chromatographic and mass
spectrometry-based approaches, while the description of DNA damage (mitochondrial vs. nuclear)
remains an important challenge [87]. It should be noticed that data obtained in different laboratories
gave rise to different results, mainly due to deviations among experimental conditions used in
various laboratories or inconsistent quantification of lesions because of oxidation artifacts [88,89].
Accurate quantification of cPu lesions is necessary to understand the biological relevance,
and therefore analytical strategies must be set up in order to deliver reproducible and reliable
results. Large discrepancies in the levels of the lesions determined by different groups are likely
due to variations in analytical procedures, mainly in the steps of DNA extraction, hydrolysis of
the nucleobases, and derivatization [30]. Each quantification technique is characterized by its own
advantages, counterbalanced by some limitations for applicability to specific fields. The 32P-postlabeling
approach for the measurement of cdA lesions developed by some research groups was important for
increasing the detection limit to 1–5 lesions per 1010 unmodified nucleosides [90,91]. This methodology
was then implemented for the identification and measurement of structurally diverse DNA carcinogen
adducts [92], 8-oxo-dG in rat tissues [93], and oxidative DNA products, emerging as a suitable approach
for detection of bulky lesions [94]. The levels of cdA in rat samples were significantly elevated in
normal newborn samples compared to those in fetuses [90]. 32P-labeled adducts could be visualized by
screen-enhanced autoradiography and quantified by Phosphorimager, Instant Imager, or Scintillation
Analyzer [91,95].
Immunoassay methodologies are simple, fast, cost-effective, and reproducible for the identification
of oxidatively induced DNA adducts within individual cells or tissues, while the combination of this
approach with immunofluorescence, along with the presence of a monoclonal antibody specific for the
lesion, enhanced the effectiveness of the method [96]. In the latter case, artifacts from interferences
were eliminated, such as endogenous antibodies and cross-reactants, increasing the specificity and the
sensitivity of this approach. The enzyme-linked immunosorbent assay (ELISA) has been shown to be
successful in a wide variety of biological matrices, such as DNA, plasma, and urine, especially for
the measurement of 8-oxo-dG, the most commonly investigated lesion as a biomarker of oxidatively
induced DNA damage [97]. Recently, an immunoassay using a novel monoclonal antibody (CdA-1)
specific for cdA in single-stranded DNA was generated [98]. The levels of cdA lesions measured
through this ELISA indicated an accumulation of cdA with age in brain tissues of Xpa (-/-) mice
compared with wild-type (wt) mice, and significantly, similar evidence was also revealed in liver and
kidney tissues among these mice at 6, 24, and 29 months of age [99].
6.2. Liquid Chromatography Tandem Mass Spectrometry (LC–MS/MS)
Although ELISA and 32P-postlabeling methods represent applicable approaches with widespread
use, owing to not requiring specialist experience and expensive equipment, lack of structural
specificity seems to be the main problem of lesion overestimation compared with the concentrations
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measured by chromatography-based techniques coupled with isotope dilution mass spectrometric
methodologies [100]. Indeed, the m/z values for parent and fragment ions contain important information
about the structure of DNA lesions and the molecular composition, and when used in these approaches,
are sufficiently specific for accurate quantification [101]. Gas chromatography/mass spectrometry
(GC/MS) has been utilized to identify R-cdG and S-cdG in DNA, including a derivatization step by
trimethylsilylation after the hydrolysis of the DNA sample [16,31,102]. However, this derivatization
step may render the implementation of GC/MS methodology inapplicable due to artifacts at several
stages of the analysis, likely due to the oxidation of the nucleobases present in acidic hydrolysis of
DNA [103].
Liquid chromatography coupled with modern highly sensitive mass detectors, which follows
a top-down approach, starting from the genetic material and going down to the single
nucleoside level, is of great interest and extensively used due to its advantages in specificity
and repeatability. On the contrary to immunoassays and the overestimation of specific DNA
adducts [97], liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis ascertains
accurate quantification of DNA adducts, providing lower limits the detection (LOD) and quantification
(LOQ), thus improving the sensitivity of the methodology. Furthermore, the use of isotopically labeled
reference compounds for the lesions enhances the reliability of the process, increasing the reproducibility
and recovery of the quantification to a great extent. All these considerations make the LC–MS/MS
approach an extremely important tool for the identification and estimation of oxidatively produced
DNA products or adducts in relation to inflammatory and age-dependent disorders. The ion–current
profiles of the corresponding mass transitions for S-cdA and S-cdG, which are acquired during
LC–MS/MS analysis of the samples, are given in Figure 10. The ions of m/z 164 and 180 (together with
169 and 185 for the labeled cdA and cdG) result from the cleavage of both the N-glycosidic and the
C4’–C5′ bonds of cPu. The stepwise procedure for the quantification of DNA lesions includes the
isolation and purification of DNA from the biological specimen (biological fluid, cells, tissues, etc.)
and the hydrolysis to single nucleosides by an enzymatic cocktail containing nucleases, followed by
the analysis and quantification by liquid chromatography coupled with tandem mass spectrometry for
the determination of the modified nucleosides. One of the problems for the exact quantification is
the contamination of the genetic material before the enzymatic hydrolysis steps or by side products,
such as those generated via oxidation of the unmodified nucleosides or/and degradation of the lesions
(e.g., via oxidation of the lesions themselves), during the procedure. In order to avoid these sample
workup artifacts, the presence of argon, metal chelators, and radical scavengers are added as part of
the method [29,104].
 
Figure 10. (A) MS/MS fragmentation spectra (ESI–MS/MS of the [M +H]+ ion) of S-cdA (m/z 250→164)
and S-cdG (m/z 266→180) lesions. Similar fragment ions were observed for R-cdA and R-cdG lesions.
(B) MS/MS fragmentation spectra (ESI–MS/MS of the [M +H]+ ion) of isotopically labeled (N = 15N)
S-cdA (m/z 255→169) and S-cdG (m/z 271→185) lesions.
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Two different approaches have been reported to date for the quantification of cPu via isotope
dilution LC–MS/MS analysis. One approach is the direct injection of the sample into the LC–MS/MS
system right after the enzymatic digestion step. The advantage of this methodology is the rapidity,
as the unmodified nucleosides and the lesions are quantified together in one single run. However,
in this approach, the samples do not pass through a purification step, and therefore materials that
are incompatible with the mass detector materials, such as buffer ions carried from the enzymatic
hydrolysis procedure, can create problems. Moreover, the unfiltered sample which is directly injected
into the LC–MS/MS system comprises the unmodified nucleosides along with the lesions, resulting in
a concentration which can be up to ∼60-fold in excess with respect to the lesions [105,106]. Another
important consequence of the latter resulting in poor sensitivity is the limited solubility of the crude
sample. A second approach for the quantification of DNA lesions is executed in two independent steps.
Firstly, the sample is analyzed by an HPLC–UV system coupled with a sample collector, where the
quantification of the unmodified nucleosides takes place based on their absorbance at 260 nm, whereas
at the elution time-windows of the modified lesions, they are collected, pooled, and concentrated.
In such an approach, the buffer ions carried from the enzymatic digestion step are separated from the
analytes and the lesions from the unmodified nucleosides [29,30]. The sample containing the lesions
can be further concentrated prior to LC–MS/MS analysis and each can be quantified by LC–MS/MS,
increasing the overall sensitivity of the quantification method. An ameliorated enzymatic digestion
protocol was developed based on the cost-effective genetically modified nuclease benzonase and the
nuclease P1, which are necessary for the quantitative release of the cPu lesions [30]. Figure 11 illustrates
a schematic representation of the isotope dilution LC–ESI–MS/MS chromatographic profile and the
fragmentation pattern in the mass detector.
Figure 11. Workflow showing protocol steps for the quantification of cPu lesions via isotope dilution
LC–ESI–MS/MS (the fragmentation pattern of the lesions is shown); dC: 2′-deoxycytidine; dG:
2′-deoxyguanosine; Thy: thymidine; dA: 2′-deoxyadenosine.
Comparison of cPu measured in an irradiated sample of calf thymus DNA by two different
LC–MS/MS methods has been reported [107]. Data are obtained from the applied dose within the
range of 0–60 Gy, and a linear dependence of lesions/106 nucleosides vs. dose has been reported. The
level of lesions/106 nucleosides/Gy in γ-irradiated samples of calf thymus DNA in aqueous solutions,
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within the range of 0–60 Gy, was found to be 0.23 for cdA and 0.35 for cdG in ds-DNA using the
method reported in Figure 11 [30], whereas the values of similar experiments were reported to be 14.2
for cdA and 20.1 cdG [105] using direct injection after the enzymatic digestion step without internal
standards (i.e., spiked with known quantities of the isotopically enriched analytes), which is a ∼60-fold
excess for both cdA and cdG.
7. Biological Studies for Health Applications
7.1. Neurological Diseases
Xeroderma pigmentosum (XP) is a rare disorder of defective UV radiation-induced damage repair
that is characterized by photosensitivity and cancer of the UV-exposed areas of the skin and mucous
membranes of the eyes and mouth at an early age. The skin is normal at birth, and with the onset
of the disorder, all patients develop freckle-like pigmentary changes in sun-exposed areas, which
eventually appear as poikiloderma [108,109]. XP can result from mutations in any of eight genes,
denoted as XPA–XPG and XPV. Cells from the patients in complementation groups A through G are
defective in nucleotide excision repair (NER) [110]. There is a relatively higher rate of XPA mutation in
the Japanese population [111,112], which results in severe loss of neurons in multiple regions of the
brain and spinal cord, with an age of onset between 7 and 13 years. The signs and symptoms of XP
neurological disease include peripheral neuropathy, sensory neural deafness, microcephaly, cerebral
dysfunction, ventricular dilation, cortical atrophy, and basal ganglia and cerebellar disturbances [113].
However, how the molecular defects in the NER pathway lead to the XP disease is far from being
fully understood.
The first observations of the relationship between defective NER and XP neurological disease were
provided by Robbins and coworkers, who examined the cell survival after exposure to UV radiation in
patient-derived cells. They observed a correlation between the poor cell survival after UV exposure
and the severity of neurodegeneration in the patients [114]. Robbins and colleagues hypothesized
that since UV light cannot reach into the human brain, XP neurological disease results from specific
endogenous DNA damages caused by free radicals, a kind of damage that is normally repaired by the
NER pathway [115].
In the of NER deficiency, this induced damage can accumulate causing neuronal death by blocking
transcription of essential genes. This study paved the way to consider other types of lesions caused
by UV light, such as pyrimidine (6-4) pyrimidine photoproducts and cyclobutane pyrimidine dimers
(CPDs) that block transcription, which are specifically repaired by NER and not by any other human
enzymatic repair process. In this scenario, the cPu lesions can fulfill many of the criteria expected
in neurodegenerative DNA lesions in XP. Specifically, these lesions are: chemically stable [116,117];
formed endogenously in mammalian cellular DNA [90,118]; repaired by the NER pathway and not by
any other known process, as proven by several studies [39,44,55,119]; able to block strongly, but not
completely, the transcription by RNA polymerase II that occurs in cells from XP patients [36,120].
These observations led some groups to propose that these lesions might be responsible, at least
in part, for the neurodegeneration suffered by xeroderma pigmentosum (XP) patients, who lack
the capacity to carry out NER [61,111,120]. Elucidating the mechanism by which cPu could have
an implication in XP remains the main goal of several research groups. The studies carried out so
far suggest three principal directions: (i) If the lesions completely block transcription by RNAPII,
multiple genes are inactivated, and consequently, the levels of encoded proteins are reduced, causing
neuronal death; (ii) If the lesions partially block transcription by RNAPII, mutant RNA transcripts
can be produced, and this can result in mutant proteins that play a role in neuronal death [121].
In addition, the presence of cPu-induced distortion in the DNA structure prevents the binding of
transcription factors (TF) [75,122] to DNA, causing reduced or dysregulated gene expression, in turn
resulting in neuronal death; (iii) Other possible implications of the presence of cPu lesions in XP
have been hypothesized by Arczewska et al. [123], who suggest that cPu in XP may impair the
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ability of BER proteins or other repair proteins to bind to cPu lesions, block transcription, and trigger
transcriptomic reprogramming.
Recent studies have demonstrated the ability of poly(ADP-ribose) polymerase 1 (PARP-1),
responsible for maintaining the integrity of the genome, to recognize and bind DNA sequences
containing S-cdA and R-cdA [40]. DNA recognition and repair proteins other than NER may bind to
such lesions but fail to repair them. This may be relevant in understanding the potential role of these
lesions in a number of neurological diseases.
A growing body of evidence [124] indicates that NER-defective diseases, besides presenting
the accumulation of nuclear DNA lesions, present high ROS levels, mitochondrial dysfunction,
and increased reliance on glycolysis. Recent evidence [125] indicates that mitochondrial dysfunction
is a neglected but important component of the DNA repair-defective syndromes. Fang et al. found
that the neurodegeneration of XPA patients may be associated with mitochondrial and mitophagic
dysfunction through PARP-1 hyperactivation and NAD*/SIRT1 reduction [126]. Moreover, this study
suggested that the dysfunction was in common with other neurodegenerative disorders, such as
ataxia–telangiectasia (AT) and Cockayne syndrome (CS). However, it is possible to consider that
because of the differences in neurodegeneration in XPA, AT, and CS, that different mechanisms are
involved in these diseases. CS is a rare autosomal recessive disease caused by mutation of either of two
genes (CSA or CSB) critical for a subpathway of NER, termed transcription-coupled NER (TC-NER),
which preferentially deals with transcription-blocking (typically bulky) lesions within active regions of
the genome. The neurological abnormalities that affect CS patients are qualitatively different from
those seen in NER-deficient XP patients. In XP, the neurons are primarily affected. In contrast, in CS,
the disease involves primarily the white matter of the brain and features brain calcification as well as
vascular abnormalities, neither of which are ever observed in XP neurologic disease [61,127]. It was
found that CSA is involved in the repair of S-cdA and 8-oxo-dG [128].
The differences between CS and XP neurological diseases reflect fundamentally different
underlying mechanisms [61,129]. Mitochondrial dysfunction might be a primary or a secondary
causative effect in these diseases, depending on the specific DNA repair defect; further evidences will
be needed to prove that the accumulation of endogenous cPu lesions in the brain plays a causative role
in XP neurological disease [99] and is involved mitochondrial and mitophagic dysfunction.
7.2. Cancer and Aging
Carcinogenesis is a complex process characterized by a progression of abnormalities over time
before a cell becomes malignant, while a variety of DNA mutations play crucial roles in the process
development. Increased rates of formation of ROS and their interaction with genetic material lead to
high yields of oxidatively induced nucleoside modifications [130]. Inability to efficiently repair these
harmful species in the genome may affect DNA integrity, causing genetic instability and enhancing
cancer risk [131,132]. The levels of cdA and cdG, in their R and S diastereoisomeric forms, have been
identified in estrogen receptor-alpha (ER-α) MCF-7 and triple-negative MDA-MB-231 breast cancer cells
upon exposure to two distinct conditions of radical stress, i.e., 5 Gy of ionizing radiation and 300 μM
hydrogen peroxide, followed by an interval period that allows DNA repair [133]. The isotope dilution
LC–ESI–MS/MS analysis revealed that ER-α MCF-7 and MDA-MB-231 cells are highly susceptible to
radiation-induced DNA damage (Figure 12). Estrogen-induced ROS formation can stimulate oxidative
DNA damage, while differences in NER efficiency of the breast tissue strongly support the association
between modified DNA nucleobases and breast cancer repair capacity [134,135]. This was the first
study reporting the simultaneous quantification of the four cPu lesions of DNA in human breast
cancer cell lines before and after treatment with DNA-damaging agents. Upon exposure to a dose
of 5 Gy, it was found that S-cdG was the most abundant lesion, with detected levels in the range of
0.03–0.14 to 0.17–0.23/106 nucleosides in both cell lines, whereas R-cdG in MCF-7 and R-cdA in MCF-7
and MDA-MB-231 cells were indicated as being significantly increased with respect to untreated cell
cultures. Exposure of cells to hydrogen peroxide revealed that the S-cdG was still observed as the most
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abundant, and statistically significant differences were obtained at the levels of R-cdA in both cell lines
along with the levels of R-cdG in MDA-MB-231 cells [133].
 
Figure 12. Levels of cPu lesions/106 nucleosides measured by LC–MS/MS from breast cancer
MDA-MB-231 and MCF-7 cells with or without exposure to γ-irradiation (upper part) and hydrogen
peroxide (lower part). The light bars (blue and green, respectively) represent samples exposed to 5 Gy
or 300 μM H2O2 followed by a 1 h repair period, and the dark bars (blue and green, respectively)
represent samples exposed to 5 Gy or 300 μM H2O2 followed by a 24 h repair period. The white
bars represent untreated samples (control). The asterisks denote a statistically significant difference
(p < 0.05) between the untreated controls and the treated samples. From reference [133].
Previous studies indicated the elevated levels of S-cdA in malignant HCC1937 and MCF-7 breast
cancer cells after exposure to hydrogen peroxide (0.04–0.06/106 nucleosides) [136]. Moreover, the levels
of R-cdG, S-cdG, and S-cdA were found to be increased in cultured lymphoblasts of women with BRCA1
mutations after exposure to 5 Gy of ionizing radiation followed by a subsequent 1 h period of cellular
repair of this damage (0.2–0.3/106 nucleosides, 0.6–0.8/106 nucleosides, and 0.2–0.7/106 nucleosides,
respectively) [137]. Increased levels of cdA and cdG have been observed in organs of prdx1+/+ and
prdx1−/− mice in a model study of the tumor susceptibility in prdx1−/− animals and the link with
oncogenes, such as c-Myc and DNA damage [138]. Furthermore, elevated cPu levels have been
measured in the skin of red Mc1re/e mice compared with albino Mc1re/e mice in a study of the
mechanism of UV-independent carcinogenesis aiming to ascertain whether ROS-mediated oxidative
DNA damage is influenced by the pheomelanin synthesis pathway [139].
Recently, the accumulation of both the R and S diastereoisomers of cPu was followed up in organs
of tumor-bearing severe combined immunodeficient (SCID) mice of different ages (4 and 17 weeks old)
in comparison with the corresponding control SCID mice, providing evidence of increased oxidatively
induced DNA damage occurring during tumor progression [140]. Identification and quantification
by isotope dilution LC–ESI–MS/MS in two distinct tissues (the liver and kidney) revealed that
tumor-bearing SCID mice had 1.1–1.4-fold higher levels of the four cyclopurines than the control
SCID mice, while S-cdG was the most abundant lesion, with levels of 0.28–0.38/106 nucleosides in the
liver and 0.24–0.25/106 nucleosides in the kidney, respectively (Figure 13). Moreover, in 17-week-old
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tumor-bearing animals, the cPu lesion levels were elevated compared to 4-week-old tumor-bearing mice,
in agreement with previously reported data among cancer and age-dependent processes [141]. The total
amount of cPu lesions in both tissues for all groups are reported in Table 2. Young and old control
SCID mice presented similar levels of cPu (0.70/106 nucleosides in the liver and 0.67/106 nucleosides in
the kidney). Among young mice, the diseased ones showed 1.1-fold higher cPu levels. Between the
early and latest stages of the lifespan of tumor-bearing SCID mice, increased damage is observed at
the levels of 1.04/106 nucleosides in the liver and 0.9/106 nucleobases in the kidney of 17-week-old
diseased mice. Important evidence also can be provided by the ratios of R/S for both cdG and cdA
in different tissue compartments. The R/S ratios were found to be almost the same in the liver and
kidney for all five experimental animal models for cdG (0.7–0.9). On the contrary, the ratio for cdA
was approximately 1.3–1.9 in the kidney and 1.5–2.3 in the liver, being twice than that of cdG [140].
 
Figure 13. Levels of cPu lesions/106 nucleosides measured by LC–MS/MS in control severe combined
immunodeficient (SCID) and tumor-bearing SCID mice. (A) Levels of R-cdG, S-cdG, R-cdA, and S-cdA
lesions in genomic DNA isolated from the liver of control SCID mice (group 1: 4 weeks old; group 2:
17 weeks old) and tumor-bearing SCID mice (group 3: 4 weeks old; group 4: 17 weeks old). (B) Levels
of R-cdG, S-cdG, R-cdA, and S-cdA lesions in genomic DNA isolated from the kidney of control
SCID mice (groups 1 and 2) and tumor-bearing SCID mice (groups 3 and 4). * Denotes a statistically
significant difference (p < 0.05) and ** denotes a statistically significant difference p < 0.005 between the
animal groups. From reference [140].
In Table 2, the diastereoisomer ratios for the different organs of control SCID and tumor-bearing
SCID mice are summarized. The diastereomeric ratio (R/S) attracts interest since it can inform on
mechanistic issues. It is worth underlining that the S form is always more abundant than the R form
in cdG, whereas in cdA, the R form is always more abundant than the S form. These cyclopurine
isomer ratios can be explained by the influence of at least two factors: (i) the local conformations of the
supramolecular organization of DNA are taken at the reactive sites prior to C5′ radical cyclization,
which make one type of diastereoisomer more prevalent, and (ii) the NER efficiency for the repair
of the diastereoisomers. Indeed, previous work in human HeLa cell extracts indicated that the cdA
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and cdG lesions are excised with similar efficiency by NER and that the R-diastereoisomers of both
cdA and cdG cause greater distortion of the DNA backbone and are better substrates of NER than the
corresponding S ones [39].
Table 2. Diastereomeric ratios (R/S) of cdG and cdA lesions in animal tissues by isotope dilution liquid
chromatography–tandem mass spectrometry #.
DNA Source R-cdG/S-cdG R-cdA/S-cdA Reference
Liver [140]
normal Swiss mice 4w 0.85 1.81
normal Swiss mice 17w 0.79 1.77
control SCID mice 4w 0.87 2.16
control SCID mice 17w 0.82 2.34
tumor-bearing SCID mice 4w 0.75 1.73
tumor-bearing SCID mice 17w 0.74 1.51
Kidney
normal Swiss mice 4w 0.86 2.03
normal Swiss mice 17w 0.77 1.72
control SCID mice 4w 0.80 1.45
control SCID mice 17w 0.84 1.49
tumor-bearing SCID mice 4w 0.85 1.56
tumor-bearing SCID mice 17w 0.79 1.88
Liver [118,142]
wild-type mice 10w 0.65 0.95
wild-type mice 21w 0.96 1.64
ERCC−/Δ mice 10w 1.20 2.65
ERCC−/Δ mice 21w 1.30 2.05
Kidney
wild-type mice 10w 0.39 0.77
wild-type mice 21w 0.22 0.38
ERCC−/Δ mice 10w 0.53 1.42
ERCC−/Δ mice 21w 0.26 0.40
Brain
wild-type mice 10w 0.45 0.64
wild-type mice 21w 0.29 0.67
ERCC−/Δ mice 10w 0.32 0.81
ERCC−/Δ mice 21w 0.44 0.90
Liver [29,143]
LEA rats 3m 0.68 0.91
LEC+/− rats 3m 0.77 1.29
LEC+/− rats 12m 0.50 0.86
LEC −/− rats 1m 0.80 1.75
LEC−/− rats 3m 0.79 0.96
LEC−/− rats 6m 0.65 1.6
Brain
LEA rats 3m 0.88 1.70
LEC+/− rats 3m 0.81 2.17
LEC+/− rats 12m 1.61 2.80
LEC−/− rats 1m 1.00 1.60
LEC−/− rats 3m 0.73 1.33
LEC−/− rats 6m 1.21 2.15
Skin [139]
red-Mc1re/e mice 0.40 0.86
albino-Mc1re/e mice 0.42 1.20
#w: weeks; SCID: severe combined immunodeficient; ERCC: Excision repair cross-complementing; LEA: Long–Evans
Agouti; LEC: Long–Evans Cinnamon.
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Increased levels of cPu lesions were observed in animal tissues and biological fluids at background
levels or at increased levels in age-related disorders as well as in other inflammation-related pathologies.
Accumulation of cPu lesions with aging in a tissue-specific manner (liver > kidney > brain) of
wild-type and DNA repair-deficient progeroid ERCC1−/Δ mice is also observed, indicating the
significant higher levels of cdA and cdG in ERCC1−/Δ mice compared to age-matched wt mice [118,142].
NanoLC–ESI–MS/MS analysis of liver tissues of Long–Evans Cinnamon (LEC) rats, as an animal model
of human Wilson’s disease, and Long–Evans Agouti (LEA) healthy rats demonstrated significant
elevated levels of cdA and cdG in both R and S isoforms in diseased animals (up to 4-fold excess
for liver tissues of LEC+/− and brain tissues of LEC−/−) [29,143]. In Table 2, the R/S levels of cdG
and cdA lesions in tissues of selected animal models associated with age-related processes are also
reported. It is worth recalling that the R/S ratios can be used to support further biological implications
in the formation and/or repair of these lesions, as discussed above. However, comparing all the data
reported in Table 2, in some studies, a clear scenario of the R/S formation cannot be drawn, probably
due to the analytical performance and uncertainty of the measurements. It would be recommended
to reach uniformity of protocols and quantitative methods in order to diminish these pitfalls. It is
worth mentioning that previous studies using different analytical tools, such as GC/MS or LC/MS,
indicated the accumulation of R-cdA and S-cdA in liver DNA of neil1−/−mice not exposed to exogenous
oxidative stress, revealing that NEIL1 plays a role in the cellular repair of R-cdA and S-cdA [144].
Previous studies by the same group on this direction highlighted elevated levels of S-cdA in organs
of csb−/− mice compared to wild-type mice, providing the evidence that CSB is implicated in the
repair of the DNA helix-distorting tandem lesion S-cdA [145] as well in tissues of prdx1−/− mice with
approximately identical R-cdG/S-cdG and R-cdA/S-cdA ratios (for cdG, it was found to be 0.23, 0.40,
and 0.17, while for cdA, 0.11, 0.08, and 0.23 in the brain, liver, and spleen, respectively) [138]. Lastly,
increased levels of S-cdA were found in polymorphonuclear leukocytes of familial Mediterranean
fever (FMF) patients when compared to control subjects [146], while R-cdA and S-cdA were found to
be elevated in urine samples of prediabetic patients [147].
7.3. Addendum
During the revision process of this review, a “Letter to the editor” was published in Free Radical
Research by Cadet et al. [148] criticizing the work produced by several laboratories [29,89,133,138,142,148]
and described here. In particular, Cadet et al. [148] questioned the effectiveness of the published
protocol on DNA samples shown in Figure 11 and of the LC–MS/MS methodologies used for detection
and quantification of cPu as biomarkers of DNA oxidation reactions. In their Letter, the authors
did not present any new experimental work, but only gave a “revisited analysis” of DNA damage
detection based on some unsuccessful attempts (Cadet et al., unpublished) made in 2000 to measure
the presence of cPu lesions in DNA by LC–ESI–MS/MS, using either the brain of NER-knockout
mice or gamma-irradiated human cells exposed to 1 kGy radiation. Therefore, based on a unique
unsuccessful study of almost twenty years ago, in their review, the authors started to cast doubts on
peer-reviewed work published in the last ten years from several important laboratories around the
world and advanced the hypothesis that cPu formation can be an experimental artifact. Apart from
the fact that the isotope dilution LC–MS/MS methodology is a sensitive methodology that nowadays
overcomes problems of low-sensitivity methods faced twenty years ago, the artifact formation in
the analysis of biological samples cannot be underestimated, especially after the well-known debate
of some years ago on similar problems raised with 8-oxo-dG lesion detection. Indeed, this review
describes the experience acquired in the last years for new and effective protocols of digestion and
LC–MS/MS analysis of DNA samples, highlighting the importance of quantitation sensitivity, accuracy,
precision, linearity, reproducibility, and recovery, along with the DNA enzymatic digestion efficiency.
The synthesis of 15N isotopically labeled compounds for each of the four cPu diastereoisomers was
also an important step that allowed to establish an analytical protocol with an HPLC cleanup and
enrichment of the samples (Figure 11). Therefore, to answer critical questions referring to supposed
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experimental artifacts, the effort and time that must be spent is such that only a few labs can afford.
By using control experiments and DNA analyses of samples before and after irradiation, the criticisms
on artifacts could be successfully overcome, and the resulting robust analytical methodology can
be nowadays used to gain information on the importance of cPu as biomarkers of hydroxyl radical
damage in aging and diseases. This addendum is made to trace the evolution of cPu research over
time and also to offer some arguments for debating how the analytical protocols can be developed and
ameliorated over time.
8. Conclusions
In this review, we have summarized the recent work on purine 5′,8-cyclo-2′-deoxynucleosides
(cPu), a subject of growing interest in studies on DNA damage and impact on human health and disease.
The cPu lesions are forms of oxidative DNA damage that can be repaired by NER with low efficiencies.
The accumulation of cPu lesions in the genome inhibits the DNA replication by diminishing the
activities of repair polymerases, RNA polymerases, and the DNA binding of transcription factors.
This results in severe adverse effects on cellular functions, including replication fork stalling, deficient
DNA repair and gene transcription, mutagenesis, and genomic instability.
The use of these lesions as candidate biomarkers of DNA damage is increasingly appreciated
because the cPu DNA lesions do not suffer from stability issues and artifacts of other oxidatively
generated DNA lesions. Moreover, an interesting feature of the cPu lesions is that they exist in four
diastereoisomeric forms in different ratios. The presence of these DNA lesions in different tissue-types
and biological environments is well-documented. However, the impact of the stereoisomeric cPu
lesions on various pathologies is poorly understood, and thus new knowledge needs to be developed
in order to achieve deeper insights into these phenomena. The state of the art described in this review
indicates that important steps have been made for clarifying many of the of biochemical and biological
processes involving cPu lesions. These achievements will certainly facilitate further extended analytical
studies of the detection of these modified nucleosides in vivo and the assessment of their impact on
genome integrity, human health, and aging.
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LC–MS/MS liquid chromatography tandem mass spectrometry
LEA Long–Evans Cinnamon
NER nucleotide excision repair
ODNs oligodeoxynucleotides
ROS reactive oxygen species
SCID severe combined immunodeficient
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Abstract: Nutritional stress disturbs the cellular redox-status, which is characterized by the increased
generation of reactive oxygen species (ROS). The NRF2-NQO1 axis represents a protective mechanism
against ROS. Its strength is cell type-specific. FaDu, Cal 27 and Detroit 562 cells differ with respect
to basal NQO1 activity. These cells were grown for 48 hours in nutritional conditions (NC): (a)
Low glucose–NC2, (b) no glucose, no glutamine–NC3, (c) no glucose with glutamine–NC4. After
determining the viability, proliferation and ROS generation, NC2 and NC3 were chosen for further
exploration. These conditions were also applied to IMR-90 fibroblasts. The transcripts/transcript
variants of NRF2 and NQO1 were quantified and transcript variants were characterized. The proteins
(NRF2, NQO1 and TP53) were analyzed by a western blot in both cellular fractions. Under NC2, the
NRF2-NQO1 axis did not appear activated in the cancer cell lines. Under NC3, the NRF2-NQO1axis
appeared slightly activated in Detroit 562. There are opposite trends with respect to TP53 nuclear
signal when comparing Cal 27 and Detroit 562 to FaDu, under NC2 and NC3. The strong activation
of the NRF2-NQO1 axis in IMR-90 resulted in an increased expression of catalytically deficient
NQO1, due to NQO1*2/*2 polymorphism (rs1800566). The presented results call for a comprehensive
exploration of the stress response in complex biological systems.
Keywords: glucose deprivation; glutamine deprivation; viability; proliferation; ROS; NRF2-NQO1
axis; IMR-90; NQO1 transcript variants; rs1800566; TP53 mutation
1. Introduction
To date, the roles of glucose and glutamine in the biology of transformed cells both in vitro
and in vivo, have been evaluated in various cellular systems, most often as separate entities. It is
well-established that cancer cells need glucose as a source of carbon. They also need glutamine.
Not only as an alternative substrate for the Krebs cycle and ATP production, but also as a source
of carbon and nitrogen, glutamine is needed for various biosynthetic reactions and glutathione
production to support antioxidant defense [1].Under normoglycemic conditions, the generation of the
fundamental metabolite nicotinamide adenine dinucleotide phosphate (NADPH) is secured via the
glucose catabolism pathway—the pentose phosphate pathway (PPP). Glucose starvation results in
Cells 2019, 8, 1001; doi:10.3390/cells8091001 www.mdpi.com/journal/cells40
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decreased ATP production and could induce oxidative stress by downregulating NADPH production
by PPP. Under these conditions, metabolic reprogramming and redox regulation are closely related
to the activation of 5′ AMP-activated protein kinase (AMPK) pathway. It is a protective mechanism
aimed at prolonging cell survival by preventing excessive NADPH consumption in fatty acid synthesis
and increasing NADPH generation in the process of fatty acid oxidation [2]. When the protective
capacity of the AMPK pathway is exceeded, the regeneration rate of glutathione decreases, and there is
an increase in ROS, an indicator of the disbalanced cellular redox status. It is well-known that ROS
are involved in the nutrient deprivation-induced Warburg effect [3]. Glutamine has also been shown
as a source of NADPH. In pancreatic cancer cells with a K-RAS-regulated metabolic pathway, the
glutamine-derived malate can be converted to pyruvate by malic enzyme. This reaction is associated
with NADPH generation [4]. It has also been shown recently that a lack of glutamine may promote
rapid and transient activation of AMPK [5].
During glucose deprivation, activated AMPK phosphorylates the wild type (WT) TP53 at serine
15, leading to G1/S cell cycle arrest and cellular senescence [6]. WT TP53 has an important role in
cellular metabolism. It inhibits the monomeric form of the enzyme glucose-6-phosphate dehydrogenase
(G6PD), which is present in the cytoplasm. This event results in one more instance of NADPH depletion.
The effect seems to be characteristic of WT TP53, but not its mutant forms. It was proposed as a main
function of cytoplasmic WT TP53 in resting cells [7].
When deprived of oxygen and glucose, the cells activate the AMPK by NAD(P)H:quinone
oxidoreductase 1 (NQO1) [8]. This enzyme was purified and characterized for the first time in 1988 [9].
It was originally considered only as a flavin adenine dinucleotide (FAD)—dependent, two-electron
reductase. There are numerous proofs of its effectiveness, associated with reducing quinones to
hydroquinones through a two-electron transfer. The catalytically active form of the enzyme is a
homodimeric protein. It has two identical active sites located at the interface between monomers
and with one FAD bound per monomer. Each of these two sites is shared by both reduced pyridine
nucleotide cofactors, NADH and NADPH [10]. The model of the NQO1 mode of action (ping-pong-bi-bi
kinetic mechanism), proposed in 1974 [11], is still considered valid. The catalytic cycle is initiated by
the binding of reduced pyridine nucleotide in the active site, followed by a hydride transfer to FAD.
It leads to a conformational change expelling the oxidized pyridine nucleotide, nicotinamide adenine
dinucleotide (NAD+), and creating an environment for quinone binding. The generation of NAD+
makes a strong, functional, yet indirect link between NQO1 and two very important cellular enzymes
relevant for metabolism and metabolic reprogramming in cancer. These are NAD+ dependent sirtuin 1
(SIRT1) and PARP-1, a major NAD+-consuming enzyme [12].
The enzymatic activity of NQO1 can be detected in the cytosol and in the nucleus [13]. It has an
important role in eliminating free radicals [14] which increase during nutritional stress. According
to the most recent data, NQO1 is a central unit of the redox-dependent switch. It depends on NQO1
conformational change, in which NADH has strong protective role against tryptic digestion and loss of
the C-terminal NQO1 domain. To a lesser extent, a protective role was also obtained with NADPH [15].
Altered pyridine nucleotide ratios could induce a switch in protein conformation. This results
in binding of NQO1 to a different set of proteins and RNA under oxidative conditions [16]. Thus,
NQO1 action influences the activity of other proteins indirectly, through generating NAD+ (SIRT1,
PARP-1) [17] and through direct binding (hypoxia-inducible factor, alpha subunit, HIF1-α, TP53) [18,19].
NQO1 stabilizes both wild-type (WT) [18] and mutant-types (MT) TP53 protein [20] by protecting
them from the ubiquitin-independent 20S proteasomal degradation. This stabilizing effect is most
prominent under oxidative stress. However, the presence of the single nucleotide variation (SNV)
rs1800566 that occurs in NQO1 exon 6, strongly decreases the enzymatic activity of NQO1 and
abolishes TP53 stability mediated by NQO1 [21,22]. This polymorphism, also known as NQO1*2
(heterozygote)/NQO1*2/*2 (homozygote), was shown to be an important factor in a poor clinical
response to quinone (mitomycin C, β-lapachone)-based chemotherapy. This is due to a lack of drug
bioactivation [23,24].
41
Cells 2019, 8, 1001
TP53, which is traditionally considered a tumor suppressor, is currently an emerging research
topic relating to nutritional stress [25]. Its connection to NQO1 may be a critical factor for cellular
adaptive stress response, especially during nutrient deprivation. The most recent data have shown
that the withdrawal of glutamine activates TP53 [26]. In a glutamine deprived cell, TP53 binds to the
promoter of the solute-like carrier family 7, member 3 (SLC7A3). It promotes cancer cell adaptation to
glutamine deprivation by upregulating SLC7A3to increase arginine uptake [27].
The state of oxidative stress is of utmost importance for activating NQO1 transcription, which is
mediated by NFE2L2 (Nuclear Factor, Erythroid 2 Like 2: NRF2). When there is an excess of ROS, NRF2
dissociates from its cytoplasmic partner Kelch-Like ECH-Associated Protein 1 (KEAP-1). It enters
the nucleus and binds to the cis-acting elements in an array of NRF2 target genes called antioxidant
response elements (AREs) [28]. These are present in the NQO1 promoter [29]. Consequentially, this
event leads to an increased transcriptional activity of the NQO1 gene. This phenomenon has been
shown in various models as a part of a strong antioxidative cellular response.
One very interesting molecular-genetic aspect of NQO1 mRNA is associated with the deposit of
four NQO1 transcript variants (TVs) in the GeneBank. The gene itself contains six exons (Figure 1). All
of them are part of the longest transcript (TV1; NM_000903.3, N= 2521 nt). Another three transcripts are
characterized, as follows: TV2: NM_001025433.2; exon 5 excluded (N = 2419 nt); TV3: NM_001025434.2,
exon 4 excluded (N = 2407 nt); TV4: NM_001286137.2, exons 4 and 5 excluded (N = 2305 nt).
 
Figure 1. Structure of the NQO1 gene, NG_011504.2.
In 1995, Gasdaska et al. described the NQO1 transcript lacking exon 4 (TV3) in cancer cell lines SW
480 and HT-29. The existence of the corresponding protein was not confirmed [30]. Seven years later, it
was proposed that the polymorphism present at the end of exon 4, rs1131341 (Arg137Trp, also known
as NQO1*3*), has a strong influence on NQO1 splicing. As a consequence, the ratio TV1/TV3 (shown
by end-point PCR to be around 9.0 in NQO1*1/*1, NQO1*2/*1, NQO1*2/2*), significantly decreases
(TV1/TV3 = 2) [31]. The ratio of TVs may vary depending on stressful conditions [30]. This was shown
only once, in the mononuclear cells obtained from patients before and at various times following
treatment with mitomycin [32]. According to SwissProt, there is only one experimentally verified
NQO1 protein variant which is coded by NQO1 TV1. It consists of 274 amino acids (30.868 kDa).
As recently shown in a yeast model, introns negatively regulate growth in a rich medium. They
are clearly required for maintaining cellular viability during the deprivation of nutrients (dextrose and
phosphates) [33]. In 2007, Pleiss et al. showed that two different stress-inducers (ethanol exposure
and amino acids deprivation) induce unique splicing profiles. This suggests that in yeast at least two
independent pathways connect the spliceosome with the cellular environment [34].
Alternative splicing was shown to take place during nutrient depletion in an organoid model
system derived from murine intestinal epithelial cells. This included exon skipping events and events
involving full intron retention (IR-S; intron retention simple) and complex intron retention (IR-C; intron
retention complex) [35].
Based on these facts, we wanted to explore selected cellular parameters (cellular viability and
proliferation rate, ROS generation) and molecular events included in the axis NRF2-NQO1/TP53,
under two different forms of nutritional stress. The transcripts (quantitatively - NRF2, NQO1 and
qualitatively - NQO1 splice variants) and proteins (NRF2, NQO1, TP53) in cytoplasmic and nuclear
cellular fractions were validated. Three cell lines originating from the head and neck squamous cell
carcinomas (HNSSC) were used: FaDu; Cal 27; and Detroit 562. These cells significantly differ with
respect to basal NQO1 activity (FaDu > Detroit 562 > Cal 27) [36]. IMR-90 fibroblasts, which are
considered as NQO1 non-expressing cell lines [37], were used as representative of an untransformed
cell line.
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2. Materials and Methods
2.1. Cell Lines and Cell Culture Conditions
The cells originating from metastatic pharyngeal cancer (pleural effusion-Detroit 562) and human
fetal lung fibroblasts (IMR-90) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The human
tongue squamous carcinoma cells (Cal 27) and human hypopharyngeal squamous carcinoma cells
(FaDu) were purchased from the American Type Culture Collection (ATCC, LGC Standards GmbH,
Wesel, Germany). The cells were cultured in T75 cell culture flasks (Sarstedt AG&Co.KG, Nümbrecht,
Germany), in Dulbecco’s Modified Eagle’s Medium (DMEM, D5796; Sigma-Aldrich, St. Louis, MO,
USA), supplemented with a 10% fetal bovine serum (FBS, Sigma-Aldrich, St. Louis, MO, USA), without
antibiotics, at 37 ◦C in a humidified atmosphere and in the presence of 5% CO2. Prior to the experiments,
the cells were harvested with 0.25% (w/v) Trypsin-0.53 mM EDTA (Ethylenediaminetetraacetic acid)
solution and counted with the trypan blue exclusion assay in Bürker-Türk hemocytometer (Brand,
Wertheim, Germany). For the experiments performed, the cells were cultured in DMEM, under the
following four nutritional conditions (NCs) with respect to glucose and glutamine: NC1-high glucose
(4.5 g/L) with l-glutamine (0.584 g/L) (D5796; Sigma-Aldrich, St. Louis, MO, USA); NC2-low glucose
(1 g/L) with l-glutamine (0.584 g/L) (D6046, Sigma-Aldrich, St. Louis, MO, USA); NC3-no glucose
and no glutamine (A14430, Gibco, Life Technologies Corporation, Grand Island, NY, USA); NC4-no
glucose (A14430), but with 0.584 g/L of l-glutamine (Sigma Aldrich, St. Louis, MO, USA).
2.2. Cell Viability Assay
Cellular viability was measured using EZ4U assay (Biomedica, Vienna, Austria), which assesses
cellular viability through reducing tetrazolium salts to colored formazan derivatives in the mitochondria
of living cells. The cells were seeded in 96-well plates (TPP, Trasadingen, Switzerland) at a density of
1×104 cells per well and cultivated in 200 μL of previously described media formulations (NC1-NC4),
supplemented with 10% FBS. After a cultivation period of 48 hours, 20 μL of the dye substrate
(tetrazolium salts) was added to each well. After a 2 h incubation, formazan derivatives were quantified
by measuring the absorbance using the microplate reader Multiskan EX (Thermo Electron Corporation,
Shanghai, China) at 450 nm, with 620 nm as a reference wavelength. Cellular viability under tested
conditions was expressed as a percentage of the viability of the control cells (cells grown in a high
glucose + glutamine, NC1, medium).
2.3. Cell Proliferation Assay
The rate of cellular proliferation was estimated through incorporating pyrimidine analogue
BrdU (5-bromo-2′-deoxyuridine), in place of thymidine, into the DNA of proliferating cells,
using the Cell Proliferation ELISA, BrdU (colorimetric) Kit (Roche Applied Science, Mannheim,
Germany). The antibody conjugated anti-BrdU-peroxidase binds incorporated BrdU. The complex
BrdU/anti-BrdU-peroxidase was detected by the reaction between peroxidase conjugated to the BrdU
antibody and the substrate (3,3',5,5'-tetramethylbenzidine). After reaching a satisfactory color intensity
(after incubating between 5 and 30 min), the reaction was stopped with 1 M H2SO4 solution.
The cells were seeded in 96-well plates (TPP, Trasadingen, Switzerland) at a density of 1×104 cells
per well and were maintained in 200 μL of previously described media formulations (NC1-NC4),
supplemented by 10% FBS. After 48 h of incubation, the assay was performed according to the
manufacturer's instructions. The reaction product (3,3',5,5'-tetramethyl-benzidine diimine) was
quantified by measuring absorbance using a microplate reader Multiskan EX (Thermo Electron
Corporation, Shanghai, China) set at 450 nm (reference wavelength: 620 nm). Cell proliferation
was expressed as a percentage of the cells grown under condition NC1 (high glucose + l-glutamine
medium).
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2.4. ROS Measurement
The intracellular levels of reactive oxygen species (ROS) were detected by DCFH-DA
(2′,7′-Dichlorofluorescin Diacetate; Sigma-Aldrich, St. Louis, MO, USA). The cells were seeded
in white 96-well plates (Thermo Fisher Scientific, Nunc A/S, Roskilde, Denmark) at a density of 1×104
cells per well and maintained in 200 μL of the previously described media formulations (NC1-NC4),
supplemented by 10% FBS. After growing for 48 hours, the cells were incubated with 20 μL of 100 μM
DCFH-DA, which was added to the culture media. After 45 min of incubation, the medium containing
DCFH-DA was replaced with 200 μL of fresh medium. The fluorescence intensity was measured
immediately (zero point) and after one hour, on a plate reader Infinite 200 PRO (Tecan Group Ltd.,
Männedorf, Switzerland). The excitation/emission wavelengths for DCFH-DA were set at 500/529 nm.
The values of the emitted fluorescence were expressed as arbitrary units, which represent the difference
between the two points of measurement (one hour and zero point). Additionally, the values were
corrected with respect to the cell numbers, which varied in relation to the treatment applied.
2.5. Nucleic Acids Extraction
The cells were cultured for 48 h at a density of 1×106 in T25 flasks (Sarstedt AG&Co.KG, Nümbrecht,
Germany), in 5 mL of the previously described media formulations (NC1-NC3), supplemented by
10% FBS.
The total RNA was extracted from the cells cultivated and treated in 25 cm2 flasks (Sarstedt
AG&Co.KG, Nümbrecht, Germany). The medium was removed and extraction was performed by
TRIzol (Invitrogen, Carlsbad, CA, USA), according to the manufacturer’s instructions. The integrity of
isolated RNA was determined by electrophoresis, on 1% agarose gel stained with ethidium bromide
(EtdBr) (Sigma-Aldrich, St. Louis, MO, USA). As there were no issues relating to the integrity of the
extracted RNA, all samples were further purified with gDNA Removal Kit (Jena Bioscience, Jena,
Germany), according to the manufacturer’s instructions. The concentration and purity of extracted
RNA was determined spectrophotometrically (BioSpec-nano, Shimadzu Biotech, Japan) by measuring
the absorbance at the following wavelengths: 230, 260 and 280 nm. The samples were stored at −80 ◦C.
The genomic DNA was extracted by phenol-chloroform extraction, after an overnight incubation
with Proteinase K (QIagen, Holden, Germany), as previously described [38]. After successful
precipitation, the samples of extracted DNA were re-suspended in TE buffer (10 mM Tris, 1 mM EDTA,
pH 7.4). The concentration and quality of the extracted DNA was determined spectrophotometrically
and electrophoretically, in 1% gel agarose stained with EtdBr. The samples were stored at +4 ◦C.
2.6. Construction of Primers
For all primers used in this research, with the exception of GAPDH1/GAPDH2 which are commonly
used, the modeling through combining the programs Primer-BLAST and Primer3Plus were performed.
Table 1 shows the primer sequences, their exact position on the RefSeq and the expected amplicon sizes.
The composition of the nucleotides of the primers used allowed the authors to perform the
polymerase chain reaction under almost identical conditions. The primers for gDNA were selected to
anneal to the template at 58 ◦C, while the primers for cDNA annealed to the template at 59 ◦C.
The three primers for GAPDH were constructed in a way which allowed combining the primer
GAPDH2 with primers GAPDH1—for determining cDNA quality and GAPDH3—for a rigorous
check of the potential gDNA contamination. These strict precautionary measures were undertaken
because the TaqMan probe used for quantifying NRF2 may bind to the gDNA, at least according a
statement provided.
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The selection of primers which would allow for the amplification of all four NQO1 TVs in one
reaction was based on the primary structure of the NQO1 TV1 mRNA (Figure 1). The primers were
complementary to the stretch of nucleotides positioned in the 3′ region of the exon 2 (NQO1F) and 5′
region of the exon 6 (NQO1R), respectively. All primers which allowed for examining the exon/intron
boundaries sequences were used only on genomic DNA.
Table 1. The positions and composition of primers used for analyses of NQO1.

















NQO1 R 5′GTCAGTTGGGATGGACTTGC3′ 905–922 TV4—469 bps
NQO1389460 F 5′CAGCTCACCGAGAGCCTAGT3′ 3756
NQO1389460 R 5′CATGGCATAGAGGTCCGACT3′ 237–257 221 bps
Genomic DNA
NQO1 g1F 5′CACACACACCCCTACAATCCCC3′ (−246)–(−225) 509 bps
NQO1 g1R 5′CCAGGTCCCTAATCTCTTCCC3′ 243263
NQO1 g2F 5′ACATTTCTGGCTACAGGAGATGGA3′ 78827905 704 bps
NQO1 g3 5′GTCAGTTGGGATGGACTTGC3′ 8573–8594
NQO1 g4F 5′CAGCTCACCGAGAGCCTAGT3′ 11299–11318 361 bps
NQO1 g4R 5′GAAATCCATGTAATACTGCACCT3′ NG_011504.2 11641–11659
NQO1 g5F 5′AGTTGGCTGACCAAGGACAA3′ 13285–13304 591 bps
NQO1 g5R 5′CCCTGCATCAGGACAGACC3′ 13855–13875
NQO1 g6F 5′TAGCTCAGGGGAGCCAAAGT3′ 15104–15124 693 bps
NQO1 g6R 5′TGAATTCCCCTGAAGGTTCGT3′ 1577715796
NQO1 g1F 5′TGGTAACGGCTAGGTAGAGGG3′ (−246)–(−225) 509 bps
NQO1 g1R 5′AGCCCAGTCGGATTTTGGTT3′ 243–263
2.7. Reverse Transcription, RT – PCR, and PCR
The reverse transcription was performed with a High-Capacity cDNA Reverse Transcription Kit
(Thermo Fisher Scientific, Waltham, MA, USA), with anchored Oligo(dT)23 primers (Sigma-Aldrich,
St. Louis, MO, USA) and 1 μg of total RNA in a 20 μL volume, according to the manufacturer’s
instructions. The reaction conditions were: 25 ◦C/10 min; 37 ◦C/120 min; 85 ◦C/5 min; 4 ◦C/indefinite.
After finalization of the reverse transcription, 80 μL of sterile, deionized water was added to the tubes
to achieve a total volume of 100 μL of cDNA, which was used for subsequent reactions.
The efficacy of reverse transcription was assessed with the end-point polymerase chain reaction
(PCR) using the primer pair GAPDH 1/GAPDH 2 and 1 μL of diluted cDNA. This template volume
was used as a standard in all end-point PCR reactions. For discovering the potentially present traces of
contaminating DNA, the primer pair GAPDH2/GAPDH3 was used, as the sequence of the GAPDH3
primer is complementary to the nucleotides in intron 5. The polymerase chain reaction was carried
out in GeneAmp PCR System 2400 (Applied Biosystems, Foster City, CA, USA). The reaction mixture
(12.5 μL) contained AmpliTaq 360 Gold Master Mix and GC Enhancer (Thermo Fisher Scientific,
Waltham, MA, USA), home-made nuclease free-water and primers (final concentration: 400 nM).
The genomic DNA was amplified with the same sets of chemicals and in the same volume, with
200 ng of gDNA. The reaction conditions were: Predenaturation 95 ◦C/5 min, followed by 35 cycles:
9 ◦C/30 s; 58 ◦C and 59 ◦C for gDNA and cDNA, respectively/30 s, 72 ◦C/30 s. The final elongation was
at 72 ◦C, for 7 min.
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2.8. Densitometry, Purification of PCR Products from Agarose Gel and Sequencing
The PCR products were separated by electrophoresis in 2% agarose gel and photographed for
future densitometric analysis, which was performed with ImageJ [39]. Bands of interest were cut out
of the gel and purified using a GenElute Gel Extraction Kit (Sigma-Aldrich, St. Louis, MO, USA),
according to the manufacturer’s instructions. After being eluted from the column, 10 μL of eluate was
loaded in 2% agarose gel in order to determine the purity and amount of eluate that was going to
be used in the sequencing reaction. Only the amplicon corresponding to TV4 needed to be purified,
re-amplified one more time with NQO1F/NQO1R and purified again. A sufficient amount of the
template was obtained for the sequencing reaction only after this additional procedure.
The sequencing reaction contained 12 μL mixture of the purified PCR product (approximately
50 ng per 100 bps), nuclease-free water and 1 μL of the forward and reverse primer used in PCR,
respectively (primer concentration 3.2 pmol/μL), for a total volume of 13 μL. The samples were
sequenced at the DNA Sequencing Core Facility of the Rudjer Boskovic Institute.
2.9. Real-Time RT-PCR and Rationale for Specific TaqMan’s Probe Selection
For quantification of NQO1 and NRF2, TaqMan chemistry was used. The reactions were performed
in a 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). We used always 1.5 μL
of cDNA template, 10 μL of TaqMan Fast Advanced Master Mix (Thermo Fisher Scientific, Waltham,
MA, USA), 1 μL of the probe and 7.5 μL of sterile, deionized water. The reactions were performed in
triplicate for each template and for each probe and in at least three biological replicates, which we tried
to associate with three consecutive passages. Microamp 96-well rxn plates (Thermo Fisher Scientific,
Waltham, MA, USA) were used, and amplification was performed under the following conditions:
Incubation 50 ◦C/2 min + 95 ◦C/10 min, followed by 40 cycles; 95 ◦C/15 s, 60 ◦C/60 s. The following
probes were used for house-keepers: GAPDH—Hs99999905_m1 (as GAPDH was used in the end-point
PCR reactions); TBP—Hs00920495_m1 (as the TBP was used in the WBs); HPRT1—Hs02800695_m1 (as
it was shown to be relatively stable in some published studies) [40].
For relative quantification, delta-delta Ct 2–ΔΔCt developed by Applied Biosystems was used,
which presumes identical amplification efficiencies of the target and reference gene and the Pfaffl
method [41], which served as a correctional factor in subsequent calculations.
2.10. Protein Extraction and Western Blot Analyses
The cells were cultured for 48 hours at a density of 1×106 in T25 flasks (Sarstedt AG&Co.KG,
Nümbrecht, Germany), in 5 mL of the previously described media formulations (NC1-NC3),
supplemented by 10% FBS. The proteins were extracted with NE-PER nuclear and cytoplasmic extraction
reagents (Thermo Scientific -Pierce Biotechnology, Rockford, IL, USA), supplemented by the protease
inhibitor (Complete Mini Protease Inhibitor Cocktail Tablets; Roche Applied Science, Mannheim,
Germany). The protein amount was estimated using the Bradford method [42]. The absorbance
was measured at 595 nm using the microplate reader Multiskan EX (Thermo Electron Corporation,
Shanghai, China). The protein samples were mixed with Laemmli buffer and boiled for 5 min at 95 ◦C.
The equal amounts of protein (10 μg) were loaded on the gel (9% resolving and 5% stacking), separated
electrophoretically and transferred to nitrocellulose membranes (Roti®-NC, Carl Roth, Karlsruhe,
Germany). The transfer efficacy was evaluated by staining the membranes with Ponceau S solution
(Sigma Aldrich, St. Louis, MO, USA). The stained membranes were scanned. After incubating the
membranes with 5% nonfat milk (Cell Signaling Technology, Danvers, MA, USA) in Tris-buffered
saline (TBS; 50 mM Tris-Cl, 150 mM NaCl, pH 7.6) containing 0.1% Tween-20 for 1 h, the membranes
were probed overnight with the following primary antibodies: (all rabbit monoclonal, Cell Signaling
Technology, Danvers, MA, USA): anti-NQO1 (1:1000; CST: #62262); anti-NRF2 (1:1000; CST:#12721);
anti-TP53 (1:1000; CST:#2527); anti-TBP (1:1000; CST:#44059); anti-β-actin (1:1000, CST:#8457). The last
two antibodies were used as the loading controls for nuclear and cytoplasmic fractions, respectively.
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The expected molecular weights of the detected proteins were: NQO1—29 kDa; NRF2—97–100 kDa;
p53—53 kDa; TBP 35–45 kDa; β-actin 45 kDa. After three washings of the membranes with TBST
(0.1% Tween 20 in 1× TBS), the immunoreactive bands were detected with an HRP- linked anti-rabbit
IgG secondary antibody (1:2000; CST: #7074). The immunological complexes were visualized using
SuperSignalTM West Pico PLUS Chemiluminescent Substrate (Thermo Scientific, Rockford, IL, USA)
and Alliance 4.7 (UVITEC, Cambridge, UK). The protein expression levels were quantified using
ImageJ and/or Image Studio Lite (LI-COR, Lincoln, NE, USA) analysis software. The relative change of
signals obtained was calculated after normalization according to the loading controls and Ponceau
S signals.
2.11. Statistical Analyses
Each experiment related to cellular biology (viability, proliferation, ROS generation) was performed
in technical triplicates or quadriplicates and repeated three times (as specified in the Figure legend).
The data obtained was analyzed with 1-way ANOVA and Tukey post-hoc test, as indicated in the
figure legends. The same principle was applied for producing and analyzing the data obtained with
molecular biology methods in biological triplicates. For both analyses and visualization, GraphPad 6.0
was used. The statistical significance of the differences obtained for all data analyzed was considered
significant at p < 0.05.
3. Results
Nutritional conditions were first profiled using the cancer cell lines originating from HNSCC:
FaDu; Cal 27; Detroit 562. In this study, highly proliferating cells were used for exploringbasic cellular
parameters before including a very slowly proliferating cell line—IMR-90 fibroblasts.
3.1. Viability, Proliferation and Generation of ROS
The choice of experimental conditions needed for nutritional stress induction, in relation to the
concentration of glucose and glutamine in the medium, was combined with measuring cellular viability
(Figure 2A), cellular proliferation (Figure 2B), and the amount of ROS generated at hour 48 (Figure 2C).
Initially, the four nutritional conditions (NC1-NC4) were established, as described in the Material and
Methods section, to which only the cancer cells were exposed. Then, based on the data obtained, this
research was extended to IMR-90, through applying nutritional conditions NC2 and NC3. NC1 should
be considered the control condition.
As presented in Figure 2A, the viability of the cancer cell lines, regardless of their genetic
background, was similar under the given conditions. Predictably, the most intensive decrease in
cellular viability (up to 70%) was recorded for all three cancer cell lines in the medium without glucose
and glutamine (NC3), when compared to both NC1 and NC2 (p < 0.0001).
The presence of glutamine in a medium without glucose (NC4) was beneficial for the viability of
all cancer cell lines (Figure 2A). It was also beneficial for the cellular proliferative capacity (Figure 2B)
of Detroit 562 (p = 0.0007) and Cal 27 (p < 0.0001), but not FaDu. The strongest ROS generation was
associated with condition NC3. The presence of glutamine in a medium without glucose (NC4) led
to a decreased ROS generation in all three cancer cell lines (Figure 2C). Under NC2, the generation
of ROS in Cal 27 and FaDu was stronger (p = 0.0055 and p < 0.0001, respectively) than in Detroit 562
(Figure 2C).
47
Cells 2019, 8, 1001
Figure 2. The viability, proliferation and generation of ROS in cancer cell lines (A–C) and IMR-90 (D–F)
after exposure to NC1-NC4 and NC1-NC3, respectively, for 48 hours. One-way ANOVA with Tukey
post-hoc test was used to test the differences with regard to nutrient conditions. The values are shown
as the mean ± 95% CI. N = 3. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
When reviewed, these data indicated that the cancer cell lines showed some interesting and
unique features. Under NC2, the generation of ROS was not significantly increased only in Detroit
562. Under NC4, when there is a lack of glucose, FaDu was far less sensitive to the rescuing effect of
glutamine on proliferative capacity.
These data are also very indicative regarding the degree of cellular sensitivity to glutamine
deprivation, showing that Cal 27 and Detroit 562 were more dependent on glutamine than was FaDu.
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Knowing that non-transformed cells are highly dependent on glucose, and relying on the data
obtained with the cancer cell lines (Figure 2A–C), we chose to continue the experiments using the
mildest (NC2) and the most robust condition (NC3), now including the IMR-90 fibroblasts.
They were considered a good control system, to compare with the cancer cell lines. The Figure 2D–F
represent IMR-90 response to NC2 and NC3. The viability of IMR-90 was unique in the extreme
sensitivity of this cell line to the mild glucose deprivation, during 48 hours (NC2; p< 0.0001) (Figure 2D).
The viability and proliferative capacity after 48 hours in NC2 (Figure 2D,E) seems to be a maximal effect
of a critical nutrient deprivation (glucose) because 48 h of cultivation in the medium without glucose
and glutamine (NC3) did not influence these cellular parameters further. However, the generation of
ROS did differ between NC2 and NC3 (p = 0.0019) (Figure 2F), although not as strong as in the cancer
cell lines (p < 0.0001) (Figure 2C). The lack of a significant change of IMR-90 viability after 48 hours of
exposure to mild and extreme starvation, is in clear contrast with the cancer cell lines and needs to be
further explored.
3.2. Quantification of NQO1 and NRF2 in a Real-Time
According to the majority of literature data, the NRF2-NQO1 axis should be highly active under
conditions which induce the generation of ROS. As a first step forward, the transcriptional activation
of NRF2 and NQO1 in real-time was explored. Three different house-keeping genes were used, as
we were aware that under the experimental conditions we chose to explore, we might not be able
to make an accurate quantification of our targets. Under the given conditions, none of the three
housekeepers (GAPDH, TBP, HPRT1) used in this research were universally stable in all four cell lines.
The changes in their transcription rates were clearly both condition specific and cell-type specific, as
already presented [40]. Finally, under the given conditions, a quantification was made by combining
these three housekeepers in a particular cell line.
The general picture shows that in all cell lines, the transcriptional activity of NRF2 increases under
NC2 and NC3 (Figure 3A,C,E,G). The quantification for FaDu, under NC3, was estimated based on
the Ct values for NRF2 and NQO1 under NC1 and NC2, in respect to NC3 (Figure 3E,F). However,
under NC2, the increasing trends of NQO1 were not present in Cal 27 and FaDu. The statistically
significant differences in transcription rates were reached only in Cal 27, for both genes: NRF2: NC1
versus NC2; p = 0.0008; NC2 versus NC3; p = 0.0102: NQO1: NC1 versus NC3; p = 0.0153; NC2 vs.
NC3; p = 0.0072 and IMR-90, but for NQO1 only: NC1 versus NC3; p = 0.0276. Notwithstanding the
mathematical calculation, it is visible that only in Cal 27 and already at NC2 does the Fold Change
of NRF2 reach a value above 2 (Figure 3A). Thus, it is quite obvious that the transcriptional level of
NRF2, with the exception of Cal 27, does not exhibit as strong changes as expected, especially not
with respect to the increased generation of ROS (all cancer cell lines: NC2 versus NC3 p < 0.0001;
Figure 2C). An increase of NQO1 mRNA was recorded under NC3 in Cal 27, Detroit 562 and IMR-90.
Due to significant variations in the transcriptional level of house-keepers in FaDu under NC3, the
target transcripts were not accurately quantified, under that condition and only in that cell line.
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Figure 3. The quantification of target transcripts, NRF2 and NQO1, in real time (RT-qPCR). One-way
ANOVA with Tukey post hoc test was used to test the differences with respect to the quantity of NRF2
and NQO1 mRNA, under different nutritional conditions. The values are shown as the mean ± SD.
N = 3. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. * The Fold Change for NRF2 and NQO1 in
FaDu under NC3 was estimated according to the Ct values.
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3.3. Three Splice Variants of NQO1 are Present in All Four Cell Lines, Notwithstanding the Experimental
Conditions Applied
In all four cell lines, three reproducible bands occurred in the end-point PCR (35 cycles), regardless
of the cellular background and/or the type of nutritional stress (Figure 4A–C). Based on their size, we
were certain of the existence of TV1 and TV4. The nature of the amplicon which was in the middle
position (as the length of TV2 and TV3 differ for only 13 nucleotides, Figure 1) was revealed only after
analyzing the sequencing data (Figure 5). Under all experimental conditions and in all cell lines, TV1
gave the most prominent signal and TV3 was visible. However, in Detroit 562, TV4 varied and was
almost undetectable. There was an additional 400 bps long amplicon present in all cell lines under all
conditions, which was not characterized further. After a densitometric analysis of the signals after 28
cycles (when the signal was less saturated) using the ImageJ, the changes in the ratio TV1/TV3 were
recorded (Figure 6).
 
Figure 4. The presence of three NQO1 splice variants in all four cell lines, under three nutritional
conditions (35 PCR cycles). L: 100 bp DNA ladder (Invitrogen). A. IMR-90 and FaDu; B. Cal 27; C.
Detroit 562. TV1: 685 bps, TV3: 571 bps and TV4: 469 bps.
Figure 5. The sequence analyses of amplicons obtained from the Cal 27 NQO1-cDNA amplified with
the primer pair NQO1F/NQO1R (Table 1), presented in Figure 4, confirm the presence of transcript
variants TV1 (A), TV3 (B), and TV4 (C). Eight nucleotides in the terminal part of the 3’ exon 3 are
common to all three amplicons and are shown in blue. The sequences of TVs were identical in all
cell lines.
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Figure 6. The dependence of the TV1/TV3 ratio on NCs applied. One-way ANOVA with Tukey
post-hoc test. The ascending trends were recorded in Cal 27 as contrasted with the other three cell lines.
The values are shown as the mean ± SD. N = 3. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
The signal obtained from TV4 was permanently low in all cell lines, under all NCs applied, and
was excluded from the analyses. The intensity of the densitometric signal originating from TV1 and
TV3 was expressed as their ratio (TV1/TV3) obtained after 28 PCR cycles (Supplementary Figure S1).
The opposite trends in Cal 27 versus three other cell lines were observed. In Cal 27, the TV1/TV3 ratio
increased from 4.47 (NC1) to 5.7 (NC2) and 6.36 (NC3) (Figure 6). The differences were statistically
significant: NC1 versus NC2: p = 0.0020; NC1 versus NC3: p = 0.0006; NC2 versus NC3: p = 0.0123.
In IMR-90, Detroit 562 and FaDu, the TV1/TV3 ratio was significantly decreased under NC3 (NC1
versus NC3; IMR-90: p = 0.0014; Detroit 562: 0.0213; FaDu: p = 0.0069). There were also significant
differences between the ratio of TVs which was observed between NC2 and NC3 (IMR-90: p = 0.0017;
Detroit 562: p = 0.0261; FaDu: 0.0031).
3.4. Detection of SNVs in Intron/Exon Boundaries
3.4.1. rs 689460, G+C, Is Present in IMR-90 and Does Not Influence the NQO1 Splicing
Based on the one paper showing that the polymorphism present at the very end of NQO1
exon 4 (rs1131341) favors occurrence of the transcript lacking exon 4 [31], and based on the cDNA
end-point PCR and sequencing data, the status of the cells with respect to rs1131341 was determined.
All exon/intron boundaries with primers shown in Table 1 were analyzed, using the gDNA as a
template. All primers, except primer NQO1 g6R (complementary to nucleotides in the 5’ part of the
exon 6), were complementary to intronic/non-coding NQO1 DNA sequence. With these sets of analyses,
we discovered a polymorphism in intron 1 (nt #248, according to NG_011504.2), present only in IMR-90
genomic DNA (Figure 7A), but not in the cancer cell lines (Figure 7B). To date, there is no data on
the potential influence of this SNV on NQO1 splicing. In order to explore the potential influence
of this polymorphism on splicing, novel primers, NQO1389460F and NQO1389460R, (Table 1) were
constructed and analyses were performed as previously described. The existence of any alternative
new splice variants which could be associated with this polymorphism, under the applied conditions
could not be confirmed (Figure 7C).
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Figure 7. A. Single nucleotide variation C+G wass present in IMR-90, in NQO1 intron 1. The terminal
part of the 3' exon 1 is shown in blue. The distance between the polymorphic locus, revealed to be rs
689,460 according to NCBI, and 3' of exon 1, is only 50 nts. B. All three cancer cell lines were homozygos,
rs 689,460 G+G, as shown here, for Cal 27. C. Single nucleotide variant C+G in IMR-90 did not influence
the NQO1 splicing. The amplicons obtained in IMR-90 under given conditions did not differ from
those obtained in homozygos (G+G) cancer cell lines (only Cal 27 is shown). L: 100 bp DNA ladder.
Lines 1–3 and lines 4–6: IMR-90 and Cal 27 under NC1, NC2 and NC3, respectively.
3.4.2. rs 689452, C+G, Is Present in Detroit 562 and Cal 27
The presence of one more SNV in intron 1 (nt# 8070, according to NG_011504.2) was further
discovered, in Detroit 562 and Cal 27 (Figure 8). The sequence variant (C+G) corresponds to rs 689452.
In IMR-90 and FaDu, this position was homozygous, C+C, as shown on Figure 8. Based on the splice
variants analyses, rs 689,452 does not influence the splicing of NQO1.
 
Figure 8. A. Single nucleotide variant, rs 689452, C+G in Cal 27 (also present in Detroit 562) is in intron
1, separated from the 5' part of exon 2 (labeled blue) by only 27 nts. B. In FaDu (shown by an arrow)
and IMR-90 (not shown), the sequence was homozygous, C + C.
3.4.3. Presence of rs1800566 in IMR-90 but Not in Cancer Cell Lines
The rs1800566 was detected only in IMR-90. This well-known polymorphism was present as
a homozygous SNV–NQO1*2/*2 (nt #15389, according to NG_011504.2), leading to a change of the
triplet CCT into TCT (Figure 9A). This is highly consequential, because this SNV missense variant,
as described earlier, leads to replacing proline with serine at position 187. This polymorphism was
shown as the one which influenced the structure of the NQO1 protein, making it highly unstable and
catalytically compromised [43]. While it is known that IMR-90 expresses only traces of NQO1 protein,
the data related to IMR-90 genotype, with respect to rs1800566, could not be found.
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Figure 9. The presence of SNV rs1800566, in IMR-90 (NQO1*2/*2; (A)) and WI-38 (NQO1*1/*2; (C)).
The homozygous triplet TCT, coding for Serine, replaces the CCT triplet coding for Proline, which was
present in all cancer cell lines, as shown for Cal 27 (B).
As human fibroblasts WI-38 express NQO1 but are not able to develop the NQO1-mediated redox
cycle that could lead to HSP90 (Heat Shock Protein) inhibition upon β-Lapachone induction [44], it was
presumed that these cells may have a genotype NQO1*1/*2. When we worked with WI-38 [45], the
DNA was preserved from an early passage and kept frozen at −20 ◦C. Indeed, WI-38 are heterozygotes,
NQO1*1/*2 (Figure 9C). This means that both commonly used cell lines are, regarding NQO1 activity,
severely compromised and represent two totally different biological systems. All cancer cell lines were
homozygous, P187P (Figure 9B – Cal 27) and the enzymatic activity of their NQO1 should be intact,
at least with respect to rs1800566.
Finally, under the given conditions, we explored the NRF2/NQO1 axis on the protein level.
In these analyses, TP53 was included. For the reasons explained earlier, western blots on nuclear and
cytoplasmic fractions were performed.
3.5. Western Blot Analyses
3.5.1. Analyses of NQO1
Under NC1, the NQO1 signal was least visible in IMR-90. Although all three cancer cell lines had
a considerably high level of NQO1 in both cellular fractions, a lower basal amount of NQO1 in Cal 27
nuclear fraction, as compared with FaDu and Detroit 562, was obvious on all our blots (Figure 10A,B).
The level of NQO1 in the cellular fractions did not significantly change under the NC2 condition.
However, some trends can be observed. There was a slight decrease of NQO1 in both cellular fractions
of Cal 27 and Detroit 562 and an increase in both cellular IMR-90 fractions. The signal in FaDu was
slightly increased in the cytoplasm, and, at the same time, there was a mild decrease in the nucleus
(Figure 10C,D). Although under NC2 densitometry registers an obvious increase of NQO1 in both
IMR-90 fractions, the intensity of the NQO1 signal remained very weak and far below the signal
obtained in all cancer cell lines and under all tested conditions.
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Figure 10. The expression of NQO1, NRF2 and TP53 in cancer cell lines and IMR-90. The representative
western blots of cytoplasmic and nuclear NQO1, NRF2 and TP53 content under different nutritional
conditions: (A) NC2 (low glucose+ l-glutamine); (B) NC3 (no glucose and no l-glutamine). The relative
expression is calculated as compared to the control condition (NC1 – high glucose + l-glutamine) for:
C-cytoplasmic and D-nuclear NQO1; E-cytoplasmic and F-nuclear NRF2; G-cytoplasmic and H-nuclear
TP53. One-way ANOVA with Tukey post hoc test was used to test the differences in relative expression
of selected proteins under different nutrient conditions. The values are shown as the mean ± SD. n = 3.
* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
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In all cancer cell lines, the more harsh condition of NC3 did not significantly affect the NQO1
cytoplasmic levels which remained close to the NQO1 control levels (NC1). In IMR-90, cytoplasmic
level of NQO1 decreased (Figure 10C). Although not statistically significant as compared with the
control (NC1), this decrease was quite intense when compared with cytoplasmic NQO1 expressed
with respect to NC2 (p = 0.0107). IMR-90 responded with increased nuclear accumulation of NQO1
when exposed to NC3 (p = 0.0056). Under the same conditions, Cal 27 showed a nuclear decrease of
NQO1 (p = 0.0457). Although the NC3 condition did not significantly affect the nuclear level of NQO1
in FaDu when compared with the control (NC1), a significant increase was recorded when compared
to NC2 (p = 0.0178). An increased nuclear NQO1 level in NC3, when compared to NC2, was also
observed in IMR-90 (p = 0.0085) (Figure 10D).
3.5.2. Analyses of NRF2
The cytoplasmic expression of NRF2 in all four cell lines was weak and unaffected by nutritional
conditions (Figure 10E). The nuclear NRF2 expression showed some differences. Although a nuclear
increase of NRF2 in all cell lines under NC2 was recorded, it was statistically significant only in FaDu
(p = 0.0414). Under NC3, a significant increase of NRF2 was recorded in the nucleus of the remaining
three cell lines (NC1 vs. NC3: Cal 27 p = 0.039, Detroit 562 p = 0.0306, IMR-90 p = 0.0103). However,
under these extreme conditions, it was not present in FaDu. With regard to all other cell lines, there
was a difference between the nuclear amount of NRF2 under NC2 and NC3 in IMR-90 (p = 0.0142),
which was manifested as a significant increase (Figure 10F).
It was proposed that NQO1 stabilizes both the wild-type and mutant-type TP53. There was a
mixed situation—wild-type NQO1 and mutant TP53 in the cancer cell lines and mutant-type NQO1
and wt TP53 in IMR-90.
3.5.3. Analyses of TP53
As expected, the wild type TP53 was not detected in the IMR-90 cytoplasm (Figure 10A,B). There
was a significantly high level of the expressed mutant types of TP53 in the cytoplasm of the cancer cells
in NC1. Cytoplasmic TP53 decreased in all cell lines under both NC2 and NC3. However, under NC2,
the decrease reached a statistically significant level only in FaDu (p < 0.0001) (Figure 10G). The nuclear
level of TP53 in Cal 27 and Detroit 562 exposed to NC2 for 48 h, was arround or slightly above the
control (NC1) values (Figure 10H). Under NC3, the strong TP53 signal in the cytoplasm of the cancer
cell lines literally disappeared (Figure 10B,G). It was present in the nucleus and showed very interesting
trends in relation to the conditions applied. In Cal 27, IMR-90 and Detroit 562, the NC3 related TP53
signal was lower than in NC2. The decrease was significant for Cal 27 and IMR-90; NC2 versus NC3;
p = 0.0411 and p = 0.0258. In FaDu, the signal of nuclear TP53 strongly increased and reached statistical
significance (NC2 versus NC3; p = 0.0025) (Figure 10H).
The images on Figure 10 were obtained with 10 micrograms of proteins, under the same conditions.
For improving the visibility of the bands corresponding to TP53 and NQO1 in IMR-90, a separate
blot was made with the same amount of protein loaded (10 μg). For detection of the signals,
software-controlled prolonged time exposure was used (Supplementary Figure S2).
3.5.4. The General Picture of the NRF2-NQO1 Axis and TP53 at the Protein Level, in the Experimental
Model
Under NC2, the NRF2-NQO1 axis did not seem to be activated in the cancer cell lines. This was
because: a) Only FaDu exhibited a significant increase of NRF2 in the nucleus, which was joined with
decreased NQO1 and TP53 signals in the nucleus; and b) Cal 27 and Detroit 562 had no significant
increase of NRF2 in their nuclear fraction, nor did they exhibit a significant change in NQO1 expression.
However, they had a slight increase of TP53 in their nuclei.
Under NC3, the NRF2-NQO1 axis seemed to have moderate activity in Detroit 562. This was
because: (a) There was a significant increase of nuclear NRF2, associated with a slight increase of
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NQO1 in both cellular fractions; (b) Cal 27 had the strongest increase of nuclear NRF2 among all the
cancer cell lines, which was not associated with the corresponding increase of NQO1; and (c) FaDu
seems to be unresponsive.
There are opposite trends with respect to the TP53 nuclear signal when comparing Cal 27 and
Detroit 562 to FaDu, under NC2 and NC3. Under NC2, the TP53 nuclear signal increased in Cal 27
and Detroit 562 and decreased in FaDu. Under NC3, the TP53 nuclear signal increased in FaDu and
decreased in Cal 27 and Detroit 562.
The axis NRF2-NQO1 was active in IMR-90, the cell line with a wt TP53. This was because: (a) a
slight and strong accumulation of NRF2 was observed in the nucleus under NC2 and NC3, respectively
(Figure 10A,B,F); and (b) and was joined by a recordable accumulation of the NQO1 (S187S) protein,
however unstable it was shown to be [43].
The simplified graphic presentation of phenomena observed at the protein level is presented in
Figure 11.
 
Figure 11. The cellular distribution and the rate of change of the NRF2, NQO1 and TP53 proteins in all
four cell lines, under NC1-NC3.
4. Discussion
The lack of nutrients leads to cellular oxidative responses. We wanted to explore the NRF2-NQO1
axis by inducing stress through incubating cancer cell lines in the following: A medium with a
decreased concentration of glucose (1 g/L) (NC2); a medium with a complete lack of glucose (NC4)
but supplemented with glutamine; and, in order to induce the strongest level of ROS, by creating an
artificial situation, using a medium deprived of glutamine and glucose (NC3). However, due to trace
amounts of glucose and glutamine in FBS, these cells were still exposed to a minimal concentration of
glucose (~0.125 g/L ≈ 0.69 mM) [46] and glutamine (0.05 mM) [47].
The cellular viability, ROS generation and rate of cellular proliferation, were measured and
compared under these four conditions, in three cancer cell lines, originating from HNSCC: FaDu,
Detroit 562 and Cal 27. According to COSMIC and published papers, these three cell lines can be
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classified according to their TP53 mutation status [48]: 1. FaDu—heterozygous mutation leading to
substitution of arginine with leucine at aa248 (R→L); 2. Cal 27—mutation (unknown zigosity status)
leading to substitution of histidine with leucine at aa193 (H→L); 3. Detroit 562 mutation (unknown
zigosity status) leading to the substitution of arginine with histidine at aa 175 (R→H). All these
mutations are in the DNA-binding domain of the TP53 protein. Based on the cellular effects observed
in the cancer cells, molecular-genetic experiments were chosen to be performed under conditions NC2
and NC3, to which fetal lung fibroblasts IMR-90 were also exposed. This cell line was used to show
how MYC, after being transduced in IMR-90, makes IMR-90 addicted to glutamine [49]. Terashima et al.
were able to stimulate NRF2 entering in the nucleus of these cells under the low glucose condition [50].
Thus, it was assumed that IMR-90 is likely to be sensitive to NC2 [49]. Many research groups were not
able to show the expressed NQO1 protein in these cells in their native state [36]. However, there are
also data showing the expressed, mature NQO1 in IMR-90 [51].
4.1. Cancer Cells and Fibroblasts IMR-90 Differ in Their Sensitivity to Nutrient Deprivation
We were aware that the chosen conditions were likely to reduce cellular viability and increase
the level of ROS, but we could not predict to what extent that would happen. What was visible
immediately was that the viability of the cancer cells under NC2 decreased significantly, but far less
than under NC3. With respect to NC2 and the cancer cell lines, our results were in the strongest
agreement with results published by Terashima et al., who presented a similar decrease of HepG2
viability cultured in a medium with low glucose (1 g/L) [50] In IMR-90 only, the NC2 condition had
extremely strong effects with respect to the examined cellular parameters. In IMR-90 only, the effect
of the NC2 condition was much stronger than in the cancer cell lines, confirming that IMR-90 are
primarily dependent on glucose. The result obtained on IMR-90 is in agreement with data presented
by Yunova et al., who also convincingly showed the sensitivity of IMR-90 to glucose deprivation [49].
With respect to glutamine, van den Heuvel et al. showed the insensitivity to glutamine depletion of
normal human lung fibroblasts (NHLF)) cells originating from lung fibroblasts [52].
As shown on Figure 2A,D, among all four tested cell lines exposed to NC2, the viability of
fibroblasts decreased below 50% (app. 80% in cancer cell lines). It did not decrease further when there
was a lack of both glucose and glutamine (NC3). One possible explanation of this effect may be the
high expression of glutamate/cystine antiporter solute carrier family 7 member 11 (SLC7A11, also
called xCT) in IMR-90 cells [53]. In cancer cells, SLC7A11 mediates the efflux of intracellular glutamate,
thereby rendering them metabolically less adaptable and more reliant on glucose for survival [54].
The drop in cellular viability of all cancer cell lines, contrary to IMR-90, was less pronounced under
NC2 than under NC3. The proliferation rate of FaDu under NC4 was far below the proliferation rate
in Cal 27 and Detroit 562. This indicates that there is a differential sensitivity to glutamine between
FaDu and the other two cancer cell lines, when there is a lack of glucose.
Both FaDu and Cal 27 cells have been reported to express a high level of SLC7A11 [55]. The relative
unresponsiveness of FaDu observed under NC4 may be explained, at least in part, by the observed
high increase of nuclear NRF2 (p = 0.0414) (Figure 10F), joined with increased NRF2 transcription and
the significantly increased generation of ROS (p < 0.0001) (Figure 2C), in response to NC2. Considering
that NRF2 has been reported to induce SLC7A11 expression in response to glucose starvation [51],
it is conceivable that FaDu cells, in which exposure to NC2 upregulated NRF2, would under NC4
(complete lack of glucose, albeit supplemented with glutamine) have a more pronounced expression
of SLC7A11 and efflux of glutamate that would prevent the recovery of cellular proliferation. Cal 27
cells, which were also reported to express a high level of SLC7A11 [55] but did not respond to NC2
by statistically significant upregulation of nuclear NRF2, significantly recovered cellular proliferation
under NC4NC4), as contrasted with FaDu cells.
Under NC3, FaDu was the only cancer cell line which had a significant increase of NQO1 in the
nucleus (NC2 vs. NC3 p = 0.0178). However, at the transcriptional level, significant changes relating to
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NQO1 transcriptional activity in FaDu were not detected, neither under NC2 (accurately measured),
nor under NC3 (approximated).
Cal 27 was the cell line with the lowest basal level of NRF2 (Figure 10A,B, NC1—nuclear fraction).
Probst et al. were able to show that the cell lines with high basal NRF2 activity exhibited little or no
increase in NQO1 mRNA levels following NRF2 activation with the compound RTA 405 [56]. We think
this fact can explain part of our results obtained on NQO1 transcripts.
4.2. Importance of Defining the SNVs, in a Given Experimental Model
When NQO1 transcripts were quantified, a significant increase of the NQO1 transcript was shown
only in IMR-90 and Cal 27 but not in FaDu (under NC2) and Detroit 562. Unfortunately, however high
was the expression in IMR-90, there was a minimal amount of NQO1 protein. The level of the NQO1
transcript in IMR-90 was strong and it did not differ from the mRNA NQO1 signal in the cancer cell
lines. A majority of research groups had not detected NQO1 protein in IMR-90 (at least not under
restful conditions). However, it seems that nobody reported the data on the IMR-90 NQO1 genotype.
After performing the DNA sequencing, it was concluded that this cell line is a NQO1*2/*2 homozygote
(rs180566). Some inconclusive data obtained on another human fibroblast cell line, WI-38, encouraged
us to analyze it in the same way. It was shown that WI-38 also bears rs180566 but is a heterozygote
(NQO1*1/*2) cell line. Thus, at least with respect to NQO1, IMR-90 and WI-38 are not normal fibroblasts.
Accordingly, any conclusion obtained on one cell line cannot be automatically translated to another (or
any other) cell line. Regarding rs180566, detailed modeling performed by Lienhart et al. [43] did not
provide a structure-based explanation for the lower enzymatic activity of NQO1 P187S. A plausible
explanation given in an in vivo model by Tsvetkov et al., should be considered in light of discovering
that E3 ligase STUB1/CHIP (C terminus of Hsc70-interacting protein) regulates the NQO1 protein
level through ubiquitination and degradation [57]. The heterozygote P187S (rs180566) was shown
to be a stronger STUB1 interactor with an increased susceptibility to ubiquitination by the E3 ligase
STUB. Thus, we concluded that the homozygote, S187S, may have even stronger affinity for STUB1.
This finally resulted in an almost undetectable NQO1 in IMR-90, notwithstanding the increase of NQO1
transcriptional activity (Figure 3; Figure 4) under NC3 which was associated with a physiological
increase of nuclear NRF2 (Figure 10B). An increased sensitivity of IMR-90 to NC2 may be a consequence
of lacking a strong mechanism for influencing the NAD(P)+/NAD(P)H redox balance during the
stress-related events, due to catalytically insufficient NQO1.
4.3. FaDu Proliferative Potential with Respect to GLS1 and Decreased Sensitivity to Glutamine When Deprived
of Glucose
It was very interesting to see that that the effect of glutamine on FaDu, with respect to proliferative
potential when deprived of glucose, exerts a less positive effect than with Cal 27 and Detroit 562
(Figure 2B). The enzyme, Glutaminase 1 (GLS1), enables malignant cells to undergo increased
glutaminolysis and utilization of glutamine as an alternative nutrient. A recently published study has
clearly shown that the expression of GLS1 in FaDu is far less prominent than in Detroit 562 cells [58].
Thus, the capacity of FaDu for glutamine utilization seems to be constitutively decreased. Although we
did not measure GLS1, we hypothesized that the less prominent rescuing effect of glutamine on FaDu
than on Detroit 562 and Cal 27, in the absence of glucose, occurs as a result of low basal expression of
GLS1 In IMR-90, GLS1 is also present at a low level and its pharmacological inhibition does not change
the level of intracellular ATP [59]. Sandulache et al. discovered that a majority of HNSCC cancer
cell lines show a dependence on glucose and not glutamine [60]. This study also referred to FaDu.
However, FaDu, as contrasted with all of the other 14 tested HNSCC (Detroit 562 and Cal 27 were
not included in the panel), did not exert a similar rate of sensitivity to non-metabolizable D-glucose
analogues. The data was: IC50 10.90 (FaDu) versus IC50 0.79 with UMSCC22B—the most sensitive
cell line.
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4.4. NQO1 and Its Splice Variants—TaqMan Probes Validation
Regardless of the conditions applied, three NQO1 transcript variants were detected. Based on WB
analyses, only the longest one, TV1, as compared with the other two, TV3 and TV4, seemed to translate
in the mature protein. The change of the ratio TV1/TV3 was measured. We have shown that only in Cal
27, under NC3, did this ratio increase. It decreased in the other three cell lines. It is unfortunate that the
NQO1 transcript fold change under NC3 in FaDu could not be accurately measured (Figure 3F), where
there was a significant decrease of the TV1/TV3 ratio (Figure 6). Based on the Ct values, we estimated
that the NQO1 transcription, under NC3, does not significantly vary from the control condition (NC1)
(Figure 3). The change of TV1/TV3 ratio was not influenced by rs1131341 [31], as all cell lines had the
same genotype with respect to this SNV. Thus, we concluded that the change TV1/TV3 depends on
both conditions applied and the cell-type specific response, which clearly differentiated Cal 27 from
other cell lines [61]. It is possible that, through this mechanism, this cell line compensates NQO1 basal
activity, which is significantly lower (90 U) than the NQO1 activity in Detroit 562 (790 U) and FaDu
(1400 U) [36]. It also raises a question with respect to compensatory mechanisms associated not only
with the level of transcription, but also with splicing, when there is a high ROS generation. Cal 27, the
cell line with the lowest NQO1 activity under basal conditions, had the strongest increase of NQO1
transcript and adjusted the TV1/TV3 ratio in favor of TV1. FaDu, the cell line with the highest NQO1
activity under basal conditions, had no increase of NQO1 transcript and reduced the TV1/TV3 ratio.
4.5. Activation of NRF2 and Sensitivity to Glutamine
In the Results section, we presented how some cellular parameters are indicative of a different
sensitivity to glutamine, which is higher in Cal 27 and Detroit 562, and lower in FaDu. How is that to
be explained, in addition to the previously given explanation relating to the cellular transporters? First,
it should be noted that the intensity of the nuclear and cytoplasmic NQO1 signal was far less prominent
in Cal 27 under NC1, than in the other two cancer cell lines (Figure 10A,B). The same phenomenon
was shown in Li’s paper [36]. The reason for less NQO1 protein is not the presence of rs18066, as Cal
27 are NQO1*1/*1. One possibility may be that these cells have a genuinely less active NRF2-KEAP1
pathway. Indeed, Romero et al. have suggested NQO1 as a suitable biomarker for NRF2 activation,
when researching a human KRAS-mutant lung adenocarcinoma (LUAD) [62]. In our experimental
model, this was not shown. However, one can speculate that the NRF2-KEAP1 axis, weaker in Cal 27
than in FaDu and Detroit 562, can be strongly activated. Based on the results presented, Cal 27 cells
indeed have a stronger potential for activating the NRF2-NQO1 axis than the other two cancer cell
lines. The activation of the NRF2-KEAP1 axis, which was shown to be, according to the majority of the
parameters measured, highly dependent on glutamine [63], needs to be explored further in dynamic
and not end-point experiments.
4.6. TP53 and Its Potential to Influence Phenomena Observed
Regarding the influence of MT TP53 on NRF2, there are many data, but there are no conclusions.
Lisek et al. showed that mutant TP53 increases NRF2 localization to the nucleus of cancer cells,
where it redirects NRF2 to ARE elements of specific genes to activate their transcription. Conversely,
it sequesters NRF2 from other targets, leading to their downregulation [64]. Kalo et al. have shown that
induction of stress in HCT116 cells bearing TP53 mutant R273H results in NRF2 nuclear accumulation.
However, the transcription of target genes was induced to a much lesser extent than in HCT116 without
TP53 activity (TP53−/−). They also showed that the down-regulation of endogenous mutant TP53,
results in increased mRNA levels of NQO1 and Hem Oxygenase (HMOX-1). Thus, they proposed
that MT TP53 promotes the survival of cells with high level ROS [65]. Under NC3, a decrease of
nuclear TP53 in Cal 27 is related to an increased transcription rate of NQO1. At the same time, the
strong increase of TP53 in the nuclei of FaDu under NC3 may be associated with its silencing effect on
NQO1 transcription (as estimated). This would be in accord with Kalo’s results, at least at the level of
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transcriptional activity of only NQO1. When we measured the transcriptional activity of HMOX-1,
a tremendous transcriptional activity of HMOX-1 in IMR-90 and FaDu under NC3 was recorded (data
not shown). This does not necessarily mean that this increased transcription relies on NRF2, as we
need to perform chromatin immunoprecipitations and selective silencing in order to understand the
molecular mechanisms involved.
One important aspect of the events which seems connected to accumulating phenomena related
to nutritional stress and TP53, may be on an entirely different level. The ubiquitin ligase Mdm-2,
which mediates TP53 degradation in the proteasome [66], is a transcriptional target of TP53 [67].
Qie et al. [68] reported the upregulated transcription of MDM2 in Hep3B cells cultured in a glutamine
free medium, despite the homozygous deletion of TP53, pointing to the existence of alternative
regulatory mechanisms. Considering the role of MDM2 in TP53 degradation, if the reported increase in
MDM2 transcripts translates to an increased protein level, one would expect a decrease in the TP53 upon
glutamine deprivation in TP53 expressing cells. Although it is seemingly surprising, a redistribution
of TP53 among cellular compartments (cytoplasm and nucleus) was observed, rather than its decrease
in the cells deprived of glutamine (NC3; Figure 10B). A possible explanation for this effect may be
the nuclear retention of TP53 due to its poly(ADP-ribosyl)ation that prevents TP53 interaction with
the nuclear export receptor CRM1 [69]. Chiodi et al. recently reported that glucose and/or glutamine
deprivation causes very rapid PARP-1 activation and protein poly(ADP-ribosyl)ation [70]. This is
consistent with the intracellular distribution of TP53 that was observed in all the tested cells grown in a
low glucose medium (NC2) or glucose- and glutamine-free medium (NC3) (Figure 10C). Namely, in all
cell lines, TP53 was less abundant in the cytoplasm of the cells grown under NC2 and almost completely
absent in the cytoplasm of the cells simultaneously deprived of glucose and glutamine (NC3). Contrary
to cytoplasm, a significant amount of TP53 was present in the nuclear fraction. The retention of TP53 in
the nuclei of all cells exposed to NC2 and NC3, regardless of their TP53 mutational status, is consistent
with the report that three amino acids (E258, D259 and E271) are the targets of poly(ADP-ribosyl)ation,
and that TP53 failed to get poly(ADP-ribosyl)ated only when all three of them were replaced with
alanine [69]. Therefore, poly(ADP-ribosyl)ation can retain both mutant and WT TP53 in the nucleus.
The importance of NQO1 activity for TP53 accumulation in the cell strongly argues in favor
of the involvement of poly(ADP-ribosy)lation in TP53 stabilization. This is because it was shown
that the inhibition of NQO1 activity by dicumarol induces proteasomal degradation of WT and MT
p53 [18]. The enzymatic activity of NQO1 is needed for generating NAD+, which is a co-substrate for
PARP-1 that transfers ADP-ribose moieties from NAD+ to proteins including TP53 [71]. Experimentally
induced PARP-1 or NAD+ deficiency has been reported to result in a significantly reduced level
and activity of TP53 [72]. Therefore, the accumulation of TP53 in the nuclei of the cells exposed to
glucose and glucose/glutamine deprivation (NC2 and NC3), may be partly mediated by NQO1 (and
other oxidoreductases like WOX1 [73]. Asher et al. [18] suggested that, considering the presence of
several putative TP53-binding elements in NQO1 promoter, NQO1 may belong to TP53-inducible
genes involved in a positive autoregulatory loop that regulates the level of TP53. Therefore, the
mutational status of TP53 may have a profound influence on NQO1 expression in cells that are exposed
to nutritional stress.
5. Conclusions
After modulating FaDu, Cal 27 and Detroit 562 for the vital cellular parameters of viability,
proliferation and generation of ROS while cultivating them under four different nutritional conditions
(NC1-NC4), some general conclusions can be drawn: (a) In relation to all three parameters analyzed,
these cell lines showed sensitivity to glucose deprivation; (b) when having available minimal amounts
of glucose and glutamine (NC2) FaDu, Cal 27, Detroit 562 responded strongly with respect to all three
parameters; (c) only FaDu cells showed an increased need for glucose, not glutamine (NC3 versus
NC4), for sustaining replication activity. A strong increase of ROS influences the NRF2-NQO1 axis
in these cells in a fashion which is apparently cell-type specific. When considering the activation of
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the axis through NRF2 nuclear accumulation, the strongest response under a milder condition (NC2)
was recorded in FaDu, associated with a decrease of the nuclear TP53 signal. Under harsh conditions
(NC3), Cal 27 and Detroit 562 responded with NRF2 nuclear accumulation, associated again, with
a decrease of the nuclear TP53 signal. Obtaining the same phenomena under different conditions
(Cal 27 and Detroit 562 versus FaDu) pointed out the differences in response to identical stress, which
correlates with the fact that only FaDu cells did not recover their replicative potential when deprived
of glucose, in the presence of glutamine.
When considering the activation of the axis through an increase in NQO1 transcription, only Cal
27 responded adequately, through an increase in the NQO1 transcription rate and a modulation of
alternative splicing, in favor of TV1. FaDu responded in an entirely different fashion, with a decrease
in NQO1 transcript and a modulation of alternative splicing, in favor of TV3. These responses may be
consequential with respect to NQO1 enzymatic activity in Cal 27 and FaDu, which was previously
shown to be 15 times higher in FaDu. Thus, the whole response of the NRF2-NQO1 axis to stress
should be considered in the broader context of the cellular background.
Detroit 562 is the cell line which moderately activated its NRF2-NQO1 axis, on both the
transcriptional and protein level. It is the only cancer cell line which had no significant increase of
ROS, under NC2.
Fibroblasts IMR-90 were entirely dependent on glucose. These cells exhibited a physiological
cellular response relating to the activation of NRF2-NQO1 axis during nutritional stress, which resulted
with hardly detectable NQO1 signals when compared to the cancer cell lines. IMR-90 are homozygous
– NQO1*2/*2, with respect to rs1800566.
Without making the genotyping in respect to rs1800566, we would still be confident that IMR-90
indeed are NQO1 non-expressing cells. According to all available data, their rs1800566 genotype
directs an extremely high rate of the NQO1 protein degradation, although the NRF2-NQO1 axis in
these cells activates during nutritional stress.
Thus, when making important conclusions on the strength of the NRF2-NQO1 axis through NQO1
protein level/enzymatic activity, the status of rs1800566, as well as specifics of the cellular background,
are always relevant and must be considered.
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AMPK 5′AMP-Activated Protein Kinase
ARE Antioxidant Response Element
ATCC American Type Culture Collection
ATP Adenosine Triphosphate
BrdU 5-Bromo-2′-Deoxyuridine
COSMIC Catalogue of Somatic Mutations In Cancer
DCFH-DA 2′,7′-Dichlorofluorescin Diacetate
DMEM Dulbecco’s Modified Eagle’s Medium
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FAD Flavin Adenine Dinucleotide





HCT116 Human Colorectal Carcinoma
HIF-1α Hypoxia-Inducible Factor, Alpha Subunit
HMOX-1 Heme Oxygenase 1
HNSCC Head and Neck Squamous Cell Carcinoma
HPRT1 Hypoxanthine Phosphoribosyltransferase 1
HSP90 Heat Shock Protein 90
IR-C Intron Retention Complex
IR-S Intron Retention Simple
KEAP-1 Kelch-Like ECH-Associated Protein 1
LUAD Lung Adenocarcinoma
Mdm-2 Mouse Double Minute 2 Homolog
MT Mutated
NADH/NAD+ Nicotinamide Adenine Dinucleotide
NADPH/NADP+ Nicotinamide Adenine Dinucleotide Phosphate
NC Nutritional Condition
NC1 Nutritional Condition 1
NC2 Nutritional Condition 2
NC3 Nutritional Condition 3
NC4 Nutritional Condition 4
NFE2L2 (NRF2) Nuclear Factor (Erythroid-Derived 2)-Like 2
NHLF Normal Human Lung Fibroblasts
NQO1 NAD(P)H:Quinone Oxidoreductase 1
PARP-1 Poly (ADP-Ribose) Polymerase 1
PCR Polymerase Chain Reaction
PPP Pentose Phosphate Pathway
ROS Reactive Oxygene Species
RT-qPCR Reverse Transcription-QuantitativePolymerase Chain Reaction
SIRT1 Sirtuin 1
SLC7A11 Solute-Like Carrier Family 7, Member 11
SLC7A3 Solute-Like Carrier Family 7, Member 3
SNP Single-Nucleotide Polymorphism
SNV Single Nucleotide Variant
TBP TATA-Box Binding Protein
TBS Tris-Buffered Saline
TBST Tris Buffered Saline with Tween-20
TE buffer Tris-EDTA Buffer
TP53 Tumor Protein P53
TV Transcript Variant
WOX1 WUSCHEL Related Homeobox 1
WT Wild-Type
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28. Krajka-Kuźniak, V.; Paluszczak, J.; Baer-Dubowska, W. The Nrf2-ARE signaling pathway: An update on
its regulation and possible role in cancer prevention and treatment. Pharmacol. Rep. 2017, 69, 393–402.
[CrossRef] [PubMed]
29. Dhakshinamoorthy, S.; Porter, A.G. Nitric oxide-induced transcriptional up-regulation of protective genes by
Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J. Biol. Chem. 2004,
279, 20096–20107. [CrossRef]
30. Gasdaska, P.Y.; Fisher, H.; Powis, G. An alternatively spliced form of NQO1 (DT-diaphorase) messenger
RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
Cancer Res. 1995, 55, 2542–2547.
31. Pan, S.-S.; Han, Y.; Farabaugh, P.; Xia, H. Implication of alternative splicing for expression of a variant
NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T. Pharmacogenetics
2002, 12, 479–488. [CrossRef] [PubMed]
32. Yao, K.S.; Godwin, A.K.; Johnson, C.; O’Dwyer, P.J. Alternative splicing and differential expression of
DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to
mitomycin C treatment. Cancer Res. 1996, 56, 1731–1736. [PubMed]
33. Parenteau, J.; Maignon, L.; Berthoumieux, M.; Catala, M.; Gagnon, V.; Abou Elela, S. Introns are mediators of
cell response to starvation. Nature 2019, 565, 612–617. [CrossRef] [PubMed]
34. Pleiss, J.A.; Whitworth, G.B.; Bergkessel, M.; Guthrie, C. Rapid, transcript-specific changes in splicing in
response to environmental stress. Mol. Cell 2007, 27, 928–937. [CrossRef] [PubMed]
35. Tsalikis, J.; Pan, Q.; Tattoli, I.; Maisonneuve, C.; Blencowe, B.J.; Philpott, D.J.; Girardin, S.E. The transcriptional
and splicing landscape of intestinal organoids undergoing nutrient starvation or endoplasmic reticulum
stress. BMC Genom. 2016, 17, 680. [CrossRef] [PubMed]
36. Li, L.-S.; Reddy, S.; Lin, Z.-H.; Liu, S.; Park, H.; Chun, S.G.; Bornmann, W.G.; Thibodeaux, J.; Yan, J.;
Chakrabarti, G.; et al. NQO1-mediated tumor-selective lethality and radiosensitization for head and neck
cancer. Mol. Cancer Ther. 2016, 15, 1757–1767. [CrossRef] [PubMed]
37. Punganuru, S.R.; Madala, H.R.; Arutla, V.; Zhang, R.; Srivenugopal, K.S. Characterization of a highly specific
NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging. Sci. Rep.
2019, 9, 8577. [CrossRef] [PubMed]
38. Green, M.R.; Sambrook, J. Isolation of high-molecular-weight DNA using organic solvents. Cold Spring Harb.
Protoc. 2017, 2017, pdb.prot093450. [CrossRef] [PubMed]
39. Rasband, W.S. ImageJ. 1997–2018; U. S. National Institutes of Health: Bethesda, MD, USA. Available online:
https://imagej.nih.gov/ij/ (accessed on 11 July 2019).
40. Krzystek-Korpacka, M.; Hotowy, K.; Czapinska, E.; Podkowik, M.; Bania, J.; Gamian, A.; Bednarz-Misa, I.
Serum availability affects expression of common house-keeping genes in colon adenocarcinoma cell lines:
Implications for quantitative real-time PCR studies. Cytotechnology 2016, 68, 2503–2517. [CrossRef] [PubMed]
41. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res.
2001, 29, e45. [CrossRef] [PubMed]
42. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [CrossRef]
65
Cells 2019, 8, 1001
43. Lienhart, W.-D.; Gudipati, V.; Uhl, M.K.; Binter, A.; Pulido, S.A.; Saf, R.; Zangger, K.; Gruber, K.; Macheroux, P.
Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone
oxidoreductase(1.). FEBS J. 2014, 281, 4691–4704. [CrossRef] [PubMed]
44. Wu, Y.; Wang, X.; Chang, S.; Lu, W.; Liu, M.; Pang, X. β-Lapachone induces NAD(P)H:quinone
oxidoreductase-1- and oxidative stress-dependent heat shock protein 90 cleavage and inhibits tumor
growth and angiogenesis. J. Pharmacol. Exp. Ther. 2016, 357, 466–475. [CrossRef] [PubMed]
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Abstract: Charcot–Marie tooth disease is a hereditary polyneuropathy caused by mutations in
Mitofusin-2 (MFN2), a GTPase in the outer mitochondrial membrane involved in the regulation
of mitochondrial fusion and bioenergetics. Autosomal-dominant inheritance of a R94Q mutation
in MFN2 causes the axonal subtype 2A2A which is characterized by early onset and progressive
atrophy of distal muscles caused by motoneuronal degeneration. Here, we studied mitochondrial
shape, respiration, cytosolic, and mitochondrial ATP content as well as mitochondrial quality control
in MFN2-deficient fibroblasts stably expressing wildtype or R94Q MFN2. Under normal culture
conditions, R94Q cells had slightly more fragmented mitochondria but a similar mitochondrial oxygen
consumption, membrane potential, and ATP production as wildtype cells. However, when inducing
mild oxidative stress 24 h before analysis using 100 μM hydrogen peroxide, R94Q cells
exhibited significantly increased respiration but decreased mitochondrial ATP production. This was
accompanied by increased glucose uptake and an up-regulation of hexokinase 1 and pyruvate
kinase M2, suggesting increased pyruvate shuttling into mitochondria. Interestingly, these changes
coincided with decreased levels of PINK1/Parkin-mediated mitophagy in R94Q cells. We conclude
that mitochondria harboring the disease-causing R94Q mutation in MFN2 are more susceptible to
oxidative stress, which causes uncoupling of respiration and ATP production possibly by a less
efficient mitochondrial quality control.
Keywords: oxidative stress; MFN2; mitochondria; fusion/fission
1. Introduction
Charcot–Marie tooth (CMT) disease is one of the most common inherited peripheral neuropathies
with a prevalence rate of 1/2500. It is clinically characterized by progressive muscle weakness
and atrophy and can be classified by electrophysiological and histological criteria as demyelinating
(CMT 1) or axonal (CMT 2) [1]. Mutations in the protein Mitofusin-2 (MFN2), a GTPase of the outer
mitochondrial membrane involved in mitochondrial fusion, causes the axonal subtype 2A which can
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be inherited in an autosomal-dominant and recessive manner. Regardless of the inheritance pattern or
the clinical manifestation of the peripheral neuropathy, the testing for MFN2 gene mutations has been
recommended as a first-line analysis in the axonal subtype [2].
The vital role of MFN2 or its close homologue MFN1 has been demonstrated in mice deficient in
either of these mitofusins as it results in embryonic lethality during mid-gestation [3]. MFN2 not only
controls fusion of the outer mitochondrial membrane [4] but also plays a critical role in the metabolic
functions of mitochondria. Suppression of MFN2 expression reduces mitochondrial membrane
potential, cellular respiration and mitochondrial proton leak [5]. Conversely, overexpression of
MFN2 increased cellular respiration even when expressed as a fusion-inactive deletion mutant [6].
Others, including us, found increased cellular respiration in MFN2-deficient mouse embryonic
fibroblasts (MEFs) compared to wildtype controls [7,8] and we recently reported that these discrepancies
might be due to differences in redox conditions sensed by the thiol switch cysteine 684 [8]. MFN2 is
also a key determinant of so-called mitochondria-endoplasmic reticulum (ER) contact sites (MERCS),
also known as mitochondria-associated membranes (MAMs), which represent hot spots of interactions
and serve as important signaling hubs between these cellular organelles. MFN2 occurs on both sides of
MAMs and apparently tethers the ER to mitochondria by homo- and heterotypic complexes with itself or
its homologue MFN1 [9]. This traditional view that lack of MFN2 loosens ER-mitochondria interaction
and thereby mitigates the inositol-1,4,5-trisphosphate (IP3) receptor dependent Ca2+ flux from the ER
to mitochondria [9], has, however, recently been challenged. By using elaborate electron microscopy
techniques, Cosson et al. found increased ER-mitochondria juxtaposition in MFN2-deficient cells [10],
thus the opposite of what was previously thought. This was later reproduced using a whole array of
different techniques and it was concluded that MFN2 rather works as a tethering antagonist preventing
an excessive, potentially toxic proximity between the two organelles [11]. However, even this was
challenged and reduced levels of the mitochondrial Ca2+ uniporter (MCU) were introduced as an
additional complicating factor [12]. It is probably safe to conclude that MFN2 is involved in MAM
formation and integrity.
Züchner et al. were the first to identify a heterozygous 281G-A transition in the MFN2 gene
in a Russian kindred with CMT2A2A with an age of disease onset between 3 and 17 years [13].
This mutation results in an arginine 94 to glutamine (R94Q) substitution in a helix bundle preceding
the GTPase domain of the protein. Transgenic mice expressing this mutation in human MFN2 develop
locomotor impairments and gait defects. This phenotype coincided with distal axon accumulation
of mitochondria in the sciatic nerve [14] and mitochondrial respiratory chain defects of complexes II
and V associated with a drastic decrease of ATP synthesis [15]. Using the same model and elaborate
techniques to quantify mitochondrial ATP and hydrogen peroxide in resting or stimulated peripheral
nerve myelinated axons in vivo, it was recently demonstrated that R94Q mitochondria fail to match the
increased demand of ATP production in stimulated axons whereas the production of H2O2 was almost
unaffected. The authors concluded that neuropathic conditions uncouple the production of reactive
oxygen species (ROS) and ATP, thereby potentially compromising axonal function and integrity [16].
Finally, R94Q MFN2 appears to lead to reduction in MERCS both in CMT2A patient-derived fibroblasts
and primary neurons in vitro and in vivo in motoneurons of the above-mentioned mouse model of
CMT2A [17]. This was associated with increased ER stress, defective Ca2+ handling, and alterations in
the geometry and axonal transport of mitochondria [17].
In this contribution, we studied mitochondrial shape, respiration, and mitochondrial quality
control in MFN2-deficient fibroblasts stably expressing wildtype or R94Q MFN2. We found that
mild oxidative stress induced by 24 h pretreatment with 100 μM hydrogen peroxide significantly
increased respiration but decreased mitochondrial ATP generation in R94Q—but not in wildtype
cells. This coincided with a defective PINK1/Parkin-mediated mitophagy. Our results suggest that the
disease-causing R94Q mutation in MFN2 uncouples mitochondrial respiration from ATP production
by a less efficient mitochondrial quality control under conditions of mild oxidative stress.
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2. Materials and Methods
2.1. Cell Culture
Cell culture experiments were carried out with Mfn2−/− and Mfn2+/+ MEF [3] kindly provided
by Timothy Shutt (University of Calgary). Cells were grown according to standard methods under
controlled conditions using in DMEM High Glucose (Sigma-Aldrich) supplemented with 10% (v/v)
fetal calf serum (FCS, Thermo Scientific, Waltham, MA, USA), 100 U/mL penicillin and 100 μg/mL
streptomycin (Thermo Scientific, Waltham, MA, USA) at 37 ◦C in a humidified incubator (5% CO2).
The PiggyBac system was used to create cells stably expressing HA-MFN2-IRES-mCherry-NLS
constructs followed by enrichment of mCherry-positive cells using fluorescence-activated cell sorting
essentially as described [18].
2.2. Immunoblotting
Cell were lysed with RIPA buffer and subjected to SDS-Page and immunoblotting according to
standard methods essentially as described [8,19]. Primary antibodies were anti-MFN2 mAB (1:500;
Abnova, Taipei City, Taiwan), anti-G6PD (1:1000; Cell Signaling, Danvers, MA, USA), anti-PKM1/2
(1:1000; Cell Signaling), anti-Hexokinase I (1:1000; Cell Signaling), anti-Hexokinase II (1:1000; Cell
Signaling) and anti-Actin mAB (1:4000; Merck Millipore, Burlington, MA, USA). Protein bands were
revealed and analyzed following incubation for 1 h at room temperature with a secondary goat
anti-mouse IgG antibody conjugated to an infrared fluorescent dye (IRDye 800, Licor, Bad Homburg,
Germany) using the Odyssey near infrared laser imaging system (Licor, Bad Homburg, Germany).
For mitophagy induction, cells were treated with 10 μM carbonyl cyanide 3-chlorophenylhydrazone
(CCCP) for the indicated time under normal culturing conditions. The reaction was stopped by
washing steps with PBS and cell lysis with RIPA buffer.
2.3. Measurement of Mitochondrial Oxygen Consumption
Intact MEF cells were monitored for mitochondrial oxygen consumption using a high-resolution
respirometer (Oxygraph-2k, Oroboros Instruments, Innsbruck, Austria) as previously described [8,19]
using identical substrates and inhibitors purchased from Sigma-Aldrich (St. Louis, MO, USA).
Briefly, after recording routine respiration, ATP synthase activity was inhibited by 2.5 μM oligomycin
to determine leak respiration. Stepwise addition of 0.5 μM carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone (FCCP) was performed to reveal the maximum capacity of the electron transfer
system (ETS). Non-mitochondrial residual oxygen consumption (ROX) was determined following
inhibition of respiration by application of 0.5 μM rotenone and 2.5 μM antimycin A. Mitochondrial
respiration changes in response to redox alterations were examined after 24 h pretreatment of cells with
100 μM hydrogen peroxide (H2O2). All experiments were carried out after correction of instrumental
background and calibration of the polarographic oxygen sensors. Data analysis was done using the
DatLab Software 5.1 (Oroboros Instruments, Innsbruck, Austria) as described [8,19] and all values
were corrected for ROX and instrumental background.
2.4. Cell Proliferation Assay
MEF cells were seeded into white 96-well plates at a density of 750 cells/well. The same day,
NanoLuc luciferase and substrate (G9711, Promega, Madison, WI, USA) were added simultaneously
to the cell culture media. Metabolically active cells can reduce the substrate, which in turn can react
with the luciferase. Total luminescence was directly measured using the Infinite 2000 Pro microplate
reader (Tecan, Männedorf, Switzerland). After 24 h, the luminescence was measured a second time
and the cells were treated with 100 μM H2O2. The luminescence was measured again after 24 h and
48 h. Data are expressed as proliferation rate normalized to the first day (proliferation rate = 0).
70
Cells 2019, 8, 1289
2.5. Quantification of ATP Levels
Relative ATP levels were determined with BTeam, a BRET-based ATP biosensor [20]. MEF cells
were seeded into white 96-well plates at a density of 2000 cells/well and transfected 24 h later
using TurboFectin reagent (OriGene, Rockville, MD, USA) with BTeam lacking a targeting sequence
(for cyto-ATP determination) or containing a mitochondrial targeting sequence (for mito-ATP
determination). After 24 h, cells were treated with H2O2 for additional 24 h and then incubated for
30 min in phenol red-free DMEM containing 10% FBS, and 30 μM NanoLuciferase (NLuc) inhibitor to
prevent unintended detection of BTeam released from dead cells. Cells were subsequently incubated
for 20 min in the presence of NLuc substrate (Promega, Madison, WI, USA) and the luminescence was
measured at 520/60 nm (ex/em) (Yellow Fluorescent Protein (YFP) emission) and at 430/70 nm (ex/em)
(NLuc emission) at 37 ◦C. Data are expressed as YFP/NLuc emission ratio.
2.6. Measurement of Total Cellular GSH
Cells were plated in a 6-well plate at a density of 200,000 cells/well, treated 24 h later for two
different time periods (2 h and 24 h) with 100 μM H2O2. Cells were washed twice with ice-cold PBS
and resuspended in 200 μL SSA/HCl buffer containing 1.3% w/v sulfosalicylic acid and 8 mM HCl
in KPE buffer. For KPE buffer, 0.1 M solutions of KH2PO4 and K2HPO4 were prepared; 16 mL and
84 mL of these solutions were mixed respectively with 5 mM EDTA in order to obtain 100 mL of a
0.1 M phosphate buffer with a pH of 7.5. Samples were vortexed and incubated on ice for 10 min
and centrifuged at 14,000 rpm for 10 min. The pellet was resuspended in 0.2 N NaOH and incubated
at 37 ◦C overnight, followed by protein quantitation (BC Assay, Interchim). The supernatant was
split into two new microcentrifuge tubes containing 12 μL of triethanolamine/H2O 1:1, for GSH and
GSSG quantification. 2 μL of 2-Vinylpyridine (2-VP, Sigma-Aldrich, prediluted 1:5 in EtOH) was
added to the GSSG tubes and incubated on ice and in the dark for one hour. GSH was then measured
by monitoring NADPH consumption by GSH reductase in KPE assay buffer, containing 2.8 mM
DTNB (5,5′-dithiobis-(2-nitro-benzoic acid)) and 1.3 mM NADPH, at 390 nm using the Infinite
2000 Pro microplate reader (Tecan, Männedorf, Switzerland) and the SpectraMax I3 microplate reader.
The same assay procedure was carried out for the 2-VP treated GSSG samples and the final GSH/GSSG
concentrations were normalized to the total protein amount. All chemicals were obtained from
Sigma-Aldrich (St. Louis, MO, USA).
2.7. Lactate Measurement
Cells were plated in a 6-well plate at a density of 200,000 cells/well and treated after 24 h with H2O2
for additional 24 h. A minimum of 200 μL of the culture medium was removed for lactate quantification,
which was performed by using the Alinity Lactic Acid Reagent Kit (8P2120, Abbott, Chicago, IL, USA)
following the manufacturers’ instructions. The reaction was measured photometrically with the Alinity
c analyzer (Abbott, Chicago, IL, USA). Measured lactate concentrations were normalized to the total
protein amount per well.
2.8. RNA Isolation and PCR
Cells were treated with 100 μM H2O2 for 24 h. RNA of cells was prepared using the
ZR RNA MiniPrep™ kit from Zymo Research (R1064, Irvine, CA, USA) following manufacturers’
instructions. RNA was reversed transcribed using the cDNA synthesis kit (Life Technologies,
4368814). Quantitative real-time PCR was performed with the 7500 Real-Time PCR Systems device
(Applied Biosystems, Foster City, CA, USA) using FAM/Dark quencher probes from the Universal
Probe Library™ (Roche, Basel, Switzerland). The expression was quantified to the relative levels
of the housekeeping gene hypoxanthineguanine phosphoribosyltransferase (HPRT), which was
assessed by FAM-TAMRA probe FAM-CCTCTCGAAGTGTTGGATACAGGGCA-TAMRA and the
primers forward GTTGCAAGCTTGCTGGTGAA and reverse GATTCAAATCCCTGAAGTACTCA.
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For amplification and detection of glutamate-cysteine ligase, catalytic subunit (GCLc), glutathione
S transferase omega 1 (GSTO1), NADPH-quinone-oxidoreductase-1 (NQO1), glutathione peroxidase
1 (GPX1), heme-oxygenase-1 (HO1) and cystine/glutamate transporter (xCT) the following primers
were used: xCT: forward TGGGTGGAACTGCTCGTAAT, reverse AGGATGTAGCGTCCAAATGC,
probe 1 (Universal Probe Library™, Roche). GCL forward GGAGGCGATGTTCTTGAGAC,
reverse CAGAGGGTCGGATGGTTG probe 2 (Universal Probe Library™, Roche). GST1 forward
CAGCGATGTCGGGAGAAT, reverse GGCAGAACCTCATGCTGTAGA, probe 60 (Universal Probe
Library™, Roche). GPX1: forward TTTCCCGTGCAATCAGTTC, reverse TCGGACGTACTTGAGGGAAT,
probe 2 (Universal Probe Library™, Roche). HO1: forward GTCAAGCACAGGGTGACAGA,
reverse ATCACCTGCAGCTCCTCAAA, probe 4 (Universal Probe Library™, Roche). NQO1: forward
AGCGTTCGGTATTACGATCC, reverse AGTACAATCAGGGCTCTTCTCG, probe 50 (Universal Probe
Library™, Roche, Basel, Switzerland). RNAse-free water was used as the non-template control. Analysis
of the results was performed using the ΔΔCT-method. All conditions were normalized to their untreated
control group.
2.9. Microscopy and Image Analysis
For microscopic image analysis, cells were plated into 8-well-glass-bottom slides (IBIDI, Gräfelfing,
Germany) to reach a final cell confluency of 60–80% on the day of image acquisition. Cells were
exposed to 100 μM H2O2 or vehicle 24 h before image recording. Image acquisition was done with the
confocal microscope Leica TCS SP5 (Leica Microsystems, Wetzlar, Germany) using a 63× oil immersion
objective. For mitochondrial morphology analysis, cells were seeded as described above, cultured
for 24 h in serum-supplemented medium and incubated for 15 min with 0.2 μM MitoTracker Red
CMXRos (Invitrogen, Carlsbad, CA, USA) in serum-free medium. Cells were washed once with PBS
(Sigma-Aldrich) and further incubated for 15 min in serum-supplemented medium. Live cell imaging
was performed with an ex/em of 560/610 nm. Cells were categorized according to their mitochondrial
morphology (tubular, mixed or fragmented) and analyzed by observers blind to the experimental
conditions and genotypes.
Cellular ROS was analyzed by staining with the CellROX reagent (Molecular Probes, Eugene,
OR, USA) in a final concentration of 5 μM for 30 min at 37 ◦C. After thoroughly washing with
PBS, pre-warmed DMEM without phenol red (Thermo Scientific) was added and the fluorescence
intensity was measured at 485/520 nm (ex/em). For glucose uptake measurement, cells were plated
into 8-well-glass-bottom slides (IBIDI, Gräfelfing, Germany). Next day, cells were treated with
100 μM H2O2 or vehicle for 24 h before cells were incubated with the fluorescent d-glucose analog
2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-d-glucose (2-NBDG) (Thermo Scientifc) at a
final concentration of 100 μM for 60 min at 37 ◦C. After washing with PBS for two times, pre-warmed
DMEM without phenol red (Thermo Scientific) was added and the fluorescence intensity was
measured at 465/540 nm (ex/em) and analyzed with ImageJ (Fiji). Transfections were performed with
Lipofectamine 2000 reagent (Thermo Scientific) according to manufacturers’ instructions. Briefly,
100 μL and 125 μL Opti-MEM (Gibco Life Technologies, Waltham, MA, USA) was mixed with 8 μL
Lipofectamine and 2.5 μg DNA, respectively. Subsequently, 90 μL of each solution was mixed and
incubated for 5 min at room temperature before 10 μL was added to each well. Image recording was
carried out 48 h after transfection. Cells were transfected with Mt-Keima (kind gift of Atsushi Miyawaki,
RIKEN Brain Science Institute, Japan) or Mito-Timer (Addgene, Watertown, NY, USA). 24 h after H2O2
treatment for Mt-Keima the intensities of the fluorescence at 620 nm were captured when excited at
550 nm and 438 nm. The intensity was analyzed using ImageJ (Fiji), selecting the cytoplasm of the
cells using regions of interest outside the nucleus and then analyzing the mean intensity. The intensity
at 550 nm was normalized to the intensity at 438 nm. For Mito-Timer, fluorescence intensity was
measured at 561/572 nm (ex/em) and 488/518 nm (ex/em). For measurement of the colocalization of
GFP-Parkin (kind gift of Julia Fitzgerald, University of Tübingen, Germany) and Mito-TurboFarRed
the fluorescence intensity was measured at 488/518 nm (ex/em) for GFP-Parkin and at 633/640 nm
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(ex/em) for Mito-TurboFarRed. Parkin-Mito-TurboFarRed colocalization was measured using the
JACoP plugin of ImageJ (Fiji).
2.10. Statistical Analyses
Statistical analyses were conducted using GraphPad Prism (GraphPad). The respective statistical
tests are mentioned in the figure legends. Statistically significant differences were assumed with
p < 0.05.
3. Results
3.1. More Fragmented Mitochondria but Similar Basal Respiration in Cells Expressing Wildtype and
Disease-Causing R94Q MFN2
We generated cells stably expressing wildtype (WT) or R94Q MFN2 in MFN2 knockout MEFs [3]
to study the effect of the disease-causing mutation R94Q on mitochondrial shape and function.
To avoid potentially toxic antibiotics such as puromycin or G418, which are often used for the
generation of stable cell lines but might affect cellular physiology, we enriched cells expressing
HA-tagged WT and mutant MFN2 inserted into the genome by Piggybac-mediated gene transfer
using several rounds of fluorescence-activated cell sorting. All stably transfected cells expressed
the red fluorescent mCherry reporter protein targeted to the nucleus downstream of an internal
ribosomal entry site (IRES). Cells expressing an additional mCherry before the IRES-mCherry
served as negative control (EV, empty vector). Both cell lines, WT and R94Q, expressed similar
levels of MFN2 shown by immunoblotting (Figure 1a). Analyzing >100 mitotracker-stained cells
classified by blinded investigators into cells containing fragmented, tubular or mixed mitochondria
demonstrated a significantly more fragmented shape of mitochondria in KO + R94Q compared to
KO + WT cells (Figure 1b). We then assessed mitochondrial respiration of intact cells in culture
medium by high-resolution respirometry assessing routine and leak respiration as well as the
maximal electron transfer capacity (ETS). Leak respiration was recorded after addition of the ATP
synthase inhibitor oligomycin and the ETS by titrating the uncoupler and protonophore FCCP as
described [21]. Non-mitochondrial oxygen consumption, ROX, which represents oxygen consumption
of auto-oxidation reactions and other cellular oxygen-consuming enzymes such as oxidase and
peroxidase [21] was recorded after inhibition of complex I with rotenone and of complex III with
antimycin A and subtracted from the routine, leak or ETS values. We observed that oxygen flow
per cell at routine respiration and the ETS was significantly increased in KO cells and in KO cells
expressing EV as previously reported [7,8] whereas overexpression of both WT and R94Q MFN2
similarly rescued the respiration phenotype to levels indistinguishable from the parental wildtype
cells (Figure 1c). We therefore detected no differences between WT and R94Q-expressing cells in
mitochondrial respiration under normal culture conditions.
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Figure 1. Fragmented mitochondria but similar basal respiration in cells expressing wildtype and
disease-causing R94Q MFN2. (A) Immunoblot showing endogenous MFN2 in wildtype (WT) cells and
similar MFN2 protein overexpression levels in MFN2 knockout (KO) cells rescued with wildtype MFN2
(KO +WT) or R94Q MFN2 (KO + R94Q). Actin served as loading control. (B) Increased mitochondrial
fragmentation in KO + R94Q cells. Mitotracker-stained cells were categorized upon their mitochondrial
morphology as tubular, mixed, or fragmented by blinded investigators. A representative picture
of KO + WT and KO + R94Q is shown. (C) Oxygen flow per cells quantitated by high-resolution
respirometry demonstrates similar routine, leak and electron transfer system capacity (ETS) of KO +WT
and KO+R94Q cells. Data are expressed as mean± SEM of n= 4 immunoblots in (A), n= 6 independent
experiments analyzed by two blinded investigators in (B), and n = 5 independent experiments in (C).
Statistical significance was determined using one-way ANOVA and Tukey’s multiple comparison test
(* p < 0.05; n.s., non-significant).
3.2. Mild Oxidative Stress Causes Increased Mitochondrial Fragmentation and Uncoupling in Cells Expressing
R94Q MFN2
We figured that a potential disease-related phenotype might be revealed by stressing the cells
and subjected the cells to conditions of mild oxidative stress induced by low levels of hydrogen
peroxide (100 μM) added once 24 h before analysis. This concentration corresponds to an intracellular
concentration of 1 μM [22] and did not compromise cell survival as examined by microscopy but slightly
slowed down the cellular proliferation rate without differences between WT and R94Q cells (Figure 2a).
The treatment however further increased the number of cells with fragmented mitochondria which
was more pronounced in the R94Q cells (Figure 2b) suggesting that the disease-causing mutation
renders the mitochondria more susceptible to oxidative stress.
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Figure 2. Oxidative stress causes increased mitochondrial fragmentation in cells expressing R94Q MFN2.
(A) Reduced but similar proliferation rate of WT and R94Q cells exposed to H2O2. Similar amounts of
cells were seeded and treated with 100 μM H2O2 24 h later. Luminescence was measured every 24 h for
72 h. Data are expressed as mean proliferation rate ± SEM of n = 4 independent experiments done in
triplicates and normalized to the first day. (B) Relative distribution of mitochondrial morphologies
in mitotracker-stained cells. Cells were categorized according to their mitochondrial morphology as
tubular, mixed, or fragmented. Data are expressed as mean ± SEM of n = 4 independent experiments
analyzed by investigators blind to cell line identity in (B). Statistical significance was determined using
one-way ANOVA and Tukey’s multiple comparison test (* p < 0.05; n.s., non-significant).
To clarify the functional consequences on mitochondrial respiration, we next compared
potential alterations in mitochondrial respiration upon hydrogen peroxide exposure. Interestingly,
hydrogen peroxide had no significant effect on routine, leak and ETS respiration in WT cells but
greatly and significantly increased all parameters in R94Q-expressing cells (Figure 3a). As this very
much resembled the phenotype we recently described for KO cells stably transfected with the mutant
C684A, a mutant that removes a cysteine involved in the process of mitochondrial hyperfusion [23],
we repeated a key experiment of this publication which demonstrated that lack of cysteine 684
increased MFN2 susceptibility to environmental redox alterations. In these experiments, we found
that treating digitonin-permeabilized cells with 1 mM GSH for 10 min greatly reduced respiration in
C684A but not in WT MFN2 cells [8]. To clarify whether R94Q has the same effect, we repeated this
experiment and studied mitochondrial respiration in the presence or absence of GSH and GSSG in
cells permeabilized with digitonin. This, however, revealed no difference between WT and R94Q cells
(Figure 3b) suggesting that the similar increase in respiration of C684A [8] and R94Q upon exposure
to 100 μM H2O2 must be caused by a different mechanism. We next assessed whether this increase
in respiration corresponds to an increased ATP production and transfected the genetically encoded
reporter BTeam [20] targeted to mitochondria or the cytosol into our cells. BTeam measures ATP by
bioluminescence resonance energy transfer (BRET) and is ratiometric, making comparison of different
cell lines feasible. Using this approach, we found no difference between the cell lines at steady state but
a significant drop in mitochondrial ATP after H2O2 exposure only in R94Q cells (Figure 3c). From these
experiments, we concluded that mild oxidative stress causes mitochondrial uncoupling of respiration
and ATP production in cells expressing the disease-causing R94Q mutation.
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Figure 3. Oxidative stress causes increased mitochondrial uncoupling in cells expressing R94Q MFN2.
(A) Representative high-resolution respirometry of intact cell recordings showing oxygen concentration
(blue line) and oxygen flow per cells (red line) over time. Time points of oligomycin (Omy), FCCP (F),
rotenone (Rot) and antimycin A (Ama) additions are indicated. Oxygen flow per cells were corrected
for ROX at the indicated mitochondrial respiration state. Basal cellular routine respiration, leak and
ETS capacity increased in R94Q but not WT treated with 100 μM H2O2 24 h prior to measurement.
(B) High-resolution respirometry of cells permeabilized with digitonin with GSH or GSSG added.
Mitochondrial respiration stimulated by ADP represents complex I (CI) activity, addition of succinate
and ADP corresponds to respiration with convergent input of electrons via complexes I and II into the
respiratory system (CII). Mitochondrial membrane integrity was tested by the application of cytochrome
c. ATP synthase inhibition by oligomycin revealed the leak state (Leak). The electron transfer system
(ETS) capacity at maximum oxygen flow per cells was determined by titration of FCCP and ROX
after antimycin A-induced inhibition of complex III. Data are expressed as mean oxygen flow per cell
corrected for ROX ± SEM at the indicated mitochondrial respiration state. GSH and GSSG had no effect
on mitochondrial respiration. Data in A and B show the mean ± SEM of n = 6 independent experiments.
Statistical significance was determined using multiple t-tests with a false discovery rate (Q) of 1%
according to the two-stage method by Benjamini, Krieger and Yekutieli (* p < 0.05; n.s., non-significant).
(C) Relative ATP levels quantitated by targeting BTeam, a ratiometric BRET-based ATP biosensor to the
cytosol or to the mitochondrial matrix. Data are expressed as YFP/NLuc emissions ratio. Statistical
variation in (C) is shown as Tukey boxplots and significance calculated using student’s t-test comparing
cell lines with and without H2O2 exposure, * p < 0.05, n = 4 independent experiments done in triplicates.
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3.3. Rather Reduced and Not Increased Oxidative Stress in Cells Expressing R94Q MFN2
We reckoned that these changes were provoked by an already higher level of oxidative stress
in R94Q cells or by a larger increase upon treatment with hydrogen peroxide. To investigate
this, we quantitated reactive oxygen levels at baseline and 24 h after 100 μM H2O2 using CellRox,
a membrane-permeable dye that greatly increases in fluorescence upon oxidation. This, surprisingly,
revealed that the untreated R94Q cells had less ROS levels than their WT counterparts (Figure 4a).
Also, hydrogen peroxide increased ROS levels in WT but not in R94Q cells (Figure 4a). As a second
readout, we quantitated oxidized GSH (GSSG) levels in these cells. This, again, demonstrated a trend
toward increased GSSG levels upon treatment in WT in line with the increase in CellRox-quantitated
ROS levels in WT cells (Figure 4b). GSSG levels were reduced in treated R94Q cells when compared
with treated WT cells (Figure 4b). These unexpected results suggested differences in the antioxidant
response between WT and R94Q cells. A major component of the cellular antioxidant response is
regulated by transcriptional mechanisms involving the up-regulation of genes with antioxidant response
elements (ARE) in their promoters [24]. We therefore quantitated the expression levels of several
such genes including glutamate-cysteine ligase, catalytic subunit (GCLc), glutathione S transferase
omega 1 (GSTO1), NADPH-quinone-oxidoreductase-1 (NQO1), glutathione peroxidase 1 (GPX1),
heme-oxygenase-1 (HO1) and xCT [24,25] at the mRNA level using quantitative RT-PCR. This revealed
overall no major differences between the cell lines (Figure 4c); GSTO and the cystine/glutamate antiporter
xCT (also known as SLC7A11) were induced in H2O2-treated cells but at least for xCT significantly less
in R94Q cells again in line with a rather reduced oxidative stress in these cells. Therefore, contrary to
our expectations, the increased respiratory activity of R94Q cells under conditions of mild oxidative
stress could not be explained by basal differences in oxidative stress or a dysregulated antioxidant
response. It is possible that the cells expressing mutant MFN2 have up-regulated antioxidant enzymes
that keep the oxidant levels low under the conditions studied. These enzymes are either not those
investigated here using quantitative RT-PCR or the up-regulation is only apparent at the protein level.
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Figure 4. Reduced and not increased oxidative stress in cells expressing R94Q MFN2. (A) Cells were
stained with CellRox and the intensity in single cells quantitated by confocal microscopy. (B) GSSG was
measured by monitoring NADPH consumption by GSH reductase in 2-vinylpyridine-treated samples.
(C) The mRNA of transcripts involved in the antioxidant response were quantified by real-time RT-PCR
using Taqman primer-probe assays for glutamate-cysteine ligase, catalytic subunit (GCLc), glutathione
S transferase omega 1 (GSTO1), NADPH-quinone-oxidoreductase-1 (NQO1), glutathione peroxidase 1
(GPX1), heme-oxygenase-1 (HO1) and xCT and normalized to the expression of the housekeeping gene
hypoxanthine-guanine phosphoribosyltransferase (hprt). RNAse-free water was used as non-template
control. Analysis of the results was performed using the ΔΔCT-method. All conditions were normalized
to their untreated control group. In all experiments, H2O2 was added 24 h before analysis. Statistical
variation is shown as Tukey boxplots and significance calculated using one-way ANOVA and Tukey’s
multiple comparisons test, * p < 0.05, in (A) n = 3 independent experiments with a total of 150–170
individual cells, in (B) n = 5 independent experiments, in (C) n = 3 independent experiments done
in triplicates.
3.4. Increased Glucose Uptake and Fueling of Mitochondria with Pyruvate in R94Q Cells
Pyruvate is the main fuel for the mitochondrial tricarboxylic acid cycle (TCA) and is generated from
glucose by the consecutive activities of hexokinase and pyruvate kinase (PKM) among other enzymes.
Hexokinase generates glucose 6-phosphate which can be turned into 6-phosphogluconolactone in
the first step of the pentose phosphate pathway (PPP) through the activity of glucose-6-phosphate
dehydrogenase (G6PD) and, instead of entering the TCA, pyruvate generated by PKM can be turned
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into lactate by lactate dehydrogenase (depicted in Figure 5a). A predominance of the PPP was
previously shown by us to play a role in the protection against oxidative stress [19,26]. To study
alterations in the metabolism upstream of the TCA cycle in WT and R94Q cells with and without
exposure to hydrogen peroxide, we quantitated glucose uptake levels using imaging of the specific
dye 2-NBDG, the abundance of hexokinase I (HK1), G6PD and pyruvate kinase PKM1/2 using
immunoblotting, and lactate levels using an enzymatic assay. This revealed a surprising decrease in
glucose uptake respectively levels in WT cells upon H2O2 treatment and an increase in R94Q cells
(Figure 5b). Hexokinase 1, the housekeeping hexokinase, was also significantly increased in R94Q cells
exposed to hydrogen peroxide compared to WT cells (Figure 5c). From the fact that the rate-limiting
enzyme of the PPP, G6PD, was down-regulated in both cell lines upon hydrogen peroxide treatment
and did not differ between the cell lines (Figure 5d), we concluded that the product of hexokinase 1,
glucose 6-phosphate, does not enter the PPP. In contrast, the similar regulation pattern of hexokinase
1 and pyruvate kinase PKM1/2 upon H2O2 exposure (Figure 5e) without significant differences in
lactate levels between the cell lines and conditions (Figure 5f) suggest that the increased pyruvate
generated by pyruvate kinase in H2O2-exposed R94Q cells does not enter glycolysis but instead fuels
the mitochondrial TCA.
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Figure 5. Glucose uptake and fueling of mitochondria with pyruvate in R94Q cells. (A) Scheme
depicting metabolism upstream of the tricarboxylic acid cycle (TCA). G6PD, glutamate 6-phosphate
dehydrogenase; PPP, pentose phosphate pathway; PEP, phosphoenolpyruvate; PKM, pyruvate
dehydrogenase isozyme M; LDHA, lactate dehydrogenase A. (B) Cells were stained with 2-NBDG
and the intensity in single cells quantitated by confocal microscopy. (C–E) Cells were treated with
100 μM H2O2 24 h prior to immunoblotting against (C) hexokinase 1 (HK1), (D) G6PD, (E) PKM
isozymes 1 and 2. Actin served as loading control. Size is indicated. (F) Lactate levels were measured
photometrically and normalized to the protein content of the wells. Statistical variation is shown as
Tukey boxplots and significance calculated using one-way ANOVA and Tukey’s multiple comparisons
test, * p < 0.05, in (A) n = 4 independent experiments with a total of 207–243 individual cells, in (C–E) n
= 2 independent blots with a total of 6 individual lysates, (F) n = 6 measurements.
3.5. Reduced Mitophagy in R94Q Cells
Therefore, R94Q cells exposed to oxidative stress take up more glucose and ramp up TCA
activity but produce less ATP suggesting that these mitochondria are less efficient. We therefore
considered a defect in mitophagy, a mitochondrial quality control system mediated by the proteins
PINK1 and Parkin, as a possible explanation. Faulty removal of unhealthy mitochondria would
80
Cells 2019, 8, 1289
probably lead to mitochondria with less efficient coupling between respiration and ATP production.
In healthy mitochondria the protein PINK1 is continuously imported and rapidly degraded [27].
When PINK1 import is stalled in unfit mitochondria, enough PINK1 kinase activity is present at the
outer mitochondrial membrane to stimulate the translocation of the E3 ubiquitin ligase Parkin to these
mitochondria [28]. Mitochondrial Parkin then ubiquitylates outer mitochondrial membrane proteins
which ultimately leads to degradation of these mitochondria via autophagosomes, a process called
mitophagy. MFN2 was repeatedly identified as being a Parkin target by unbiased methods. In our
cells, dissipation of the mitochondrial membrane potential with the uncoupler CCCP—which activates
Parkin by increasing endogenous PINK1 protein—indeed resulted in ubiquitination and subsequent
degradation of WT but less of R94Q MFN2 (Figure 6a). This effect was most pronounced 2 h after CCCP
addition and had a similar trend for the Parkin target TOM2 whereas VDAC1 was not down-regulated
at this time point (Figure 6b). These results suggested a defect in the removal of unfit mitochondria.
Figure 6. CCCP-induced degradation of MFN2 in R94Q cells. (A) Cells were treated with the uncoupler
CCCP for the indicated time and immunoblotted against MFN2 in (A) and against TOM20 or VDAC1
in (B). Actin served as loading control. Size is indicated. Statistical variation is shown in (A) as Tukey
boxplots and significance calculated using one-way ANOVA and Tukey’s multiple comparisons test,
* p < 0.05 with n = 5 independent experiments and in (B) as individual data points, mean ± SEM.
This was then reproduced using the genetically encoded reporter mitoKeima [29] which can be
used to quantitate the amount of mitochondria being removed by lysosomal degradation. We found
less lysosomal mitochondria in R94Q-expressing cells at steady-state conditions which could be
increased by treatment with hydrogen peroxide but still not to the levels observed in untreated WT
cells (Figure 7a). The same picture emerged when we quantitated the basal colocalization between
Parkin-GFP and mitochondria (Figure 7b). We therefore conclude that the R94Q mutation in MFN2
results in a less efficient mitochondrial quality control leading to uncoupled mitochondrial respiration
and ATP production in conditions of mild oxidative stress.
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Figure 7. Steady-state mitophagy and mitochondrial Parkin localization in R94Q cells. (A) Cells
were transfected with mitochondrially targeted mKeima and fluorescence at 620 nm quantified after
excitation at 550 nm (red) and 438 nm (green) by confocal microscopy. Scale bar is 5 μm. (B) Cells
were transfected with Parkin-GFP and mitochondrially targeted TurboFarRed and the fluorescence
intensity measured at 488/518 (ex/em) for GFP-Parkin and at 633/640 (ex/em) for Mito-TurboFarRed.
Scale bar is 5 μm. Parkin-Mito-TurboFarRed colocalization was quantitated using the JACoP plugin
of ImageJ and is expressed as Pearson’s coefficient. Statistical variation is shown as Tukey boxplots
and significance calculated using one-way ANOVA and Tukey’s multiple comparisons test, * p <0.05,
in (A) n = 5 independent experiments, in (B,C) n = 3 independent experiments with a total of (B) 91–115
and (C) 59–61 individual cells.
4. Discussion
We here investigated how a mutation in MFN2 that causes neuronal degeneration of peripheral
motoneurons in the hereditary polyneuropathy CMT2A alters key characteristics of mitochondria-like
shape, respiration and ATP generation under optimal culture conditions and after a single exposure to
mild oxidative stress. Interestingly, under optimal culture conditions only mitochondrial shape was
affected by the mutation; R94Q cells had more fragmented mitochondria at baseline. The additional
challenge with a low dose of hydrogen peroxide however unmasked additional and probably
relevant changes of respiration and mitochondrial ATP generation. Oxidative challenge triggered
the mitochondria of cells expressing the R94Q variant of MFN2 but not wildtype to produce less
ATP despite an increased oxygen consumption which coincided with an even more fragmented
mitochondrial shape. This additional stress thus caused these mutant mitochondria to behave like cells
completely lacking MFN2 where mitochondrial respiration was also found to be increased (see Figure 1c
and data shown previously [7,8]). It needs to be pointed out, however, that others reported a reduced
mitochondrial membrane potential, cellular respiration and leak after down-regulation by antisense
oligonucleotides in myoblasts [5] or in heart mitochondria obtained from MFN2−/− mice. This is
possibly because these studies were done in skeletal and heart muscle, in tissue and cells, respectively.
Interestingly, the cysteine switch C684A which seems to be implicated in mitochondrial hyperfusion,
a cellular stress response program, does not mediate the response to oxidative stress in this case as
experiments exposing mitochondria to glutathione which attenuates respiration in C684A cells [8]
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had no effect in the CMT2A-R94Q cells. However, oxidative signaling does not only result in direct
modification of so-called thiol switches, reversible modifications of cysteine thiols that play a key
role in redox signaling and regulation [30,31], but can also generate second messengers such as
4-hydroxynonenal (HNE), an amphipathic molecule that is generated in response to lipid oxidation
which can covalently modify residues in many proteins in different cellular compartments including
mitochondria [32]. An effect of HNE on MFN2 has however not been reported yet.
Using mice expressing the R94Q mutation in neurons—of course a much better model of the
disease—others observed a combined defect of mitochondrial complexes II and V associated with
a drastic decrease of ATP synthesis caused by succinate oxidation [15]. Interestingly, these changes
could be reversed by the inhibition of mitochondrial ATP-sensitive potassium channels with
5-hydroxydecanoate [15]. Maybe the hydrogen peroxide challenge affected succinate oxidation.
Others also reported that R94Q mitochondria failed to up-regulate ATP production following burst
neuronal activation [16]. In wildtype neurons, a first burst generated a H2O2 but no ATP peak and
a second burst applied 30 min later generated a second H2O2 peak followed by an ATP rise 20 min
later. In neurons from R94Q mice, this ATP peak was greatly attenuated [16] which is in line with our
findings that prior H2O2 exposure affects ATP production.
In our cells, the mitochondrial uncoupling of ATP generation and respiration triggered by mild
oxidative stress coincided with an altered mitochondrial quality control. We observed a less efficient
degradation of MFN2 upon membrane dissipation which is generally attributed to the PINK1/Parkin
pathway and less Parkin colocalization with mitochondria under steady-state conditions. It was
previously shown that PINK1 phosphorylates MFN2 and promotes Parkin-mediated ubiquitination and
subsequent degradation [33]. In these experiments, accumulation of morphologically and functionally
abnormal mitochondria in MFN2-deficient MEFs induced respiratory dysfunction [33] similar to our
observations. Interestingly, loss of Beclin-1, an important autophagy protein involved in autophagosome
formation and maturation, inhibits CCCP-induced Parkin translocation to mitochondria and MFN2
ubiquitination and degradation [34]. Surprisingly, Beclin-1 depletion also rescued the suppression
of mitochondrial fusion in MFN2-deficient cells [34] suggesting that MFN2 mutation may somehow
affect this pathway although this is difficult to fathom. Alternatively, the mutation could affect
phosphorylation of MFN2 by PINK1 required for Parkin binding and mitochondrial Parkin translocation
which suppresses mitophagy, however, without impairing mitochondrial fusion [35]. It must be
mentioned that others found enhanced, thus not decreased, mitophagy in motoneurons from induced
pluripotent stem cells obtained from patients with CMT2A. This observation was accompanied by
global reduction in mitochondrial content and changes in mitochondrial positioning without significant
differences in survival and axon elongation [36]. These patient-derived neurons show an increased
expression of PINK1, PARK2, BNIP3, and a splice variant of BECN1 that appears to be a trigger for
mitochondrial autophagic removal [36]. It is possible that this splice variant is only expressed in
human motoneurons thus explaining the opposite findings. This view is strengthened by the findings
that MFN2 deficiency in mouse muscle reduced autophagy and impaired mitochondrial quality thus
contributing to an exacerbated age-related mitochondrial dysfunction [37]. Similar to our findings
where the R94Q cells had less reactive oxygen levels under optimal conditions, these authors found that
aging-induced Mfn2 deficiency triggers a ROS-dependent adaptive signaling pathway by induction
of the HIF1α transcription factor and BNIP3 which may compensate for the loss of mitochondrial
autophagy and thereby protect mitochondria [37]. Yet others proposed that different levels of MFN1,
a close homologue of MFN2, could alter the effect of mutant R94Q MFN2 on Parkin-mediated
mitochondrial degradation indicating that augmentation of MFN1 in the nervous system could be a
viable therapeutic strategy for CMT disease [38].
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7. Kawalec, M.; Boratyńska-Jasińska, A.; Beręsewicz, M.; Dymkowska, D.; Zabłocki, K.; Zabłocka, B. Mitofusin
2 Deficiency Affects Energy Metabolism and Mitochondrial Biogenesis in MEF Cells. PLoS ONE 2015, 10,
e0134162. [CrossRef]
8. Thaher, O.; Wolf, C.; Dey, P.N.; Pouya, A.; Wüllner, V.; Tenzer, S.; Methner, A. The thiol switch C684 in
Mitofusin-2 mediates redox-induced alterations of mitochondrial shape and respiration. Neurochem. Int.
2017. [CrossRef]
9. De Brito, O.M.; Scorrano, L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456,
605–610. [CrossRef]
10. Cosson, P.; Marchetti, A.; Ravazzola, M.; Orci, L. Mitofusin-2 Independent Juxtaposition of Endoplasmic
Reticulum and Mitochondria: An Ultrastructural Study. PLoS ONE 2012, 7, e46293. [CrossRef]
11. Filadi, R.; Greotti, E.; Turacchio, G.; Luini, A.; Pozzan, T.; Pizzo, P. Mitofusin 2 ablation increases endoplasmic
reticulum-mitochondria coupling. Proc. Natl. Acad. Sci. USA 2015, 112, E2174–E2181. [CrossRef] [PubMed]
12. Naon, D.; Zaninello, M.; Giacomello, M.; Varanita, T.; Grespi, F.; Lakshminaranayan, S.; Serafini, A.;
Semenzato, M.; Herkenne, S.; Hernández-Alvarez, M.I.; et al. Critical reappraisal confirms that Mitofusin
2 is an endoplasmic reticulum-mitochondria tether. Proc. Natl. Acad. Sci. USA 2016, 113, 11249–11254.
[CrossRef] [PubMed]
13. Züchner, S.; Mersiyanova, I.V.; Muglia, M.; Bissar-Tadmouri, N.; Rochelle, J.; Dadali, E.L.; Zappia, M.;
Nelis, E.; Patitucci, A.; Senderek, J.; et al. Mutations in the mitochondrial GTPase mitofusin 2 cause
Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 2004, 36, 449–451. [CrossRef] [PubMed]
14. Cartoni, R.; Arnaud, E.; Médard, J.-J.; Poirot, O.; Courvoisier, D.S.; Chrast, R.; Martinou, J.-C. Expression of
mitofusin 2R94Q in a transgenic mouse leads to Charcot–Marie–Tooth neuropathy type 2A. Brain 2010, 133,
1460–1469. [CrossRef]
15. Guillet, V.; Gueguen, N.; Cartoni, R.; Chevrollier, A.; Desquiret, V.; Angebault, C.; Amati-Bonneau, P.;
Procaccio, V.; Bonneau, D.; Martinou, J.-C.; et al. Bioenergetic defect associated with mKATP channel opening
in a mouse model carrying a mitofusin 2 mutation. FASEB J. 2011, 25, 1618–1627. [CrossRef]
16. Van Hameren, G.; Campbell, G.; Deck, M.; Berthelot, J.; Gautier, B.; Quintana, P.; Chrast, R.; Tricaud, N.
In vivo real-time dynamics of ATP and ROS production in axonal mitochondria show decoupling in mouse
models of peripheral neuropathies. Acta Neuropathol. Commun. 2019, 7, 86. [CrossRef]
84
Cells 2019, 8, 1289
17. Bernard-Marissal, N.; van Hameren, G.; Juneja, M.; Pellegrino, C.; Louhivuori, L.; Bartesaghi, L.; Rochat, C.;
El Mansour, O.; Médard, J.-J.; Croisier, M.; et al. Altered interplay between endoplasmic reticulum and
mitochondria in Charcot-Marie-Tooth type 2A neuropathy. Proc. Natl. Acad. Sci. USA 2019, 116, 2328–2337.
[CrossRef]
18. Nickel, N.; Cleven, A.; Enders, V.; Lisak, D.; Schneider, L.; Methner, A. Androgen-inducible gene 1 increases
the ER Ca(2+) content and cell death susceptibility against oxidative stress. Gene 2016, 586, 62–68. [CrossRef]
19. Pfeiffer, A.; Schneider, J.; Bueno, D.; Dolga, A.; Voss, T.-D.; Lewerenz, J.; Wüllner, V.; Methner, A. Bcl-xL
knockout attenuates mitochondrial respiration and causes oxidative stress that is compensated by pentose
phosphate pathway activity. Free Radic. Biol. Med. 2017, 112, 350–359. [CrossRef]
20. Yoshida, T.; Kakizuka, A.; Imamura, H. BTeam, a Novel BRET-based Biosensor for the Accurate Quantification
of ATP Concentration within Living Cells. Sci. Rep. 2016, 6, 39618. [CrossRef]
21. Pesta, D.; Gnaiger, E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized
fibers from small biopsies of human muscle. Methods Mol. Biol. 2012, 810, 25–58. [PubMed]
22. Sies, H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative
eustress. Redox Biol. 2017, 11, 613–619. [CrossRef] [PubMed]
23. Shutt, T.; Geoffrion, M.; Milne, R.; McBride, H.M. The intracellular redox state is a core determinant of
mitochondrial fusion. EMBO Rep. 2012, 13, 909–915. [CrossRef] [PubMed]
24. Baxter, P.S.; Hardingham, G.E. Adaptive regulation of the brain’s antioxidant defences by neurons and
astrocytes. Free Radic. Biol. Med. 2016, 100, 147–152. [CrossRef] [PubMed]
25. Nguyen, T.; Nioi, P.; Pickett, C.B. The Nrf2-antioxidant response element signaling pathway and its activation
by oxidative stress. J. Biol. Chem. 2009, 284, 13291–13295. [CrossRef]
26. Pfeiffer, A.; Jaeckel, M.; Lewerenz, J.; Noack, R.; Pouya, A.; Schacht, T.; Hoffmann, C.; Winter, J.; Schweiger, S.;
Schäfer, M.K.E.; et al. Mitochondrial function and energy metabolism in neuronal HT22 cells resistant to
oxidative stress. Br. J. Pharmacol. 2014, 171, 2147–2158. [CrossRef]
27. Narendra, D.; Tanaka, A.; Suen, D.-F.; Youle, R.J. Parkin is recruited selectively to impaired mitochondria
and promotes their autophagy. J. Cell Biol. 2008, 183, 795–803. [CrossRef]
28. Clark, I.E.; Dodson, M.W.; Jiang, C.; Cao, J.H.; Huh, J.R.; Seol, J.H.; Yoo, S.J.; Hay, B.A.; Guo, M. Drosophila
pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006, 441, 1162–1166.
[CrossRef]
29. Katayama, H.; Kogure, T.; Mizushima, N.; Yoshimori, T.; Miyawaki, A. A sensitive and quantitative technique
for detecting autophagic events based on lysosomal delivery. Chem. Biol. 2011, 18, 1042–1052. [CrossRef]
30. Leichert, L.I.; Dick, T.P. Incidence and physiological relevance of protein thiol switches. Biol. Chem. 2015,
396, 389–399. [CrossRef]
31. Groitl, B.; Jakob, U. Thiol-based redox switches. Biochim. Biophys. Acta 2014, 1844, 1335–1343. [CrossRef]
[PubMed]
32. Milkovic, L.; Cipak Gasparovic, A.; Zarkovic, N. Overview on major lipid peroxidation bioactive factor
4-hydroxynonenal as pluripotent growth-regulating factor. Free Radic. Res. 2015, 49, 850–860. [CrossRef]
[PubMed]
33. Chen, Y.; Dorn, G.W. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged
mitochondria. Science 2013, 340, 471–475. [CrossRef] [PubMed]
34. Choubey, V.; Cagalinec, M.; Liiv, J.; Safiulina, D.; Hickey, M.A.; Kuum, M.; Liiv, M.; Anwar, T.; Eskelinen, E.-L.;
Kaasik, A. BECN1 is involved in the initiation of mitophagy: It facilitates PARK2 translocation to mitochondria.
Autophagy 2014, 10, 1105–1119. [CrossRef] [PubMed]
35. Gong, G.; Song, M.; Csordás, G.; Kelly, D.P.; Matkovich, S.J.; Dorn, G.W., II. Parkin-mediated mitophagy
directs perinatal cardiac metabolic maturation in mice. Science 2015, 350, aad2459. [CrossRef] [PubMed]
36. Rizzo, F.; Ronchi, D.; Salani, S.; Nizzardo, M.; Fortunato, F.; Bordoni, A.; Stuppia, G.; Del Bo, R.; Piga, D.;
Fato, R.; et al. Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human
Charcot-Marie-Tooth 2A motor neurons. Hum. Mol. Genet. 2016, 25, 4266–4281. [CrossRef] [PubMed]
37. Sebastián, D.; Sorianello, E.; Segalés, J.; Irazoki, A.; Ruiz Bonilla, V.; Sala, D.; Planet, E.; Berenguer Llergo, A.;
Muñoz, J.P.; Sánchez Feutrie, M.; et al. Mfn2 deficiency links age-related sarcopenia and impaired autophagy
to activation of an adaptive mitophagy pathway. EMBO J. 2016, 35, 1677–1693. [CrossRef]
85
Cells 2019, 8, 1289
38. Zhou, Y.; Carmona, S.; Muhammad, A.K.M.G.; Bell, S.; Landeros, J.; Vazquez, M.; Ho, R.; Franco, A.; Lu, B.;
Dorn, G.W.; et al. Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type
2A model. J. Clin. Investig. 2019, 130, 1756–1771. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Increasing the TRPM2 Channel Expression in Human
Neuroblastoma SH-SY5Y Cells Augments the
Susceptibility to ROS-Induced Cell Death
Xinfang An 1, Zixing Fu 1, Chendi Mai 1, Weiming Wang 1, Linyu Wei 1, Dongliang Li 1,
Chaokun Li 1,* and Lin-Hua Jiang 1,2,*
1 Sino-UK Joint Laboratory for Brain Function and Injury and Department of Physiology and Neurobiology,
Xinxiang Medical University, Xinxiang 453003, China; anxinfang2018@126.com (X.A.);
fuzixing1991@126.com (Z.F.); mcdhsm@163.com (C.M.); wangweiming2015@126.com (W.W.);
wly98124@126.com (L.W.); xyldl8@126.com (D.L.)
2 School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 JT, UK
* Correspondence: lichaokun@hotmail.com (C.L.); l.h.jiang@leeds.ac.uk (L.-H.J.)
Received: 13 November 2018; Accepted: 30 December 2018; Published: 8 January 2019
Abstract: Human neuroblastoma SH-SY5Y cells are a widely-used human neuronal cell model in
the study of neurodegeneration. A recent study shows that, 1-methyl-4-phenylpyridine ion (MPP),
which selectively causes dopaminergic neuronal death leading to Parkinson’s disease-like symptoms,
can reduce SH-SY5Y cell viability by inducing H2O2 generation and subsequent TRPM2 channel
activation. MPP-induced cell death is enhanced by increasing the TRPM2 expression. By contrast,
increasing the TRPM2 expression has also been reported to support SH-SY5Y cell survival after
exposure to H2O2, leading to the suggestion of a protective role for the TRPM2 channel. To clarify
the role of reactive oxygen species (ROS)-induced TRPM2 channel activation in SH-SY5Y cells,
we generated a stable SH-SY5Y cell line overexpressing the human TRPM2 channel and examined
cell death and cell viability after exposure to H2O2 in the wild-type and TRPM2-overexpressing
SH-SY5Y cells. Exposure to H2O2 resulted in concentration-dependent cell death and reduction in
cell viability in both cell types. TRPM2 overexpression remarkably augmented H2O2-induced cell
death and reduction in cell viability. Furthermore, H2O2-induced cell death in both the wild-type
and TRPM2-overexpressing cells was prevented by 2-APB, a TRPM2 inhibitor, and also by PJ34 and
DPQ, poly(ADP-ribose) polymerase (PARP) inhibitors. Collectively, our results show that increasing
the TRPM2 expression renders SH-SY5Y cells to be more susceptible to ROS-induced cell death and
reinforce the notion that the TRPM2 channel plays a critical role in conferring ROS-induced cell
death. It is anticipated that SH-SY5Y cells can be useful for better understanding the molecular and
signaling mechanisms for ROS-induced TRPM2-mediated neurodegeneration in the pathogenesis of
neurodegenerative diseases.
Keywords: human neuroblastoma SH-SY5Y cells; TRPM2 channel; ROS; neuronal cell death
1. Introduction
Mammalian cells express a large family of transient receptor potential (TRP) cationic channels
that are activated by poly-modality and play a role in a diversity of physiological and pathological
processes [1–5]. These channels are often grouped based on sequence relatedness into canonical
(TRPC), vanilloid (TRPV), melastatin (TRPM), mucolipins (TRPML), polycystins (TRPP) and ankyrin
(TRPA) subfamilies. The TRPM2 channel is gated by intracellular ADP-ribose (ADPR) [6] and has
been recognised as a key molecular mechanism that confers cells with a prominent sensitivity to
reactive oxygen species (ROS), thanks to the well-documented ability of ROS to induce poly(ADPR)
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polymerase (PARP)-dependent generation of ADPR [7–10]. The TRPM2 channel is expressed in
both excitable and non-excitable cells [7–10]. More than a decade worth of studies have shown the
TRPM2 channel as a common mechanism mediating cell death after exposure to high levels of ROS
or diverse pathological stimuli or factors that are known to induce ROS generation. For example,
increasing evidence shows that the TRPM2 channel plays an important role in mediating neuronal cell
death in the brain, as a result of exposure to ROS, amyloid-β peptide, 1-methyl-4-phenylpyridine ion
(MPP) and ischemia-reperfusion [11–24]. Therefore, ROS-induced TRPM2 channel activation has been
proposed to contribute to the pathogenesis of ischemia stroke and neurodegenerative conditions such
as Alzheimer’s disease (AD) and Parkinson’s diseases (PD) [25–30].
Human neuroblastoma SH-SY5Y cells have been widely used as a human neuronal cell model
in the study of the molecular and signaling mechanisms for neurodegeneration, particularly those
related to PD because of the catecholaminergic, albeit strictly speaking not dopaminergic, neuronal
properties [31]. Studies from other groups and us have consistently documented functional expression of
the TRPM2 channel in SH-SY5Y cells [21,23,24,32–34], but the findings regarding the role of the TRPM2
channel in SH-SY5Y cells are intriguing. A recent study using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium (MTT) assay has shown that concentration-dependent reduction in cell viability
after exposure to 10 to 400 μM H2O2 or 125 to 500 μM MPP via inducing H2O2 generation [23].
The cytotoxicity induced by both H2O2 and MPP was significantly suppressed by inhibition of
the TRPM2 channel with flufenamic acid (FFA), a TRPM2 channel inhibitor [7]. In addition,
MPP-induced detrimental effect on the cell viability was attenuated by small inference RNA (siRNA)-
mediated knockdown of the TRPM2 expression and, conversely, enhanced by increasing the TRPM2
expression [23]. These results strongly support that the TRPM2 channel has a critical role in mediating
H2O2/MPP-induced SH-SY5Y cell death [23]. However, an earlier study using the MTT assay showed
that increasing the TRPM2 expression in SH-SY5Y cells resulted in higher cell viability after exposure to
50 to 100 μM H2O2 for 6 or 24 h [32], leading to the recent proposal of a protective role for the TRPM2
channel in cell survival [33,34].
To clarify the role of ROS-induced TRPM2 channel activation in SH-SY5Y cells is critical for the
question of whether or not this human cell model can be used to gain insights into the molecular and
signaling mechanisms for TRPM2-dependent neurodegeneration. For example, in addition to the
revelation of a role for the TRPM2 channel in mediating MPP-induced SH-SY5Y cell death, the recent
study by Sun et al. [23] has found strong up-regulation of the TRPM2 expression in MPP-treated
SH-SY5Y cells as observed in the substantia nigra pars compacta (SNpc) of the brains from PD patients
and PD mice induced by injection with 1-methyl-4-phenyl-tetrahydropyridine to selectively destroy
dopaminergic neurons in the SNpc region. These observations raise an interesting question with
respect to the role of the TRPM2 channel in mediating dopaminergic neuronal death and, therefore,
the pathogenesis of PD. In the present study, we aimed to test the hypothesis that increasing the
TRPM2 expression results in greater susceptibility of SH-SY5Y cells to ROS-induced cell death.
We generated a stable SH-SY5Y cell line overexpressing the human TRPM2 channel and used the
propidium iodide (PI) staining assay to directly examine H2O2-induced cell death in the wild-type (WT)
and TRPM2-overexpressing cells. To make our results more comparable to those reported by previous
studies, we also determined cell viability after exposure to H2O2 in the WT and TRPM2-overexpressing
cells. Our results from measuring cell death and cell viability provide consistent evidence to show
that exposure to H2O2 induces SH-SY5Y cell death, regardless of the TRPM2 expression level, and that
increasing the TRPM2 expression augments the susceptibility to ROS-induced cell death.
2. Materials and Methods
2.1. General Chemicals and Culture Medium
General chemicals used in this study were purchased from Sigma, except those indicated
specifically. Dulbecco’s modified Eagle’s medium (DMEM) and penicillin/streptomycin were from
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GIBCO. Foetal bovine serum (FBS) and trypsin-ethylenediaminetetraacetic acid (EDTA) were from
Beyotime Biotechnology (Nantong, China).
2.2. Cell Culturing
SH-SY5Y cells were kindly provided by Dr. J.A. Sim (University of Manchester, Manchester, UK)
and maintained in standard cell culture medium (DMEM supplemented with 10% FBS, 100 units/mL
of penicillin and 100 μg/mL of streptomycin) in a tissue incubator (Thermofisher, Waltham, MA, USA)
at 37 ◦C in the presence of 5% CO2. Cells were passaged every 3 to 4 days or when they became 70% to
80% confluent.
2.3. Propidium Iodide (PI) Staining Cell Death Assay
Cell death was examined using the PI staining assay as described in our previous studies [24,35].
In brief, cells were seeded in 24-well plates at 2 × 104 cells per well in 500 μL of standard culture
medium and incubated overnight. After cells were treated with H2O2, PI, and Hoechst 33342 were
added into the culture medium with the final concentrations of 2 μg/mL and 1 μg/mL, respectively.
Cells were incubated at 37 ◦C for 30 min. In experiments examining the effects of inhibitors on
H2O2-induced cell death, cells were treated with the inhibitor at indicated concentrations 30 min
before and during exposure to H2O2. Images were captured using an AxioVert A1 fluorescence
microscope (Zeiss). For each condition in every independent experiment, three wells of cells were used,
one randomly selected field in each well was imaged, and at least 500 cells from three images/wells
were analyzed. Cell death was presented as a percentage of PI-positive cells in all cells identified by
Hoechst 33342 staining in the same fields.
2.4. Generation of SH-SY5Y Cells Overexpressing the Human TRPM2 Channel
The internal ribosome entry site (IRES) bicistronic construct that enables expression of separate
TRPM2 protein and enhanced green fluorescent protein (GFP) under the control of the same promoter,
pTRPM2-IRES-GFP, was generated by ligation of the full-length human TRPM2 cDNA [6] and
pGFP-IRES fragment that were both amplified by polymerase chain reaction (PCR). Primers for
PCR are available upon request. PCR was performed using Phusion polymerase (New England
Biolabs, Beijing, China) and the following protocols: 120 s at 98 ◦C, followed by 25 cycles for TRPM2
or 20 cycles for pGFP-IRES fragment, and a final step of 10 min at 72 ◦C. Each cycle comprised 30 s at
98 ◦C, 30 s at 58 ◦C, and 5 min at 72 ◦C for TRPM2 or 30 s at 98 ◦C, 30 s at 58 ◦C, and 3 min at 72 ◦C for
pGFP-IRES. Ligated PCR products were transformed into competent DH5α Escherichia coli (Takara,
Beijing, China). Positive colonies were identified by PCR and sequencing the PCR products. Plasmids
were purified, and the construct was further confirmed by DNA sequencing.
For transfection, SH-SY5Y cells were cultured in standard culture medium in six-well plates
and transfected with the pTRPM2-IRES-GFP construct using Xfect transfection reagent (Clonetech,
Beijing, China) according to the manufacturer’s instructions. Transfected cells were identified by
examining GFP expression using a fluorescence microscope 48 h post transfection and also using flow
cytometry 72 h post transfection. GFP-positive SH-SY5Y cells were incubated in standard culture
medium containing 400 μg/mL G418 for another 2 weeks. Individual cells were inoculated into a
96-well plate and, after being cultured in G418-containing standard culture medium for 1 month, cells
showing strong GFP expression were selected and expanded. The TRPM2 protein expression in the
stable cell line used in this study was further verified by Western blotting.
2.5. Flow Cytometry
Cells were cultured for 3 days before they were harvested for analysis using flow cytometry.
Approximately 10,000 cells were analyzed for positive expression of GFP, using a flow cytometer (BD
Biosciences, Beijing, China) and 488 nm/512 nm filters.
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2.6. Western Blotting
The TRPM2 protein expression was examined using standard sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting. In brief, cell lysates were
prepared in the radioimmuno-precipitation assay buffer (Beyotime Biotechnology, Nantong, China)
containing 1 mM phenylmethane sulfonyl fluoride. The protein concentrations in cell lysates were
determined using a bicinchoninic acid assay kit (Beyotime Biotechnology). Twenty microliters of cell
lysate containing 80 μg proteins alongside protein markers (Beyotime Biotechnology) were separated
by electrophoresis on 15% SDS-PAGE gels and transferred to nitrocellular membranes (Millipore,
Burlington, MA, USA). The membranes were blocked by 5% non-fat milk in Tris-buffered saline
containing 0.05% Tween 20 (TBST) and then incubated with the primary anti-TRPM2 antibody
at a dilution of 1:200 (ab87050, Abcam, Shanghai, China) or anti-glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) at 1:1000 (Hangzhou Goodhere Biotechnology Co, Hangzhou, China) at 4 ◦C
overnight. After extensive washing in TBST, the membranes were incubated with the secondary
horseradish peroxidase-conjugated goat anti-rabbit IgG antibody at 1:800 (Affinity Biosciences,
Cincinnati, OH, USA) at room temperature for 1 h. After extensive washing in TBST, the proteins were
visualized using an enhanced chemiluminescence kit (Beyotime Biotechnology), and the images were
captured using an Amersham Imager 600 system (GE Healthcare, Chicago, IL, USA).
2.7. Cell Counting Kit-8 (CCK-8) Cell Viability Assay
The cell viability was examined using Cell Counting Kit-8 (CCK-8) assay kits (Dojindo Molecular
Technologies, Shanghai, China) according to the manufacturer’s instructions. Cells were seeded
in 96-cell plates at 1 × 104 cells per well in 100 μL of standard culture medium and incubated
overnight. After cells were treated with H2O2 at indicated concentrations, 10 μL of CCK-8 reagent
was added to each well and incubated in a tissue culture incubator at 37 ◦C for 1 h. The absorbance
at 450 nm was determined, using a Bio-Tek800 microplate reader (BioTek Instruments, Winooski,
VT, USA). Three wells of cells were used for each condition for every independent experiment. The cell
viability in H2O2-treated cells was presented as a percentage of that in control or untreated cells in
parallel experiments.
2.8. Data Presentation and Statistical Analysis
The results are presented as mean ± standard error mean (SEM), where appropriate, with “n”
representing the number of independent experiments. Comparisons were performed using GraphPad
Prism software, with p < 0.05 considered to be statistically significant. One-way analysis of variance
(ANOVA) and post hoc Tukey’s test were used for multiple groups to compare cell death or cell
viability for the same type of cells, that is, WT or TRPM2-overexpressing cells. Two-way ANOVA
and post hoc Tukey’s test were used to compare cell death or cell viability between the WT and
TRPM2-overexpressing cells that were treated with the same concentration of H2O2.
3. Results
3.1. H2O2 Induces Cell Death via PARP-Dependent TRPM2 Channel Activation
We started with using the PI staining assay to detect cell death following exposure to 100 to
500 μM H2O2 for 24 h in the WT SH-SY5Y cells. Representative images are shown in Figure 1A, and the
results from three independent experiments are summarized in Figure 1B. Exposure to H2O2 resulted
in concentration-dependent cell death. The cell death was negligible (3.8 ± 1.0%, n = 3) under control
conditions or in untreated cells, but there was a noticeable increase in cell death after exposure to
H2O2, with 11.4 ± 2.0%, 27.6 ± 6.0%, 51.9 ± 6.2%, and 95.0 ± 1.4% at 100, 300, 400, and 500 μM H2O2,
respectively, although the increase reached a statistically significant level (p < 0.05) only for 400 and
500 μM H2O2.
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Figure 1. Exposure to H2O2 induces concentration-dependent cell death in SH-SY5Y cells. (A) Representative
bright field and fluorescence images showing propidium iodide (PI) and Hoechst staining in control
cells and cells after exposure to 100, 300 or 400 μM H2O2 for 24 h. (B) Mean ± standard error mean
(SEM) percentage of cell death after exposure to indicated concentrations of H2O2 from 3 independent
experiments. **, p < 0.01 and ***, p < 0.001, compared to control cells without exposure to H2O2.
As has been shown in many cell types, ROS can activate the TRPM2 channel via a PARP-dependent
mechanism [7]. To confirm that H2O2-induced cell death resulted from PARP-dependent TRPM2
channel activation in SH-SY5Y cells, we moved on to examine the effects of pharmacological inhibitors
of PARP. Cells were treated 30 min before and during 24 h exposure to 400 μM H2O2 with 30 μM PJ34
and 10 μM 3,4-dihydro-5[4-(1-piperindinyl)butoxy]-1(2H)-isoquinoline (DPQ), two structurally distinct
PARP inhibitors that have been shown in our recent study to be effective in inhibiting H2O2-induced
TRPM2-mediated microglial cell death [34]. Indeed, cell death was reduced from 69.1 ± 3.0% in
cells treated with H2O2 alone to 24.3 ± 1.0% in cells that were also treated with PJ34, indicating a
strong inhibition (Figure 2A,B; n = 3; p < 0.001). Similarly, H2O2-induced cell death was reduced to
15.4 ± 1.1% in DPQ-treated cells from 62.3 ± 5.9% in cells treated with dimethyl sulfoxide (DMSO),
the solvent used to prepare DPQ stock solution (Figure 2A,B; n = 3; p < 0.001). We next examined
the effect of treatment with 100 μM 2-APB, a TRPM2 channel blocker that can inhibit H2O2-induced
TRPM2-mediated cell death [34]. Treatment with 2-APB also strongly suppressed H2O2-induced cell
death from 62.3 ± 5.9% in DMSO-treated cells to 12.4 ± 2.4% in 2-APB-treated cells (Figure 2A,B; n = 3;
p < 0.001). Treatment with DMSO or the inhibitor alone resulted in no or minimal increase in cell death
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(Figure 2B). Collectively, these results provide evidence to support the notion that PARP-dependent
TRPM2 channel activation mediates H2O2-induced cell death in SH-SY5Y cells, which is consistent
with a recent study that reports a role for the TRPM2 channel in H2O2-induced cell death in SH-SY5Y
cells based on the measurement of cell viability [23].
Figure 2. Effects of treatment with polymerase (PARP) or melastatin 2 (TRPM2) channel inhibitor on
H2O2-induced cell death in SH-SY5Y cells. (A) Representative fluorescence images showing staining
with PI and Hoechst of control cells and cells treated with indicated conditions. Treatment with the
inhibitors or dimethyl sulfoxide (DMSO) started 30 min before and during exposure to 400 μM H2O2
for 24 h. (B) Mean ± SEM percentage of PI-positive cells under indicated conditions, as shown in panel
A, from three independent experiments. ***, p < 0.001 compared with untreated cells, and ###, p < 0.001
compared to cells treated with H2O2 alone or treated with H2O2 and DMSO.
3.2. TRPM2 Overexpression Augments the Susceptibility to H2O2-Induced Cell Death
To examine the effect of increasing the TRPM2 expression in SH-SY5Y cells on H2O2-induced
cell death, we made a mammalian expression construct using the IRES technology to generate a
stable SH-SY5Y cell line expressing the human TRPM2 protein and GFP under the control of the same
promoter (see Materials and Methods). Positively transfected SH-SY5Y cells were initially identified
by the positive GFP expression as shown using fluorescent microscopic imaging (Figure 3A) and flow
cytometry analysis (Figure 3B). As shown by Western blotting, SH-SY5Y cells showed endogenous
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expression of the TRPM2 protein with the expected molecular weight (171 kDa), as reported in previous
studies [23,24] and, as anticipated, the TRPM2 protein expression was noticeably increased in the
GFP-positive cells (Figure 3C).
 
Figure 3. Generation of TRPM2-overexpressing SH-SY5Y stable cells. (A) Represent bright field and
fluorescence images of wild-type (WT) and TRPM2-overexpressing (OE) cells. (B) Flow cytometry
analysis of green fluorescent protein (GFP) expression in the WT (left) and OE (right) cells. (C) Western
blots showing expression of TRPM2 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in the
WT and OE cells. The solid arrowheads in the top and bottom panels indicate TRPM2 and GAPDH,
respectively. The empty arrowhead in the top panel indicates a non-specific and high molecular weight
protein, which was present in both the WT and OE cells with a similar level. There was a strong
increase in the TRPM2 protein expression in the OE cells (lanes 1–2) as compared to the endogenous
TRPM2 protein expression in the WT cells (lanes 3–4), where the GAPDH expression level was similar
in both cell types.
We next performed parallel experiments using the PI staining assay to compare H2O2-induced
cell death in the WT and TRPM2-overexpressing SH-SY5Y cells after exposure to 30, 100, and 300 μM
H2O2 for 24 h. The results from three independent experiments are summarized in Figure 4A.
After exposure to 30 μM H2O2, there was a slight but statistically insignificant increase in cell
death in the TRPM2-overexpressing cells as compared to that in the WT cells. Cell death upon
exposure to 100 μM H2O2 was increased from 11.3 ± 1.9% in the WT cells to 93.3 ± 1.0% in
the TRPM2-overexpressing cells (Figure 4A; n = 3; p < 0.001). Similarly, cell death induced by
exposure to 300 μM H2O2 was increased from 25.5 ± 4.8% in the WT cells to 96.2 ± 0.4% in the
TRPM2-overexpressing cells (Figure 4A; n = 3; p < 0.001). These results clearly indicate that increasing
the TRPM2 expression in SH-SY5Y cells remarkably augments the susceptibility to H2O2-induced
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cell death. To verify that such increased H2O2-induced cell death was mediated by PARP-dependent
activation of the TRPM2 channel as shown above in the WT cells, we examined the effects of PJ34,
DPQ or 2-APB on H2O2-induced cell death in the TRPM2-overexpressing cells. We used the same
experimental conditions for the TRPM2-overexpressing cell as for the WT cells described above, that is,
exposure of cells to 400 μM H2O2 for 24 h and treatment of cells with 30 μM PJ34, 10 μM DPQ,
or 100 μM 2-APB 30 min before and during exposure to H2O2. The results are shown in Figure 4B,C.
Cell death in the TRPM2-overexpressing cells was reduced from 91.7 ± 0.5% in cells treated with
H2O2 alone to 13.1 ± 0.8% (n = 3; p < 0.001) in cells that were also treated with PJ34. Similarly,
H2O2-induced cell death of 82.0 ± 3.8% in DMSO-treated cells was reduced to 17.7 ± 1.5% (n = 3;
p < 0.001) in DPQ-treated cells or 7.1 ± 1.0% in 2-APB-treated cells (n = 3; p < 0.001). Again, treatment
with DMSO or the inhibitor alone caused no or minimal cell death in the TRPM2-overexpressing cells
(Figure 4C). These pharmacological results are readily reconciled with the above-described observation
that increasing the TRPM2 expression enhanced the susceptibility to ROS-induced cell death and,
taken together, provide consistent evidence to support that ROS-induced PARP-dependent activation
of the TRPM2 channel, regardless of its expression, results in cell death.
Figure 4. Increasing the TRPM2 expression in SH-SY5Y cells augments the susceptibility to
H2O2-induced cell death. (A) Mean ± SEM percentage of PI-positive cells in the WT and
TRPM2-overexpressing (OE) cells after exposure to indicated concentrations of H2O2 from three
independent experiments. ***, p < 0.001, compared to cells without exposure to H2O2 in the OE cells;
###, p < 0.001 compared between the WT and OE cells exposed to the same concentration of H2O2.
(B) Representative fluorescence images showing staining with PI and Hoechst in the OE cells treated
with indicated inhibitors, 30 min before and during exposure to 400 μM H2O2 for 24 h. (C) Mean ±
SEM percentage of PI-positive cells under indicated conditions in the OE cells from three independent
experiments. ***, p < 0.001 compared to control cells; ###, p < 0.001 compared to cells treated with H2O2
alone or treated with H2O2 and DMSO.
3.3. TRPM2 Overexpression Reduces the Cell Viability after Exposure to H2O2
As mentioned above, previous studies mainly used the MTT assay to examine the cell viability
and the effects of increasing the TRPM2 expression on the cell viability after exposure to H2O2 or
MPP [23,32]. The MTT assay is a metabolic assay that measures the live cells, whereas the PI assay
is used to detect cell death, particularly necrotic cell death. To make more direct or meaningful
comparisons, we finally examined the effects of exposure to 30 to 400 μM H2O2 for 24 h on the cell
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viability of the WT and TRPM2-overexpressing SH-SY5Y cells using the CCK-8 assay, which is based on
the same principle as the MTT assay. Our results from three independent experiments are summarized
in Figure 5. Exposure to H2O2 resulted in a concentration-dependent reduction in cell viability in both
the WT and TRPM2-overexpressing cells. In the WT cells, the mean cell viability was 101.5 ± 5.0%,
101.5 ± 5.9%, 52.1 ± 0.6%, and 31.6 ± 4.7% after 24 h exposure to 30, 100, 300, and 400 μM H2O2,
respectively. The cell viability was statistically significantly lower after exposure to 300 μM (p < 0.05)
or 400 μM H2O2 (p < 0.001), but not 30 or 100 μM H2O2. These results are similar to those in a recent
study reporting a significant reduction in cell viability after exposure to 200 or 400 μM, but not 10
or 100 μM H2O2 [23]. In the TRPM2-overexpressing cells, the mean cell viability was 92.6 ± 2.8%,
87.8 ± 3.8%, 5.6 ± 0.4%, and 3.2 ± 0.2% after exposure to 30, 100, 300, and 400 μM H2O2, respectively.
The cell viability was significantly lower after exposure to 300 μM or 400 μM H2O2 (p < 0.001 in both
cases), but not 30 or 100 μM H2O2 (Figure 5). The mean cell viability in the TRPM2-overexpressing
cells was lower compared to that in the WT cells after exposure to the same concentration of H2O2,
but the difference reached a statistically significant level only for 300 μM (p < 0.001) and 400 μM H2O2
(p < 0.05) (Figure 5). These results from measuring cell viability also show that TRPM2 overexpression
increases the susceptibility of SH-SY5Y cells to ROS-induced cell death.
Figure 5. Increasing the TRPM2 expression in SH-SY5Y cell enhances H2O2-induced reduction in
cell viability. Mean ± SEM cell viability, as a percentage of that under control conditions, in the WT
and TRPM2-overexpressing (OE) cells after exposure to indicated concentrations of H2O2 for 24 h.
The results were from three independent experiments. *, p < 0.05 and ***, p < 0.001, compared to cells
without exposure to H2O2 in the WT or OE cells, respectively; #, p < 0.05 and ###, p < 0.001 compared
between the WT and OE cells treated with the same concentration of H2O2.
4. Discussion
The present study shows that exposure of SH-SY5Y cells to H2O2 induced concentration-
dependent cell death as well as confirming the finding that H2O2 induced a concentration-dependent
reduction in cell viability. Furthermore, we show that increasing the TRPM2 expression enhanced
H2O2-induced cell death and reduction in cell viability, consistently indicating that increasing the
TRPM2 expression in SH-SY5Y cells augments the susceptibility to H2O2-induced cell death.
The TRPM2 channel has been shown to mediate ROS-induced cell death in many cell types [7].
In SH-SY5Y cells, previous studies using the MTT assay showed a concentration-dependent reduction
in cell viability after exposure to 50 to 100 μM H2O2 [32] or 10 to 400 μM H2O2 or 125 to 500 μM MPP
via inducing H2O2 generation [23]. The present study also demonstrated concentration-dependent cell
death after exposure to 30 to 500 μM H2O2, using the PI staining assay (Figures 1 and 4A), and also a
concentration-dependent reduction in cell viability after exposure to 30 to 400 μM H2O2, using the
CCK-8 assay (Figure 5). However, regarding the effects of H2O2 on cell viability, there were noticeable
differences between the present and previous studies. The earlier study reported that exposure to 50
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or 100 μM H2O2 for 6 or 24 h reduced the cell viability [32]. The present study found a significant
reduction in cell viability only after 24 h exposure to higher concentrations of H2O2 (300 and 400 μM)
but not to lower concentrations including 100 μM H2O2, the condition used in the aforementioned
previous study [32]. In accordance with our study, Sun et al. have recently shown that the cell viability
was significantly reduced after exposure to 200 and 400 μM H2O2, but not 10 or 100 μM H2O2 [23].
They also reported reduced cell viability following exposure to MPP at high concentrations (250 and
500 μM) but not at a low concentration (125 μM) [23]. The reasons for these discrepancies remain
unclear but the cells used, particularly the proliferative properties of the cells, are likely to contribute,
considering that cell proliferation can influence the number of live cells which is measured using the
MTT and CCK-8 assays.
In the present study, we showed significant inhibition of H2O2-induced cell death by 2-APB
(Figure 2). Similarly, Sun et al. have reported suppression by FFA of H2O2-induced reduction in cell
viability [23]. Both 2-APB and FFA are known to inhibit the TRPM2 channel, but neither of them is
specific to the TRPM2 channel [7]. Nonetheless, the inhibition of H2O2-induced cell death by 2-APB in
this study and by FFA in the study by Sun et al. [23] are in support of the notion that the TRPM2 channel
activation is critical for H2O2-induced cell death or reduction in cell viability. We also showed that
H2O2-induced cell death was strongly inhibited by PJ34 and DPQ (Figure 2), confirming an important
role for PARP in ROS-induced TRPM2 channel activation and ensuing cell death [7]. We showed here
that increasing the TRPM2 expression augmented H2O2-induced reduction in cell viability as well as
H2O2-induced cell death (Figures 4A and 5). Sun et al. have reported that MPP-induced reduction in
cell viability was strongly attenuated by FFA and also by siRNA-mediated knockdown of the TRPM2
expression and by contrast exacerbated by increasing the TRPM2 expression [23]. The observations that
H2O2-induced cell death in the TRPM2-overexpressing cells was largely prevented by 2-APB, PJ34, and
DPQ (Figure 4B,C) strongly disfavor, albeit not completely ruling out, the possibility that alterations in
TRPM2-independent mechanism(s) give rise to the increased susceptibility to H2O2-induced cell death.
Overall, our results suggest that ROS-induced PARP-dependent activation of the TRPM2 channel,
regardless of its expression level, leads to SH-SY5Y cell death. These findings reinforce the notion
that the TRPM2 channel is a key and common meditator for ROS-induced cell death in SH-SY5Y
cells [23,24] as reported in neurons [11–13,21] and other types of cells [7,35–38].
However, studies examining the effect of increasing the TRPM2 expression in SH-SY5Y have
led to the proposal of a different role for the TRPM2 channel [32–34]. An earlier study reported that
the reduction in cell viability after exposure to 50 and 100 μM H2O2 for 6 or 24 h was attenuated
by increasing the TRPM2 expression, suggesting a role for the TRPM2 channel in supporting cell
survival and proliferation [32]. As we showed here, increasing the TRPM2 expression resulted in no
significant protection against the reduction in cell viability after exposure to 30 and 100 μM H2O2 for
24 h, but a further reduction in cell viability after exposure to 300 and 400 μM H2O2 for 24 h (Figure 5).
The study by Sun et al., while not examining the effect on H2O2-induced reduction in cell viability,
has shown that increasing the TRPM2 expression enhanced the reduction in cell viability after exposure
to a high concentration of MPP [23], as we observed here after exposure to high concentrations of H2O2.
As discussed above, it is highly likely that the discrepancy in part arises from the cells used. It is worth
mentioning that increasing the TRPM2 expression has been shown to induce cell death or reduce cell
viability after exposure to H2O2 in other cell types. For example, in human embryonic kidney 293 cells
that are largely void of endogenous TRPM2 expression, overexpression of the recombinant TRPM2
channel strongly reduced cell viability following exposure to H2O2, determined using the trypan blue
exclusion assay, or increased cell death after exposure to H2O2, shown by staining with PI and Alexa
Fluor 488-annexin V [36]. Likewise, in human monocytic U937 cells which endogenously express the
TRPM2 channel, increasing the TRPM2 expression enhanced H2O2-induced reduction in cell viability
based on the trypan blue exclusion assay and apoptotic cell death determined by staining with Alexa
Fluor 594-annexin V [37].
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As already mentioned above, cell death has been assessed directly by PI staining for necrotic cell
death or annexin V staining for apoptotic cell death and also indirectly using the MTT and CCK-8
assays that measure the number of live cells. In this study, we assessed H2O2-induce cell death using
the PI staining and CCK-8 assays. As discussed above, the results from these two measurements overall
provide consistent evidence to show that exposure to H2O2 resulted in concentration-dependent cell
death and that increasing the TRPM2 expression enhanced the susceptibility to H2O2-induced cell
death (Figure 1, Figure 4A, and Figure 5). Nonetheless, a close examination of the data reveals a
noticeable difference. Increasing the TRPM2 expression in SH-SY5Y cells conferred a significant
increase in cell death (Figure 4A) but resulted in a modest reduction in cell viability after exposure to
100 μM H2O2 (Figure 5). Such a difference may result from the experimental conditions used (e.g., a
high cell seeding density used for the CCK8 assay versus a low cell seeding density for the PI staining
assay) as well as the aforementioned proliferative properties of the cells. Therefore, cautions needs to
be exercised in conducting quantitative comparisons and interpretation of the results obtained using
different experimental conditions and/or methods.
Recent studies, using TRPM2-knockout mice in combination with disease models, support a
critical role for the TRPM2 channel in mediating ROS-induced neuronal death and in contributing to
the pathogenesis of ischemia-reperfusion brain damage and neurodegenerative diseases, such as
AD [27–30]. SH-SY5Y cells have been useful as a human neuronal cell model in the study of
neurodegeneration [31]. In a recent study using SH-SY5Y cells, we have recently revealed TRPM2
channel activation as a critical step in a positive feedback signaling mechanism that causes lysosomal
and mitochondrial dysfunction to drive delayed neuronal cell death [24]. Such information is helpful
in gaining mechanistic insights into TRPM2-dependent delayed neuronal death responsible for
ischemia-reperfusion brain damage [15,18]. As already introduced above, in addition to the revelation
of the importance of the TRPM2 channel in mediating MPP-induced SH-SY5Y cell death, Sun et al.
have shown strong up-regulation of the TRPM2 expression in MPP-treated SH-SY5Y cells as observed
in the SNpc region of the brains from PD patients and also PD mice [23]. These new findings point to
the TRPM2 channel for its potential role in mediating loss of dopaminergic neurons, the key event in
the pathogenesis of PD [39]. It is anticipated that SH-SY5Y cells should be useful for researchers to
gain a better understanding of TRPM2-dependent signaling mechanisms for neurodegeneration that
are relevant to the pathogenesis of PD.
5. Conclusions
The present study provides evidence to show that PARP-dependent activation of the TRPM2
channel in SH-SY5Y cell mediates ROS-induced cell death and increasing the TRPM2 expression
augments the susceptibility to ROS-induced death. As shown by recent studies, using SH-SY5Y cells as
a human neuronal cell model should help in interrogating TRPM2-dependent signaling mechanisms
in neuronal cell death and related neurodegenerative diseases.
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Abstract: Oxidative stress (OS) has been linked to blood–brain barrier (BBB) dysfunction which in
turn has been implicated in the initiation and propagation of some neurological diseases. In this study,
we profiled, for the first time, two endothelioma cell lines of mouse brain origin, commonly used as
in vitro models of the blood–brain barrier, for their resistance against oxidative stress using viability
measures and glutathione contents as markers. OS was induced by exposing cultured cells to varying
concentrations of hydrogen peroxide and fluorescence microscopy/spectrometry was used to detect
and estimate cellular glutathione contents. A colorimetric viability assay was used to determine
changes in the viability of OS-exposed cells. Both the b.End5 and bEnd.3 cell lines investigated
showed demonstrable content of glutathione with a statistically insignificant difference in glutathione
quantity per unit cell, but with a statistically significant higher capacity for the b.End5 cell line for de
novo glutathione synthesis. Furthermore, the b.End5 cells demonstrated greater oxidant buffering
capacity to higher concentrations of hydrogen peroxide than the bEnd.3 cells. We concluded that
mouse brain endothelial cells, derived from different types of cell lines, differ enormously in their
antioxidant characteristics. We hereby recommend caution in making comparisons across BBB models
utilizing distinctly different cell lines and require further prerequisites to ensure that in vitro BBB
models involving these cell lines are reliable and reproducible.
Keywords: oxidative stress; blood–brain barrier; bEnd5; bEnd.3; glutathione; viability
1. Introduction
The blood–brain barrier (BBB) is a functional and morphological interface between the systemic
blood circulation and the CNS. The central regulatory component is the brain capillary endothelial
cell (BEC), which is assisted by a number of cellular entities, viz. pericytes and astrocytes, together
forming an interface, described as the neuro-vasculo-glial unit (NVU). The NVU has the dynamic
ability to respond to the homeostatic changes in the brain interstitium ensuring a stable environment
for neuronal functionality [1]. From a research point of view, it is therefore of interest to understand the
capability of the BEC to withstand oxidative stress (OS), and to scrutinize the BBB in vitro models used
to study these physiological processes. However, from a therapeutic point of view the strict regulatory
mechanisms for molecules to cross the barrier provide a serious clinical challenge to molecules of
desired therapeutic interest to reach their neural target sites [2–5].
Endothelial dysfunction-mediated vascular diseases such as BBB dysfunction have been well linked
to excess production of reactive oxygen species (ROS) [6,7]. A major source of ROS in these conditions
is the upregulation of nicotinamide adenine dinucleotide phosphate oxidase (Nox, especially Nox2)
activity [8,9]. Excess superoxide (O2−) produced primarily from increased Nox activity undergoes both
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spontaneous and enzymatic dismutation by superoxide dismutases (SOD), resulting in increase and/or
accumulation of its dismutation product, hydrogen peroxide (H2O2) [10]. Keeping vascular endothelial
cells in redox balance involves the activities of several endogenous antioxidants whose activities
may be enzymatic or non-enzymatic [10]. Superoxide dismutase (SOD) is an enzymatic, first-line,
intracellular antioxidant that catalyzes the conversion of superoxide to hydrogen peroxide [11]. Other
important enzymatic antioxidants such as glutathione peroxidase (GPx), and catalase (CAT), help to
neutralize H2O2 to water and oxygen [11]
Endothelial nitric oxide synthase (eNOS) is another enzyme which normally plays a protective role
in the vascular endothelial cell through its production of nitric oxide (NO) while oxidizing its substrate
L-arginine to L-citrulline using molecular oxygen (O2) [12,13]. However, parallel upregulation of eNOS
and Nox as occurs in many vascular diseases results in eNOS uncoupling with subsequent conversion
of eNOS to an O2−-producing enzyme that contributes to further vascular oxidative stress [14–16].
Furthermore, free radicals such as superoxide can attack polyunsaturated fatty acids (PUFAs) such as
arachidonic acid in the cell membranes of vascular endothelial cells to yield advanced lipid peroxidation
end products (ALEs) [17]. One of ALEs of relevance is 4-hydroxynonenal (4-HNE), an electrophile that
is highly reactive towards nucleophilic thiols and amino groups [17,18]. It readily reacts with proteins
(4-HNE-protein adduction), lipids, and nucleic acids of DNA. Its reaction with proteins modifies
their activity thus acting as a second messenger in various biologic activities including modification
of enzymatic actions or transcription factor modulations that determine cell survival or death [18].
Oxidative stress (OS) occurs in the cells when an unbalanced accumulation of ROS exists within the cell
and/or in its immediate environment [19]. BBB dysfunction in relation to OS has been implicated in the
initiation and propagation of several neurological conditions such as epilepsy, stroke, and degenerative
neuropathies such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis [20,21]. Thus,
OS has been scientifically documented as a common factor to both the etiologies of these neurological
disorders as well as abnormal BBB function. Cell modeling has, to date, provided a robust tool in the
in vitro study of the BBB [22,23]. The brain microvascular endothelial cells are the principal cells of the
BBB which have had several cell models characterized for use as in vitro models in the study of the
BBB [24]. This study focused on two mouse-derived cell lines, b.End5 and bEnd.3, established for use
as in vitro models of the BBB [25,26]. It is of interest to understand how the endothelial cells of the BBB
respond to oxidative stress as well as the endothelial cell-specific events that underlie the abnormalities
of BBB permeability. It is, however, disconcerting that most of the in vitro cell models in use for BBB
studies have not been characterized for their oxidative/antioxidant features, which are necessary for
the definition of OS, as well as for features that characterize changes in oxidative stress responsible
for the observation of abnormal permeability under OS conditions. In this study, we profiled for
the first time, b.End5 and bEnd.3 cells, both mouse-derived cell lines obtained after immortalizing
primary mouse brain endothelial cells by infection with middle T antigen-expressing polyoma virus,
for their resistance against a suitably-selected ROS, hydrogen peroxide (H2O2), which can permeate
all intracellular membranes and thus exert its effects on organelles [27]. Cellular glutathione content
(reduced/oxidized form [GSH/GSSG]), a well reported marker of cellular oxidative status, is a tripeptide,
L-γ-glutamine-L-cysteinyl-glycine, that acts as an endogenous cellular antioxidant either by direct
neutralization of ROS or as cofactor for the antioxidant enzyme, glutathione peroxidase (GPx) [28].
[Hereafter, we refer to the full component of reduced and oxidized glutathione as ‘total glutathione
while GSH and GSSG refer to the ‘reduced glutathione’ and ‘glutathione disulfide/oxidized glutathione’
fractions respectively]. This functional capability of GSH is conferred by its active thiol group residing
in its cysteine residue [29]. Glutathione exists within cells in either the reduced (GSH) form or in
oxidized form as glutathione disulfide (GSSG). It is usually synthesized as GSH but oxidized to GSSG
upon participating in a redox reaction. Changes in cellular reduced glutathione content as well as
changes in cell viabilities were used to assess cellular capacities to respond to varying levels of ROS.
This protocol is robustly useful whenever it is desired to use these cells to study oxidant effects on
the BBB.
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2. Materials and Methods
2.1. Bio-Reagents
Analytical grade reagents were used for all experiments. These included monochlorobimane
(Molecular Probe M1381MP, Eugene, OR 97402, USA), trypan blue, (Gibco 1520-061, Gaithersburg
MD 20877, USA), tris (2-carboxyethyl) phosphine hydrochloride, TCEP (Sigma C4706, Laramie,
WY 82070, USA), GSH-GloTM Glutathione Assay Kit (Promega V6911/2, Madison, WI 53711, USA),
Trolox ((±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid, Sigma 238813, Laramie, WY
82070, USA), Cell Proliferation Kit II (XTT) (Roche, Sigma 11465015001, Laramie, WY 82070, USA),
and hydrogen peroxide (30%, Merck Millipore 107209, Feldbergstraße 80, 64293 Darmstadt, Germany).
2.2. Cell Cultures
Two mouse brain endothelioma cell lines (b.End5 and bEnd.3) were used in this study. The b.End5
(ECACC 96091930, Salisbury, Wiltshire SP4 0JG, UK) cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM Lonza BE 12-719F, Salisbury, MD 21801, USA.) supplemented with 10%
fetal bovine serum (FBS Biowest12010S181G, Rue du Vieux Bourg, 49340 Nuaillé, France), 100 U/mL
penicillin/streptomycin (Lonza DE17-602E), 1 mM sodium pyruvate solution (Lonza BE13-115E),
and 1% non-essential amino acids (NEAA Lonza BE13-114E) at 37 ◦C and 5% CO2 in a humidified
incubator. For all experiments, b.End5 cells at passages 5–20 were used and culture medium was
changed every 2–3 days. Prior to experimentation, cells were rinsed in 1× phosphate buffer solution
(PBS). The adherent cells were detached by the addition of 0.25% trypsin-EDTA after which equal
volume of fresh media was added and the cell suspension aspirated into 15 mL conical tubes. The cell
suspensions were then centrifuged for 5 min at rpm of 2500 to obtain a cell pellet. The supernatant was
then removed by gentle aspiration and thereafter, 5 mL of fresh media added to bring the cell pellets
back in suspension. The bEnd.3 (ATCC® CRL-2299, Gaithersburg, MD 20877, United States ) cells were
cultured in Dubelcco’s Eagle’s medium (Gibco 11320074) supplemented with 10% fetal bovine serum
(FBS Biowest S12010S181G), 100 U/mL penicillin/streptomycin (Lonza DE17-602E), and L-glutamine to
a final concentration of 4.1 mM (Invitrogen 25030081, Camarillo, CA 93012, United States ) and at 37 ◦C
and 5% CO2 in a humidified incubator. The bEnd.3 cells used for all experiments were at passages
5–20 and the medium was changed every 2–3 days. Prior to cell seeding for experiments, adherent
bEnd.3 cells were similarly brought to suspension as described for the b.End5 cells.
2.3. Hydrogen Peroxide Treatments
A stock solution of H2O2 (9.8 M, Merck Millipore, Feldbergstraße 80, 64293 Darmstadt, Germany)
was diluted to the required concentrations in complete media. Cultured b.End5 and bEnd.3 cells
were divided into labelled treatment wells exposed to H2O2 concentrations ranging between 10 μM
and 2 mM and cells that were unexposed to H2O2 served as control. To determine the antioxidant
capacity of cultured cells both b.End5 and bEnd.3 cells were seeded in separate transparent 96-well
plates at 1 × 104 cells per well in 200 μL of normal media and allowed to attach overnight. Media
were then aspirated and replaced with either 100 μL of fresh media to serve as control or 100 μL of
media dosed with the appropriate concentrations of hydrogen peroxide for another 24 h. Experiments
were repeated thrice and average values of parameters were recorded. Viability of the cells exposed
to different concentrations of hydrogen peroxide were then analysed and compared against viability
measures for the control cells under same duration in culture.
2.4. Viability Assay
Cells were cultured in a transparent 96-well plate as described for hydrogen peroxide treatments.
Equal numbers of b.End5 cells were seeded into eighteen treatment (H2O2) wells (n = 3) starting from
control (unexposed) and treatment with [H2O2] in multiples of 50 μM up to a maximum of 850 μM.
For cultured bEnd.3 cells, equal numbers of cells were seeded into sixteen sets of 3 wells (n = 3) and
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treated as control (unexposed), then [H2O2] in multiples of 10 μM up to 100 μM and then in multiples
of 100 μM up to a maximum of 500 μM. A blank column of three wells was also included in both
treatment plates to facilitate the determination of relative absorbance units. The XTT [30] viability
assay kit (Roche) was used to quantify cell viability after treatment for 24 h. The XTT reagent was
reconstituted by mixing 100 μL of electron-coupling reagent (0.383 mg/mL) with 5 mL of XTT labelling
reagent (1 mg/mL) to activate it as per manufacturer′s recommendation. Reconstituted XTT, 50 μL,
was then added to each well containing 100 μL of cell culture and incubated for 4 h at 37 ◦C in a CO2
incubator. Absorbance was then read for each well at 450 nm and blank-corrected values obtained using
a GloMax–Multi Detection System (Promega, Madison, WI 53711, USA). The absorbance measures
directly correlated with the viability of the cells in each well.
2.5. Fluorescent Detection of Glutathione in Cultured Cells
Equal numbers of b.End5 and bEnd.3 cells were cultured under standard conditions on microscopic
glass slides in separate Petri dishes. The cells were then allowed to attach overnight in all Petri dishes
and cells on each slide were used to demonstrate glutathione. Briefly, the medium was removed
from the attached cells and were rinsed twice with PBS solution, pH, 7.4, and then incubated with
monochlorobimane solution (mBCl, Molecular ProbeTM M1381MP) 60 μM in complete DMEM for
30 min [31]. Following mBCl loading, slides were fixed using a mixture of 4% paraformaldehyde (PFA)
and 0.2% glutaraldehyde (GA) in PBS solution at pH 7.4 for 10 min and following fixation, cells were
nuclear-counterstained by incubating slides with 20 μg/mL propidium iodide (PI) solution for 15 min.
DABCO (1,4-diazobicyclo-[2,2,2]-octane) mountant, 20 μL, was added to each slide mounted with
cover slips. Cells on each slide were then viewed and imaged under a Nikon Eclipse 50i fluorescent
microscope at λex/λem of 365/490 nm and 439/636 nm for mBCl and PI, respectively.
2.6. Quantification of Total Cellular Glutathione in bEnd5 Cells
To accurately quantify the total amount of glutathione in a single b.End5/bEnd.3 cell, we used
a GSH-Glo™ Glutathione Assay Kit which works by a luminescence assay to detect and quantify
glutathione [32]. The assay is based on the conversion of a luciferin derivative into luciferin in
the presence of glutathione, catalyzed by glutathione-S-transferase (GST). The reaction is further
coupled with a firefly luciferase which leads to the generation of luminescence signal proportional
to the amount of glutathione in the sample. To estimate glutathione fairly accurately in 1 × 104 cells,
according to manufacturer’s recommendation and to control for cell proliferation occurring alongside
cell attachment, cells were plated in white 96-well plates and incubated at 37 ◦C and 5% CO2 at
a density of 4 × 103 cells per well for the b.End5 cells and 4.5 × 103 cells per well for the bEnd.3
cells, based on an optimized number of the respective cells that gave the target density at 24 h in
culture (based on our data from proliferation study, not shown). Cells were plated in columns of
four wells (n = 4) in a 96-well white bottom plate and 100 μL of prepared 1X GSH-Glo reagent was
transferred to each well. In order to measure the total glutathione (GSH + GSSG), 100 μL of 1 mM tris
(2-carboxyethyl) phosphine (TCEP) was added to a group of four wells in addition to the GSH-Glo
reagent according to the GSSG recycling method [33]. The contents of the wells were agitated briefly
on an orbital shaker before incubation at room temperature for 30 min. Then, 100 μL of reconstituted
luciferin detection reagent was transferred to each well, and the plate was mixed briefly on an orbital
shaker before incubation at room temperature for 15 min. Luminescence values were then read using a
GloMax–Multi Detection System (Promega, Madison, WI 53711, USA). Luminescence readings were
converted to GSH concentration using a standard curve generated from a 5 mM GSH standard supplied
by the manufacturer.
2.7. Statistical Analysis
Statistical analysis was done using Graph Pad Prism.5 statistical analysis software. Data were
expressed as mean ± SEM and significant differences in data were accepted at p < 0.05
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3. Results
In this study differences in antioxidant capacities of two brain endothelial cell lines from the same
animal species were observed. We firstly established baseline data for both cell lines in terms of their
endogenous glutathione concentrations, and secondly, we profiled the response of these cell lines to an
exogenous ROS stress, H2O2, with respect to the content of the endogenous antioxidant, glutathione,
using fluorescent imaging, and fluoro-spectrometric quantification.
3.1. Both b.End5 and bEnd.3 Cells Demonstrated Glutathione Presence on Fluorescent Microscopy
We first investigated presence and distribution of glutathione in each of the selected cell lines.
Monochlorobimane with propidium iodide nuclear counterstaining revealed blue fluorescence due to
the presence of glutathione while the nuclei fluoresced red (Figure 1). Both cells appeared intensely
fluorescent for glutathione, however, bEnd.3 showed less cytoplasmic glutathione possibly due to
a higher nucleo-cytoplasmic ratio. Variable segments and rings of blue fluorescence were observed
around the periphery of the nuclei in both cells (Figure 1, Plates A2 and B2) which are evidence
of glutathione presence within the nuclear structure. This was more prominently observed at the
nucleo-cytoplasmic interface in both cell types and especially in the bEnd.3 cell (Figure 1, Plate B2).
 
Figure 1. Micrographs show fluorescent images of b.End5 (A1) and (A2) and bEnd.3 cells (B1) and (B2)
in normal culture. Both cells showed blue monochlorobimane solution (mBCl) fluorescence (due to
binding with reduced glutathione (GSH)) in their cytoplasm, though at the higher magnification b.End5
appeared more deeply stained. Furthermore, plate A2 revealed a lower nucleo-cytoplasmic ratio in
b.End5 cells suggesting more cytoplasmic GSH content than in bEnd.3 cells. Furthermore, multiple
segments and rings of blue fluorescence (white arrows) were indicative of glutathione observed within
the nuclei and nucleo-cytoplasmic interface in the cells of both cell types (Plates A2 and B2).
3.2. Glutathione Contents of Both b.End5 and bEnd.3 Cells Are Comparable in Normal Culture
The difference in blue fluorescence between the two cell types provided micrographical evidence
for the presence and distribution of glutathione. The objective quantification of the levels of glutathione
in each cell type was required to compare the cells’ ability to respond to OS (Figure 2).
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Figure 2. The above diagram illustrates the redox buffering reaction of the glutathione system.
Glutathione peroxidase (GPx) enzymatically converts H2O2 to 2H2O using reduced glutathione (GSH)
as substrate which is then converted to its oxidized form, glutathione disulfide (GSSG) in the process.
The GSSG in a second reaction involving glutathione reductase enzyme is converted back to GSH
and thus GSH is recycled. The glutathione reductase reaction contributes significantly to the cellular
maintenance of pooled reduced glutathione for redox defense.
Total and reduced fraction of the glutathione content in both cell types were experimentally
determined while the content of oxidized glutathione was derived by deduction of the reduced
glutathione values from the respective total glutathione values. The value of the total glutathione
was obtained by reducing the GSSG fraction in each sample using TCEP which also has the ability
to recover protein-bound GSH. However, because GSH exists within cells either freely or bound to
proteins the recovered GSH still constituted a fraction of the total glutathione pool. In b.End5 cells
the amount of glutathione per unit cell was higher than that of bEnd.3, however, the difference was
not statistically significant (p = 0.1325) (Figure 3). Estimated values were 2.769 ± 0.113 fM/cell for
b.End5 and 2.305 ± 0.219 fMol/cell for bEnd.3. Corresponding GSSG values for both b.End5 and bEnd.3







Figure 3. A comparison of GSH concentration in the two types of cells revealed no statistical difference
between the two means (Student′s t test: p = 0.1325).
3.3. Antioxidant Capacity Is Higher in b.End5 Cells
Although both cell lines tested showed that glutathione was abundantly present in both the
cytoplasm and nucleoplasm, the response of these cell lines to ROS stress remains to be investigated.
Both bEnd.3 and b.End5 cells treated with increasing concentrations of hydrogen peroxide showed
changes in viability which correlated with the relative absorbance units obtained from XTT proliferation
assay. The assay is based on the cleavage of the yellow tetrazolium salt, XTT, to form an orange
formazan dye by mitochondrial dehydrogenases in metabolically active cells. Because an increase in
the number of cells results in an increase in the overall activity of mitochondrial dehydrogenases in
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the samples, these changes correlated to the amount of orange formazan formed, a parameter that
was monitored by the relative changes in the absorbance. The viability changes in both cells were
normalized as percentages of the control, unexposed, cells and plotted against the logarithmic values
of the various concentrations and the half-maximal inhibitory concentrations (IC50) were determined
and compared for the two cells (Figure 4A,B). Experiments were repeated three times and average
values were analyzed. Results showed that the IC50 for the b.End5 cell was significantly higher than
for the bEnd.3 cell (Figure 4C).



























Figure 4. A non-linear regression analysis of logarithmic values of [H2O2] against normalized viability
was used to determine the hydrogen peroxide concentration that caused 50% inhibition of cell viability
in b.End5 cells. Cells were exposed to [H2O2] that ranged between 0 (control) and 850 μM for 24 h
in flat-bottom transparent 96-well plates. Viability changes correlated to the absorbance measured
at 450 nm from each well following incubation with XTT reagent for 4 h. (A) Results showed IC50
for b.End5 cell as equivalent of 486.4 μM at r2 = 0.9566. (B) Data for bEnd.3 cells was obtained by
exposing cultured bEnd.3 cells to [H2O2] ranged from 0 (control) to 500 μM and non-linear regression
analysis done as described above. Results showed IC50 for bEnd.3 cell to be 74.55 μM at r2 = 0.9687 μM.
(C) Graph of the IC50 values for the b.End5 compared with the same values for the bEnd.3 cells
(annotation * denotes statistically significant difference between the values shown). IC50 values for
b.End5 and bEnd.3 cells were statistically compared using the Student′s t test. The analyzed data
showed that the IC50 value was significantly higher for b.End5 cell than for the bEnd.3 cell (p < 0.0001).
3.4. Glutathione Was More Resistant to Oxidant Depletion in b.End5
Changes in the glutathione content of equal number of cells were plotted against the hydrogen
peroxide concentrations. This allowed for the analysis of the physiological response (endogenous
antioxidant response) of the two cell lines to increased H2O2 concentrations. The profile in glutathione
depletion against increasing concentrations of hydrogen peroxide for the two cell lines was examined
(Figure 5A,B). The data showed a steady decline in the glutathione content of the bEnd.3 cells (Figure 5B)
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while the b.End5 cells, in contrast, showed an initial significant increase in glutathione content and then
a decline (Figure 5A). In b.End5 cells, glutathione increase was sustained either higher or at par with
the control cells until about a concentration of 500 μM which was close to its IC50 value (Figure 5A).
Also, the glutathione content of b.End5 cells were observed to decline to a steady lowest value at about









Figure 5. (A) and (B) show trends in the glutathione contents of b.End5 and bEnd3 cells with exposure
to increasing [H2O2]. Cells were exposed to increasing concentrations of [H2O2] for 24 h and average
cellular glutathione contents estimated using the GSH-Glo kit. Glutathione contents of the cells
correlated directly to the relative luminescent values (RLU) obtained following incubation with the
optimized reagents of the GSH-Glo assay kit described. Data in Figure 4A represents b.End5 cells
and shows an upward trend in the glutathione content of the b.End5 cells upon exposure to [H2O2]
of 0–250 μM. Above this concentration was observed a downward trend though values remained
higher or at par with the starting point until [H2O2] higher than 500 μM. From this point a steady
decline occurred until about 1 mM [H2O2] followed by a plateau but not a complete depletion. Data in
Figure 4B represent the trend in bEnd.3 glutathione changes with increasing [H2O2]. A steady decline
was observed until complete depletion at about 400 μM [H2O2].
4. Discussion
Although several previous reports have reported the existence of strain-specific genes in
contributing to some differences in the physiological characteristics of different organs and/or systems
in animals of the same species [34–36], researchers have largely ignored this evidence in choosing
cell lines to model a physiological system. This is particularly evident in the use of cell lines
modelling the BBB, where a variety of primary and immortalized cell lines have been used to study
its physiological functions. This phenomenon creates un-necessary murkiness in comparing data
between different studies. In this study, we were able to illustrate convincingly that differences in
the antioxidant characteristics of the two cell lines (b.End5 and bEnd.3) (Figure 4A–C) of the same
species, have distinctly different response profiles to an escalating ROS stressor. These two cells
were derived from primary brain endothelial cells of two different mouse strains, BALB/c and SV129
respectively, by infection with a retrovirus coding for the Polyoma middle T-antigen [37,38]. Both have
been used extensively to study BBB function [39–41], all with the underlying assumption, that there is
physiological parity between these cell lines.
We investigated the cellular content of the glutathione antioxidant in the two cell types under
normal culture conditions (as per the instructions provided by the suppliers), first by fluorescent
microscopy, and although we easily established the cellular presence for glutathione, we were unable
to distinguish clear quantitative differences between the two cell lines. Close examination of the
fluorescence micrographs clearly illustrated the even distribution of glutathione throughout the
cytoplasm of both cell types, however, the higher ring of fluorescence just inside the nuclear membrane
seem to suggest that glutathione plays an important role in neutralizing ROS entering into the
nucleus. Given that DNA fragmentation is prone under conditions of OS [42,43], this provides solid
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circumstantial evidence as to the role of glutathione in protecting the nuclear material from ROS
compromise. Although fluorescence demonstrated the presence of glutathione in both types of cells, the
presence of blue fluorescence provided subjective evidence of increased cytoplasmic glutathione within
b.End5 cells as evidenced by a lower nucleo-cytoplasmic ratio in the b.End5 cells with consequently
more cytoplasmic content of glutathione.
Our quantitative data of the glutathione content of the b.End5 and bEnd.3 cell types substantiated
our visual observations and, although b.End5 cells had a slightly higher mean glutathione content,
statistically no significant difference in glutathione quantity was found between the respective cell lines
(Figure 3). Calculations from data indicated that the GSH concentration per unit cell for the b.End5
and bEnd.3 cell types were within the range of 2.769 ± 0.113 fMol and 2.305 ± 0.219 fMol respectively.
Both cell types also have GSH/GSSG ratio of approximately 95%/5% which indicated that both cells
were redox-stable in normal culture. Comparisons of the average cellular glutathione per single cell
for both the b.End5 and bEnd.3 cell lines predict that these cells are well suited for OS resistance in that
their GSH contents are in the range of cells specialized for detoxification, such as the liver cancer cell
line, HepG2 with GSH content of 2.9 fMol/cell [44]. These data, taken independently endorses the use
of these cell lines for BBB modeling. It is presumptuous to assume that simply on the basis that the
cell lines have similar basal levels of endogenous antioxidants that these cells may indeed respond
to incremental ROS stress in a similar manner. This is all the more complicated given the arbitrary
concentrations of ROS stressors used in experiments to demonstrate OS on the BBB [45,46].
To evaluate the response of the endogenous antioxidant glutathione to incremental concentrations
of H2O2 in each cell-line, we then determined the relative levels of OS that causes decompensation of
the GSH/GSSG antioxidant system in the cell after 24 h exposure (Figure 4A,B). In this study we profiled
the cell lines using the glutathione system which has been reported as a reliable and sensitive marker
of oxidative cellular status [47,48]. Furthermore, because the physiological variable of cell viability was
used as a general indicator of the response of the cells to ROS (H2O2), it is scientifically plausible that
viability changes will be a reliable indicator of the total cellular antioxidant capacity, and therefore, a
singular marker (glutathione) would provide enough insight on the differences in the total antioxidant
capacities of the two cell lines. Using the IC50 [49]values for comparison, we documented for the
first time evidence of a significantly greater capability of the b.End5 cells to neutralize higher ROS
concentrations than the bEnd.3 cells ([p < 0.0001] Figure 4C). When we studied the profile in the GSH
depletion within the cells exposed to increasing ROS load the data showed that the bEnd3 cell type has
a very limited ability for de novo upregulation of glutathione synthesis under condition of increased
ROS accumulation (Figure 5B), whereas the b.End5 cell type showed ability to sustain adequate levels
of glutathione, to elevate levels of GSH in response to initial low concentration of ROS, and to maintain
this sustained endogenous GSH levels despite several subsequent increases in the concentration of ROS
(Figure 5A). The mechanism for this divergent reaction of the glutathione system in the two cell types
against increasing concentration of ROS is not clear, and requires further study. However, this observed
difference is suggestive of inter-strain differences in the system that regulates ROS accumulation
within these cells, as has been reported for several diverse physiological characteristics in different
strains of cells from the same species of animal [35,49,50]. Differentially expressed genes in specific
domains of the system that regulate ROS in intracellular milieu or perhaps strain-specific genetic
alteration following viral oncogenic transformation of the primary cells could be responsible [51].
Mouse strain-specific differences in neuro-behavior, neuronal excitability, susceptibility to fibrosis,
anti-inflammatory response, and bone density have been previously reported [50]. These previous
reports have strengthened our position that strain-specific genes are very important in shaping the
phenotypic differences in the two cell types investigated with respect to their glutathione system
plasticity to OS. This finding has an important bearing on experimental designs aimed at studying
effects of OS on the BBB. However, whether these two mouse cells respond differently to OS in the
in vivo situation is not known. We propose here that a genome-wide genetic screen of the cells in use
for evaluating the physiology of the BBB will identify important differences in the genes that control
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several key functions of the BBB [52]. Also, further research is required to determine these properties
in primary cells of the mouse brain endothelial cells with the potential for the unraveling of the true
behavior of the mouse brain endothelial cells during OS conditions with respect to capacity for ROS
neutralization and the glutathione system response.
Given that under control conditions we are confident that the BECs would be in redox balance,
it is, therefore, unimportant to localize the source of endogenous ROS production in response to
exogenous ROS exposure, neither does it make scientific sense to measure ROS production from the
cell organelles when the source of ROS was clearly defined as the experimental treatment (exogenous
H2O2). Exogenous ROS treatment would gauge the physiological capacity of the cells to respond to
ROS exposure from an exogenous source. Exogenous exposure would be additional to the normal
ROS load generated by normal physiological cellular processes. Thus, the measuring of ROS levels
while exposing cells to exogenous H2O2 in this study would be superfluous. Nevertheless, it might
be assumed that the study largely ignored the spatiotemporal localization and quantification of
endogenous ROS production, but we are aware of the lack of the use of these techniques, which
is intended to be the focus of our future study, in which we propose to measure ROS produced
endogenously by cellular organelles using a combination of immuno-electron microscopy as qualitative
and ELISA as semi-quantitative methods [53–55].
5. Conclusions
The glutathione system responses and ROS buffering capacities are clearly linked and they
determine the magnitude of ROS that induces OS in the b.End5 and bEnd.3 mouse brain endothelial
cell line models of the BBB. Strain-specific differences in the different cells will result in different
definitions of OS in different models of different animal strains within the same species. Thus it is
important to establish experimental parameters that best define OS for each endothelial cell model of
the BBB for reproducibility. Such information will avail researchers of opportunity to verify and select
appropriate models of BBB endothelial cells for specific redox investigations and enable them to draw
comparable and reproducible conclusions.
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Abstract: Free radicals are important antimicrobial effectors that cause damage to DNA, membrane
lipids, and proteins. Professional phagocytes produce reactive oxygen species (ROS) and reactive
nitrogen species (RNS) that contribute towards the destruction of pathogens. Toll-like receptors
(TLRs) play a fundamental role in the innate immune response and respond to conserved microbial
products and endogenous molecules resulting from cellular damage to elicit an effective defense
against invading pathogens, tissue injury, or cancer. In recent years, several studies have focused on
how the TLR-mediated activation of innate immune cells leads to the production of pro-inflammatory
factors upon pathogen invasion. Here, we review recent findings that indicate that TLRs trigger a
signaling cascade that induces the production of reactive oxygen and nitrogen species.
Keywords: free radicals; antimicrobial; toll-like receptors
1. Introduction
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are recognized for their dual
role as both deleterious and beneficial species. The overproduction of ROS/RNS results in damage to
cell structures, including lipids and membranes, proteins, and DNA, inhibiting their normal function.
In contrast, the salutary effects of ROS/RNS occur at low/moderate concentrations in cellular responses,
including in defense against infectious agents, in the function of a number of cellular signaling pathways,
and the induction of a mitogenic response [1]. The subtle balance between beneficial and harmful
effects of ROS/RNS is a very important aspect of living organisms and is achieved by a mechanism
called “redox regulation” which maintains cellular “redox homeostasis” using the antioxidants
system [2]. ROS and RNS are generated using several different processes including (i) irradiation by
UV light, X-rays, and gamma-rays; (ii) as products of metal-catalyzed reactions; (iii) by neutrophils and
macrophages during inflammation; and (iv) as products of mitochondria-catalyzed electron transport
reactions [3]. An important potential source of oxidizing agents is the phagocytic leukocytes within
the body. Neutrophils, monocytes, and macrophages are the most prominent immune cell types
that release various pro- and anti-inflammatory mediators for both host defense and inflammatory
responses [4]. Oxidation intermediates are also involved in these processes. The cumulative production
of ROS/RNS from either endogenous or exogenous sources is termed oxidative stress. Oxidation
intermediates are essential activators of oxidative stress. This is because low levels of free radicals,
including ROS and RNS, form a stressful oxidative environment that can clear invading pathogens and
maintain physiological homeostasis [5]. Although innate immunity is the first line of defense against
pathogens, Toll-like receptors (TLRs) also play a crucial role in the early host defense mechanism [6].
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In recent years, there have been a significant number of discoveries regarding how the TLR-mediated
activation of innate immune cells leads to the production of pro-inflammatory factors upon pathogen
invasion. In this review, we discuss recent research findings on TLR activities, with a particular focus
on TLR-mediated signaling pathways that are activated during nitroxidative stress.
2. Nitroxidative Stress
2.1. Formation of Nitroxidative Stress
Nitroxidative stress is a cellular condition that reflects a physiological imbalance where excessive
reactive nitrogen and reactive oxygen species are present. Under this condition, an excessive production
of ROS and RNS occurs, exceeding a level that the body’s antioxidant mechanisms can cope with.
Examples of ROS species include the superoxide anion (O2−), hydrogen peroxide (H2O2), and
hydroxyl radicals (•OH) [7]. RNS include nitric oxide (NO), nitrogen dioxide (NO2), and the powerful
oxidant peroxynitrite (ONOO−) [8]. During microbial infections, excessive NO produced has varying
functions, ranging from anti-microbial and anti-inflammatory host defense and cell protection to
proinflammatory and cytotoxic activities [9]. The NO produced in inflamed tissues during infection
or inflammation are affected by the concomitant production of oxygen radicals, particularly O2− and
H2O2. The interaction of NO with reactive oxygen species causes the formation of several reactive
nitrogen oxides, these reactive nitrogen intermediates have a great possibility of causing oxidative
and nitrative stress through the oxidation and nitration of biological molecules [10]. A study in mice
shows that O2− was produced by neutrophils and macrophages in the liver, which is associated
with prolonged granulomatous lesions in infected with Salmonella typhimurium. The inhibition of
O2− generation by in vivo superoxide dismutase (SOD) treatment results in a reduction in the area of
liver lesions, simultaneously accelerating bacterial growth in the liver. The result suggests that O2−
may be involved in the host defense mechanism against S. typhimurium infections [11]. Granulocyte
peroxidases, such as myeloperoxidase, play an important role in oxidative stress [12]. In neutrophils,
H2O2 produced by O2− is metabolized by myeloperoxidase into a strong oxidant, hypochlorous
acid (HOCl), in the presence of chloride ions. HOCl plays an important role in host defense and
inflammatory tissue injury. In addition, myeloperoxidase generates reactive nitrogen species in vivo
only when nitrite and nitrate are available [13]. Overproduced ROS and RNS can easily and rapidly
react with intracellular macromolecules, causing oxidative damage to cellular structures that result in
progressive physiological dysfunction, which is associated with many pathological conditions. ROS
are the major causative factor in steatohepatitis and insulin resistance [14]. Various neurodegenerative
diseases, such as Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD), and
amyotrophic lateral sclerosis (ALS), can be the result of oxidative stress [15].
2.2. Antioxidant Systems
There are two types of antioxidant systems in the body. The first one is formed by antioxidant
enzymes, which includes superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase
(GSH-Px). The other is formed by non-enzymatic antioxidants which includes vitamin C, glutathione
(GSH), melatonin, and trace elements [16]. Antioxidant substances catalyze the formation of active
oxygen intermediates, scavenge free radicals, and terminate peroxidation. ROS is mainly produced
by Nicotine adenine dinucleotide phosphate (NADPH) oxidase [17]. When stimulated, NADPH
oxidase induces electron transmembrane transport and generates O2−. As O2− is unstable, it is
rapidly converted into H2O2, which can then be transformed into H2O and O2•− or other active
oxide derivatives.
RNS family members are derived from NO through the action of nitric oxide synthase
(NOS). NOS is a multidomain enzyme that contains binding sites for the cofactors NADPH, flavin
adenine dinucleotide (FAD), flavin mononucleotide (FMN), and (6R-)5,6,7,8-tetrahydrobiopterin (BH4).
It catalyzes the production of NO and L-citrulline from L-arginine. The availability of L-arginine is one
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of the rate-limiting factors in cellular NO synthesis and secretion. There are three members of the NOS
family: neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS). As nNOS and
eNOS are constitutively expressed and not inducible, they are not associated with the inflammatory
response [18]. The iNOS isoform is upregulated by inflammatory stimulating factors [19] and can be
activated by phagocytes after stimulation with PRR agonists, IFN-γ, and proinflammatory cytokines [20].
In turn, the produced NO is able to stimulate the expression of the transcription factor NF-E2-related
factor-2 (Nrf2) in macrophages, upregulate ferroportin (FPN), and contribute to nutritional immunity
in macrophages [21]. Nrf2 plays a key role in anti-inflammation and oxidation stress and triggers the
expression of the downstream target genes catalase (CAT), superoxide dismutase (SOD), glutathione
S-transferase alpha 1 (GSTα1), quinone oxidoreductase 1 (NQO1), γ-glutamylcysteine synthetase
(γ-GCS), and heme oxygenase-1 (HO-1).
Phosphoinositide 3-kinase (PI3K) and MAPK signaling pathways regulate activation of the
Nrf2-antioxidative response element pathway [22]. Oxidative stress activates NF-κB and induces
inflammatory responses. Together, Nrf2 and NF-κB cooperatively regulate the oxidative stress
response [23]. Oxidation intermediates exert antimicrobial actions against a broad range of pathogens.
Indeed, chronic granulomatous disease (CGD) patients that are deficient in oxidation intermediates are
susceptible to extracellular bacterial infections [24]. CGD is characterized by inherited defects
in the innate immune system resulting from mutations in the genes encoding any of the five
components of the NADPH oxidase complex, including gp91-phox, p22-phox, p40-phox, p47-phox,
and p67-phox [25]. However, some bacteria have devised strategies to escape killing using oxidation
intermediates. Mycobacterium tuberculosis binds to macrophage-expressed complement receptor 1
(CR1) and complement receptor 3 (CR3) to overcome reactive oxygen intermediates (ROI) and
reactive nitrogen intermediates (RNI) production. This allows for the safe access of pathogens to
their intracellular habitat. Staphylococcus aureus releases adenosine to overcome oxidative killing
in phagocytes and produces the enzymes SOD and CAT to eliminate oxidation intermediates [26].
Mitochondria are major sources of ROS production in cells [27]. Mice with reduced macrophage ROS
levels (through the overexpression of CAT in their mitochondria) showed an impaired ability to kill
intracellular bacteria following intraperitoneal infection with Salmonella typhimurium. This confirms
that ROS play a key role in bactericidal activity [28].
3. TLRs and Their Signaling Pathway
3.1. An Introduction on TLRs
Microbial structures and molecules are crucial for their survival and virulence. Pathogen-associated
molecular patterns (PAMPs) are highly conserved structural components that are uniquely associated
with microorganisms [5]. These include LPS, lipoproteins, carbohydrates, flagellin, and nucleic
acids. Upon long-term exposure to pathogens, the innate immune system provides a faithful
mechanism to rapidly sense and respond to PAMPs using a number of structurally unrelated host
proteins called pattern recognition receptors (PRRs) [6]. PRRs play important intracellular roles to
eliminate infection and initiate inflammatory responses [29]. To date, four different classes of PRR
families have been identified, including C-type lectin receptors (CLRs), RIG-I-like receptors (RLRs),
nucleotide-binding-domain and leucine-rich-repeat-containing receptors (NLRs), and TLRs [30]. PRRs
are strategically distributed in the cell to enable the recognition of both extracellular and intracellular
pathogens. For example, TLRs and CLRs localize to plasma or endosomal membranes, whereas
RLRs and NLRs are cytosolic [31]. TLRs are type I integral membrane glycoproteins that are
characterized by an N-terminal extracellular domain with leucine-rich repeats (LRRs) that recognize
PAMPs, a transmembrane region, and a cytoplasmic Toll/IL-1R homology (TIR) domain that mediates
downstream signaling [30]. TLRs are one of the most-investigated PRR families and are able to detect
a wide range of PAMPs, including bacterial lipopolysaccharides (LPS), lipoproteins, flagellin, and
nucleic acids. Many structural studies on TLRs, including X-ray crystallography, have been undertaken
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to investigate the basis of their ligand recognition [5]. In zebrafish (Danio rerio), 19 putative TLR
variants, the orthologs of mammalian TLR 2–5 and 7–9, a fish specific receptor type group, and three
putative splice variants have been identified [32]. Some studies on oxidative stress in the zebrafish
model have been done, including a study evaluating the effects of dietary supplementation with the
probiotic Bacillus amyloliquefaciens R8, which has a heterologous expression of xylanase from rumen
fungi, on zebrafish. The result shows it improved expression levels of oxidative stress-related genes in
the fish liver [33]. Zebrafish embryo exposure to Triclocarban (TCC) at environmental concentrations
significantly affects the expression of immune-response-related genes following oxidative stress and the
release of proinflammatory mediators through the Toll-like receptor signaling pathway [34]. Thirteen
TLRs have been discovered in mammals to date [35]. TLR1-9 is present in both humans and mice.
Mouse TLR10 is nonfunctional owing to a retroviral insertion. Human TLR11 is a pseudogene,
and TLR12 and TLR13 are absent from the human genome. Studies with TLR-knockout mice have
demonstrated that each TLR subgroup recognizes distinct PAMPs and initiates a particular immune
response (Table 1) [36]. Studies of Drosophila TLRs also support the fact that distinct TLRs may differ
in their signaling ability. In Drosophila, toll and 18-wheeler sharing homologous cytoplasmic domains
activate different and nonoverlapping gene expressions when faced with fungi and bacteria. TLRs
are expressed in a variety of cells and tissues, including dendritic cells, mononuclear macrophages,
and granulocytes. Immune cells are capable of recognizing distinct molecular patterns to elicit a
specific response against pathogens or endogenous factors released as a result of cellular damage.
TLRs can recognize PAMPs in different cell compartments, including the plasma membrane, endosomes,
lysosomes, and endocytic lysosomes. However, the TLRs must be appropriately localized in cells to
recognize their ligands. This is also important for self-tolerance and downstream signal transduction.
When TLR4 interacts with myeloid differentiation factor 2 (MD2) and CD14, an LPS receptor is then
combined with a ligand [37]. This alerts the immune system to the presence of invading organisms,
so that an immediate response can be configured to contain the pathogen. Later, during the start of
acquired immunity, the recognition event is provided information about the nature of the invading
microorganism. From this information, it is determined whether T helper (Th) 1 cells differentiate into
Th1 cells that promote cell-mediated immunity or Th2 cells that promote humoral responses [38].
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Table 1. TLR Recognition of Microbial Components [36,39,40].
TLR Usage Expression Patterns in Leucocytes
Cellular
Localization
Microbial Component Recognized by the Receptor






TLR2 T-Lymphocytes Cell surface Triacyl lipopeptides
PMNs Diacyl lipopeptides










TLR3 DCs Endosome dsRNA






TLR5 PMNs Cell surface Flagellin
Mononuclear phagocytes
DCs




TLR7 T-Lymphocytes Endolysosome ssRNA
B-Lymphocytes Imidazoquinoline
DCs
TLR8 T-Lymphocytes Endolysosome Loxoribine
Mononuclear phagocytes ssRNA
DCs Imidazoquinoline




TLR10 B-Lymphocytes Cell surface not determined
DCs




3.2. Signaling Pathway of TLRs
TLRs generally function as homodimers. However, TLR2 exists as a heterodimer with another TLR
molecule, for example TLR2/TLR1 and TLR2/TLR6. TLR2 recognizes lipoteichoic acid, lipopeptides,
peptidoglycan, and Zymosan [41], whereas TLR4 homodimers specifically recognizes lipopolysaccharides
(LPS) from Gram-negative bacteria heat-shock proteins [42] and viral components such as the fusion protein
from respiratory syncytial virus (RSV) [24]. TLR5, TLR9, and TLR3 recognize the flagellin component
of bacterial flagella, genomic DNA, and the viral replication intermediate dsRNA, respectively [43–46].
All TLRs except TLR3 utilize MyD88 to activate NF-κB and MAPK and induce an overproduction of
inflammatory cytokines [47]. This pathway is called the MYD88-dependent pathway. Toll-interleukin1
receptor (TIR) domain containing adaptor protein (TIRAP) assists the recruitment of MyD88 to the surfaces
of TLR2 and TLR4. TIRAP has a lipid-binding region that binds to PI (4,5) P in the plasma membrane and
PI (3) P on the endosome, allowing the formation of functional signaling complexes at their respective
positions [48]. In MYD88-independent pathways, TRIF is recruited to TLR3 and TLR4, which results in
the activation of interferon regulatory factor 3 (IRF3), nuclear factor kappa-light-enhancer of activated B
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cells (NF-κB), and mitogen-activated protein kinase (MAPK) to induce the production of type I interferons
and inflammatory cytokines. TRAM is selectively recruited to TLR4 to link TRIF and TLR4. Although
TLR3 is able to bind directly to TRIF, this interaction requires the phosphorylation of two tyrosine residues
in the cytoplasmic region of TLR3 [49,50].
Two distinct TLR signaling pathways have been identified based on the availability of adaptor
molecules. Both pathways activate downstream signaling molecules that lead to the secretion of
inflammatory cytokines, type I interferon (IFN), chemokines, and antimicrobial peptides [51]. These
instigate neutrophil recruitment, macrophage activation, and the induction of IFN-related genes, which
directly kill pathogens. In addition, the activation of the TLR signaling pathway leads to the maturation
of dendritic cells (DCs) and contributes to adaptive immunity (Figure 1).
Figure 1. MYD88-dependent pathway (left). MYD88-independent pathways (right) [52].
4. TLRs and Nitroxidative Stress
Under normal conditions, TLRs are maintained at relatively stable levels by intracellular
modulation (such as alternative splicing) and degradation by ubiquitination and deubiquitination.
Transgenic animals overexpressing TLRs and TLR knockouts have been studied to determine the role of
TLRs during bacterial infection in vivo. S. typhimurium is a Gram-negative bacterium that replicates in
macrophages and has PAMPs that are detectable by at least four TLRs: lipoprotein (TLR2), LPS (TLR4),
flagellin (TLR5), and CpG-DNA (TLR9) [53]. In this review, we will focus on data obtained for the TLR2
and TLR4 signaling pathways in mammalian immune cells, which are linked to nitroxidative stress.
Molecules found in nitroxidative stress, such ROS and NO, are found in response to microbial
invasion during the neutrophil and macrophage respiratory burst. Both oxidative stress and infective
stress can share the same TLR signaling pathways [54]. TLRs interact with adaptor molecules such as
MyD88 and TRIF to activate downstream signaling through NF-κB, AP-1, and interferon-regulatory
factor-3 (IRF-3). The expression of inflammatory mediators is upregulated; involve notably pro-oxidant
enzymes such as NOX and iNOS, producing high levels of ROS [55]. To examine whether TLR signaling
could enhance ROS production, a study in RAW 264.7 macrophages shows the use of all kinds of TLRs
agonist. The production of ROS was triggered only upon signaling from the cell-surface TLRs (TLR1,
TLR2 and TLR4), the same as exposure of cells to rotenone and antimycin A, compounds known to
increase mitochondrial O2– generation, and increased cellular H2O2 [28].
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4.1. TLR2 and Nitroxidative Stress
TLR2 recognizes Gram-positive bacteria, including mycobacteria, and viruses and their products.
Most Gram-positive bacteria, such as Bacillus anthracis, S. aureus, and Clostridium tetani, cause a wide
range of diseases in both immunocompetent and immunocompromised hosts [43]. TLR2 is widely
expressed in innate immune cells and epithelial cells and is highly expressed in peripheral blood
monocytes. TLR2 was found to induce neutrophil activation and its expression is upregulated when
it recognizes its corresponding PAMP. This results in the production of NO and pro-inflammatory
cytokines, including tumor necrosis factor α (TNF-α), interleukin (IL)-1β, IL-6, and chemokines. TNF-α
and IL-1β are both able to stimulate the production of monocyte chemotactic protein-1 (MCP-1).
MCP-1 expression is also induced by oxidative stress [56]. TLR-2 relies on the MyD88 signaling
pathway to activate the NF-κB and MAPK pathways. Phosphorylated MAPK then activates the
transcription factor activator protein-1 (AP-1) and the PI3K/protein kinase B (Akt) signaling pathway
to induce immune responses. AP-1 is a transcription factor that mediates pro-inflammation through
core components including c-Jun and c-Fos. Overexpression of c-Jun induces the production of
inflammatory mediators [57].
During pathogen infection, inflammation is accompanied by an anti-inflammation reaction. Native
CD4+ cells differentiate into Th1 and Th2 cells. The Th1 response produces IL-12 to promote the
production of IFN-γ, which functions to inhibit the differentiation of Th2 cells. The Th2 response is
characterized by low IFN-γ levels and high IL-4 levels, as well as the production of IL-6 and IL-10.
IL-6 produced by Th2 cells acts as a mediator of the acute phase response. It is able to accelerate the
infiltration of inflammatory cells [58] but, at later phases, can increase anti-inflammatory cytokine
expression to prevent an immune overreaction [59]. IFN-γ levels are low during the Th2 response as it is
able to inhibit Th2 cells and the production of IL-10 to decrease the levels of Th1-related cytokines. Mice
deficient in TLR2 experienced strong immune reactions and were susceptible to S. aureus [60]. Another
study revealed that TLR2 signaling contributes to high mortality during polymicrobial intra-abdominal
sepsis. This suggests that a novel therapeutic approach to treat severe sepsis would be to specifically
target the TLR2 signaling pathway [61].
A previous study reported that mice challenged with Pam3CSK4, a TLR2 agonist, had reduced
infiltration of chemokines and inflammatory cells within their tissues [62]. Furthermore, a study by
our laboratory revealed that Pam3CSK4 could activate monocytes/macrophages. An overexpression of
TLR2 in transgenic goats caused early expression of the pro-inflammatory cytokines’ TNF-α and IL-1β,
followed by a continuous increase in the expression of the anti-inflammatory factor IL-4. In addition,
TLR2 overexpression induced the expression of Th1 type cytokines. A skin inflammation experiment
showed that TLR2 overexpression accelerated the inflammatory process in transgenic goats [63].
Free radicals are necessary for the host defense against microbial invasion and inflammatory
injury. Following macrophage activation by TLR2, high levels of NOS and ROS are released, in
addition to NO and H2O2, to the area of inflammation under oxidative stress. Intriguingly, a study
using RAW264.7 cells indicated that NF-κB activation was significantly enhanced upon exposure to
NO [64]. Even relatively low levels of NO are able to trigger downstream pathways and maintain
the correct functioning of the defense mechanism. However, NF-κB activation is inhibited by high
concentrations of NO or the overexpression of antioxidants. The inhibition of NF-κB activation has
been shown to decrease the inflammatory response and prevent tissue damage. GSH, SOD, and CAT
are key anti-oxidative substances in a host organism. Activated NF-κB can induce the secretion of
pro-inflammatory factors and also reduce cellular SOD activity. As described earlier, NO levels are
regulated by iNOS. Activated Nrf2 can induce the expression of the proinflammatory gene COX-2
by inhibiting NF-κB activity, which reduces iNOS expression [65]. Furthermore, Nrf2 activation can
directly regulate c-Jun signaling activity and suppress COX-2 expression. COX-2 overexpression was
found to inhibit PI3K activity and the Nrf2-mediated anti-oxidation reaction [30]. A study of healthy
people and coronary artery disease (CAD) patients shows the activation of the Nrf2 pathway as an
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antioxidant response mechanism in monocyte-derived macrophages (MDMs) [66]. The activation of
Nrf2 protects human coronary artery endothelial cells against oxidative challenge [67].
AP-1 family members include Jun and Fos. Jun subclasses include c-jun and JunB. Fos subclasses
include c-fos and FosB. Different types of AP-1 transcription factor dimer combinations have different
functions in gene expression regulation. Increased levels of c-Fos and c-Jun subunits negatively regulate
the expression of the anti-oxidation genes NAD(P)H: quinone oxidoreductase 1 (NQO1), GSTα1,
SOD1, and CAT. HO-1 is a rate-limiting enzyme that participates in anti-inflammatory reactions and
is induced in response to oxidative stress. HO-1 gene activation has been demonstrated to inhibit
AP-1 activity [68]. The activity of AP-1 was observed to increase in Nrf2 knockout cells throughout
the JNK/c-Jun pathway, leading to the upregulation of HO-1 expression [69]. Our laboratory results
indicate that Nrf2 upregulation, through the overexpression of TLR2 in transgenic goats, inhibited
COX-2 expression and increased the expression of the c-Jun gene in monocytes/macrophages by TLR2
ligand stimulation. In addition, lower levels of anti-oxidation stress enzymes were observed in cells
overexpressing TLR2 compared with wild-type cells. This, in turn, improved the activity of GSH,
and the GSH consumed could be rapidly resynthesized [63]. TLR2 overexpression also upregulates
PI3K and increases HO-1 gene expression. However, the concentrations of malondialdehyde (MDA),
a marker of lipid peroxidation, and NO in cells overexpressing TLR2 remained relatively low and
were maintained at stable levels (Figure 2). In combination, these data indicate that tissue damage can
be prevented through TLR2 overexpression.
Figure 2. The TLR2 signal pathway involved in oxidative stress [48,55]. The TLR2 signaling pathway
activates the MYD88 pathway to activate the NF-κB and MAPK pathways under the action of the ligand
Pam3CSK4. Phosphorylation of MAPK then activates transcription factor activator protein-1 (AP-1)
and PI3K/protein kinase signaling pathways to induce an immune response. AP-1 is a transcription
factor that mediates pro-inflammatory factors, and NO levels are regulated by iNOS. Nrf2 can induce
the expression of pro-inflammatory factors by inhibiting the expression of pro-inflammatory NF-κB,
which is a rate-limiting enzyme involved in the anti-inflammatory reaction and can induce oxidative
stress. GSH, SOD, and CAT are all in a key antioxidant in the host organism. Activated NF-κB reduces
cellular SOD activity.
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4.2. TLR4 and Nitroxidative Stress
A specific ligand is mediated by the TLR4/MD2 complex, together with the co-receptor CD14, then
recruits downstream adaptors to activate the MyD88- and TRIF-dependent pathways [58]. By activating
these two pathways, TLR4 participates in innate immunity in the host’s defense against Gram-negative
bacterial infections, as well as in many inflammatory and autoimmune diseases. The TLR4 signaling
pathway is activated upon the invasion of animal cells by pathogenic microorganisms. This triggers
a cascade of reactions to promote the production and release of inflammatory cytokines, which
induces the chemotactic aggregation of macrophages. However, recently, an interesting study has
demonstrated palmitate-stimulated CD11b + F4/80 low hepatic infiltrating macrophage ROS generation
by dynamin-mediated endocytosis of TLR4 and NOX2, independent from MyD88 and TRIF [14].
Several studies have demonstrated that TLR4-mutant enterocytes have a decreased sensitivity
to LPS compared with wild-type cells [70]. Moreover, TLR4-mutant mice exhibit a suppressed
inflammatory response [71]. This is because TLR4-deficient mice are unable to secrete IL-1 or IL-12
and express IL-6 at lower levels when stimulated with LPS [72]. Mice with targeted deletions of
multiple inflammatory immune and antioxidant genes are susceptible to oxidative lung injuries [73].
Overexpression of TLR4 in mice amplifies the host response to LPS and provides a survival advantage
of increased disease resistance [74]. LPS recognition stimulates TLR4 signaling pathways that lead
to the activation of multiple downstream signaling pathways. In research on TLR4 overexpressing
ovine macrophages, TLR4 initially promoted the production of proinflammatory cytokines TNFα and
IL-6 by activating TLR4-mediated IRAK4-dependent NF-κB and MAPK (JNK and ERK1/2) signaling.
This was later impaired due to the increased internalization of TLR4 into the endosomal compartment
of macrophages. Then, the overexpression of TLR4 triggered TBK1-dependent interferon-regulatory
factor-3 (IRF-3) expression, leading to the induction of IFN-β and IFN-inducible genes. The bacterial
burden after infection with live S. typhimurium in these macrophages was decreased significantly [75].
TLR4 has also been shown to be involved in the phagocytosis of various bacterial species via its
interaction with MAPK, Janus kinase 2 (Jak2), PI3K, and various receptors [76]. The expression of these
factors was observed to increase following S. typhimurium infection of transgenic TLR4-overexpressing
sheep. Ovine monocytes/macrophages overexpressing TLR4 were able to phagocytize higher numbers
of bacteria and also showed a higher phagocytic ability at an early stage, even when infected with
a lower bacterial dose. This suggests that TLR4 overexpression causes an increase in scavenger
receptor expression. In addition, TLR4 overexpression increased the number of bacteria that could
adhere to individual monocytes/macrophages, as well as the number of monocytes/macrophages
able to participate in bacterial adhesion. In contrast, the inhibition of TLR4 reduced S. typhimurium
internalization, actin polymerization, scavenger receptor expression, and the adhesive capacity of
immunocytes. These findings are consistent with previous data using PI3K inhibitors, suggesting
that TLR4 interacts with PI3K to enable S. typhimurium phagocytosis through the regulation of
scavenger receptor expression, actin polymerization, and the alteration of the adhesive capacity of
monocytes/macrophages [77]. In the infection experiment of Escherichia coli in a TLR4-overexpressing
transgenic (Tg) sheep model, monocytes of Tg sheep could phagocytize more bacteria and exhibited
higher adhesive capacity. Using specific inhibition of p38 MAPK, c-Jun N-terminal kinase (JNK), or
extracellular signal-regulated kinases (ERKs), the TLR4-dependent E. coli internalization in sheep
monocytes was reduced. p38, JNK, and ERK are all mitogen-activated protein kinases (MAPKs), which
are important downstream signaling molecules of TLR4. These results provide valuable insight into
the bacterial internalization mechanisms in sheep [78].
Our research laboratory generated transgenic sheep overexpressing TLR4 that had two TLR4 copies
inserted into germ cells. About 90–95% of Gram-negative bacteria are considered to be harmful to their
hosts. Many intracellular bacteria, such as Brucella, Tubercle bacilli, and Salmonella, are pathogenic to both
animals and humans and they can be transmitted from animals to humans. As China has a large sheep
breeding industry, the most harmful of these infections are brucellosis caused by Brucella melitensis.
It not only brings huge economic losses but also causes security risks. The design of TLR4 expression
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sheep provides an important theoretical basis for transgenic disease-resistant breeding. LPS stimulation
of these transgenic sheep enhanced the inflammatory response, which aids the clearance of pathogens.
This could cause excessive oxidative stress that would cause tissue damage [79]. However, TLR4 is able
to tightly regulate oxidative stress throughout these processes. Upon bacterial invasion, TLR4 triggers
the activation of inflammatory factors such as NF-κB and AP-1. The mechanism by which TLR4
mediates the production of ROS involves the membrane-associated enzyme complex NADPH oxidase.
Mouse peritoneal macrophages activated by LPS resulted in an increase in the functional activity of
NADPH oxidase [80]. The NADPH oxidase inhibitor, apocynin, protected mice from LPS-induced
lethality by decreasing the expression level of inflammatory cytokines in vivo [81]. Research using a
yeast two-hybrid and glutathione S-transferase pull-down assay model has suggested that there may
be a direct interaction between TLR4 and NADPH oxidase in mediating the LPS-induced production
of ROS. The carboxy-terminal region of Nox4, a subunit of NADPH oxidase, interacted directly with
the Toll/IL-1 receptor (TIR)-domain of TLR4 after LPS stimulation [82]. Intriguingly, another study on
neutrophils shows that the synthesis of NADPH oxidase was also controlled by TLR4 through the
interleukin-1 receptor-associated kinase 4 (IRAK4) pathways. Phosphorylation of the cytosolic factor
p47 phox is essential for the activation of NADPH oxidase. The data shows that p47 phox is a substrate
for IRAK-4 [83].
In addition, TLR4 can trigger the transcription of the iNOS gene, which promotes NO production.
Furthermore, iNOS produces peroxide and O2− radicals. NO synthesis not only requires L-arginine
as a substrate but also several cofactors for its catalytic activity [84]. BH4 is an essential co-factor for
all NOSs. BH4 bioavailability is a critical factor in regulating the balance between NO and O2−
production [85]. This has been demonstrated when diabetic mice underwent transgenic over-induction
of BH4 synthesis to preserve NO-mediated endothelial function [86]. ROS such as O2− and ONOO−
are able to rapidly oxidize BH4, leading to BH4 catabolism and depletion [87]. The oxidation of BH4
results in the formation of dihydrobiopterin (BH2), which binds to NOS and generates O2–, but
not NO [88]. Guanosine triphosphate cyclohydrolase I (GCHI) is a rate-limiting enzyme in BH4
synthesis. A novel study investigating the relationship between activated GCHI with BH4 revealed
that GCHI-transgenic mice stimulated with LPS showed a marked increase in the expression of renal
iNOS and NO production (Figure 3) [89].
ROS can induce NF-κB activation and upregulate the cytokine-induced iNOS gene, resulting in the
release of excessive amounts of NO. Our research revealed that these inflammatory factors accelerate
the inflammatory response by reducing SOD activity and increasing MDA production. SOD is depleted
during the clearance of oxygen free radicals. Therefore, tissues can then be subsequently damaged
by ROS accumulation [90]. Inflammatory events are often accompanied by oxidative stress, which
generates lipid peroxidation products such as 4-hydroxy-2-nonenal (4-HNE). The study in primary
neuronal cultures from TLR4 mutant mice and wild-type control mice show that TLR4 expression
increases in neurons when exposed to the HNE, and TLR4 signaling increases the vulnerability
of neurons to oxidative stress. This indicates that TLR4 signaling may play a role in Alzheimer’s
disease (AD) pathogenesis, possibly being activated by membrane-associated oxidative stress [91].
Another study found that 4-HNE blocks TLR4-mediated macrophage activation, gene expression,
and phagocytic functions. This is done at least partly by suppressing receptor dimerization [92].
The expression of the anti-inflammatory enzyme HO-1 was found to increase in sheep overexpressing
TLR4, which can directly regulate AP-1 expression. Increased HO-1 activity can suppress TLR4-induced
signal transduction [93]. Our data showed that CAT activity was reduced and GSH-Px expression was
increased following the LPS stimulation of sheep overexpressing TLR4. Another study suggested that
GSH-Px acts in the place of CAT to eliminate H2O2 in certain tissues. We predict that GST may play a
critical role in regulating antioxidative enzyme expression. GST transcription can be upregulated and
downregulated with AP-1 and GSH, respectively. ROS-mediated inflammation can be reversed by
adding exogenous GSH, which can be transferred to glutathione disulfide (GSSG) to eliminate free
radicals and avoid oxidative damage to tissues. The overexpression of TLR4 in sheep resulted in a more
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rapid GSH consumption that dramatically increased GSSG and resulted in severe oxidative damage.
Our laboratory showed that TLR4-induced oxidative stress occurred as a result of NO synthesis.
Figure 3. TLR4 signal pathway in oxidative stress [73,75]. TLR4 interacts with myeloid differentiation
factor 2 (MD2), CD14, and specific ligand LPS receptors, then recruits downstream adaptors to activate
MyD88− and TRIF-dependent pathway-mediated IRAK4-dependent NF-κB, which can trigger the
transcription-promoting NO. The GCHI-iNOS gene shows a significant increase in the expression of
iNOS and NO, which accelerates the inflammatory response by reducing SOD activity and increasing
MDA production. GSH eliminates free radicals and prevents oxidative damage.
TLR4 and its downstream signaling pathways are involved in the activation of GCHI expression [94].
In turn, GCHI plays an important role in the regulation of iNOS expression. The expression of NADPH
oxidase and iNOS in a group of transgenic sheep overexpressing TLR4 was significantly greater
compared with a WT group at 1 and 8 h, but these returned to normal levels at 48 h. This observation
indicates that TLR4 can regulate the expression of both NADPH oxidase and iNOS. In addition,
overexpressed TLR4 inhibited SOD activity and triggered AP-1 to activate downstream antioxidative
genes that protect against oxidative stress [90].
5. Conclusions
Toll-like receptors (TLRs) act as immune receptors to initiate innate immunity and acquired
immunity. They play an important role in the development of oxidative stress in the body. TLRs
activate cells to produce pro-inflammatory factors in pathogen invasion, which can act as secondary
messengers to regulate oxidative stress. Furthermore, TLRs can produce antioxidant mechanisms that
interact to regulate oxidative stress. Our study shows that under the stimulation of LPS, transgenic
overexpressing TLR4 sheep can rapidly trigger the TLR4 signaling pathway and upregulate the
expression of cytokines in a short time, thus reducing the inflammatory reaction time, which is of
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great significance for improving the disease resistance of sheep. Positive individuals can significantly
increase the adhesion of bacteria, which plays an important role in the timely removal of pathogens.
Next, we will further evaluate the phagosome clearance ability of our transgenic sheep during an
infection of phagocytic bacteria.
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Abstract: Although granulocytes are the most abundant leukocytes in human blood, their involvement
in the immune response against cancer is not well understood. While granulocytes are known for
their “oxidative burst” when challenged with tumor cells, it is less known that oxygen-dependent
killing of tumor cells by granulocytes includes peroxidation of lipids in tumor cell membranes,
yielding formation of reactive aldehydes like 4-hydroxynonenal (4-HNE) and acrolein. In the present
work, we investigate the role of reactive aldehydes on cellular redox homeostasis and surface toll-like
receptor 4 (TLR4) expression. We have further study the granulocyte-tumor cell intercellular redox
signaling pathways. The data obtained show that granulocytes in the presence of 4-HNE and acrolein
induce excessive ROS formation in tumor cells. Acrolein was also shown to induce granulocyte TLR4
expression. Furthermore, granulocyte-mediated antitumor effects were shown to be mediated via
HOCl intracellular pathway by the action of NADPH oxidase. However, further studies are needed
to understand interaction between TLR4 and granulocyte-tumor cell intercellular signaling pathways.
Keywords: reactive oxygen species (ROS); oxidative stress; lipid peroxidation; acrolein;
4-hydroxynonenal (4-HNE); oxidative burst; granulocytes; cancer cells; growth control;
cancer regression
1. Introduction
Granulocytes are the most abundant leukocytes in the human body, which provide the first line of
defense against pathogens and play a fundamental role in the innate immune response [1]. Although
granulocytes are closely associated with tumor cells, their exact role within tumor microenvironment
remains controversial [2–4]. Activated granulocytes generate vast amounts of reactive oxygen species
(ROS) that were shown to be crucial for the oxygen-dependent killing of tumor cells [5,6]. ROS
generation by activated granulocytes involves various mechanisms, among which NADPH oxidase
seems to be the key source of granulocyte derived ROS during the oxidative burst [7,8]. Activation of
NADPH oxidase was shown to be toll-like receptor 4 (TLR4)-dependent in response to hemorrhagic
shock or pathogens [9,10]. Over a decade ago it was suggested that a tumor cell-induced oxidative
burst of granulocytes could also be via activation of toll-like receptors (TLR) [5], however this still
remains to be elucidated.
Depending on the amount of ROS and their distance from the target cells, ROS can mediate
cellular responses or cause oxidative damage to macromolecules [3,11,12]. Bauer has earlier described
four ROS intercellular signaling pathways, among which the induction of apoptosis of transformed
cells was mainly via HOCl intercellular signaling pathways [13]. In granulocyte-mediated tumor cell
destruction, this pathway would depend on the superoxide anion (•O2−) derived from both sides.
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The granulocyte NADPH oxidase generates •O2− that further dismutase to hydrogen peroxide (H2O2).
The H2O2 is then converted into HOCl by the action of myeloperoxidase (MPO). HOCl can also
react with •O2−, yielding highly reactive hydroxyl radical (OH•), that is able to directly induce lipid
peroxidation (LPO) [3].
Peroxidation of polyunsaturated fatty acids (PUFAs) that are esterified in membranes can yield
reactive aldehydes, such are acrolein and 4-hydroxynonenal (4-HNE). High amounts of reactive
aldehydes are cytotoxic. However, in small amounts they have important cell signaling roles of
regulating cell proliferation, differentiation, and apoptosis. Reactive aldehydes are longer living
molecules, compared to ROS, that alter different signaling pathways either directly or indirectly by
covalent modification of macromolecules [14–16]. Reactive aldehydes can also be generated by activated
granulocytes that employ an MPO hydrogen peroxide chloride system that can convert L-threonine
into 2-hydroxypropanal, an acrolein precursor, and acrolein [17]. Although the involvement of reactive
aldehydes in tumor development has been intensively studied for decades, the exact mechanisms of
their concentration dependents and cell type specific effects on the tumor–host relationship need to be
further elucidated [18–23].
Therefore, in the present work we investigate the involvement of two particular reactive aldehydes,
acrolein, being the most reactive, and 4-HNE, a major biomarker of lipid peroxidation also denoted
as “second messenger of free radicals”, on the respiratory burst of granulocytes, as well as the
granulocyte-cancer cell intercellular signaling, in order to reveal the critical steps responsible for
granulocyte-mediated destruction of cancer cells.
2. Materials and Methods
2.1. Animals
Experiments were performed on three-month-old male Sprague Dawley rats. Water and food
were given ad libitum. All the experiments were performed in accordance with the ILAR Guide for the
Care and Use of Laboratory Animals, EU Council Directive (86/609/EEC) and the Croatian Animal
Protection Act (Official Gazette 135/06). Ethical approval obtained from the RBI and MSES for the
grant MSES 098-0982464-2519.
2.2. Treatment of Animals and Isolation of Granulocytes
As a source for granulocytes, 4 healthy control rats were used. Rats were s.c. injected with
5 mL Sephadex on each side, in the lower dorsal quadrant, and 24 h later the Sephadex papules were
surgically removed and the granulocytes were isolated, as described before [5]. The granulocyte cell
suspension was counted and diluted in a RPMI 1640 medium to the desired concentration, while their
viability, checked by the trypan blue exclusion test, was found to be 97%.
2.3. Tumor Cell Lines
Three rat derived cell lines, C6 glioma, Walker W256 carcinoma, and PC12 rat adrenal
pheochromocytoma, (ATCC, CCL-107, CCL-38, CRL-1721) were used. The cells were adapted
to grow as monolayers cultured at 37 ◦C in a RPMI 1640 medium, supplemented with 5% (W256 and
PC12) or 10% (C6) fetal bovine serum (FBS) and 1% Penicillin/Streptomycin in a humidified atmosphere.
2.4. 4-HNE and Acrolein
The aldehyde, in the form of 4-hydroxy-2-nonenal-dimethylacetal (HNE-DMA), was kindly
provided by the Institute of Molecular Biology, Biochemistry and Microbiology, Graz, Austria. Prior to
the experiment, it was activated with 1 mM HCl (Kemika, Zagreb, Croatia) for 2 h. The concentration
of HNE was determined by spectrophotometry (UV-1601 spectrophotometer; Shimadzu, Tokyo,
Japan) [24].
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Prior to treatment, cells were left in a serum free medium for 1 h. HNE and acrolein were freshly
prepared before each experiment and used in a concentration of 12.5 μM in a RPMI medium (2% FCS).
2.5. Investigating the Ability of 4-HNE and Acrolein to Modulate Granulocyte and Tumor Cells
Redox Homeostasis
Intracellular ROS production was examined in granulocytes and tumor cells using a redox
sensitive probe 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA; Fluka, Steinheim, Germany),
as described before [25,26]. Briefly, the tested cells (granulocytes or tumor cells) were treated with
10 μM DCFH-DA in Hanks’ Balanced Salt Solution (HBSS) in 5% CO2/95% air at 37 ◦C for 30 min.
Afterwards the DCFH loaded cells were either co-cultured with the other type of cells (tumor cells
or granulocytes, respectively) or left alone as control. The seeding density of the granulocytes and
tumor cells, cultured in 96-well microcytoplates, was 2 × 105 and 2 × 104 cells per culture, respectively.
The mixed cultures were then washed and incubated with an HBSS buffer, supplemented with 12.5 μM
HNE, 12.5 μM acrolein, or left untreated as control. After 2 h, the fluorescence intensity was measured
with a Variant fluorescence spectrophotometer with an excitation wavelength of 500 nm and emission
detection at 529 nm. The arbitrary units, relative fluorescence units (RFU), were based directly on
fluorescence intensity.
2.6. Determination of Surface TLR4 Expression by Flow Cytometry
Influence of reactive aldehydes on the TLR4 expression was measured in granulocytes and W256
tumor cells. The seeding density of granulocytes, cultured in 24-well plates, was 106 cells per culture
in the RPMI 1640 medium. The seeding density of the tumor cells was 2 × 105 cells per culture,
irrespective if cultured alone or if added to the granulocytes. The cell cultures were incubated for 2 h
in the RPMI 1640 medium, supplemented with 12.5 μM HNE, 12.5 μM acrolein, or left untreated as
control, at 37 ◦C in a humidified air atmosphere with 5% CO2. Cells were then washed with PBS and
incubated with an anti-TLR4 antibody (Abcam, Cambridge, UK) or an isotype control (Abcam, UK) for
60 min, followed by the incubation with an AlexaFluor 488 conjugated secondary antibody (Invitrogen,
Carlsbad, CA, USA) for 60 min on ice. The stained cells were then analyzed with FACSCalibur™
(Becton Dickinson, San Jose, CA, USA). The results were analyzed with WinMDI v2.9 software (Joseph
Trotter, San Diego, CA, USA).
2.7. The Effect of Granulocyte Intercellular HOCl Signaling on the Tumor Cell Proliferation
Granulocytes were co-cultured with tumor cells at a ratio of 10:1 in 96-well plates and the
proliferation of C6 and PC12 tumor cells was measured by the 3H-thymidine (3H-TdR) incorporation
assay, similarly to as described before [27]. The effects of HOCl intercellular redox signaling on tumor
cell proliferation were investigated using the NADPH oxidase inhibitor apocynin (APO, 50 μg/mL,
Sigma, Steinheim, Germany), the peroxidase inhibitor 4-aminobenzoyl hydrazide (ABH, 25 μM, Acros
Organics, Geel, Belgium), the HOCl scavenger taurine (Tau, 25 mM, Sigma), the hydroxyl radical
scavenger mannitol (Man, 10 mM, Kemika, Zagreb, Croatia), or the singlet oxygen scavenger histidine
(2 mM, Sigma). Briefly, tumor cells alone or co-cultured with granulocytes were exposed to different
inhibitors and incubated for 24 h at 37 ◦C in a humidified air atmosphere with 5% CO2. After 24 h,
radioactive 3H-TdR was added to each culture and left for additional 48 h. The incorporation of 3H-TdR
was measured by a β-liquid-scintillation counter (LS 3800 Series; Beckman, Indianapolis, IN, USA).
2.8. Statistics
Descriptive statistics were shown as the mean ± SD. The significance of differences between
groups was assessed using the Student t-test and the Chi-square test. When more than two groups
were compared, we used one sided ANOVA with appropriate post hoc testing. The IBM SPSS Statistics
v21 (IBM Corp., New York, NY, USA) software for Microsoft Windows were used. Differences with p
less than 0.05 were considered as statistically significant.
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3. Results
Intracellular ROS production in granulocytes and W256 tumor cells is presented in Figure 1.
Exposure of granulocytes to reactive aldehydes 4-HNE and acrolein did not stimulate granulocyte
intracellular ROS production, while acrolein itself even reduced granulocyte intracellular ROS
production when compared to untreated granulocytes (p < 0.05). However, in the presence of
W256 tumor cells, granulocytes showed a significant increase of the intracellular ROS production.
Such increment of the oxidative burst of granulocytes was further enhanced in the presence of acrolein
(Figure 1A, p < 0.05), but not in the presence of 4-HNE (Figure 1A, p > 0.05). Granulocytes themselves
did not influence intracellular ROS production in W256 cancer cells (Figure 1B, p > 0.05), while the
addition of both reactive aldehydes caused a significant increase of intracellular ROS production by
cancer cells (Figure 1B, p < 0.05, for both 4-HNE and acrolein).
Figure 1. Intracellular ROS production in granulocytes (A) and in W256 tumor cells (B). Mean values ±
SD are given, (*) significance p < 0.05 compared to untreated granulocytes, (**) significance p < 0.01
compared to co-culture of granulocytes and W256 tumor cells and (***) significance p < 0.05 compared
to co-culture of granulocytes and W256 tumor cells.
The impact of 4-HNE and acrolein on the TLR4 surface expression of granulocytes and of W256
cancer cells is shown in Figure 2. Although 4-HNE did not show any particular effect on the TLR4
expression, a significant shift was observed when granulocytes were exposed to acrolein, regardless of
the presence of tumor cells (Figure 2).
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Figure 2. Representative flow cytometry histograms showing TLR4 surface expression on granulocytes
and W256 tumor cells. Granulocytes and tumor cells were stained with antibodies specific for TLR4
(open histogram) or their isotype control (gray histogram).
Since the anticancer effects of granulocytes were already well studied on W256 cancer cells,
the effect of granulocytes on the proliferation of the other murine cancer cells, notably on PC12
pheochromocytoma and C6 glioma, were studied for the first time, as is shown in Figure 3. Granulocytes
inhibited the proliferation by 40% and 55% for C6 and for PC12 tumor cells, respectively. In order to
understand the impact of specific granulocyte derived ROS and the importance of intercellular redox
signaling, the specific parts of intercellular HOCl signaling pathway were inhibited by the addition of
respective inhibitors. Treatment of tumor cells with mannitol, histidine, taurine, and ABH did not
have effect on C6 cell proliferation, while it reduced proliferation of PC12 cells. However, treatment of
both C6 and PC12 cells with APO inhibited tumor cell proliferation compared to untreated tumor cells
with the value p < 0.05. Furthermore, while the addition of mannitol, histidine, taurine, and ABH to
the co-culture of granulocytes and tumor cells did not show any effect on the tumor cell proliferation,
compared to untreated co-cultures (p > 0.05 for both cell lines), the addition of APO, which specifically
inhibits the NADPH oxidase, abolished the anti-tumor effect of granulocytes (p < 0.05 for both C6
and PC12).
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Figure 3. Granulocyte HOCl intercellular redox signaling inhibits tumor cell proliferation. C6 (A) or
PC12 (B) tumor cells treated with granulocytes in the presence or absence of inhibitors (Man—hydroxyl
radical scavenger; Tau—HOCl scavenger; His—singlet oxygen scavenger; APO—NADPH oxidase
inhibitor; ABH—peroxidase inhibitor). Mean values ± SD are given, (*) significance p < 0.01, compared
to untreated tumor cells, (**) significance p < 0.01 compared to co-culture of granulocytes and tumor
cells, and p > 0.01 compared to tumor cells alone.
4. Discussion
The role of granulocytes in the host’s defense against cancer is not well understood, although
the important role of granulocyte-derived ROS in the oxygen-dependent killing of tumor cells was
recognized more than 30 years ago [28]. In the meantime, dual roles of granulocytes, both in tumor
progression [5,6] and tumor regression [4,26,29], were documented. Since it is known that ROS generated
by an oxidative burst of granulocytes can lead to production of reactive aldehydes acting as “second
messengers of free radicals”, we hypothesize that reactive aldehydes in the presence of granulocytes
might be the crucial factors determining the fate of cancer cells. In favor to our hypothesis are not
only results of the current study, but also earlier studies, especially on human colon carcinoma [30].
Namely, production of 4-HNE by inflammatory and stromal cells increased autocrine/paracrine
suppression of colon epithelial cells through TGF-β1 and c-Jun N-terminal kinase upregulation [31].
Complementary to that, acrolein was found to be associated with colon tumorigenesis, too. Namely, in
cases of adenomas, the amount of acrolein was increased from a moderate appearance in tubular and
villotubular low-grade adenomas to abundant and diffusive distribution in high-grade villotubular
adenomas and Dukes A carcinomas. However, in advanced Dukes B and C carcinomas, acrolein was
hardly noticed, while, opposite to cancer tissue, acrolein was abundant in non-malignant colon tissue
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adjacent to the cancer [32]. Though, it was initially assumed that such changes in reactive aldehydes, in
particular of acrolein which is not usually present in human tissue under physiological circumstances,
might reflect negative consequences of the food-derived LPO. Recent findings on human liver and
primary, as well as metastatic, lung cancer suggest that reactive aldehydes might actually represent an
important mechanism of host defense against cancer invasion [33,34]. Moreover, direct involvement of
4-HNE and acrolein was reported for granulocyte-mediated W256 regression. So, we may assume that,
in addition to cases of human cancer, granulocytes might be the source of reactive aldehydes in the
vicinity of cancer [28]. As the acrolein formation was observed in an early stage of W256 regression, we
have proposed that acrolein might serve as a mediator of positive feedback to promote myeloperoxidase
activity and further induce ROS production, eventually generating 4-HNE [29]. In the present work
we show for the first time that reactive aldehydes, in the tested concentrations, did not solely affect
in vitro cellular redox homeostasis, either of tumor cells or granulocytes. However, because acrolein
enhanced the oxidative burst of granulocytes in the presence of W256 cells and vice versa, our current
findings are in line with our earlier hypothesis. Although 4-HNE had similar effects in our study, the
fact that it was less potent than acrolein might reflect differences in their biochemical reactivity and/or
its recently reported inhibitory effect on the granulocyte activation and phagocytosis [35].
The most important role of reactive aldehydes might be in the disturbance of tumor cell redox
homeostasis, as indicated in the current study, showing that only granulocytes in the presence of
reactive aldehydes have the ability to significantly affect the redox balance of tumor cells. Namely,
acrolein was shown to upregulate granulocyte surface TLR4 expression. However, whether the increase
in TLR4 abundance on the membranes is the result of a shuttling of the protein or is an induction of the
overall protein, still remains to be elucidated. Increased membrane expression of granulocyte TLR4
could impact specific signaling pathways, like NF-kappa B and STAT3, and could mediate molecular
mechanisms to promote NADPH oxidase activation and, consequently, ROS production and growth
suppression/decay of tumor cells [36]. Indeed, the granulocyte mediated antitumor effect was inhibited
by APO, an NADPH oxidase inhibitor, but not by Man (a hydroxyl radical scavenger), Tau (a HOCl
scavenger), His (a singlet oxygen scavenger), or ABH (peroxidase inhibitor). We have also observed
that, despite the fact that APO blocked the anti-cancer effect of granulocytes, without the presence
of granulocyte, APO was able to inhibit tumor cell proliferation. The inhibitory effect of APO has
already been described earlier on both human and rat prostate cancer cell lines by inducing the cell
cycle arrest [37,38]. In LNCaP prostate cancer cells, APO had an anti-proliferative effect only when
added at higher concentrations, while it did not have effects at lower concentrations [38]. The above
could explain the effects observed in this study, where addition of granulocytes increased the APO
targets and decreased the chance of the inhibitor to exhibit its effects on tumor cells. Hence, our
results indicate that granulocyte mediated malignant destruction is dependent on HOCl intercellular
signaling pathways by the action of the NADPH oxidase. Similarly, recent study also highlighted the
importance of the HOCl signaling pathway as the pathway that might prevent tumorigenesis in the
lactobacillus/peroxidase system mediated antitumor effect [39].
The results of our study suggest two possible mechanisms of involvement of reactive aldehydes
in the anti-cancer effects of granulocytes, as follows:
1. Reactive aldehydes, by impairing the membrane integrity, enable ROS to enter the tumor cells or
2. coordinated action of granulocyte derived ROS and reactive aldehydes can induce excessive
intracellular ROS production, thus causing decay of cancer cells.
In conclusion, reactive aldehydes, formed as a consequence of an intense oxidative burst
of granulocytes, might mediate antitumor effects of granulocytes by impairing tumor cell redox
homeostasis and, also, at least in the case of acrolein, induce granulocyte TLR4 expression. The link
between TLR4 expression and NADPH oxidase stimulated ROS generation is well known and might
explain the granulocyte-mediated antitumor effects through the HOCl intracellular pathway by the
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action of the NADPH oxidase, which could eventually determine the tumor–host relationship in a
desirable way for cancer regression.
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Abstract: Cannabidiol (CBD), a natural phytocannabinoid without psychoactive effect, is a well-known
anti-inflammatory and antioxidant compound. The possibility of its use in cytoprotection of cells
from harmful factors, including ultraviolet (UV) radiation, is an area of ongoing investigation.
Therefore, the aim of this study was to evaluate the effect of CBD on the regulatory mechanisms
associated with the redox balance and inflammation in keratinocytes irradiated with UVA [30 J/cm2]
and UVB [60 mJ/cm2]. Spectrophotometric results show that CBD significantly enhances the activity
of antioxidant enzymes such as superoxide dismutase and thioredoxin reductase in UV irradiated
keratinocytes. Furthermore, despite decreased glutathione peroxidase and reductase activities,
CBD prevents lipid peroxidation, which was observed as a decreased level of 4-HNE and 15d-PGJ2
(measured using GC/MS and LC/MS). Moreover, Western blot analysis of protein levels shows that,
under stress conditions, CBD influences interactions of transcription factors Nrf2- NFκB by inhibiting
the NFκB pathway, increasing the expression of Nrf2 activators and stimulating the transcription
activity of Nrf2. In conclusion, the antioxidant activity of CBD through Nrf2 activation as well as its
anti-inflammatory properties as an inhibitor of NFκB should be considered during design of new
protective treatments for the skin.
Keywords: cannabidiol; UV radiation; keratinocytes; antioxidants; inflammation; intracellular
signaling; Nrf2; NFκB
1. Introduction
It is believed that various disorders of human skin are the result of oxidative stress occurring in
skin cells. Therefore, maintaining the redox balance is very important, especially because the skin
remains in constant contact with the environment, plays an important role in the body’s response to
environmental factors, and also mediates the transmission of environmental signals to the organism [1].
Exposure to solar UV radiation is a causative factor in acute skin photodamage, chronic photoaging,
and photocarcinogenesis [2,3]. UVA and UVB radiation have different biological effects on skin cells,
but the common feature is to cause a redox imbalance with a shift towards oxidation. This is a result of
increased reactive oxygen species (ROS) generation, which under physiological conditions are involved
in cell signaling, but in the case of overproduction can also lead to cell damage. Cell damage is favored
in the setting of UV radiation due to the reduction of effective endogenous antioxidant protection [4].
Oxidative stress caused by both endogenous and environmental factors reflects an imbalance
between the number of oxidants produced in skin cells and the amount of antioxidant gene products
(superoxide dismutase [SOD], catalase [CAT], glutathione [GSH], peroxidase [Px], etc.) maintaining the
redox balance [5]. From this point of view, the expression of Nrf2, a transcription factor ubiquitously
expressed in all tissues, including skin, which modulates the levels of cytoprotective protein expression,
seems very important. Nrf2 protein levels and its activity are tightly regulated [6]. Activation is
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significantly related to the oxidative modification of the cysteine reactant Keap1, its cytosol inhibitor,
which is responsible for targeting Nrf2 to ubiquitination and proteasomal degradation [7]. In contrast,
the activation mechanisms of Nrf2 involve kinase signaling pathways, with Nrf2 phosphorylation
being ultimately responsible for its translocation into the cell nucleus [8]. Natural compounds, such as
sulforaphane and its derivatives, as well as various drugs, also play a role as activators or inhibitors of
Nrf2 [9,10].
One of the natural compounds that can support the skin’s antioxidant system is the main
component of the Cannabis sativa extract, cannabidiol (CBD). CBD is a phytocannabinoid, which has
no psychoactive effect, but aroused interest due to the therapeutic potential for many disease states
that have been studied in animal models [11–14]. It has antioxidant, anti-inflammatory, anxiolytic,
antitumor and anti-cancer properties [15,16]. Due to the chemical structure (Figure 1), CBD, like other
antioxidants, interferes with the free radical chain reactions mainly in the propagation and the final
phase, capturing free radicals or transforming them into less reactive forms [17]. In addition, CBD leads
to a decrease in oxidative conditions in cells, which is associated with chelation of transition metals
and reduction of prooxidative enzymes, which leads to prevention of ROS [18]. Notwithstanding the
reduction of levels of oxidants, CBD modifies the redox balance also by changing the level/activity of
antioxidants [19].
Figure 1. Cannabidiol chemical structure.
CBD, like endocannabinoids, acts not only directly, but also indirectly through receptors.
By activating A2A adenosine receptors, it inhibits the NFκB inflammatory pathway and reduces
the level of proinflammatory cytokines, including TNFα [20]. This phytocannabinoid has a low
affinity for cannabinoid receptor 1 (CB1) and behaves like an incompetent antagonist; therefore,
it can increase stimulation of the cannabinoid system. It inhibits the anandamide transport and its
degradation of by fatty acid amide hydrolase [21]. In addition, CBD exhibits weak inverse agonism
towards the cannabinoid receptor 2 (CB2). It can act as an “indirect” CB1/CB2 agonist by weak
inhibition of anandamide enzymatic hydrolysis [22]. CBD may also have effects at the level of
other endocannabinoids, including 2-arachidonylglicerol (2-AG) [23]. Moreover, it modulates the
activity of G protein-coupled receptors (GPCRs) that are activated by endocannabinoids and related
compounds [24].
The broad action of CBD does not remain indifferent to the genetic material. It has been found
that CBD by inhibition of the DNA repair enzyme PARP-1 can induce cytotoxicity [25] and acts
destructively in relation of DNA of cancer-transformed cells therefore CBD has been suggested as a
promising antitumor factor [26]. Moreover, anti-inflammatory and modulatory effects of CBD promote
the attenuation of various autoimmune conditions in animal models, including skin diseases such
as psoriasis [27]. In addition, by affecting skin cells, it inhibits the proliferation and differentiation of
human keratinocytes via CB1 and CB2 independent epigenetic mechanisms [28].
Therefore, the aim of this study was to evaluate the effect of CBD on regulatory mechanisms
related to redox balance and inflammation in keratinocytes after UVA and UVB irradiation.
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2. Materials and Methods
2.1. Cell Culture and Treatment
Human keratinocytes (CDD 1102 KERTr) were obtained from American Type Culture Collection
(ATCC, Virginia, USA). Keratinocytes were cultured in Keratinocyte Serum-Free Medium (Gibco,
Grand Island, NY) that contained fetal bovine serum (10%), epidermal growth factor (EGF 1–53; 5 μg/L),
50 U/mL penicillin and 50 μg/mL streptomycin. Cells were cultured in a humidified atmosphere with
5% CO2 at 37 ◦C. When the cells (passage 9–11) reached 70% confluency, they were washed with warm
PBS (37 ◦C). Cells were exposed to UV radiation in cold PBS (4 ◦C) to avoid heat stress and oxidation of
the medium components. The exposure dose that corresponded to 70% cell viability measured by the
MTT assay was used [29]. The cells were irradiated on ice at a distance of 15 cm from the assembly of
6 lamps (Bio-Link Crosslinker BLX 312/365; Vilber Lourmat, Germany), 6W each, which corresponds to
4.2 mW/cm2 and 4.08 mW/cm2, respectively for UVA (365 nm) and UVB (312 nm). Total radiation doses
were 30 J/cm2 UVA and 60 mJ/cm2 UVB. After radiation, cells were incubated for 24 h under standard
conditions without rinsing; control cells that did not receive irradiation were incubated in parallel.
To examine the effect of CBD on keratinocytes all cell groups, control cells and cells after UVA and
UVB irradiation were cultured in medium containing 1 μM CBD (THC-Pharm, Frankfurt, Germany).
After 24 h incubation, all cells were washed with PBS, collected by scraping into cold PBS and
centrifuged. Cells were then resuspended in PBS and subjected to sonication. Total protein content in
cell lysate was measured using a Bradford assay [30].
2.2. Cell Viability
To examine the effect of CBD on UV irradiated keratinocytes, cells were incubated after irradiation
for 24 h under standard conditions in medium containing 0, 0.1, 0.5, 1, 2, 4, 10, 25, 50, 100 nmoles/mL
CBD in ethanol. The MTT assay was used to examine the effect of CBD concentration on keratinocyte
viability compared to control cells [29].
2.3. Determination of Superoxide Anion Generation
The generation of superoxide anions was detected using an electron spin resonance (ESR)
spectrometer e-scan (Noxygen GmbH/Bruker Biospin GmbH, Berlin, Germany), where selective
interaction of the spin probes CMH (1-hydroxy-3-methoxy-carbonyl-2,2,5,5-tetrame-thylpyrrolidine,
200 μM) with ROS formed a stable nitroxide CM-radical with a half-life of 4 h. Thus, ROS formation
was measured by assessing the kinetics of nitroxide accumulation based on the electron spin resonance
amplitude of the low field component of ESR spectra. The rate of superoxide radical formation was
determined by measuring superoxide dismutase (SOD)-inhibited nitroxide generation [31].
2.4. Determination of Antioxidant Enzyme Activity
SOD (Cu/Zn–SOD, EC.1.15.1.1) activity was determined according to the method of Misra and
Fridovich [32] as modified by Sykes and co-authors [33], which measures the activity of cytosolic SOD.
One unit of SOD was defined as the amount of the enzyme that inhibits epinephrine oxidation to
adrenochrome by 50%. Enzyme specific activity was expressed in units per milligram of protein.
Glutathione peroxidase (GSH-Px, EC.1.11.1.6) activity was assessed spectrophotometrically using
the method of Paglia and Valentine [34]. GSH-Px activity was assayed by measuring the conversion of
NADPH to NADP+. One unit of GSH-Px activity was defined as the amount of enzyme catalyzing the
oxidation of 1 μmol NADPH/min at 25 ◦C and pH 7.4. Enzyme specific activity was expressed in units
per mg of protein.
Glutathione reductase (GSSG-R, EC.1.6.4.2) activity was measured according to the method of
Mize and Longdon [35] by monitoring the oxidation of NADPH at 340 nm. One unit of GSSG-R
oxidized 1 mmol of NADPH/min at 25 ◦C and pH 7.4. Enzyme specific activity was expressed in
milliunits per milligram of protein.
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The thioredoxin reductase (TrxR, EC. 1.8.1.9) activity was measured using a commercially
available kit (Sigma-Aldrich, St. Louis, MO, USA). The principle on which this kit is based is the
NADPH-mediated reduction of 5,5′-dithiobis(2-nitrobenzoic) acid (DTNB) to 5-thio-2-nitrobenzoic
acid (TNB), which produces a strong yellow color that is measured at 412 nm [36]. Enzyme activity
was expressed in units per milligram of protein.
2.5. Determination of Non-Enzymatic Antioxidant Level
Glutathione was quantified using the capillary electrophoresis (CE) method of Maeso and
co-authors [37]. Samples were sonicated in Eppendorf tubes with 2 mL of a mixture containing
ACN/H2O (62.5:37.5, v/v) and centrifuged at 29,620× g for 10 min. The supernatant was immediately
subjected to CE. The separation was performed on a capillary with 47 cm total length (40 cm effective
length) and 50 m i.d. and was operated at 27 kV with UV detection at 200 ± 10 nm. The GSH
concentration was determined using a calibration curve range: 1–120 nmol/L (r2 = 0.9985) and the
level of GSH was expressed as nanomoles per milligram of protein.
Thioredoxin level was quantified using the ELISA method [38]. Prepared standards and cell
lysates were loaded into ELISA plate wells (Nunc Immuno Maxisorp, Thermo Scientific, Waltham, MA,
USA) and incubated at 4 ◦C overnight with anti-thioredoxin primary antibody (Abcam, Cambridge,
MA, USA). After washing, the plates were incubated for 30 min with peroxidase blocking solution
(3% H2O2, 3% fat free dry milk in PBS) at RT. The goat anti-rabbit secondary antibody solution (Dako,
Carpinteria, CA, USA) was then added to each well, and the plates were incubated for 1 h at RT.
Chromogen substrate solution (0.1 mg/mL TMB, 0.012% H2O2) was added to each well, and the plates
were incubated for 40 min at RT. The reaction was stopped by addition of 2M sulfuric acid. Absorption
was read at 450 nm with the reference filter set to 620 nm. Level of thioredoxin was expressed as the
micrograms per milligram of protein.
2.6. Determination of Lipid Peroxidation Product
Lipid peroxidation was estimated by measuring the level of 4-hydroxynonenal (4-HNE). Aldehyde
was measured by GC/MSMS (Agilent Technologies, Palo Alto, CA, USA), as the O-PFB-oxime-TMS
derivative, using a modified method of Liu and co-authors [39]. Benzaldehyde-D6 was added
to the cell lysates as an internal standard, and aldehydes were derivatized by the addition of
O-(2,3,4,5,6-pentafluoro-benzyl) hydroxyamine hydrochloride (0.05 M in PIPES buffer, 200 μL) and
incubating for 60 min at RT. After incubation, samples were deproteinized by the addition of 1 mL
of methanol and O-PFB-oxime aldehyde derivative was extracted by the addition of 2 mL of hexane.
The top hexane layer was transferred into borosilicate tubes, and evaporated under a stream of argon
gas, followed by the addition of N,O-bis(trimethylsilyl)trifluoroacetamide in 1% trimethylchlorosilane.
A 1 μL aliquot was injected on the column. Derivatized aldehyde was analyzed using a 7890A GC–7000
quadruple MS/MS (Agilent Technologies, Palo Alto, CA) equipped with a HP-5ms capillary column
(0.25 mm internal diameter, 0.25 μm film thickness, 30 m length). Derivatized aldehyde was detected in
selected ion monitoring (SIM) mode. The ions used were: m/z 333.0 and 181.0 for 4-HNE-PFB-TMS and
m/z 307.0 for IS derivative. Level of 4-HNE was expressed as the nanomoles per milligram of protein.
2.7. Determination Of Anti-Inflammatory Eicosanoid
15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) was estimated using ultra-performing liquid
chromatography tandem mass spectrometry (LCMS 8060, Shimadzu, Kyoto, Japan) [40]. PGF2α-d4
was used as an internal standard for quantification. Lipid mediators were extracted using SPE and
analyzed in negative-ion mode (MRM). The precursor to the product ion transition was m/z 315.2→271.2
for 15d-PGJ2. The level of 15d-PGJ2 was expressed as picomoles per milligram of protein.
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2.8. Determination of Protein Expression
Western blot analysis of cell protein was performed according to Eissa and Seada [41]. Whole cell
lysates or membrane fractions were mixed with sample loading buffer (Laemmli buffer containing
5% 2-mercaptoethanol), heated at 95 ◦C for 10 min, and separated using 10% Tris-Glycine SDS-PAGE.
Separated proteins in the gels were electrophoretically transferred to nitrocellulose membrane. The
membrane was blocked with 5% skim milk in TBS-T buffer (Tris buffered saline with 5% Tween-20) for
1 h. Primary monoclonal antibodies raised against phospho-Nrf2 (pSer40), HO-1, Keap1, WTX, DPP3,
CBP, TNFα, NFκB (p52), IKKα, IKKβ, phosphor-IκB (pSer36), p38, phospho-MAPK (phospho-p44/42),
phospho-ASK-1 (pThr845) PGAM5, NLRP3, β-actin (Sigma-Aldrich), and Bach1, KAP1, p21, p62,
Ref-1, NFκB (p65) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used at a concentration
of 1:1000. Alkaline phosphatase-labeled secondary antibodies against mouse, rabbit or goat were
used at a concentration of 1:1000 (Sigma-Aldrich, St. Louis, MO, USA). Protein bands were visualized
using the BCIP/NBT Liquid substrate system (Sigma-Aldrich) and were quantitated using the Versa
Doc System and Quantity One software (Bio-Rad Laboratories Inc., CA, USA). Level of proteins was
expressed as the percentage of the value determined from the control cells
2.9. Determination of Keap1 Structure
Human Keap1 (Sino Biological, cat. 11981-H20B) was dissolved in 25 mM AMBIC and divided
into portions containing 30 μg of protein. One sample was incubated for 1 h at 4 ◦C with 10 μM CBD,
while an untreated sample was used as a control. Each sample was digested with trypsin (1:50) for
4 h at 37 ◦C. Digestion was stopped by addition of 10% formic acid (FA) to a final concentration 0.1%.
Samples were dried, resuspended in 50 μl ACN + 0.1% FA, and separated using an Ultimate 3000
(Dionex, Idstein, Germany) onto a 150 mm × 75 mm PepMap RSLC capillary analytical C18 column
with 2 μm particle size (Dionex, LC Packings, Idstein, Germany). The peptides eluted from the column
were analyzed using a Q Exactive HF mass spectrometer with an electrospray ionization source (ESI)
(Thermo Fisher Scientific, Bremen, Germany) as described previously [42]. Data were acquired with
the Xcalibur software (Thermo Fisher Scientific, Bremen, Germany).
2.10. Determination of Protein Localization
Cells were seeded in BD Falcon™ 96-well clear bottom black tissue culture plates optimized for
imaging applications at 10,000 cells per well. After treatment with UV radiation and/or a 24 h incubation
with CBD, cells were fixed with 3.7% formaldehyde solution for 10 min and permeabilized with 0.1%
Triton X-100 solution for 5 min. Next, the cells were washed twice with PBS, and non-specific binding
was blocked by adding a 3% FBS solution for 30 min. After that time, the cells were incubated with
an anti-Nrf2 rabbit polyclonal antibody or an anti-NFκB mouse polyclonal antibody (Sigma-Aldrich;
1:1000) for 1 h at RT, washed three times with PBS and incubated with fluorescent (FITC) anti-rabbit
or anti-mouse secondary antibody (BD Pharmingen, San Diego, CA) for 60 min in the dark. After
washing, nuclei were stained with Hoechst 33342 (2 μg/mL) and analyzed using microscopy imaging.
Images of FITC-labeled cells were acquired using a 488/10 excitation laser and a 515LP emission laser.
2.11. Statistical Analysis
Data were analyzed using standard statistical analyses, including ANOVA, and the results
are expressed as the mean ± standard deviation (SD) for n = 5. P-values less than 0.05 were
considered significant.
3. Results
The assessment of the effect of different concentrations of CBD on the survival of keratinocytes by
means of the MTT test indicated that concentrations of up to 1 μM CBD did not affect the survival
of control keratinocytes (Figure 2). Higher concentrations caused a gradual decrease in cell survival,
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so that at a concentration of 10 μM it reached values of about 75% of control cells viability. In the case
of cells irradiated with UVA radiation, both in the absence of CBD and in the presence of CBD up to
4 μM, the survival rate was maintained at 70%, and at higher concentrations was further reduced.
In contrast, keratinocytes irradiated with UVB radiation were characterized by approximately 70%
survival from 0 to 10 μM CBD and at higher CBD concentrations, the viability was somewhat reduced.
Figure 2. The influence of cannabidiol (CBD) on viability of keratinocytes exposed to UVA (30 J/cm2)
and UVB (60 mJ/cm2) irradiation measured by MTT test. Mean values ± SD of five independent
experiments are presented: x statistically significant differences vs. group without radiation or chemical
treatment, p < 0.05; a statistically significant differences vs. UVA or UVB group, p < 0.05.
Results showed that keratinocytes irradiated with UVA or UVB were characterized by an altered
redox balance associated with a more than 2-fold increase in superoxide anion production and a
significant decrease in Cu, Zn-SOD and TrxR activity, especially after UVB irradiation (Table 1).
Moreover, UV radiation enhanced the cytoprotective factors phospho-ASK-1 and Ref-1 expression
by about 2- and 3-fold (Table 1, Figure 3), respectively. These changes were accompanied by a
significant reduction in the level of non-enzymatic antioxidant parameters, such as GSH and Trx.
As a consequence, despite the increase in the activity of enzymes involved in the GSH metabolism,
oxidative metabolism of phospholipids increased 2-3 times after UVA or UVB exposure, which was
manifested by an increased level of the lipid peroxidation product, 4-HNE. Treating keratinocytes with
CBD significantly reduced the production of ROS, especially after UVA irradiation. In addition, CBD
increased the antioxidant capacity manifested by significantly increased activity of Cu, Zn-SOD and
TrxR and the level of Trx. On the other hand, the UV-increased Ref-1 and phospho-ASK-1 expression
was partially restored following CBD treatment. However, after the use of CBD, the GSH-Px and
GSSG-R activity was reduced, as well as GSH levels in control or irradiated cells. The consequence of
the observed CBD-induced changes in redox parameters was the reduction in the intensity of lipid
peroxidation, which was seen as a significant decrease in the level of 4-HNE, especially in keratinocytes
treated with CBD after UVA irradiation.
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Table 1. The influence of cannabidiol (CBD) on ROS generation (by ESR) and antioxidant capacity
estimated as protein (Cu,Zn-SOD, GSH-Px, GSSG-R, TrxR by spectrometry) and non-protein antioxidants
(GSH by CE, Trx by Elisa, Ref-1 and phospho-ASK-1 by Western blotting) as well as lipid peroxidation
(4-HNE by GCMS) of keratinocytes exposed to UVA (30 J/cm2) and UVB (60 mJ/cm2) irradiation.
Determined Parameter
Groups
Control CBD UVA UVA + CBD UVB UVB + CBD
Superoxide anion
(nmol/min/mg protein) 90 ± 7 58 ± 5
x 240 ± 12 x 87 ± 9 a 216 ± 11 x 105 ± 9 x,a
Cu.Zn-SOD
[mU/mg protein] 28.0 ± 1.5 48.4 ± 3.1
x 23.1 ± 1.4 x 51.4 ± 2.9 x,a 21.5 ± 1.3 x 53.6 ± 3.1 x,a
GSH-Px
[U/mg protein] 14.6 ± 0.9 13.5 ± 1.2 34.4 ± 1.9
x 22.8 ± 1.7 x,a 37.5 ± 2.2 x 26.5 ± 1.5 x,a
GSSG-R
[mU/mg protein] 14.3 ± 1.2 7.2 ± 0.4
x 18.6 ± 0.9 x 26.5 ± 1.8 x,a 20.2 ± 1.0 14.7 ± 0.9
GSH
[nmol/mg protein] 17.1 ± 0.8 11.7 ± 0.7
x 11.5 ± 0.6 x 10.3 ± 0.6 x,a 10.9 ± 0.5 x 9.3 ± 0.5 x,a
TxrR
[U/mg protein] 14.0 ± 0.7 17.2 ± 0.8
x 10.2 ± 0.6 x 16.1 ± 0.7 x,a 8.2 ± 0.3 x 15.4 ± 0.6 x,a
Trx
[g/mg protein] 1.63 ± 0.09 2.74 ± 0.17
x 1.05 ± 0.05 x 1.79 ± 0.11 x,a 0.84 ± 0.04 x 1.16 ± 0.06 x,a
Ref-1
[vs. control] 1.00 ± 0.06 0.96 ± 0.04 3.10 ± 0.07
x 1.60 ± 0.06 x,a 3.10 ± 0.09 x 1.70 ± 0.06 x,a
phospho-ASK-1
[vs. control] 1.00 ± 0.04 1.10 ± 0.04 2.10 ± 0.07
x 1.70 ± 0.06 x,a 2.30 ± 0.09 x 1.60 ± 0.06 x,a
4-HNE
[nmol/mg protein] 26.1 ± 1.3 23.5 ± 1.4 52.4 ± 2.7
x 35.6 ± 1.9 x,a 73.4 ± 3.7 x 64.7 ± 3.5 x,a
Mean values ± SD of five independent experiments are presented. x statistically significant differences vs. control
group, p < 0.05; a statistically significant differences vs. UVA or UVB group, p < 0.05.
Figure 3. The influence of cannabidiol (CBD) on Ref-1 and phospho-ASK-1 (pThr845) levels in
keratinocytes exposed to UVA (30 J/cm2) and UVB (60 mJ/cm2) irradiation.
Irradiation of keratinocytes with UV not only changed the activity and level of antioxidants,
but also the expression and transcriptional activity of Nrf2 and NFκB, two transcription factors
whose biological activity depends on each other and which participate in the modulation of redox
imbalance and inflammation. UVA and UVB radiation increased the expression of NFκB (p52 and
p65), while CBD treatment only partially, but significantly reduced this increase (Figure 4). However,
keratinocytes treated with CBD alone were characterized by increased expression of NFκB. In addition,
CBD used alone or after irradiation enhanced the expression of TNFα, an NFκB transcriptional activity
product. Analyzing the NFκB activators and inhibitors, it can be concluded that the expression of
the phosphorylated form of the basic NFκB inhibitor, IκB, was lowered by UV radiation and was
significantly increased by CBD, particularly after UVB irradiation. In contrast, in the case of NFκB
activators, CBD acted in a different way. It inhibited the expression of factors associated with the
activation of inflammation, such as NLRP3 and PGAM5, and simultaneously activated IKK components,
especially IKKα, whose expression was lowered by UV radiation as well as the protein p62 that is a
direct linking element of the NFκB and Nrf2 pathways.
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Figure 4. The influence of cannabidiol (CBD) on NFκB [p52] and NFκB [p65] transcriptional activity
and its activators and inhibitors expression in keratinocytes exposed to UVA (30 J/cm2) and UVB
(60 mJ/cm2) irradiation. Mean values ± SD of five independent experiments are presented. x statistically
significant differences vs. control group, p < 0.05; a statistically significant differences vs. group without
cannabidiol, p < 0.05.
Increased expression of NFκB (p52 and p65) by CBD promoted the increased expression of Nrf2
responsible for the transcription of cytoprotective proteins, which is confirmed by the increased
biosynthesis of HO-1 and Trx and TrxR (Table 1, Figure 5). At the same time, the level of basic inhibitors
Nrf2, cytosolic Keap1 and the nuclear Bach1 was decreased, as well as the level of PGAM5 that
participate in inflammatory processes. Moreover, CBD stimulated the expression of Nrf2 activators
(such as KAP1, p21, p62) in control keratinocytes two-fold. In contrast, in cells irradiated with UV,
CBD only slightly increased the expression of p21 and p62 proteins.
Analyzing the decrease in the expression of the basic Nrf2 cytosolic inhibitor Keap1, it can be
concluded that it was associated with a disruption of both inhibitors and activators of this factor
(Table 2). In the case of the activators, the most unambiguous changes were observed in the DPP3
level, the expression of which was increased two-fold in all groups after the use of CBD. On the other
hand, CBD significantly reduced the expression of another Keap1 activator, protein WTX. In the case of
Keap1 inhibitors, CBD strongly increased 15d-PGJ2 level in the control cells, but after exposure to UV
radiation the CBD effect was observed as a reduction in the level of this eicosanoid.
In contrast, CBD in all cases reduced the level of inhibitors such as 4-HNE and PGAM5.
Additionally, CBD influenced Keap1 activity by adduct formation on cysteine-288, which is responsible
for Keap1 conformation and its interaction with Nrf2, as well as on cysteine-151 that is present in a
Keap1 region responsible for Cul3 binding and indirectly contributes to Nrf2 ubiquitination (Figure 6).
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Figure 5. Effect of cannabidiol (CBD) on Nrf2 transcriptional activity and the level of its activators and
inhibitors in keratinocytes exposed to UVA (30 J/cm2) and UVB (60 mJ/cm2) irradiation. Mean values
± SD of five independent experiments are presented: x statistically significant differences vs. control
group, p < 0.05; a statistically significant differences vs. group without cannabidiol, p < 0.05.
Table 2. Effect of cannabidiol (CBD) on Keap1 expression and the level of its activators (determined by
Western blotting) and inhibitors (determined by Western blotting–PGAM5 and by LCMS–4-HNE and




Control CBD UVA UVA + CBD UVB UVB + CBD
Keap1
[vs. control] 1.00 ± 0.05 0.79 ± 0.04
x 0.81 ± 0.04 x 0.63 ± 0.03 x,a 0.78 ± 0.04 x 0.47 ± 0.02 x,a
Inhibitors
4-HNE
[nmol/mg protein] 26.1 ± 1.3 23.5 ± 1.4 52.4 ± 2.7
x 35.6 ± 1.9 x,a 73.4 ± 3.7 x 64.7 ± 3.5 x,a
15d-PGJ2
[pg/mg protein] 6.2 ± 0.36 11.8 ± 0.86
x 13.8 ± 0.81 x 10.1 ± 0.60 x,a 15.4 ± 0.91 x 11.2 ± 0.72 x,a
PGAM5
[vs. control] 1.00 ± 0.04 0.93 ± 0.05 0.88 ± 0.04
x 0.81 ± 0.04 0.39 ± 0.02 x 0.30 ± 0.02 x,a
Activators
WTX
[vs. control] 1.00 ± 0.04 0.92 ± 0.05 0.82 ± 0.04
x 0.75 ± 0.04 x 0.75 ± 0.04 x 0.45 ± 0.02 x,a
DPP3
[vs. control] 1.00 ± 0.05 1.81 ± 0.09
x 0.66 ± 0.03 x 1.47 ± 0.07 x,a 0.44 ± 0.02 x 1.83 ± 0.11 x,a
Mean values ± SD of five independent experiments are presented. x statistically significant differences vs. control
group, p < 0.05; a statistically significant differences vs. group without cannabidiol, p < 0.05.
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Figure 6. The localization of cysteine residues within Keap1 domains that form adducts with cannabidiol
(CBD). Bolded cysteine residues are the most sensitive for oxidation.
Moreover, observed changes in proteins levels were accompanied with changes in translocation
of transcriptional factors (Nrf2 and NFκB) to the nucleus. CBD led to the Nrf2 nuclear translocation in
non-irradiated cells (Figure 7). However, the UVA induced Nrf2 nuclear translocation was slightly
reduced by CBD, which was observed as increased Nrf2 level mainly in the cytosol. This effect was not
observed in the case of cells treated with UVB and CBD. Different results were observed in the case of
NFκB, where CBD treatment slightly enhanced NFκB levels in the cytoplasm but did not lead to its
nuclear translocation. In the case of keratinocytes exposed to UV radiation the significant increase in
NFκB level in the nucleus was observed, however, CBD treatment following UV radiation enhanced
NFκB level in whole cells, but, especially in the case of UVA, prevented its accumulation in the nucleus.
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Figure 7. The influence of cannabidiol (CBD, 1 μM) on Nrf2 (A) and NFκB (p52) (B) nuclear localization
in keratinocytes (control and exposed to UVA (30 J/cm2) and UVB (60 mJ/cm2) radiation). Nuclei were
stained with Hoechst 33342 (blue) and antibodies against Nrf2 or NFκB (p52) were detected with
fluorescent (FITC) secondary antibody (red dots).
4. Discussion
UVA and UVB radiation show different biological effects on skin cells, but the common
characteristic of their action is to cause a redox imbalance, with a shift towards oxidation reactions [4].
This situation leads to the formation of oxidative stress as a result of which the metabolism of
membrane phospholipids is increased and causes intensified generation of lipid mediators, which
are products of reactions dependent on ROS or enzymes [43,44]. The main group of compounds
generated during the enzymatic metabolism of phospholipids are endocannabinoids, which indirectly,
by activating cannabinoid receptors (CB1/2), may modify the redox balance and inflammation in the
cells, including UV irradiated cells [4,45,46]. Therefore, cannabinoids appear to be very promising
therapeutic compounds.
One of the naturally occurring phytocannabinoids, and therefore a compound with potential
protective effects, is CBD, which has antioxidant and anti-inflammatory properties [11,12]. It was
demonstrated that this cannabinoid is a stronger antioxidant than α-tocopherol and ascorbic acid [47].
It has been also shown that in various diseases CBD reduces the intensity of ROS generation and
oxidative stress formation, which decreases lipid mediators [48,49].
The results of this study indicate that CBD used under physiological conditions causes slight
increases in the level of proinflammatory factors in the NFκB pathway and partially modifies the
cytoprotective activity of Nrf2 in keratinocytes. This effect is not visible in cells with UV-induced
metabolic stress, in which CBD partially normalizes redox balance and reduces inflammation in
keratinocytes exposed to UVA and UVB radiation, which experience oxidative stress resulting from
excessive production of ROS and consequently enhanced lipid peroxidation with 4-HNE as a main
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reactive electrophilic aldehyde as well as reduced antioxidant capacity, which reveals cytoprotective
CBD (anti-inflammatory and antioxidant) properties that may indicate the need to adapt cells to
pathophysiological conditions [50].
However, a completely different response of GSH- and thioredoxin-dependent antioxidant
systems to CBD is observed for both unexposed and irradiated cells. The thioredoxin system consists of
thioredoxin and thioredoxin reductase, which contains in its active site a highly reactive selenocysteine
that is susceptible to oxidative (mainly by ROS) or electrophilic (mainly by 4-HNE) attack [51,52].
This makes it an important sensor of the redox cell state. Adducts created by 4-HNE can influence
proliferation, differentiation and even cells apoptosis [53]. Therefore, in keratinocytes after CBD
treatment, when ROS and lipid mediators levels are reduced, thioredoxin level and thioredoxin
reductase activity are enhanced. Moreover, the data suggest that the thioredoxin system might reduce
the oxidized cysteine residues in Keap1, a cytosol inhibitor of Nrf2 (the transcription factor responsible
for cytoprotective protein biosynthesis), to restore its functionality [54]. On the other hand, in the
case of the glutathione system, CBD decreases both the level of GSH and the activity of glutathione
peroxidase. This may indicate a greater affinity of CBD for probably selenocysteine residues of these
elements of the glutathione system. Moreover, CBD enhancing Nrf2 transcriptional activity leads to
increase in the level of thioredoxin and thioredoxin reductase that levels are regulated by transcriptional
action of Nrf2 [51]. Therefore, it is believed that the thioredoxin system is essential for the survival
of keratinocytes, their protection against UV radiation and the improvement of wound healing [55].
However, this protection is not seen in CBD-treated keratinocytes because, as our results indicate,
CBD modifies the structure of two of five essential cysteines in Keap1, leading to a decrease in its
biological activity. Another explanation for this phenomenon may be the greater affinity of 4-HNE
for glutathione than the thioredoxin system components and the interaction with the nucleophilic
elements of this active/catalytic centers [56]. That may be confirmed by the decreased level of free
4-HNE in keratinocytes after CBD treatment.
These data show that CBD effectively supports the thioredoxin system, which is mainly responsible
for maintaining the redox balance in the cytosol, while decreasing the efficiency of the GSH-dependent
system, which is responsible for maintaining the redox balance in the mitochondrium and the
endoplasmic reticulum [57]. Regardless of its direct antioxidant activity, cytoplasmic Trx regulates
the activity of transcription factors, either directly (NFκB), or indirectly, i.e., AP-1, through interaction
with the Ref-1 nuclear factor [58]. It demonstrates enhanced expression after UV radiation but reduced
levels following CBD treatment. Under the influence of oxidative stress, both Trx and NFκB migrate
from the cytoplasm to the nucleus, where Trx reduces the NFκB cysteine needed for its transcriptional
activity [59]. Therefore, the CBD-induced increase in Trx level may protect against NFκB enhanced
expression. Another equally important function of the thioredoxin-dependent system is participation
in the regulation of gene expression by affecting apoptosis-regulating kinase (ASK-1) [60], whose
expression is inhibited by a system of thioredoxins in UV-irradiated and CBD treated keratinocytes,
thus protecting the cells from apoptosis, which may be the result of oxidative stress caused by radiation.
Increased expression of NFκB after UV irradiation and CBD treatment promotes enhanced
expression of Nrf2, which induces the transcription of cytoprotective proteins required for resistance
to stress [61]. However, Nrf2 activity depends on various activators and inhibitors [4]. Nrf2 is
physiologically complexed with Keap1, causing this transcription factor to be the target for proteasomal
degradation [62]. We showed that CBD modifies Keap1 Cys151 that participates in the Cul3-Keap1
complex formation that is needed for interaction with Nrf2. Because of decreased expression and
structural modification of Keap1 in irradiated as well as CBD-treated keratinocytes, Nrf2 is transferred
to the nucleus to a greater extent than in the control. Moreover, CBD increases the levels of Nrf2
activators, such as p21, KAP1 and p62 in control keratinocytes, while p21 is also increased in UV
irradiated cells. In a non-canonical pathway, p62 activates Nrf2 in an autophagy-dependent manner,
while Nrf2 positively regulates the expression of p62 genes and over expression of p62 is sufficient
to inactivate Keap1 [63]. In addition, CBD tended to reduce the expression of PGAM5 phosphatase,
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which can interact with both Keap1 and Nrf2 [64]. At the same time, the expression of DPP3, a Keap1
activator, is increased. The combined effect of CBD on activators and inhibitors results in a significant
reduction in Keap1 biological activity, which is seen as the enhanced expression of Nrf2.
As a consequence, increased Nrf2 target gene expression supports the stress resistance of irradiated
cells and induces changes in metabolic pathways that participate in cellular defense by enhancing
the removal of cytotoxic ROS and electrophiles including 4-HNE [65]. One of the classic activities of
Nrf2 is the regulation of the HO-1 gene. It was earlier shown that HO-1 and its metabolites, such
as CO and bilirubin, have significant anti-inflammatory activity mediated by Nrf2 [66]. However,
HO-1 expression after UV radiation and CBD treatment is smaller than it can be expected after Nrf2
enhanced level. The results of this study confirm that the increased expression of Nrf2 and HO-1 after
keratinocyte treatment with CBD results in a decrease in ROS generation, which in turn may inhibit
the activation of the NLRP3 inflammasome. This mediates the secretion of the pro-inflammatory
cytokine IL-1B, which induces cell death [67]. We have shown that CBD activates Nrf2 and partially
inhibits UV-induced activation of NLRP3 and NFκB. However, the enhanced level of Trx as a result
of CBD treatment could additional decrease the activation of the NLRP3 inflammasome. Therefore,
the observed expression of the NLRP3 inflammasome is probably a result of CBD and Trx effects,
which ultimately results in the inhibition of the expression of NLRP3. It has been previously shown
that other natural and synthetic compounds (EGCG, biochanin) also demonstrate an inhibitory effect
of Nrf2 on the activation of the NLRP3 inflammasome [68].
CBD under physiological conditions may stimulate the generation of many signaling factors-
including the anti-inflammatory prostaglandin 15d-PGJ2, which can regulate COX activity. 15d-PGJ2
inhibits COX2 activity during inflammation but increases it under physiological conditions [69]. It was
earlier shown that CBD reduces the activity of the NFκB pathway with a decrease in TNFα level [70].
Moreover, 15d-PGJ2 as an electrophilic molecule may form adducts with proteins, changing their
structure and functions. This triggers important biological responses, including protection against
inflammation as well as oxidative stress. 15dPGJ2 may exert anti-inflammatory activity by stimulating
the Nrf2 pathway through the formation adducts with Keap1 and facilitate the dissociation of Nrf2
from the Keap1 adduct and consequent translocation of the transcription factor into the nucleus. This
promotes up-regulation of cytoprotective genes, including HO-1 [71], which is also observed in this
study after CBD treatment of UV irradiated keratinocytes. A similar effect may be demonstrated by
interaction of electrophilic 4-HNE and PGJ2 with Keap1 [43,72].
On the other hand, oxidative stress and inflammation are believed to cause Nrf2 overexpression
to protect cells from the effects of ROS overproduction as well as proinflammatory cytokines [73].
Therefore, if CBD is used, the observed overexpression of Nrf2 may be the result of the overproduction
of TNFα, while the expression of TNFα may be dependent on both NFκB and Nrf2 activity. Nrf2
and NFκB cellular signaling pathways interact to control the transcription and functions of different
proteins and it have been shown that direct or indirect activation and inhibition occur between members
of the Nrf2 and NFκB pathways [39]. At the same time, suggested the role of Keap1 not only in Nrf2
but also in NFκB inhibition by complex formation [74], as well as Keap1 structure modifications by
CBD additionally explain the observed increase in the level of both Nrf2 and NFκB factors. These
study indicate that in UV and CBD treated cells, Nrf2 activation partially leads to inhibition the NFκB
signaling pathway.
The transcription factor NFκB is in equilibrium with its inhibitor IκB, which is degraded in
response to stress stimuli, such as after UV irradiation, and its expression increases after treatment
with CBD. One of the inhibitors of NFκB-IκB complex is 4-HNE, which level increases under stress
conditions but partially is decreased by CBD [43]. In addition, IκB activated kinase (IKK) results
in the phosphorylation of NFκB, which promotes its release and translocation into the nucleus and
transcription of pro-inflammatory mediators such as IL-6, TNF-α, iNOS and IL-1 [75]. It is also known
that the Nrf2 inhibitor complex, Keap1/Cul3, may target the IKKβ element of IKK for ubiquitination
and degradation [76]. A modified Keap1 level by CBD treatment indicated by our study and structure
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by 4-HNE and 15d-PGJ2 as was shown in the literature [43,77] due to UV and CBD treatment reduces
the possibility of forming the Nrf2-Keap1/CuI3 complex and increases the transcriptional activity of
both Nrf2 and NFκB. On the other hand, the increased expression of NFκB p65/RelA subunit after UV
radiation and CBD treatment simultaneously imports Keap1 into the nucleus, where it terminates Nrf2
transcription of the genes by exporting this factor back to the cytoplasm [78]. However, when both
transcription factors reach the nucleus, they need CREB binding protein (CBP) coactivators that are
necessary for gene transcription [79], but the expression of CBP is already significantly increased by UV
radiation and additionally by CBD treatment, so it probably does not require activators. Nevertheless,
due to the action of UV and CBD, these two pathways can also be activated mutually, oxidative stress
induced by NFκB activation facilitates Nrf2 translocation into the nucleus to protect cells against
inflammation and oxidative damage.
5. Conclusions
These findings suggest that CBD activates Nrf2 and partially inhibits activation of NFκB. This
activity is supported by cellular activators and inhibitors including lipid mediators such as 4-HNE and
15d-PGJ2, whose elevated level is a response to metabolic stress accompanying both UV irradiation
and CBD treatment and which may interact with both Nrf2 and NFκB pathways.
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Abstract: In this study, we investigated the effects of NAD(P)H oxidase (NOX) inhibitor VAS2870
(3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine) on the histamine-induced elevation
of free cytoplasmic calcium concentration ([Ca2+]i) and the secretion of von Willebrand factor (vWF)
in human umbilical vein endothelial cells (HUVECs) and on relaxation of rat aorta in response to
histamine. At 10 μM concentration, VAS2870 suppressed the [Ca2+]i rise induced by histamine.
Inhibition was not competitive, with IC50 3.64 and 3.22 μM at 1 and 100 μM concentrations of
histamine, respectively. There was no inhibition of [Ca2+]i elevation by VAS2870 in HUVECs
in response to the agonist of type 1 protease-activated receptor SFLLRN. VAS2870 attenuated
histamine-induced secretion of vWF and did not inhibit basal secretion. VAS2870 did not change the
degree of histamine-induced relaxation of rat aortic rings constricted by norepinephrine. We suggest
that NOX inhibitors might be used as a tool for preventing thrombosis induced by histamine release
from mast cells without affecting vasorelaxation.
Keywords: histamine; calcium; endothelial cells; NADPH-oxidase; VAS2870; von Willebrand factor;
aorta; relaxation
1. Introduction
Histamine plays an important role as chemical mediator in multiple physiological and
pathophysiological processes in central and peripheral tissues. Mast cells and basophils are
important sources of histamine, which is released from granule stores in response to several stimuli.
The pleiotropic effects of histamine are mediated via four G protein-coupled receptor (GPCR) subtypes
(H1R–H4R), which differ in their distribution, ligand binding, signaling pathways, and functions [1].
Histamine acts as a full agonist on the receptors, with subtype-specific differences in affinity. H1R is
ubiquitously expressed and mediates its effects by Gq/11 activation via phospholipase C (PLC) and to
a minor degree by PLA2 and PLD. Activation of H1R leads to an increase of inositol-1,4,5-triphosphate
(IP3) and 1,2-diacylglycerol (DAG), associated with an increase of the intracellular Ca2+ concentration,
followed by activation of protein kinase C (PKC). Other signaling pathways include the stimulation
of adenylyl cyclase via H2R with the formation of cAMP, inducing the generation of NO; the NF-κB
cascade leads to a release or increase in the expression of (pro)inflammatory mediators (P-selectin,
ICAM-1, VCAM-1, iNOS, IL-1beta, IL-6, TNF-alpha, etc.) [2]. Brain vascular endothelial cells (ECs)
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express histamine H1 and H2 receptors, which regulate brain capillary permeability. Also, histamine
receptor genes Hrh3 and Hrh4, for corresponding H3 and H4 receptors, are expressed in rat brain
ECs, which are potentially important for the regulation of blood–brain barrier permeability, including
trafficking of immunocompetent cells [3]. H4 receptors play a dominant role in histamine-induced
eosinophil adhesion to endothelium [4].
Reactive oxygen species (ROS) in large amounts clearly have detrimental effects on cell physiology,
whereas low concentrations of ROS are permanently produced in cells and play a role as signaling
molecules. An imbalance in ROS production and defense mechanisms can lead to pathological vascular
remodeling. Among the possible sources of ROS within endothelial and/or neighboring cells are
mitochondria, NADPH-oxidases, xanthine oxidase, peroxidases, NO-synthases, cytochrome P450,
cyclooxygenases, lipoxygenases, monoamine oxidases, and the hemoglobin of red blood cells [5–7].
Among these possible sources of ROS, nicotinamide adenine dinucleotide phosphate (NADPH)
oxidases (NOXs) play a central role. NOXs are present in neutrophils, where they mostly determine
the non-specific immune response [8]. In the ischemic-reperfusion condition, NOXs substantially
determine tissue injury by generating ROS in ECs and smooth muscle cells (SMCs) of blood vessels [9].
In ECs, four NOX isoforms include the superoxide-generating enzymes NOX1, NOX2, and NOX5
and the hydrogen-peroxide-generating enzyme NOX4 [10]. NOX2 is the most studied isoform of
NOX, which generates superoxide anion in professional phagocytes and many other cells. In ECs,
it is the predominant form, and all four subunits of NOX2 are present [11,12]. It is activated
by angiotensin II [13], oxidized low-density lipoproteins [14], cytokines, and growth factors [15].
Superoxide anion generated by NOX2 causes the inactivation of nitric oxide and promotes the
development of endothelial dysfunction, hypertension, and inflammation [16]. NOX4 predominantly
generates hydrogen peroxide (H2O2). H2O2 produced by endothelial NOX4 potentiates vasorelaxation
induced by acetylcholine and histamine [17]. Activators of other NOXs do not affect the activity
of NOX4, which is constitutive, since the generation of H2O2 in cells is dependent on the level of
expression of NOX4 [18]. NADPH oxidases of the DUOX group (DUOX1 and DUOX2) also generate
H2O2 [19,20], though their existence and/or functional significance in ECs and SMCs has not been
clearly shown.
Calcium-dependent NOX5 has been implicated in the oxidative damage of ECs in atherosclerosis
and hypertension [21]. It is noteworthy that NOX5 is expressed in primates but does not occur
naturally in rodents. In transgenic mice expressing human NOX5 in a vascular SMC-specific manner,
agonist-induced vasoconstriction was exaggerated, and endothelium-dependent vasorelaxation was
attenuated [22].
The influence of ROS on Ca2+ signaling in EC has been demonstrated in several works [23–30].
ROS can activate various calcium channels of the endoplasmic reticulum and plasma membrane, such
as InsP3- and ryanodine-sensitive channels, and some cation channels of the TRP superfamily [25,31,32].
NOX-derived ROS are critical for the generation of Ca2+ oscillations in response to histamine in human
aortic endothelial cells [33]. Recently, we demonstrated an involvement of two-pore channels in
an H2O2-induced increase in the level of calcium ions in the cytoplasm of human umbilical vein
endothelial cells (HUVECs) [34]. This could be coupled with exocytosis of the von Willebrand factor
(vWF) in these cells in response to H2O2 [35]. The vWF release from EC is induced by superoxide
anion [30]. In the present work, we studied the role of NOX in histamine-induced Ca2+ rise and
vWF secretion in HUVECs and NOX involvement in rat aorta relaxation in response to histamine.
To solve these questions, we used VAS2870 as a tool inhibitor of NOXs [36]. VAS2870 belongs to the
triazolopyrimidines, which are regarded as the most specific inhibitors of NOXs [37].
158
Cells 2019, 8, 196
2. Methods
2.1. Reagents
VAS2870, histamine, and SFLLRN were from SigmaAldrich (St. Louis, MO, USA);
CalciumGreen/AM and dihydroethidium were from Thermo Fischer Scientific (Waltham, MA, USA).
VAS2870 was dissolved at a 10 mM concentration in DMSO. Before being added to the cells, it was
dissolved to the required concentrations in physiological salt solution (PSS). DMSO at appropriate
concentrations was used as a vehicle control. PSS was added as a vehicle control for histamine
and SFLLRN.
2.2. Cell Culture
Human umbilical vein endothelial cells (HUVECs) were isolated according to [38]. The cells were
grown in plastic dishes pre-coated with gelatin, using M199 medium with Earl’s salts and 20 mM
HEPES containing 20% fetal calf serum (SigmaAldrich), 300 μg/mL endothelial growth supplement,
isolated from rabbit brain, 100 μg/mL heparin and gentamicin. We used the cells on early passages
(1–4). Accutase® was applied for passaging the cells (SigmaAldrich).
2.3. Measurement of Free Cytoplasmic Calcium Concentration in HUVECs
HUVECs grown in 96-well plates were loaded with 1 μM CalciumGreen/AM dissolved with
0.02% Pluronic F-127 in M199 during 1 h at 37 ◦C in a CO2 incubator (New Brunswick Scientific, Edison,
NJ, USA). Measurement of [Ca2+]i was performed in physiological salt solution (PSS) containing NaCl
(145 mM), KCl (5 mM), MgCl2 (1 mM), CaCl2 (1 mM), HEPES (5 mM), and D-glucose (10 mM), at pH
7.4. Fluorescence was registered at 485 nm (excitation) and 530 nm (emission) at 25 ◦C using a Synergy
4 Microplate Reader (BioTek, Winooski, VT, USA). The changes in [Ca2+]i in HUVECs are presented as
the ratio of the increment in F530 and initial F530. Each curve in in the graph is a superposition of three
curves recorded simultaneously from three wells in a plate.
2.4. Registration of ROS Generation in HUVECs
Kinetics of ROS generation in HUVECs was registered with the fluorescent indicator
dihydroethidium. The fluorescence was measured by a Synergy 4 Microplate Reader (BioTek) with
excitation filter 485 nm (bandwidth 20 nm) and emission 620 nm (bandwidth 40 nm). The bandwidth
of the emission filter is enough wide to cover a large part of the emission of the oxidation products of
DHE [39]. The cells grown in 96-well plates were incubated with different concentrations of VAS2870 or
vehicle control (dimethylsulfoxide at final concentrations from 0.006% to 0.2%) during 5 min and then
DHE at final concentration 2.5 μM was added. The slight inhibitory effect of DMSO on DHE oxidation
at a concentration of 0.2% was taken into account when analyzing the data. The oxidation kinetics of
DHE determined by the increase in fluorescence was linear during the 60 min of incubation both in the
absence and in presence of VAS2870. The increase in fluorescence in the absence of VAS2870 was taken
as 100%. The results are presented as the mean values obtained in three experiments with different cell
preparations. In each experiment, the experimental point was a mean value of the fluorescence from
six wells in a 96-well plate.
2.5. Measurement of vWF Secretion
HUVECs grown in 48-well plates were incubated in PSS at 30 ◦C during 5 min with or without
10 μM VAS2870. Then, histamine at final concentration or vehicle were added and the cells were
incubated for 30 min. The extracellular fluid from each well was collected in a separate tube and frozen.
Later, it was used for the measurement of vWF concentration with a TECHNOZYM vWF:Ag ELISA
kit (Technoclone, Vienna, Austria). The values of the secreted vWF are the means of six measurements.
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2.6. Registration of Aorta Contraction
Aorta were isolated from male Wistar rats weighing 250–300 g. The rats were anesthetized with
25% urethane (4 mL/kg) and decapitated. All manipulations with the animals were performed in
accordance with the guide for the care and use of Laboratory animals of the Bioethics committee
of the Koltsov Institute of Developmental Biology and European Convention for the Protection of
Vertebrate Animals used for Experimental and Other Scientific Purposes. Aorta were cleaned from
connective tissue and cut into rings with a width of around 2 mm. Experiments were performed
on a four-channel wire myograph (ADInstruments, Bella Vista, New South Wales, Australia) using
LabChart 7.3.7 program for data acquisition and analysis. The rings were mounted on the holders in
chambers filled with Krebs–Henseleit solution (37◦C) perfused with 95% O2/5% CO2 and extended
with a force of 1 g. Contractility of the vessel rings and intactness of its endothelium were tested
by adding 10−7 M norepinephrine and then 10−5 M carbachol. After washing, norepinephrine and
carbachol were added again. Aortic rings with relaxation of at least 50% were used for the experiments.
2.7. Statistics
Data are presented as mean ± SEM. The number of measurements is presented in the legend to
the figures. In each case at least three independent experiments were performed with different cell
or vessel preparations. Statistical significance was calculated using Excel 2003 and MedCalc 18.9.1
statistical software according the Student-Neuman-Keuls test. The IC50 values were determined with
GraphPad Prism 8.0.
3. Results and Discussion
We studied the effect of VAS2870 on [Ca2+]i elevation induced by histamine. At a concentration
of 10 μM, VAS2870 almost completely suppressed the calcium signal of 1 mM histamine, while
there was no significant inhibition of the action of PAR1 agonist SFLLRN (Figure 1). The effect of
VAS2870 was not competitive toward histamine, since wat is observed at a low concentration of
VAS2870, which is two orders of magnitude lower than the concentration of histamine. We determined
the concentration-dependence curves for the inhibition by VAS2870 of [Ca2+]i elevation at different
histamine concentrations (Figure 2c). The IC50 for VAS2870 calculated from these data was 3.64 and
3.22 μM at 1 and 100 μM concentrations of histamine, respectively. These results suggest the existence
of a specific mechanism of histamine-induced [Ca2+]i mobilization in HUVECs. The following data
provide evidence in favor of this conclusion. It has been shown that two-pore channels activated by
NAADP are involved in histamine-induced [Ca2+]i mobilization in HUVEC via H1 receptors, while
calcium signaling of thrombin is independent from NAADP [40,41].
VAS2870 in micromolar concentrations is widely used to suppress NOX activity in different types
of cells [42–45]. The IC50 for VAS2870’s effect on NOX activity in a cell-free system with membranes
and cytosol from human neutrophils was 10.6 μM, and in intact HL-60 cells the IC50 was 2 μM [43].
However, according to Gatto et al. [46], in neutrophils, ROS generation is inhibited by VAS2870 at
submicromolar concentrations with an IC50 of 77 nM. We determined which concentration of VAS2870
suppresses ROS production in HUVECs. For this purpose, dihydroethidium (DHE) was used. VAS2870
reduced the rate of DHE oxidation in HUVECs with an IC50 of 2.47 μM (Figure 2d). At a 20 μM
concentration, VAS2870 suppressed nearly half of ROS formation measured with DHE, and its effect
reached a plateau. The reason for this might be that oxidation of DHE in cells is caused only partially
by superoxide anion [39]. The values of IC50 for the inhibition of ROS generation and suppression
of histamine-induced [Ca2+]i elevation in HUVECs were very close, which suggests a link between
these processes. VAS2870 is an inhibitor of NADPH-oxidase isoforms NOX1/2/4 [47,48] and does not
suppress NOX5 [22]. It has been demonstrated that VAS2870 reverses oxidative stress, which is caused
by NOX1/2 activation [49]. We propose that the suppression of histamine-induced [Ca2+]i increase in
HUVECs might occur due to the inhibition of NOX2 because this form of NOX is under the control of
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several intracellular regulatory pathways [9], while the activity of NOX4 is mostly regulated by the
level of expression. In addition, it has been shown that increased expression of NOX4 in endothelial
cells enhances endothelium-dependent relaxation [17].
Figure 1. The influence of VAS2870 (10 μM) on calcium signaling in response to histamine (10 μM) and
agonist of PAR1 SFLLRN (2 μg/mL). (a) The curves represent the data of one of three experiments
with similar results; (b) The bars represent the mean values of [Ca2+]i increase in three independent
experiments. [Ca2+]i was measured as a relative increase in CalciumGreen fluorescence. In control
experiments, the vehicle, dimethylsulfoxide (DMSO) at a final concentration 0.1%, was added instead
of VAS2870.
Figure 2. The influence of different concentrations of VAS2870 on histamine-induced [Ca2+]i increases
and on the generation of reactive oxygen species (ROS) in human umbilical vein endothelial cells
(HUVECs). (a,b) The kinetics of [Ca2+]i elevation in HUVECs in response to 1 and 100 μM
histamine, respectively. (c) Concentration-dependent curves of the inhibition of [Ca2+]i increases.
(d) Concentration-dependence curve of the inhibition of dihydroethidium (DHE) oxidation by
VAS2870. Each point in (c,d) is a mean of three values from three independent experiments on
different cell preparations. In control experiments, it was demonstrated that DMSO at concentrations
on which it was applied to the cells along with VAS2870 did not suppress histamine-induced [Ca2+]i
elevation and oxidation of DHE.
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Evidence in favor of NOX involvement in histamine-induced calcium signaling was published
quite a long time ago by Hu and co-workers [33], wherein they demonstrated that NOX-derived
ROS were critical for generating the Ca2+ oscillations in response to histamine in human aortic ECs.
Recently, it was demonstrated that in microglial cells, histamine stimulates ROS formation due to the
activation of NOX1 via H1 receptors [50]. We expected that histamine might affect ROS generation in
HUVECs. However, there was no increase in the rate of DHE oxidation in the presence of histamine
(Figure 3). SFLLRN also did not produce any effect. It might be suggested that either histamine does
not stimulate the generation of superoxide anion in HUVECs, or the method with DHE is not sensitive
enough to detect the increment in ROS formation due to histamine. It should be mentioned that
in [33] 2′,7′-dihydrodichlorofluorescin diacetate was used as a fluorescent probe. Elucidation of the
mechanism of NOX involvement in signal transduction from histamine receptors in HUVECs requires
further research.
Figure 3. The influence of SFLLRN and histamine on DHE oxidation in the absence and presence of
VAS2870. Physiological salt solution (PSS) was used as a vehicle control for the agonists. Each value is
a mean of three values from three independent experiments with different cell preparations. DMSO at
final concentration 0.1% was used as a vehicle control for VAS2870. The difference between the values
in the absence and presence of VAS2870 was statistically significant (p < 0.01).
The next task was to study how VAS2870 can affect physiological reactions of ECs activated
by histamine, which causes secretion of vWF in HUVECs due to the activation of H1 receptors.
This secretion is mediated by the elevation of cytoplasmic calcium ion concentration [40,51]. We showed
that, in the presence of VAS2870, the effect of histamine on vWF secretion was attenuated, though
VAS2870 did not inhibit the basal secretion of vWF (Figure 4). This result correlates with our data on
the inhibition of histamine’s effect on [Ca2+]i by VAS2870.
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Figure 4. The influence of histamine on the secretion of von Willebrand factor (vWF) in the absence or
presence of VAS2870. HUVECs were incubated at 30 ◦C during 5 min with 10 μM VAS2870 or vehicle
(DMSO at final concentration 0.1% in the wells of a 48-well plate. Then, 100 μM histamine, or PSS as a
vehicle control, were added to the cells, and they were additionally incubated for 30 min. Each value is
a mean of the data from three independent experiments.
Among the physiological effects of histamine, relaxation of blood vessels is one of the most
important, so the next task was to evaluate the influence of VAS2870 on this function. We determined
the histamine-induced decrease of the contraction force of rat aortic rings preconstricted with
norepinephrine. The rings were preincubated for 30 or 60 min with VAS2870 or vehicle before adding
norepinephrine, followed by the addition of histamine. At concentrations of 10 and 100 μM, histamine
induced the relaxation of the rings. Surprisingly, there was no attenuation of histamine-induced
relaxation after preincubation of the rings with VAS2870 (Figure 5). It can be assumed that in rat aortic
ECs VAS2870 does not produce as strong an inhibition of histamine-induced [Ca2+]i rise as in HUVECs.
It is known that histamine elevates [Ca2+]i in HUVEC due to its mobilization from endoplasmic
reticulum via the channels activated by inositol 1,4,5-trisphosphate and from endolysosomal vesicles
via two-pore channels [40,41]. The relative roles of these two calcium signaling mechanisms might be
different in ECs from rat aorta and human umbilical vein. Another possible explanation is that the role
of calcium ions entering the cytoplasm from different sources is different in the case of vasorelaxation
and vWF secretion. It has been demonstrated that the suppression of Ca2+ release from endolysosomal
vesicles inhibits vWF secretion induced by histamine [40]. On the other hand, endothelium-dependent
vasorelaxation depends on store-operated Ca2+ entry [52].
In [49], it was demonstrated that VAS2870 improves endothelium-dependent relaxation of
spontaneously hypertensive rat (SHR) aortas induced by acetylcholine. The reason for the difference of
these data and our results about the lack of VAS2870’s effect on endothelium-dependent vasorelaxation
is the increased level of ROS in the aorta of SHR due to the elevated expression of NOX1 and
NOX2. The inhibition of their activity by VAS2870 improved impaired the acetylcholine-induced
relaxation of spontaneously hypertensive rat aortas [49]. In control normotensive Wistar-Kioto
rats, VAS2870 does not affect endothelium-dependent relaxation. There is evidence that VAS2870
can normalize arteriolar flow-induced dilation caused by oxidative stress at hyperinsulinemia [53].
In experiments with murine aorta rings it was demonstrated that their incubation in conditions of
hyperglycemia-induced oxidative stress causes impairment of vasodilation mediated by PAR2 agonists,
and VAS2870 improved this function [54]. From all these data it can be concluded that VAS2870 is able
to improve endothelial-dependent vasorelaxation at pathological state associated with oxidative stress
when NOX1 and NOX2 activities are increased, while in normal vessels it does not affect relaxation.
This is also supported by our data.
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Figure 5. Relaxation of rat aortic rings preconstricted by norepinephrine (NE) in response to 100 μM
histamine in the absence and presence of VAS2870. VAS2870 at a concentration of 10 μM or vehicle was
added to the rings 30 min or 1 h before NE. (a) Typical curves of the contraction and relaxation. (b) The
degrees of relaxation in the absence and presence of VAS2870 (n = 10 for control and for VAS2870 from
five independent experiments). In each experiment there were measurements from two control and
two experimental aortic rings.
Inhibition of vWF secretion by VAS2870 indicates that ROS produced by NOXs are involved
in this reaction. Direct activation of vWF secretion was demonstrated for superoxide anion [30].
We have recently shown that H2O2 induces the exocytosis of vWF in HUVECs [35]. The physiological
significance of the stimulation of vWF exocytosis and secretion by ROS is not clear. However, this effect
could take place in pathophysiological conditions when hyperactivation of vWF secretion occurs.
It was demonstrated that histamine released from mast cells is one of the factors initiating deep vein
thrombosis due to excessive secretion of vWF [55]. Thus, it could be suggested that NOX inhibitors
might be used as a tool for preventing deep vein thrombosis induced by histamine release from
mast cells without affecting vasorelaxation. In fact, the number of pathological states which could be
targeted by VAS2870 or other NOX inhibitors together with or alternatively to other pharmaceuticals
has been increasing over the past several years [56].
Endothelial activation initiates multiple processes, including hemostasis and inflammation.
The molecules that contribute to these processes are co-stored in secretory granules, the Weibel-Palade
bodies (WPBs) being the most known and important in ECs. It was previously shown that
Ca2+-elevating agonists can deplete the cell of almost all WPBs, whereas cAMP-elevating agonists
selectively release a pool of mature WPBs that contain vWF but little or no P-selectin [57].
NOX inhibitors can control the release of granule content from ECs to allow differentiated responses,
and the development of selected agonists for tuning the endothelial response is currently an urgent
problem [58].
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Abstract: Reactive oxygen species (ROS) induce nuclear factor erythroid 2–related factor 2 (Nrf2)
activation as an adaptive defense mechanism, determining the synthesis of antioxidant molecules,
including heme-oxygenase-1 (HO-1). HO-1 protects cells against oxidative injury, degrading free
heme and inhibiting ROS production. HO-1 is highly expressed in macrophages during plaque growth.
Macrophages are morpho-functionally heterogeneous, and the prevalence of a specific phenotype
may influence the plaque fate. This heterogeneity has also been observed in monocyte-derived
macrophages (MDMs), a model of macrophages infiltrating tissue. The study aims to assess oxidative
stress status and Nrf2/HO-1 axis in MDM morphotypes obtained from healthy subjects and coronary
artery disease (CAD) patients, in relation to coronary plaque features evaluated in vivo by optical
coherence tomography (OCT). We found that MDMs of healthy subjects exhibited a lower oxidative
stress status, lower Nrf2 and HO-1 levels as compared to CAD patients. High HO-1 levels in MDMs
were associated with the presence of a higher macrophage content, a thinner fibrous cap, and a
ruptured plaque with thrombus formation, detected by OCT analysis. These findings suggest the
presence of a relationship between in vivo plaque characteristics and in vitro MDM profile, and may
help to identify patients with rupture-prone coronary plaque.
Keywords: oxidative stress; nuclear factor erythroid 2–related factor 2; heme-oxygenase-1; macrophages;
plaque vulnerability; optical coherence tomography
1. Introduction
The progression of coronary atherosclerotic plaque and its destabilization with plaque rupture and
thrombus formation are the key mechanisms of acute myocardial infarction (AMI) [1,2]. Post-mortem
reports have demonstrated that the vulnerable plaque is characterized by a large lipid/necrotic core,
a thin fibrous cap, and a great amount of resident macrophages [3]. Macrophages are versatile
cells and, in relation to microenvironmental stimuli, they respond by activating different signal
transduction pathways, expressing several receptors, and acquiring specific phenotypes. At coronary
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atherosclerotic plaque level, macrophage population is also characterized by morphological and
functional heterogeneity that may enhance plaque growth and/or rupture [4].
An increasing body of evidence suggests that oxidative stress is closely associated with the
atherosclerotic process and plaque instability [5,6] through different pathological mechanisms,
including endothelial dysfunction, lipid oxidation, expression of adhesion molecules, and monocyte
recruitment [7–9]. In response to oxidative stress stimuli, cells implement several defense mechanisms
and, among them, the activation of nuclear erythroid factor 2 – related factor 2 (Nrf2)/heme oxygenase-1
(HO-1) pathway was reported to be associated with atherosclerosis [10,11]. Under unstressed conditions,
Nrf2 is constitutively expressed and sequestrated in the cytoplasm by Keap1 (Kelch-like erythroid
cell-derived protein with cap ’n’ collar homology-associated protein 1), inducing its proteasomal
degradation. On the other hand, under an oxidative stress stimulus, the complex Keap1/Nrf2 dissociates
itself, and Nrf2 translocates into the nucleus. At this level, Nrf2 binds the antioxidant responsive
element and promotes the transcription of proteins with antioxidant activity. Among them, HO-1 plays
a fundamental role in the antioxidant mechanism within the cell by degrading the prooxidant heme
to carbon monoxide, biliverdin, and ferrous ion [11]. In addition, HO-1 induction partially inhibits
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity representing a mechanism of
cytoprotection against oxidative stress [12].
HO-1 expression is induced by various proatherogenic stimuli and risk factors for cardiovascular
diseases [13–15]. HO-1 is highly expressed in atherosclerotic plaques, mainly localized in macrophages
and foam cells [16], where its antioxidant and anti-inflammatory properties could be fundamental to
counteract the development of early stage lesions [17]. In particular, HO-1 reduces the immune cell
recruitment and infiltration [18], regulates the macrophage polarization also driving a phenotypic shift
towards an anti-inflammatory phenotype [19,20], and inhibits the maturation of dendritic cells [21],
thus affecting lesion formation.
HO-1 may also affect plaque progression and its anti-atherogenic role was highlighted in in vitro
and in vivo models. Indeed, the induction of HO-1 in co-cultures of human aortic endothelial cells
and smooth muscle cells inhibited the monocyte oxidized low density lipoprotein (oxLDL)-dependent
chemotaxis [22]. Accordingly, the evidence of an augmented atherogenesis after HO-1 inhibition
and an attenuation in the development of atherosclerotic lesion after HO-1 induction confirms this
protective role. Indeed, accelerated and more advanced atherosclerotic plaques were described in
HO-1 knockout mice [23]. Moreover, the inhibition of HO-1 expression in hyperlipidemic rabbits [24]
or in LDL-receptor deficient mice fed with high-fat diet [25] resulted in greater atherosclerotic lesions
and increased plasma and tissue lipid peroxide levels.
Despite these preclinical studies, HO-1 levels, higher than those of healthy subjects, were observed
in lymphocytes and monocytes isolated from coronary artery disease (CAD) patients. In particular, its
expression was higher in patients with AMI than in those with stable angina (SA) [26]. More recently,
Cheng et al. showed an increased HO-1 expression in carotid atherosclerotic lesions with a vulnerable
phenotype. Of note, the HO-1 levels positively correlated with plaque macrophage and lipid content,
and they inversely correlated with stable plaque features, like the presence of intra-plaque smooth
muscle cells and collagen [16]. Overall, animal and human studies suggest that HO-1 reflects the severity
of atherosclerosis, indicating that a high level of this protein in vulnerable plaque macrophages may
represent an antioxidant response, aiming at counteracting the oxidative damage inside atherosclerotic
plaque [16,27].
Since resident macrophages are not easily obtainable and manageable, macrophages obtained
from a spontaneous differentiation of monocytes (MDMs) are considered to be a good in vitro
model to study tissue macrophages. We have previously reported the co-existence of two main and
different macrophage morphotypes (round and spindle cells) after 7-day culture of human monocytes
isolated from healthy subjects [28]. Similarly to tissue macrophages heterogeneity [4], different MDM
morphotypes showed different functional properties: in particular, round-shaped cells were reminiscent
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of M2 macrophage phenotype with anti-inflammatory and reparative characteristics. On the contrary,
spindle-shaped cells showed a pro-inflammatory profile resembling M1 macrophages [28].
In our more recent study, we demonstrated that the peculiar morpho-phenotype profile of MDMs
isolated from CAD patients is associated with the characteristics of coronary vulnerable plaque, as
assessed by optical coherence tomography (OCT) [29]. This accurate intracoronary imaging technique
allows the visualization and the characterization of the atherosclerotic plaque [30,31] providing its
detailed architecture and highlighting the rupture prone plaques.
Currently, no data have been provided on the association between HO-1 levels and macrophage
phenotype in CAD patients. In this work, we investigated HO-1 levels and the activation of Nrf2/HO-1
axis in different MDM morphotypes obtained from healthy subjects and CAD patients, also in relation
to coronary plaque morphology and activity, as analyzed in vivo by OCT.
2. Materials and Methods
2.1. Study Population
Thirty consecutive CAD patients undergoing coronary angiography, due to SA or AMI, as their
first manifestation of ischemic heart disease, were enrolled at Centro Cardiologico Monzino, Milan,
Italy. SA was defined as angina on effort with a stable pattern of symptoms for at least the last six
months prior to admission; AMI diagnosis encompassed patients presenting with non-ST-elevation
(NSTEMI) or ST-elevation-acute myocardial infarction (STEMI). NSTEMI was defined as chest pain
at rest in the last 48 h preceding the admission associated with evidence of transient ST-segment
depression on 12-lead electrocardiogram and normal (unstable angina) or elevated (NSTEMI) serum
troponin I (TnI) levels. The diagnosis of STEMI was based on typical symptoms lasting more than
30 min and new ST-segment elevation at the J point in ≥2 contiguous leads. Exclusion criteria were:
Previous history of CAD; severe chronic heart failure, severe heart valve disease, acute and chronic
infections, liver diseases, neoplasia, evidence of immunologic disorders, recent (<3 months) surgical
procedures or trauma and use of anti-inflammatory or immunosuppressive drugs and antioxidant
supplements. All AMI included patients underwent percutaneous coronary intervention, specifically
within 24 h from admission for NSTEMI and within 12 h of symptom onset for STEMI patients. OCT
assessment was performed both in SA and in AMI in order to investigate coronary plaque features.
The control group consisted of 10 healthy subjects, with neither history of CAD, nor cardiovascular risk
factors, nor inflammatory disorders, and specifically not taking any cardiovascular therapy. The ethics
committee approved the study protocol, and all participants provided written informed consent to
participate in the study. The study was performed according to the Declaration of Helsinki.
2.2. Monocyte Isolation and Culture
Venous blood samples were drawn from the antecubital vein of healthy subjects and CAD patients
when fasting into tubes containing ethylenediaminetetraacetic acid (EDTA) (9.3 mM; Vacutainer Systems,
Becton Dickinson, USA). Mononuclear cells were isolated by Ficoll-Paque Plus (GE Healthcare, Milan,
Italy) density centrifugation and plated (2 × 106/mL) in 35 mm well plates (Primaria, Falcon, Como,
Italy) as previously described [11]. After 90 min, non-adherent cells were removed and adherent cells
were cultured over 7 days at 37 ◦C (5% CO2) in Medium 199 (Lonza, Milan, Italy) supplemented with
2 mM l-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, and 10% autologous serum without
replacement of the medium throughout the entire culture period. MDM morphology was examined by
phase contrast microscopy (Axiovert 200 M; Zeiss, Milan, Italy) at 20× or 40×magnification. MDMs
were defined spindle/elongated when a length > 70 μm and a width < 30 μm were detected, and
round MDMs when width and length were similar and >30 to 40 μm. Cells, whose morphology and
dimension did not satisfy the above criteria, were classified as undefined.
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2.3. Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Analysis
For the determination of reduced (GSH) and oxidized (GSSG) glutathione levels, MDMs were
washed with phosphate buffer saline (PBS) and detached by gentle scraping. After centrifugation
(400× g, 10 min), the supernatant was removed and MDMs were lysed in PBS containing 0.1 μg of
leupeptin, 0.2 M benzamidine, and 1 μg of trypsin inhibitor. Lysed cells were mixed in a 1:1 (v/v)
ratio with 10% trichloroacetic acid (TCA) containing 1 mM EDTA. After centrifugation (10,000× g,
10 min) at room temperature (RT), the supernatant was diluted 1:20 with 0.1% formic acid. The analysis
was performed using LC-MS/MS method as previously described [32]. Liquid chromatography was
performed on Luna analytical PFP column (100 × 2.0 mm, 3 μm) using an Accela HPLC pump
system (Thermo Fisher Scientific, Milan, Italy). Mass spectrometric analysis was performed using a
TSQ Quantum Access (Thermo Fisher Scientific) triple quadrupole mass spectrometer coupled with
electrospray ionization (ESI) operated in positive mode.
2.4. Western Blot Analysis
Western blot analysis was performed on MDMs total lysate, and on MDMs cytosolic and
nuclear fractions.
To obtain MDMs total lysate, cells were harvested and lysated in a buffer composed by 20 mM
Tris, 4% sodium dodecyl sulfate (SDS) and 20% glycerol, containing 1 mM sodium orthovanadate,
1 mM NaF, 1 μg/mL leupeptin hemisulfate, 1 mM benzamidine hydrochloride, 1 mM EDTA, 10 μg/mL
soybean trypsin inhibitor, 0.5 mM pefabloc, 0.5 mM dithiothreitol (DTT) [33].
For the isolation of cytosolic fraction, MDMs were harvested in 50 μL of buffer containing
10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT and then Triton X-100 (0.2% final
concentration) was added. Cells were centrifuged at 15,000× g for 1 min at 4 ◦C to separate cytosols
from nuclei [34]. The supernatant containing cytosolic fraction was used for the analysis and the pellet
was used for nuclear fraction extraction.
The pellet nuclear fraction was washed with a buffer (20 mM HEPES, pH 7.9, 400 mM NaCl, 25%
glycerol, 1.5 mM MgCl2, 0.2 mM EDTA) containing 0.5 mM PMSF, and 0.5 mM DTT and centrifuged at
15,000× g (10 min, 4 ◦C) [34]. The supernatant containing nuclear fraction was used for the analysis.
SDS-polyacrylamide gel electrophoresis (PAGE) was performed as previously described [33].
After blotting, membranes carrying MDMs total lysates were incubated overnight at 4 ◦C with primary
antibodies directed against HO-1 (1:250) (catalogue number: ab13248; Abcam, Milan, Italy) or Nrf2
(1:200) (Santa Cruz Biotechnology; catalogue number: sc-722, Milan, Italy).
Membranes carrying MDMs cytosolic and nuclear fraction samples were incubated overnight at
4 ◦C with primary antibodies directed against Nrf2 (1:200) (Santa Cruz Biotechnology). After incubation
with horseradish peroxidase-conjugated anti-mouse (1:10,000, catalogue number: 715-035-151) or
anti-rabbit secondary antibody (1:5000, catalogue number: 111-035-003) (Jackson ImmunoResearch
Labs Inc., Li StarFISH, Milan, Italy), as appropriate, for 1 h at RT, protein bands were detected by
chemiluminescence. β-Actin was used as internal standard for control of protein load.
2.5. Immunofluorescence Analysis
Immunofluorescence was performed as previously described [35]. Fixed MDMs were incubated
overnight at 4 ◦C with a monoclonal rabbit anti-human HO-1 antibody (1:100) (Abcam), or with
a polyclonal rabbit anti-human Nrf2 antibody (1:200) (Santa Cruz Biotechnology). Detection was
performed with Alexa Fluor 488 (1:200, catalogue number: A11034, 60 min at RT) (Life Technologies
Italia, Monza, Italy). Nuclei were visualized by Hoechst 33258 (1:10,000, catalogue number: B2883)
(Sigma-Aldrich, Milan, Italy). Negative control experiments were performed by omitting the primary
antibodies. Fluorescence quantification was performed as previously described [33]. Data are expressed
as mean ± SD of fluorescence intensity/μm2 for each MDM morphotype, subtracted of the negative
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control value obtained in the absence of primary antibody. Multiple fields of view (at least three fields,
400×magnification) were captured for each culture.
2.6. OCT Image Acquisition and Analysis
OCT examination was performed in AMI patients at culprit lesion and in SA patients at the minimal
lumen area (MLA) site. Some plaque characteristics were determined such as the measurement of
the thickness of fibrous cap, lipid content, and macrophage accumulation. Fibrous cap thickness was
defined as the minimum distance from the coronary artery lumen to the inner border of the lipid
pool and a thin-cap fibroatheroma (TCFA) was defined as a minimal fibrous cap thickness ≤ 65 μm;
thick-cap fibroatheroma was a plaque with a minimal fibrous cap thickness > 65 μm. The max lipid arc
was measured on the frame with the largest lipid core by visual screening. A plaque showing two or
more lipid containing quadrants was considered a lipid-rich plaque. A lipid plaque with fibrous cap
discontinuity and cavity formation inside the plaque was defined as rupture plaque. A thrombus was
defined as an irregular mass protruding into the lumen with a measured dimension > 250 μm.
The macrophage infiltration (MØI) in the analyzed lesions by OCT, has been assessed as previously
reported [36], according to the International Working Group for Intravascular Optical Coherence
Tomography (IWG-IVOCT) Consensus standards [37]. Briefly, macrophages were qualitatively
identified on raw OCT data within a 300 × 125 μm2 (lateral x axial) region of interest (ROI). In
particular, macrophages have been visualized by OCT imaging as signal-rich, distinct, or confluent
punctate regions that exceed the intensity of background speckle noise and generate a backward
shadowing. For caps having a thickness < 125 μm2, the depth of the ROI was matched to the cap
thickness. Median filtering was performed with a 3 × 3 square kernel to remove speckle noise. In
plaques with MØI, quantitative evaluation of macrophage content was obtained by measuring the
normalized standard deviation (NSD) known to have a high degree of positive correlation with
histological measurements of macrophage content, by using a dedicated software provided by S. Jude
medical [38,39]. In particular, NSD was measured for each pixel within each cap using a 125 μm2
window centered at the pixel location:
NSD (x,y) = [σ (x,y)125 μm2/(Smax-Smin)] × 100 (1)
where NSD (x,y) is the normalized standard deviation of the OCT signal at pixel location (x,y), Smax
is the maximum OCT image value, and Smin is the minimum OCT image value. Pixels within the
(125 × 125) μm2 window that did not overlap with the segmented cap were excluded.
2.7. Statistical Analysis
Continuous variables are presented as mean ± SD, variables not normally distributed are
presented as median and interquartile ranges (IQR), and categorical variables as absolute numbers
and percentages. Comparisons between ‘healthy subjects’ vs. ‘CAD patients’ groups were performed
using independent samples t-Test for normally distributed variables and Wilcoxon rank-sum test for
not normally distributed variables.
Comparisons between ‘healthy subjects’ vs. ‘SA’, ‘NSTEMI’, and ‘STEMI’ groups were performed
using ANOVA Test for normally distributed variables and Kruskal–Wallis Test for not normally
distributed variables. Categorical variables were compared using Fisher’s exact test. Post-hoc testing
of main effects was performed using Bonferroni adjustment for multiple comparisons (α/[number of
comparisons]). Correlations between variables were determined using Spearman’s rank test. Trends of
variation from healthy subjects to STEMI patients were assessed by general linear models. All tests
were two-sided, and a p value of less than 0.05 was required for statistical significance. All calculations
were computed by using SAS software package v9.4 (SAS Institute Inc., Cary, NC, USA).
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3. Results
3.1. Clinical Features
Demographic and clinical characteristics of the enrolled subjects are shown in Table 1. CAD
patients had higher body mass index (BMI) and they were more frequently males. Moreover, as
expected, in CAD group there was a prevalence of subjects with cardiovascular risk factors as smoking,
diabetes, dyslipidemia, hypertension, and family history of cardiovascular disease. Despite there
being more subjects with dyslipidemia among CAD patients, the LDL cholesterol values were similar
between patients and healthy subjects, as the result of pharmacological treatment. Furthermore, CAD
patients had higher levels of glycaemia and of C-reactive protein (hs-CRP), an inflammatory marker.
Of the 30 consecutive CAD patients, 10 (33.3%) had a diagnosis of SA, whereas 20 (66.6%) of AMI
(10 NSTEMI (33.3%) and 10 STEMI (33.3%)). Among CAD patients, those with STEMI showed a higher
BMI, higher levels of hs-CRP, creatinine, glycaemia, total cholesterol, triglycerides, TnI, and creatine
phosphokinase-MB (CK-MB). In addition, lower high-density lipoprotein (HDL) cholesterol levels were
observed in AMI patients. No difference in admission therapy was observed among CAD patients.
3.2. Oxidative Stress Status
The levels of GSH and GSSG, whose ratio is a recognized index of oxidative stress, were measured
in MDMs obtained from the study population. The results are showed in Figure 1. The GSH/GSSG
ratio was significantly lower in CAD patients as compared to healthy subjects. The analysis of the
different clinical presentations of CAD revealed a progressive decrease of GSH/GSSG ratio in MDMs
going from SA, NSTEMI, to STEMI patients (ptrend < 0.005).
3.3. HO-1 and Nrf2 Expression
MDMs of CAD patients displayed higher levels of HO-1 protein as compared to those observed in
healthy subjects (0.12 ± 0.09 vs. 0.06 ± 0.02, p < 0.05) (Figure 2a). Moreover, the immunofluorescence
analysis showed higher protein levels in spindle compared to round cells in all study patients’ groups.
(Figure 2b) with a significant increase in both MDM morphotypes of STEMI patients. A progressive
increase was also shown going from healthy subjects to STEMI patients (ptrend round < 0.0002, ptrend
spindle < 0.0001; Figure 2c).
This behavior was mirrored by the levels of the transcription factor Nrf2. Higher levels of total
Nrf2 were detected in CAD patients as compared to healthy subjects (1.49 ± 0.73 vs. 0.51 ± 0.62,
p < 0.01) (Figure 3a). In addition, the evaluation of Nrf2 levels in cytoplasmic and nuclear fractions
demonstrated a significant increase of Nrf2 translocation into the nucleus in CAD patients as compared
to those of healthy subjects (Figure 3b). The immunofluorescence analysis of the MDM morphotypes
evidenced significantly higher Nrf2 protein levels in both spindle and round MDMs of AMI patients
(NSTEMI and STEMI) as compared to those of healthy subjects (Figure 3c). Furthermore, an increasing
trend in protein levels was detected in both MDM morphotypes paralleling the severity of the clinical
presentations (ptrend round < 0.02, ptrend spindle = 0.06) (Figure 3d).
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Figure 1. GSH/GSSG evaluation in monocyte-derived macrophages (MDMs). MDMs were obtained
from CAD patients and healthy subjects. Data are expressed as mean± SD and derive from independent
cultures obtained from 10 healthy subjects and 30 CAD patients (SA n = 10; NSTEMI n = 10; STEMI
n = 10. * p < 0.05 vs. healthy subjects.
Figure 2. HO-1 levels in CAD patients and healthy subjects. (a) The protein levels of HO-1 were
detected by western blot analysis. β-actin was used as a control of protein loading. Densitometry is
shown in the bar graph. Data are expressed as mean ± SD and derive from MDMs obtained from 10
healthy subjects and 17 CAD patients. (b) Representative images of HO-1 in round and spindle MDMs
obtained from healthy subjects and CAD patients (400× original magnification), nuclei were visualized
by Hoechst 33258. (c) Quantitative analysis of HO-1 in round and spindle MDMs. Data are expressed
as mean ± SD of fluorescence intensity/μm2 (at least three fields, 400×magnification, were analyzed)
and data derive from independent cultures obtained from 10 healthy subjects and 30 CAD patients
(SA n = 10; NSTEMI n = 10; STEMI n = 10. # p < 0.05 vs. round; * p < 0.05, ** p < 0.01, *** p < 0.001 vs.
healthy subjects.
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Figure 3. Nrf2 levels in CAD patients and healthy subjects. (a,b) Nrf2 levels in (a) total cellular lysate,
(b) nuclear and cytosolic compartments were detected by western blot analysis. β-actin was used as a
control of protein loading. Densitometry is shown in the bar graph. Data are expressed as mean ± SD
and derive (a) from MDMs obtained from 10 healthy subjects and 17 CAD patients; (b) from MDMs
obtained from 5 healthy subjects and 5 CAD patients. (c) Representative images of Nrf2 in round and
spindle MDMs obtained from healthy subjects and CAD patients (400× original magnification), nuclei
were visualized by Hoechst 33258. (d) Quantitative analysis of Nrf2 in round and spindle MDMs. Data
are expressed as mean ± SD of fluorescence intensity/μm2 (at least three fields, 400× magnification,
were analyzed) and derive from independent cultures obtained from 10 healthy subjects and 30 CAD
patients (SA n = 10; NSTEMI n = 10; STEMI n = 10). * p < 0.05, ** p < 0.01, vs. healthy subjects.
3.4. Association Between In Vivo Plaque Morphology and HO-1 Levels in MDMs
The coronary plaque characteristics in CAD patients are illustrated in Table 2.
Table 2. Optical coherence tomography features of coronary plaque in CAD patients.
Variables CAD (n = 30)
Lipid plaque, n (%) 26 (86.67)
Fibrous plaque, n (%) 1 (3.33)
Calcific plaque, n (%) 3 (10)
Plaque rupture, n (%) 15 (50)
MLA, mm2 (IQR) 1.70 (1.43–2.58)
TCFA, n (%) 15 (50)
Thrombus, n (%) 14 (46.67)
Lipid quadrants, n 2.70 ± 1.02
Lipid arc, degree ◦ (IQR) 163 (133.5–280)
Max lipid arc, degree ◦ 206.37 ± 87.10
Macrophage infiltration detection, n (%) 21 (70)
Macrophage NSD 6.24 ± 1.16
MLA: Minimal lumen area; TCFA: Thin-cap fibroatheroma; NSD: Normalized standard deviation. Data are expressed
as mean ± SD or median and IQR.
177
Cells 2019, 8, 356
Patients with high levels of HO-1 in both MDM morphotypes more frequently displayed a TCFA
(p = 0.049 and p = 0.015, spindle and round, respectively) (Figure 4a), a ruptured plaque (p = 0.001
and p = 0.036, spindle and round, respectively) (Figure 4b), and presence of thrombi (p = 0.0005 and
p = 0.028, spindle and round, respectively) (Figure 4c).
Figure 4. In vivo plaque features and HO-1 levels in MDM morphotypes. (a) Association between
HO-1 levels and thin cap fibroatheroma (TCFA), (b) fibrous cap integrity, (c) presence of thrombi
detected by means of optical coherence tomography (OCT). Data are expressed as median and IQR.
* p < 0.05, ** p < 0.01.
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In addition, in both MDM morphotypes we observed significant positive correlations between
HO-1 levels and macrophage content (NSD) (spindle: r = 0.62, p = 0.003; round: r = 0.59, p = 0.005)
(Figure 5a). Moreover, borderline positive correlations were observed between HO-1 levels and max
lipid arc (spindle: r = 0.34, p = 0.06; round: r = 0.43, p = 0.02) (Figure 5b).
Figure 5. Correlations between in vivo plaque features and HO-1 levels in MDM morphotypes.
Correlation between HO-1 levels in round and spindle MDMs and (a) macrophage content (NSD) and
(b) max lipid arc, detected by means of OCT in in vivo plaque.
4. Discussion
In the present study we demonstrate higher HO-1 protein levels and the activation of its related
Nrf2/HO-1 pathway in MDMs obtained from CAD patients as compared to those obtained from healthy
subjects. For the first time, we analyzed this pathway in the different MDM morphotypes. Moreover,
we show a positive association between HO-1 levels in MDMs obtained in vitro and the vulnerable
coronary plaque features, as detected in vivo by OCT.
HO-1 is a stress response protein that is expressed in several cell types, including macrophages.
It is induced by several stimuli inducing oxidative stress, such as cardiovascular risks factors [13–15],
hypoxia [40], and GSH depletion [41]. In line with in animal models studies [42,43], our previous data
obtained in whole blood from CAD patients demonstrated a reduction of GSH levels and a related
imbalance of the GSH/GSSG ratio, that is commonly used as an index of oxidative status [44,45]. Here,
we detect a progressive decrease of this marker in MDMs obtained from SA, NSTEMI, and STEMI
patients, indicating an increase of oxidative stress status in patients with a worse prognosis.
Augmented oxidative stress levels activate the Nrf2/HO-1 pathway as one of the cellular protective
mechanisms. The important protective role of HO-1 against human atherosclerosis has been highlighted
in population genetic studies that evidenced a polymorphism in the promoter region of human HO-1
gene associated with atherosclerosis predisposition [46–48]. In the clinical setting HO-1 deficiency
is a very rare condition, but the autopsy case report of HO-1 deficient boy showed hyperlipidemia,
presence of foam cells in the liver, and of fatty streak and fibrous plaque in the aorta. These are several
lines of evidence that outline the role of HO-1 against atherogenesis [49].
Nevertheless, in our experimental conditions, MDMs from CAD patients expressed a progressive
increase of HO-1 levels in both morphotypes, going from healthy to STEMI patients. This is in
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line with previous studies that infer an adaptive defense role of HO-1 against atherosclerosis [50].
The mechanisms underlying the cardioprotective function of HO-1 involve the antioxidant action of its
products [51,52], the reduction in leukocyte recruitment and infiltration, and the suppression of the
pro-inflammatory response of immune cells [18].
The increase in HO-1 levels observed in our study CAD population goes in parallel with the
increased levels of Nrf2, the transcription factor involved in cell protection from oxidant stressors.
Several results strengthen the anti-atherogenic role of Nrf2 in preserving vascular integrity and
endothelial function [53], potentially through the release of NO [54] and the protection from cell
apoptosis [55]. Moreover, the activation of Nrf2 protects human coronary artery endothelial cells
against oxidative challenge [56]. In the present study, we also demonstrate the activation of Nrf2
pathway by its translocation into the nucleus. Indeed, CAD MDMs show higher levels in the nucleus
as compared to healthy MDMs. In turn, the latter exhibit very low and feeble protein levels in the
nucleus, and high protein levels in the cytosol. This is in line with Nrf2 cytosolic localization in
basal condition, where Nrf2 is associated to Keap-1 protein, which induces its ubiquitination and
proteasomal degradation. The increase of the Nrf2 stability and its translocation into the nucleus in
response to stress signals activates the antioxidant gene transcription [57].
This defense mechanism is evidenced also in atherosclerotic plaques by the presence of high levels
of HO-1. Notably, its levels in both carotid [16] and coronary [58] lesions positively correlated with
atherosclerotic grade and plaque vulnerability. In addition, Li et al. showed increased levels of HO-1
in lymphocytes and monocytes associated with the severity of the pathology [59]. Accordingly, in
our study, patients with the highest levels of HO-1 in MDMs, more frequently showed a vulnerable
coronary plaque featured by a TCFA, and an increase in macrophage and lipid content. In addition, in
our study, higher levels of HO-1 are detected in MDMs of CAD patients that presented with ruptured
plaque and with the presence of thrombus as compared to those with non-ruptured plaque and without
thrombi formation. This finding may be explained in light of previous studies reporting a positive
correlation between HO-1 and matrix metalloproteinase-9 levels and a negative correlation between
the presence of smooth muscle cells and collagen deposition [16]. Moreover, it has been observed that
MMP-9 is abundant in carotid plaques characterized by the presence of intraplaque hemorrhage [60].
Overall, these results highlight the activation of Nrf2/HO-1 pathway as an antioxidant response
mechanism in MDMs from CAD patients and point out that HO-1 levels may reflect coronary plaque
vulnerability. This association could help in identifying patients with rupture-prone plaque and
suggests Nrf2/HO-1 pathway as a new potential therapeutic target to counteract plaque progression.
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Abstract: It has been documented that reactive oxygen species (ROS) contribute to oxidative stress,
leading to diseases such as ischemic heart disease. Recently, increasing evidence has indicated that
short-term intermittent hypoxia (IH), similar to ischemia preconditioning, could yield cardioprotection.
However, the underlying mechanism for the IH-induced cardioprotective effect remains unclear.
The aim of this study was to determine whether IH exposure can enhance antioxidant capacity,
which contributes to cardioprotection against oxidative stress and ischemia/reperfusion (I/R) injury
in cardiomyocytes. Primary rat neonatal cardiomyocytes were cultured in IH condition with an
oscillating O2 concentration between 20% and 5% every 30 min. An MTT assay was conducted to
examine the cell viability. Annexin V-FITC and SYTOX green fluorescent intensity and caspase 3
activity were detected to analyze the cell death. Fluorescent images for DCFDA, Fura-2, Rhod-2,
and TMRM were acquired to analyze the ROS, cytosol Ca2+, mitochondrial Ca2+, and mitochondrial
membrane potential, respectively. RT-PCR, immunocytofluorescence staining, and antioxidant
activity assay were conducted to detect the expression of antioxidant enzymes. Our results show that
IH induced slight increases of O2−· and protected cardiomyocytes against H2O2- and I/R-induced cell
death. Moreover, H2O2-induced Ca2+ imbalance and mitochondrial membrane depolarization were
attenuated by IH, which also reduced the I/R-induced Ca2+ overload. Furthermore, treatment with IH
increased the expression of Cu/Zn SOD and Mn SOD, the total antioxidant capacity, and the activity
of catalase. Blockade of the IH-increased ROS production abolished the protective effects of IH on the
Ca2+ homeostasis and antioxidant defense capacity. Taken together, our findings suggest that IH
protected the cardiomyocytes against H2O2- and I/R-induced oxidative stress and cell death through
maintaining Ca2+ homeostasis as well as the mitochondrial membrane potential, and upregulation of
antioxidant enzymes.
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1. Introduction
Obstructive sleep apnea (OSA), also known as intermittent hypoxia (IH), is characterized by
repetitive episodic obstructions of airflow during sleep [1]. It has been indicated that IH is related to
cardiovascular diseases, including hypertension, stroke, and myocardial infarction [2,3]. On the other
hand, some studies have demonstrated that IH can protect against the cell death induced by ischemia
or ischemia reperfusion (I/R) injury [4–6]. Several mechanisms have been proposed to be involved in
the IH-induced protective effects, including activation of hypoxia-responsive genes, amelioration of
coronary circulation, activation of protein kinase C, balance of Ca2+ handling activity, and inhibition of
mitochondrial permeability transition pores (mPTP) opening [6–10]. However, the complete effects
and underlying mechanisms of IH on cardiac function are still unclear.
Ca2+ homeostasis, which is dependent on a complex network of ion transporters, channels, and
regulatory proteins, is important for maintaining cardiac functions. It has been demonstrated that
the activities of L-type Ca2+ channel (LTCC), ryanodine receptors (RyR), sarcoplasmic/endoplasmic
reticulum Ca2+-ATPase (SERCA) and phospholamban were regulated by Ca2+/calmodulin-dependent
kinase II (CaMKII) and cAMP-dependent protein kinase A (PKA), and these proteins have been
demonstrated to be involved in regulating intracellular Ca2+ homeostasis under physiological and
pathophysiological conditions [11,12]. In recent years, post-translational oxidative modification of
LTCC, RyR and SERCA caused by ROS also has been reported [13]. ROS has been considered an
important signaling molecule in regulating cardioprotection. It has been shown that dimethylthiourea
(DMTU), a potent hydroxyl radical scavenger, inhibits the ischemic preconditioning-mediated tyrosine
kinase phosphorylation and cardioprotection [14]. Furthermore, the cardioprotective effects induced
by diazoxide, a selective opener of the mitochondrial ATP-sensitive potassium channel, are abolished
by N-acetyl cysteine, a ROS scavenger [15]. ROS has also been demonstrated to regulate other signaling
molecules or channels, including protein tyrosine kinase, MAP kinase, phospholipase c (PLC), NFκB,
IP3 receptor, ryanodine receptor, and Na+/Ca2+ exchanger (NCX) [16]. These findings suggest that
ROS play a crucial role in the preconditioning-induced cardioprotection.
Intracellular Ca2+ plays an important role in regulating cardiomyocyte behavior under
physiological and pathophysiological conditions, such as myocyte excitation-contraction coupling, cell
proliferation and differentiation, and cell death. Disruptions in Ca2+ handling can contribute to the
pathogenesis of many diseases, such as Alzheimer’s disease, Huntington’s disease, and congestive
heart failure [17]. Previous studies reported that IH can prevent the I/R-induced cell death via
ameliorating Ca2+ homeostasis by increasing the activities of RyR, SERCA, and NCX during I/R [6,9].
I/R injury can induce burst ROS production to trigger cytosolic Ca2+ overload, leading to an excessive
increase in mitochondrial Ca2+, which in turn induces mPTP to open and depolarizes the mitochondrial
membrane potential. The opening of mPTP leads to a loss of ATP, mitochondrial swelling, and release of
cytochrome c, resulting in apoptosis [18]. Zhu et al. reported that IH improves mitochondrial tolerance
to Ca2+ overload and delays oxidative stress-induced mPTP opening [7]. Additionally, it has been
indicated that IH can increase the expression of superoxide dismutase (SOD) and glutathione peroxidase
(GPx) [19]. These findings reveal that oxidative stress might play a key role in inducing intracellular
Ca2+ overload, and IH probably enhances the antioxidant capacity to prevent oxidative stress-induced
intracellular Ca2+ overload. However, the relationship between IH-increased antioxidant enzyme
expression and the balance of Ca2+ handling activity is still unclear. In this study, we aimed to
determine whether IH induced cardioprotective effects through improving the intracellular Ca2+
balance via ROS-increased antioxidant capacity.
2. Materials and Methods
2.1. Chemicals
Fluorescent indicators were purchased from Molecular Probes (Eugene, OR, USA). Fetal bovine
serum (FBS), penicillin, and trypsin were from Gibco/Life Technologies (Rockville, MD, USA). All
other chemicals were purchased from Sigma (St. Louis, MO, USA).
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2.2. Preparation of Neonatal Rat Cardiomyocytes
Neonatal rat cardiomyocytes were prepared and cultured as described previously [20]. Briefly,
1–2-day-old Sprague-Dawley rats (both sexes) were sacrificed by decapitation. The ventricles were
pooled from several hearts and minced into small pieces. Cardiac tissues were digested using 0.051%
pancreatin and 0.01% collagenase in Hank’s solution, and then incubated with F-12 medium containing
80% F-12 nutrient mixture, 10% horse serum, 10% FBS, and 1% penicillin (Gibco/Life Technologies) to
inactivate enzymatic digestion. Cells were pre-plated on a 10-cm dish for 1 h at 37 ◦C in a 5% CO2
incubator to remove fibroblasts. Subsequently, cardiomyocytes were seeded on 24-mm collagen-coated
cover slips in F-12 medium, and then added 10μM cytosine arabinoside to inhibit fibroblast proliferation.
The medium was replaced daily during the experiments. All animal studies were performed following
the recommended procedures approved by the Institutional Animal Care and Use Committee of Tzu
Chi University (PPL number: 104107) and conform to the guidelines from Directive 2010/63/EU of the
European Parliament on the protection of animals used for scientific purposes or the NIH guidelines.
2.3. IH Exposures
Neonatal rat cardiomyocytes were placed in Plexiglas box chambers (length 25 cm, width 30 cm,
and height 15 cm). The cardiomyocytes were exposed to room air (RA)/normoxia (20% O2, 5% CO2, and
75% N2) or IH (5% O2, 5% CO2, and 90% N2 for 30 min alternating with 30 min RA) for 1–4 days using a
timer solenoid valve control [20]. Oxygen fractions in the chambers were continuously monitored by an
oxygen detector. A micro dissolved oxygen electrode from Lazar Research Laboratories (DO-166MT-1,
Los Angeles, CA, USA) was used to detect fluctuations in oxygen concentrations in the medium and
the chamber.
2.4. Ischemia and Reperfusion (I/R) Injury
Simulated I/R in cultured cardiomyocytes was performed using a modified protocol described
previously [21]. Briefly, cardiomyocytes were stabilized at 37 ◦C in Normal Tyrode (NT) buffer (140 mM
NaCl, 4.5 mM KCl, 2.0 mM CaCl2, 1.2 mM MgCl2, 11 mM glucose, and 10 mM HEPES, with pH
adjusted to 7.4 using NaOH) for 10 min, transferred to 100% N2-saturated ischemia buffer (123 mM
NaCl, 8 mM KCl, 2.5 mM CaCl2, 0.9 mM NaH2PO4, 0.5 mM MgSO4, 20 mM Na-lactate, and 20 mM
HEPES with pH adjusted to 6.0 using NaOH) for 6 h, and then reperfused with a culture medium for
12 h in a 5% CO2 incubator.
2.5. Analysis of Cell Death by Flow Cytometry
Apoptosis/necrosis was determined using Annexin V-FITC Apoptosis Detection Kit (BioVision, Inc.,
Mountain View, CA, USA) according to the manufacturer’s recommendations. Cardiomyocytes were
washed with NT, dissociated by trypsin gently, harvested by centrifugation, and stained with Annexin
V-FITC and SYTOX green (BioVision, Inc.) in binding buffer for 10 min at RT. Fluorescence was detected
on a Gallios Flow Cytometer (Beckman Coulter, Indianapolis, IN, USA). The excitation/emission
wavelengths for Annexin V-FITC and SYTOX were 488/520 nm. Based on the staining intensity, the cell
population was divided into three groups: live cells (M1), apoptotic cells (M2), and necrotic cells (M3).
2.6. Cell Viability Assay
Cell viability was measured by the MTT assay preformed in triplicate. Briefly, cardiomyocytes
were washed with NT, and incubated in culture medium containing 50 μg/mL MTT for 1 h at 37 ◦C
in a 5% CO2 incubator. After removal of the MTT medium, 1 mL of DMSO was added to each dish
to dissolve the precipitate for 10 min, and then detected by a Multiskan EX ELISA Reader (Thermo
Scientific, Rockford, IL, USA). The absorbance at 570 nm of the control group cells was considered to
be 100%.
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2.7. Imaging of Intracellular Reactive Oxygen Species (ROS)
Intracellular levels of ROS were detected using 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein
diacetate acetyl ester (CM-H2DCFDA; DCFDA). DCFDA fluorescence is triggered by oxidation via
hydroxides (OH−), hydrogen peroxides (H2O2) or hydroxyl radicals (OH ·). Cardiomyocytes were
loaded with 5 μM DCFDA for 30 min at RT, and washed twice with NT buffer. Using a real-time
fluorescence imaging system including Sutter LAMBDA-LS/30 (Leica, Microsystems, Wetzlar, Germany),
1.10 set Filter wheel with Smart Shutter (Leica), and inverted fluorescent microscope (DMI3000 B;
Leica) to detect fluorescence signal. Cells perfused continuously with NT buffer (37 ◦C) were used
for fluorescent imaging. The wavelength of 480 nm was used for DCFDA excitation and 535 nm for
emission. Signal increases are presented as the peak/basal fluorescence ratio (F/F0).
2.8. Flow Cytometric Analysis for Oxidative Stress Detection
Intracellular levels of ROS were detected by DCFDA. After IH or H2O2 treatment, cardiomyocytes
were washed with NT solution, loaded with 5 μM DCFDA for 30 min at RT. Subsequently, cells were
trypsinized, resuspended, and placed on ice. Fluorescence was measured on a Gallios Flow Cytometer
(Beckman Coulter). The excitation/emission wavelengths for DCFDA was 488/540 nm (FL1).
2.9. Quantitative Real-Time PCR
Total RNA was isolated from neonatal rat cardiomyocytes using TRIzol reagent (Life Technologies)
according to the manufacturer’s protocol. cDNA was synthesized using a VersoTM cDNA Kit (Thermo).
Total RNA (3 μg) was used for quantitative real-time PCR, which was performed using Maxima SYBR
Green qPCR Master Mix (2×) (Thermo) with a LightCycler 480 (Roche). The primer sequences were as
follows: CuZnSOD: forward 5′-TGG GAG AGC TTG TCA GGT G-3′, reverse 5′-CAC CAG TAG CAG
GTT GCA GA-3′; MnSOD: forward 5′-GCC TCC CTG ACC TGC CTT AC-3′, reverse 5′-GCA TGA TCT
GCG CGT TAA TG-3′; Catalase: forward 5′-CCC AGA AGC CTA AGA ATG CAA-3′, reverse 5′-GCT
TTT CCC TTG GCA GCT ATG-3′; GPx: forward 5′-GTG TTC CAG TGC GCA GAT ACA-3′, reverse
5′-GGG CTT CTA TAT CGG GTT CGA-3′; and GAPDH: forward 5′-ATG TTC CAG TAT GAC TCC
ACT CAC G-3′, reverse 5′-GAA GAC ACC AGT AGA CTC CAC GAC A-3′. All gene expression was
analyzed using the comparative Ct method (2−ΔΔCt); ΔΔCt = ΔCt (sample) − ΔCt (reference) relative
to β-actin levels.
2.10. Measurement of Total Antioxidant Capacity and Catalase and Glutathione Peroxidase Activity
Cardiomyocytes were scraped on ice and centrifuged at 1400× g at 4 ◦C for 10 min. The cell
pellet was sonicated in assay buffer on ice, and centrifuged at 10,600× g at 4 ◦C for 15 min. Protein
concentration in supernatants was quantified using the Protein Assay kit (Biorad, Hercules, CA, USA).
Equal amounts of protein lysates were used for determination of total antioxidant capacity (TAC),
catalase and glutathione peroxidase (GPx) activity. TAC was measured using the Antioxidant Assay
Kit (Cayman Chemical, Ann Arbor, MI, USA). Catalase activity was measured using the Catalase
Assay Kit (Cayman Chemical). GPx activity was measured using the Glutathione Peroxidase Assay Kit
(Cayman Chemical). These assay kits were used according to the manufacturer’s instructions. 96-Well
assay plates were read using an ELISA plate reader (Thermo Scientific) at 405 nm for TAC, at 540 nm
for CAT, and at 340 nm for GPx.
2.11. Immunocytofluorescence Staining
Cardiomyocytes were fixed with methanol at 4 ◦C for 10 min or 10% formalin in NT at RT for
1 h, incubated in 5% non-fat milk for 60 min to block the non-specific IgG followed by primary
antibody for 60 min at 37 ◦C, and then incubated with secondary antibody (FITC-conjugated goat
anti-rabbit IgG or anti-mouse IgG) for 60 min at 37 ◦C. Images were obtained by confocal microscopy
with resolution of 512 × 512 pixels. Green fluorescence represented FITC with excitation/emission
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wavelengths at 488/530 nm. MnSOD (1:200) and CuZnSOD (1:200) antibodies were purchased from
Upstate Biotechnology (Lake Placid, NY, USA).
2.12. Imaging of Intracellular Ca2+ Concentrations ([Ca2+]i)
Cardiomyocytes were loaded with 5 μM Fura-2 AM for 60 min at RT, and then washed twice with
NT buffer. A real-time fluorescence imaging system, including Sutter LAMBDA-LS/30 (Leica), 1.10 set
Filter wheel with Smart Shutter (Leica), and inverted fluorescent microscope (DMI3000 B; Leica), was
used to detect fluorescence signal. Cells perfused continuously with NT buffer (37 ◦C) were used for
fluorescent imaging. Fura-2 was excited alternately at 340/380 nm, and emission was monitored at
520 nm. [Ca2+]i were expressed as a ratio of F340/F380. Simulated I/R in cultured cardiomyocytes were
placed on inverted fluorescent microscope. Cardiomyocytes were placed in a plexiglass box chamber
containing 100% N2, and perfused with 100% N2-saturated ischemia buffer for 30 min followed by
reperfusion for 30 min with 100% O2-saturated NT buffer.
2.13. Imaging of Mitochondrial Ca2+ Concentration ([Ca2+]m)
Changes in mitochondrial Ca2+ concentration were recorded using Rhod-2 AM. Cells were loaded
with 5 μM Rhod-2 AM and 0.02% Pluronic F127 for 1 h at RT. The cells were also loaded with 300 nM
MitoTracker Green FM (MTG) to detect the localization of mitochondria. Using time-lapse confocal
laser scanning microscopy (TCS-SPII; Leica) to detect fluorescence signal. Cells perfused continuously
with NT buffer (37 ◦C) were used for fluorescent imaging. Rhod-2 was excited at 514 nm, and emission
was monitored at >530 nm. [Ca2+]m were presented as the peak/basal fluorescence ratio (F/F0). MTG
was excited at 488 nm, and emission was monitored at >520 nm.
2.14. Measurement of Mitochondrial Membrane Potential Using Flow Cytometry
Changes in mitochondrial membrane potential (ΔΨm) were recorded with tetramethylrhodamine
methyl ester perchlorate (TMRM). Cells were loaded with 500 nM TMRM and Pluronic F127 for
30 min at RT. After washing with NT, cardiomyocytes were harvested, and fluorescence was
measured on a FACSCalibur Flow Cytometer (Becton Dickinson Biosciences, San Jose, CA, USA). The
excitation/emission wavelengths for TMRM was 488/580 nm (FL2)
2.15. In Situ Labeling of Activated Caspase-3
In situ labeling of activated caspase-3 was carried out using a CaspGLOW Fluorescein Active
Caspase-3 Staining Kit (BioVision, Inc.). After treatment, cells were incubated with FITC–DEVD–FMK
for 1 h at RT. Cardiomyocytes were fixed with 4% formaldehyde for 1 h, and then incubated with
Hoechst 33342 for 15 min. Images were obtained using confocal microscopy. FITC was represented by
green fluorescence with excitation/emission wavelengths at 488/>530 nm. Hoechst 33342 fluorochrome
was represented by blue fluorescence with excitation/emission wavelengths at 364/400–470 nm.
2.16. Statistics
All results are expressed as means and standard errors of the means (mean ± SEM). Statistical
differences were compared using the unpaired t-test, taking p-values < 0.05 as significant. Data
obtained from three or more groups were compared by one-way ANOVA followed by LSD tests.
p-values < 0.05 were considered significant.
3. Results
3.1. Effects of IH on Cell Death
It has been demonstrated that pathogenic or beneficial effects of IH depend on hypoxic oxygen
concentration, hypoxia duration, number of cycles, and IH pattern [22]. Initially, we examined whether
IH can prevent cell death. Cardiomyocytes were treated with IH for 1–4 days, followed by 30 μM
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H2O2 treatment for 40 min, and then the cell viability was measured using the MTT assay. As shown
in Figure 1A, the viability of cells treated with four days IH (IH4) was not significantly different from
the viability of those treated with RA. However, treatment with IH for 1–4 days time-dependently
attenuated the H2O2-induced cell death. Furthermore, cytometric analysis for Annexin V-FITC and
SYTOX green revealed that the percentage of apoptotic and necrotic cells was not significantly different
between the RA-treated group and the IH4-treated group. In this study, the H2O2-treated group was
used to serve as a positive control for the occurrence of apoptosis and necrosis (Figure 1B,C).
Figure 1. Effects of IH cell death. (A) Primary cultured neonatal cardiomyocytes were treated with
RA or IH for 1–4 days followed by 30 μM H2O2 treatment for 40 min. Cell viability was determined
using MTT assay. Treatment with IH for four days did not significantly affect the cell death. In contrast,
treatment with H2O2 significantly reduced the cell viability However, treatment with IH for four days
significantly reduced the H2O2-induced cell death. Data represent the means ± SEM. RA: n = 10, IH4:
n = 3, RA + H2O2: n = 10, IH1 + H2O2: n = 4, IH2 + H2O2: n = 4, IH3 + H2O2: n = 4, IH4 + H2O2:
n = 10. * p < 0.05. (B) The representative plot shows flow cytometry analysis of Annexin V-FITC
and SYTOX green florescence intensity in the cells treated with RA, IH4 or H2O2. (C) The left panel
shows the percentage of viable cells (M1), apoptotic cells (M2), and necrotic cells (M3) in the RA-,
IH4-, and H2O2-treated groups. The middle panel shows that the percentage of apoptotic cells in the
IH4-treated group was not significantly different from the RA-treated group. The right panel shows
that the percentage of necrotic cells in the IH4-treated group was not significantly different from the
RA-treated group. H2O2 treatment was serviced as a positive control for the induction of cell death.
Data represent the means ± SEM. RA: n = 6, IH4: n = 3, H2O2: n = 6. * p < 0.05. RA, room air; IH4,
intermittent hypoxia for four days.
3.2. Effects of IH on the Endogenous Antioxidant Defense in Cardiomyocytes
Previously, we demonstrated that IH can protect cardiomyocytes against the H2O2-induced cell
death [21]. Here, we further investigated whether IH can enhance the antioxidant defense capacity to
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against oxidative stress. To address this issue, the cells were treated with IH for four days, followed by
perfusion with 30 μM H2O2 to increase the intracellular ROS level, which was detected by fluorescence
probe, DCFDA, and the signals were detected by a real-time fluorescence imaging system (Figure 2A).
In the RA-treated group, H2O2 treatment increased the level of intracellular ROS approximately
5-fold compared with the baseline. IH4 significantly attenuated the H2O2-induced increases of the
intracellular ROS levels (Figure 2B). Next, we examined the mRNA expression levels of antioxidant
enzymes by Q-PCR. As shown in Figure 2C, IH4 significantly increased the mRNA levels of Cu/Zn
SOD and MnSOD. However, the mRNA levels of catalase and GPx did not change significantly. We
further measured the activity of catalase, GPx and TAC using assay kit. The activities of catalase
(Figure 2D), GPx (Figure 2E), and TAC (Figure 2F) were significantly higher in the IH4-treated group
than the RA-treated group. These data suggest that treatment with IH for four days increased the
endogenous antioxidant defense capacity.
Figure 2. Effects of IH on endogenous antioxidant defense in cardiomyocytes. (A) The time course
of intracellular ROS changes in cardiomyocytes perfused with H2O2 (30 μM) was recorded by a
real-time fluorescence imaging system. Treatment of cardiomyocytes to IH for four days attenuated the
H2O2-induced increases of intracellular ROS level. (B) The difference between baseline and plateau
of DCFDA (F/F0) was defined as ΔDCFDA. The quantitative results show that the H2O2-induced
intracellular ROS increase was significantly lower in cardiomyocytes treated with IH4 than with RA.
Data represent the means ± SEM. n = 8 for each group, * p < 0.05. (C) The levels of Cu/Zn SOD and
MnSOD mRNA were significantly higher in the IH4-treated group than the RA-treated group. Data
represent the means ± SEM. n = 7 for each group. * p < 0.05. (D) The activity levels of catalase (D), GPx
(E), and TAC (F) were significantly higher in the IH4-treated group than in the RA-treated group. (The
activities of catalase, GPx and TAC were determined by ELISA. Data represent the means ± SEM. RA:
n = 5, IH4: n = 5. * p < 0.05.
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3.3. Effects of IH on Oxidative Stress-Induced Intracellular Ca2+ Disturbance and Mitochondrial
Membrane Depolarization
Previous studies have suggested that oxidative stress induces intracellular Ca2+ overload, which in
turn causes mitochondrial membrane depolarization, hence leading cell death [23,24]. To test whether
IH can prevent oxidative stress-mediated accumulation of intracellular Ca2+, the cardiomyocytes were
treated with IH for four days followed by 30 μM H2O2 treatment to increase the intracellular ROS
level, and then subjected to the intracellular Ca2+ concentration detection in the IH- and RA-treated
cells by fluorescence probe, Fura-2. Our data show that IH4 significantly attenuated the H2O2-induced
increases of the intracellular Ca2+ levels (Figure 3A,B). Using fluorescence probe, Rhod-2, we further
demonstrated that IH4 significantly attenuated the H2O2-induced increases of the mitochondrial Ca2+
levels (Figure 3C,D). It has been suggested that excessive ROS can open mitochondrial permeability
transition pore, hence leading mitochondrial membrane depolarization [24]. We further examined
whether IH can prevent oxidative stress-mediated mitochondrial membrane depolarization. The
change of mitochondrial membrane potential was evaluated by flow cytometry analysis using a
fluorescence probe, TMRM, which is a cell-permeant dye that accumulates in healthy mitochondria
and can be detected a strong signal. When the mitochondrial membrane depolarizes, TMRM was
released from the mitochondria and weak signal was detected. We measured the average of TMRM
fluorescence intensity of 10,000 cells per well. The average of TMRM in the RA group was as 100%
(Figure 3E). As illustrated in Figure 3F, the TMRM signals in the IH-treated group were significantly
lower than in the RA group. Under H2O2 treatment conditions, however, the IH4-treated group
showed significantly higher TMRM signals than the RA group. These data demonstrate that treatment
of cardiomyocytes with IH for four days significantly attenuated the H2O2-induced intracellular Ca2+
overload and mitochondrial membrane depolarization.
Figure 3. Effects of IH on H2O2-induced intracellular Ca2+ increase and mitochondrial membrane
depolarization. (A) The left panel shows the time course of cytosolic Ca2+ changes in cardiomyocytes
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perfused with H2O2 (30 μM), and recorded by a real-time fluorescence imaging system. Treatment
of cardiomyocytes to IH for four days attenuated H2O2-induced increases of the cytosolic Ca2+ level.
The right panel shows representative images of cytosolic Ca2+ stained by Fura-2 (pseudo color). The
open circle indicated the area that was examined for the intensity of Fura-2 staining. (B) The difference
between the baseline and plateau of Fura-2 (F340/F380) was defined as ΔFura-2. The quantitative results
show that the H2O2-increased cytosolic Ca2+ was significantly lower in the cardiomyocytes treated with
IH4 than with RA. Data represent the means ± SEM. n = 6 for each group. * p < 0.05. (C) The left panel
shows the time course of mitochondrial Ca2+ changes in cardiomyocytes perfused with H2O2 (30 μM),
and recorded by confocal microscope. Treatment of cardiomyocytes to IH for four days attenuated the
H2O2-induced increases of mitochondrial Ca2+ level. The right panel shows representative images of
mitochondrial Ca2+ stained by Rhod-2 (pseudo color). (D) The difference between baseline and plateau
of Rhod-2 (F/F0) was defined as ΔRhod-2. The quantitative results show that the H2O2-increased
mitochondrial Ca2+ was significantly lower in the cardiomyocytes treated with IH4 than with RA. Data
represent the means ± SEM. n = 3 for each group. * p < 0.05. (E) The representative plots show the
mitochondrial membrane potential changes measured by flow cytometry analysis using mitochondrial
membrane potential probe, TMRM. (F) The quantitative results are measured and normalized to RA.
Mitochondrial membrane potential was significantly lower in the cardiomyocytes treated with IH4
than with RA. However, treatment of cardiomyocytes with IH for four days significantly attenuated the
H2O2-induced depolarization of mitochondrial membrane potential. Data represent the means ± SEM.
RA: n = 10, IH4: n = 10, H2O2: n = 4, IH4 + H2O2: n = 4. * p < 0.05. Mit, mitochondria; N, Nucleus.
3.4. Involvement of ROS Generation in the IH-Increased Antioxidant Defense and Cardioprotective Effects
It has been suggested that ROS can serve as a mediator to trigger signaling pathways involved in
regulating cardioprotective effects [20,21]. Flow cytometry analysis demonstrated that IH4 significantly
increased the intracellular ROS generation. However, treatment of cardiomyocytes with an antioxidant,
such as Apo, Phe, or MnTBAP, abolished the IH4-increased intracellular ROS generation (Figure 4A,B).
We further investigated whether IH can increase antioxidant enzyme expression. Cardiomyocytes
were treated with IH for four days with or without Phe (100 nM), an antioxidant, and the expression
of Cu/Zn SOD and MnSOD were detected by immunocytofluorescence staining. IH4 significantly
increased the expression of Cu/Zn SOD and MnSOD. However, Phe abolished the IH4-increased Cu/Zn
SOD and MnSOD expression (Figure 4C,D). We also measured the total antioxidant capacity (TAC) to
clarify whether IH increased endogenous antioxidant defense system via intracellular ROS generation.
The levels of TAC were significantly higher in the IH4-treated group than in the RA-treated group.
However, treatment of cardiomyocytes with IH for four days with Phe (100 nM) or SOD (5 U) abolished
the IH4-increased TAC (Figure 4E). To investigate whether ROS was a key mediator contributing to
the IH-induced cardioprotective effects, cardiomyocytes were pre-treated for four days with IH and
Apo (100 μM), Phe (100 μM), or MnTBAP (50 μM) together to prevent ROS generation, followed by
30 μM H2O2 treatment for 40 min, and then subjected to measure the cell viability by MTT assay. As
shown in Figure 4F, treatment with IH for four days significantly attenuated the H2O2-decreased cell
viability. However, treatment with IH together with an antioxidant, such as Apo, Phe, or MnTBAP,
abolished the IH-protected cell death. These data suggest that IH increased ROS generation, which
upregulated antioxidant enzyme expression and increased the total antioxidant capacity, thereby
preventing cell death.
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Figure 4. Involvement of ROS generation in the IH-increased antioxidant expression and
cardioprotective effect. (A) The representative plots show the intracellular ROS change in various
treatment measured by flow cytometry analysis using intracellular ROS probe, DCFDA. The result
of cells treated with H2O2 (30 μM) in the RA was used as the positive control and shown with the
red line, whereas treatment with IH4, IH4/Phe, or IH4/MnTBAP was shown with the green line.
(B) The quantitative results show that the level of intracellular ROS was significantly higher in the
cardiomyocytes treated with IH4 than with RA. However, co-treatment with an antioxidant, such as
Apo, Phe, or MnTBAP, abolished the IH4-increased intracellular ROS level. Data represent the means ±
SEM. RA: n = 10, IH4: n = 6, IH4/Apo: n = 6, IH4/Phe: n = 6, IH4/MnTBAP: n = 6. * p < 0.05. (C) The
representative images show the expression of Cu/Zn SOD and MnSOD (green fluorescence) detected
by immunocytofluorescence staining. The nucleus was stained by Hoechst 33342 (blue fluorescence).
(D) The quantitative results show that the levels of Cu/Zn SOD and MnSOD were significantly higher
in the cardiomyocytes treated with IH4 than with RA. However, co-treatment with Phe, an antioxidant,
abolished the IH4-increased Cu/Zn SOD and MnSOD expression. Data represent the means ± SEM.
(n = 12). * p < 0.05. (E) The levels of TAC were significantly higher in the IH4-treated group than the
RA-treated group. However, co-treatment with an antioxidant, Phe or SOD, abolished the IH4-increased
TAC. Total antioxidant capacity as determined by assay kit. Data represent the means ± SEM. RA: n = 3,
IH4: = 3, IH4/Phe: n = 3, IH4/SOD: n = 3. * p < 0.05 (F) Neonatal cardiomyocytes were treated with IH
for four days, and then co-treated with IH and an antioxidant, Apo, Phe or MnTBAP, followed by 30 μM
H2O2 treatment for 40 min. Treatment with IH4 prevented the H2O2-induced cell death. However,
co-treatment with Apo, Phe or MnTBAP abolished the IH-prevented cell death. Data represent the
means ± SEM. RA: n = 10, RA + H2O2: n = 10, IH4 + H2O2: n = 10, IH4/Apo + H2O2: n = 4, IH4/Phe +
H2O2: n = 6, IH4/MnTBAP + H2O2: n = 6. * p < 0.05.
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3.5. Effects of IH on the I/R-Induced Cell Death in Cardiomyocytes
We previously demonstrated that Ca2+ overload plays an important role in the I/R-induced
cell death [25]. In Figure 3, we demonstrated that IH4 significantly attenuated the H2O2-induced
cytosolic Ca2+ overload. We further investigated whether IH could also prevent the I/R-induced
cytosolic Ca2+ overload and cell death. After treatment with IH for four days, cardiomyocytes were
placed in a plexiglass box chamber containing 100% N2, perfused with 100% N2-saturated ischemia
buffer for 30 min, and followed by reperfusion for 30 min with 100% O2-saturated NT solution.
Fluorescence probe, Fura-2, was used to detect the changes of Ca2+ during I/R. Our results show
that IH4 significantly attenuated the I/R-induced increases of the cytosolic Ca2+ levels (Figure 5A,B).
Moreover, treatment with IH for four days also significantly attenuated the I/R-decreased cell viability.
However, treatment with IH for four days in the presence of an antioxidant, Apo, Phe or MnTBAP,
abolished the IH-prevented cell death (Figure 5C). We also detected the level of cleaved caspase-3 to
analyze apoptosis status in cardiomyocytes. As shown in Figure 5D, IH4 significantly decreased the
I/R-induced apoptosis. Finally, flow cytometry analysis was conducted to measure the percentage of
live cells (M1), apoptotic cells (M2) and necrotic cells (M3) in cardiomyocytes (Figure 6A). I/R increased
the occurrence of apoptosis (Figure 6B) and necrosis (Figure 6C), and this effect was significantly
attenuated by IH4 treatment. However, the IH-prevented apoptosis were abolished by co-treatment
with Phe or MnTBAP. IH4 also significantly attenuated the I/R-induced necrosis. Noticeably, treatment
with Phe or MnTBAP alone did not induce apoptosis or necrosis. These data suggest that IH prevented
the I/R-induced cytosolic Ca2+ overload and cell death via ROS generation.
Figure 5. Effects of IH on the I/R-induced cytosolic Ca2+ increases and cell death. (A) The time course
of cytosolic Ca2+ changes in cardiomyocytes perfused with ischemic and reperfusion buffer to mimic
I/R injury, and recorded by a real-time fluorescence imaging system. Treatment of cardiomyocytes to
IH for four days attenuated the ischemia and reperfusion-induced increases of cytosolic Ca2+ level.
(B) The difference between the baseline and plateau of Fura-2 (F340/F380) was defined as ΔFura-2.
195
Cells 2019, 8, 564
The quantitative results show that the ischemia and reperfusion-increased cytosolic Ca2+ was
significantly lower in cardiomyocytes treated with IH4 than with RA. Data represent the means
± SEM. n = 4 for each group. * p < 0.05. (C) Neonatal cardiomyocytes were treated with IH for four
days, and then co-treated with IH and antioxidant, Apo, Phe or MnTBAP, followed by I/R treatment.
Treatment with IH4 prevented the I/R-induced cell death. However, co-treatment with Apo, Phe or
MnTBAP abolished the IH-prevented cell death. Data represent the means ± SEM. n = 5 for each
group. * p < 0.05. (D) The left panel shows the representative images of activated caspase-3 expression
detected by CaspGLOW fluorescein active caspase-3 staining kit after I/R treatment. The right panel
gives the quantitative results, showing that the expression of active caspase-3 was significantly lower in
cardiomyocytes treated with I/R + IH4 than with I/R + RA. Data represent the means ± SEM. (n = 14).
* p < 0.05. I/R, ischemia/reperfusion.
Figure 6. Effects of IH on the I/R-induced apoptosis and necrosis. (A) The representative plots
show the flow cytometry analysis of Annexin V-FITC and SYTOX green florescence intensity in the
cardiomyocytes treated with RA, IH4 and IH4 with an antioxidant, Phe or MnTBAP, followed by
ischemia for 6 h and reperfusion for 12 h. M1, M2, and M3 represent the population of viable cells,
apoptotic cells and necrotic cells, respectively. IH4 attenuated the I/R-induced apoptosis (B) and
necrosis (C). IH4 with Phe or MnTBAP abolished the IH4-attenuated the I/R-induced apoptosis and
necrosis.. Data represent the means ± SEM. RA: n = 10, RA + I/R: n = 6, IH4 + I/R: n = 5, IH4/Phe + I/R:
n = 6, IH4/MnTBAP + I/R: n = 6, Phe: n = 4, MnTBAP: n = 4. * p < 0.05. I/R, ischemia/reperfusion; IH,
intermittent hypoxia; Phe, Phenanthroline.
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4. Discussion
In this study, we demonstrated that IH4 attenuated the H2O2-induced cytosolic and mitochondrial
Ca2+ overload through ROS production, thereby preventing mitochondrial membrane depolarization.
It has been reported that IH could prevent cytosolic Ca2+ overload through various pathways. To our
knowledge, this is first demonstration that IH can protect cardiomyocytes against the H2O2- and
I/R-induced oxidative stress and cell death through maintaining the Ca2+ homeostasis.
Gu et al. reported that IH could reduce myocardial Ca2+ overload and hypoxia/reoxygenation
injury through upregulating PGC-1α and regulating the energy metabolism of glucose and lipid
mediated by activating the HIF-1α-AMPK-PGC-1α signaling pathway [26]. HIF-1 plays a central role
in cellular signaling in hypoxia adaption. It has been demonstrated that cyclic hypoxia-reoxygenation
activates HIF-1 expression, which triggers expression of vascular endothelial growth factor and
erythropoietin to promote angiogenesis and anti-infarct effects [10]. It has also been reported that HIF-1
could improve intracellular Ca2+ handling to prevent cell death. HIF-1stabilization increases protein
expression of SERCA2, resulting in cytosolic Ca2+ reuptake into ER stores faster in thymocytes [27].
Furthermore, ischemic preconditioning activated HIF-1/Sp1 complex to increase NCX1 gene and
protein expression to attenuate oxygen and glucose deprivation-induced neuronal cell death [28].
On the other hand, IH regulated the activities of Na+/K+ pump and Na+/Ca2+ exchanger to prevent
Ca2+ overload and I/R injury through the PKC-mediated pathway has also been reported [29–32].
Additionally, IH has been shown to be able to inhibit mitochondrial Ca2+ overload and mitochondrial
membrane depolarization, hence preventing against reperfusion injury [7,33]. Reduction of Ca2+
overload has been demonstrated to contribute to the IH-prevented mitochondria-mediated cell death.
During I/R injury, a burst of ROS leads to cell death, mediated by intracellular Ca2+ overload [34].
Excessive ROS can directly modify many Ca2+-handling proteins, such as RyR, SERCA, and NCX, to
influence cardiomyocyte viability and heart functions [35]. We observed that treatment with IH for four
days prevented the I/R- and H2O2-induced Ca2+ overload associated with an increase of antioxidant
defense capacity through non-lethal ROS generation. IH can not only upregulate the expression of
Cu/Zn SOD and MnSOD proteins but also increases catalase and GPx activity. Aguilar et al. also
found that IH can increase SOD and GPx expression in cardiac tissue associated with a higher ejection
and shortening fraction of the left ventricle function [19]. Increases of antioxidant capacity prevent
intracellular Ca2+ overload through improving the intracellular Ca2+ handling capacity.
ROS can be both harmful and protective [36]. It has been shown that several intracellular sources
including mitochondria, NADPH oxidase, xanthine oxidase, and uncoupled nitric oxide synthase can
generate ROS [35]. Our data revealed that apocynin (Apo), a NADPH-oxidase inhibitor, Phenanthroline
(Phe), an iron chelator that blocks the formation of hydroxyl radicals, and MnTBAP, a SOD mimetic,
inhibited the IH-induced ROS generation. Our data also revealed that IH-induced ROS generation did
not cause cell death (Figure 1). Furthermore, reduction of ROS generation abolished the IH-induced
prevention of cell death in cardiomyocytes (Figure 5C). Estrada et al. also found that treatment of
mongrel dogs with IH for 20 days induces robust cardioprotection against I/R, manifested by a 90%
reduction in left ventricular infarct size. However, the cardioprotective effects induced by IH are
abolished by pre-treatment with an antioxidant, N-acetylcysteine (NAC). They demonstrated that ROS
are obligatory participants in regulating cardioprotection induced by IH [37]. It seems that non-lethal
ROS may play an important role in the IH-induced cardioprotection.
In cells, large amount of ROS induces severe oxidative stress, which causes damages of DNA, lipids
and proteins, thereby contributing to many different disease developments, including cardiovascular
diseases [38]. However, it has also been demonstrated that ROS can serve as a redox signaling molecule
in physiological conditions. Kelch-like ECH-associated protein-1 (Keap1) is a redox sensor associated
with NFE2-like 2 (Nrf2). ROS oxidation of cysteines in Keap1 leads to Nrf2 release and translocation
into the nucleus. Subsequently, the Nrf2-small Maf heterodimer binds to the antioxidant-responsive
element (ARE), resulting in upregulation of antioxidant genes, including SOD and GPx [39–41].
In addition, PPARγ has been reported to be able to directly modulate the expression of several
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antioxidants, such as MnSOD and GPx3 [42]. Our data revealed that IH-increased non-lethal ROS
generation upregulated the expression of Cu/Zn SOD and MnSOD proteins and increased catalase and
GPx activity. However, the mechanisms underlying ROS-increased antioxidant enzyme expression in
IH still require future investigation.
We also observed that the mRNA levels of CAT and GPx did not change (Figure 2D). However, the
enzyme activity of CAT and GPx increased (Figure 2C). CAT and GPx mRNA expression was probably
time-dependent [43]. It has been reported that mRNA half-lives were about several minutes to several
hours. Therefore, mRNA was degraded, but the protein expression or activity still increased [44].
IH has been demonstrated to exert beneficial effects on myocardial infarction, cardiac function,
arrhythmias, and coronary flow [10]. IH could cause greater left ventricle ejection fraction and
fractional shortening [19]. IH also protects the myocardium from I/R injury and maintains contractility
by upregulating ATF6 through the Akt-mediated signaling pathway [45]. Wang et al. reported
that IH can improve post-ischemic recovery of myocardial contractile function through the Akt and
the PKC-ε pathway via enhancing the production of ROS during early reperfusion [46]. Although
there are many different protocols for IH treatment, the findings from the present study and other
labs strongly suggest that IH can trigger multiple pathways to protect cardiomyocytes and the
heart against I/R injury. In conclusion, the findings of the present study demonstrate that IH could
protect cardiomyocytes against H2O2- and the I/R-induced oxidative stress and cell death through the
maintenance of Ca2+ homeostasis, mitochondrial membrane potential, and upregulation of antioxidant
enzymes via non-lethal ROS production.
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Abstract: Hydroxyapatite-based biomaterials are commonly used in surgery to repair bone damage.
However, the introduction of biomaterials into the body can cause metabolic alterations, including
redox imbalance. Because vitamins D3 and K (K1, MK-4, MK-7) have pronounced osteoinductive,
anti-inflammatory, and antioxidant properties, it is suggested that they may reduce the adverse
effects of biomaterials. The aim of this study was to investigate the effects of vitamins D3 and K,
used alone and in combination, on the redox metabolism of human osteoblasts (hFOB 1.19 cell
line) cultured in the presence of hydroxyapatite-based biomaterials (Maxgraft, Cerabone, Apatos,
and Gen-Os). Culturing of the osteoblasts in the presence of hydroxyapatite-based biomaterials
resulted in oxidative stress manifested by increased production of reactive oxygen species and
decrease of glutathione level and glutathione peroxidase activity. Such redox imbalance leads to lipid
peroxidation manifested by an increase of 4-hydroxynonenal level, which is known to influence the
growth of bone cells. Vitamins D3 and K were shown to help maintain redox balance and prevent
lipid peroxidation in osteoblasts cultured with hydroxyapatite-based biomaterials. The strongest
effect was observed for the combination of vitamin D3 and MK-7. Moreover, vitamins promoted
growth of the osteoblasts, manifested by increased DNA biosynthesis. Therefore, it is suggested
that the use of vitamins D3 and K may protect redox balance and support the growth of osteoblasts
affected by hydroxyapatite-based biomaterials.
Keywords: hydroxyapatite-based biomaterials; osteoblast growth; redox balance; vitamins;
lipid peroxidation; 4-hydroxynonenal; oxidative stress
1. Introduction
Hydroxyapatite-based biomaterials possess osteoconductive properties and can also act as
three-dimensional scaffolds to support bone regeneration [1]. However, introducing biomaterials
into the body can lead to metabolic alterations. Namely, interactions between osteoblasts and
biomaterials may interfere with cellular metabolism, including redox balance leading to oxidative
stress [2]. The ingredients released by biomaterials may also take part in this activity [3,4]. Compounds
released from bone substitutes can have adverse effects on the viability and function of osteoblasts,
even in the absence of physical contact [2,5,6]. There is also evidence that the production of
pro-inflammatory cytokines by osteoblasts is increased in the presence of hydroxyapatite [7]. The lack
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of cytocompatibility of bone substitutes can hinder bone regeneration and prolong wound healing [8].
To reduce the cytotoxicity of biomaterials and enhance their desirable bioactivities, they are often
modified by the inclusion of various compounds, including growth factors [9] and antioxidants, e.g.,
N-acetylcysteine [5], or combined with other components, such as matrix-derived proteins [10].
The physiology of bone metabolism is dependent on the synergistic interplay between vitamins
D3 and K [11]. The active form of vitamin D3 is 1,25-dihydroxycholecalciferol (1,25(OH)2D3; calcitriol).
Calcitriol forms a complex with a specific nuclear receptor, commonly known as the vitamin D receptor
(VDR), to control the expression of key bone-related proteins in osteoblasts, including osteocalcin (OC),
and to regulate calcium and phosphate homeostasis [12,13]. The antioxidant and anti-inflammatory
properties of vitamin D3 have been confirmed both in vitro and in vivo. Under pathological conditions,
vitamin D3 has been shown to enhance the level and activity of antioxidant proteins which protect
cellular proteins from oxidative modification. Vitamin D3 activates the Nrf2-Keap1 antioxidant
pathway leading to transcription of antioxidant proteins and has been shown to reduce levels of
advanced glycation end-products in the aortic wall of diabetic rats [14,15]. Administering vitamin
D3 to rats increased the activity of an antioxidant enzyme superoxide dismutase (SOD) in the liver.
Furthermore, a decrease in vitamin D3 levels in the blood serum in obese children was correlated
with a decrease in SOD levels [16–19]. Changes in antioxidant capacity correspond to an increase in
lipid peroxidation [20]. Vitamin D3 also inhibits oxidative stress and endoplasmic reticulum stress in
endothelial cells thereby reducing the risk of cardiovascular disease in humans [21] and preventing
endothelial cell death [22]. In addition, vitamin D3 plays a role in T cell-mediated immunity [23].
The vitamin K family is a group of fat-soluble vitamins that regulate metabolic processes [24].
The two main forms of vitamin K are phylloquinone (K1) and menaquinone (K2), including the
menaquinone-4 (MK-4) and menaquinone-7 (MK-7) homologues. Vitamin K1 is transported to the
liver where it regulates the production of coagulation factors, whereas vitamin K2 is found in many
tissues, including bone, where it regulates the activity of vitamin K-dependent proteins, such as
matrix carboxyglutamic acid (Gla)-protein (MGP) and OC (GLA protein) [25]. Bone metabolism
depends on interaction between vitamins D3 and K2. Vitamin D promotes vitamin K-dependent
protein production while vitamin K activates proteins involved in bone metabolism. Vitamin K acts
as a cofactor in the carboxylation of glutamic acid (Glu) to Gla and the metabolically active form
of OC, which can bind and deposit calcium in the extracellular matrix [11,26]. In vitro, vitamin K2
was shown to promote osteoclast apoptosis in a dose-dependent manner and to suppress osteoblast
apoptosis [27,28]. Moreover, it was found that vitamin K2 increases the number and activity of
osteoclasts [28] and the MK-4 homologue promotes osteoblast differentiation and proliferation of
osteoclasts [29].
Vitamin K participates in blood coagulation, signal transduction processes, and cell
proliferation [30], and has the ability to alter redox balance in cells [31]. In its reduced form, vitamin K
hydroquinone (KH2) protects phospholipid membranes from peroxidation by direct reactive oxygen
species (ROS) uptake [32]. During the vitamin K cycle, hydroquinone is reconstituted with the
participation of vitamin K epoxide reductase complex subunit 1 (VKORC1) [31]. Vitamin K inhibits the
activation of 12-lipoxygenase (12-LOX) to prevent the formation of ROS [33]. The antioxidant actions
of vitamins K1 and K2 (MK-4) protect oligodendrocytes and neurons from oxidative stress caused
by glutathione (GSH) deficiency [34]. Nanomolar concentrations of vitamins K1 and K2 (MK-4)
were also shown to prevent oxidative stress-induced neuronal death [33]. Since oxidative stress is
directly associated with inflammation, vitamin K may reduce oxidative stress by lowering levels of
pro-inflammatory factors [35,36].
There is a growing body of evidence to suggest vitamin K and vitamin D have synergistic effects
on bone metabolism [11,37,38]. The aim of the present study was to investigate the effect of vitamin D3
and K on cellular metabolism and to determine whether vitamins D3, K1, MK-4, and MK-7 could be
potentially used to support bone regeneration alongside hydroxyapatite-based biomaterials. Therefore,
redox balance in osteoblasts cultured in presence of biomaterials was determined. The biomaterials
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characterized by origin—human (Maxgraft), bovine (Cerabone), porcine (Apatos and Gen-Os),
and composition—hydroxyapatite (Maxgraft, Cerabone, Apatos) and hydroxyapatite enriched with
collagen (Gen-Os) were examined.
2. Materials and Methods
2.1. Materials
To evaluate the in vitro effect of vitamin K (K1, MK4, and MK7) and vitamin D3 on osteoblasts’
metabolism cultured with biomaterial cells were cultured on commercial biomaterials of different
origin and chemical composition. Vitamin K1 (Sigma–Aldrich, St. Louis, MO, USA), vitamin
K2 (Menaquinone 4, MK4 (Sigma–Aldrich, St. Louis, MO, USA) and Menaquinone 7, MK7 (was
chemically synthesized by the Pharmaceutical Research Institute, Warsaw, Poland)), and vitamin
D3 (1,25-dihydroxyvitamin D3 (1,25(OH)2D3) (Santa Cruz Biotechnology, USA)), was added to cells.
Four different hydroxyapatites: human origin (Maxgraft, Botiss biomaterials GmgH, Germany),
bovine origin (Cerabone, Botiss Biomaterials GmbH, Germany), porcine origin (Apatos, Tecnoss,
Italy), and porcine hydroxyapatite with preserved collagen (Gen-Os, Tecnoss, Italy) were used
for experiments.
2.2. Cell Cultures and Treatments Used
All experiments were performed using a human fetal osteoblast cell line (hFOB 1.19) obtained from
ATCC (American Type Culture Collection, Menassas, VA, USA). The optimal time to assess metabolic
changes during osteoblast differentiation is about 20 days [39]. During this period, three stages of
osteoblast differentiation can be distinguished: proliferation (until day 4), synthesis of extracellular
matrix (between 12–16 days), and mineralization of the extracellular matrix of the bone (about day
20) [39,40]. Cells were cultured for 20 days at 39 ◦C in 5% CO2 in air in a 1:1 mixture of Ham’s F12
medium and Dulbecco’s modified Eagles’s medium containing 2.5 mmol/L L-Glutamine without
phenol red and supplemented with 0.3 mg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin,
and 10% fetal bovine serum (FBS). Culture medium was renewed every 2 days.
For all experiments, osteoblasts were seeded on each of the hydroxyapatite-based biomaterials
(Maxgraft, Cerabone, Apatos, Gen-Os; 100 mg/well) at a density of 1 × 105 cells/well in 6-well
plates. The influence of vitamin D3 and vitamin K on osteoblast growth was investigated by dividing
the cells into several treatment groups: cells treated with vitamin D3, cells treated with vitamin K
(K1, MK-4, or MK-7), and cells treated with combinations of vitamin D3 and K (D3+K1, D3+MK-4,
or D3+MK-7). Controls without any hydroxyapatite were cultured in parallel. Cells were supplemented
with vitamin K1 and K2 (MK-4 and MK-7) at a concentration of 10 μmol/L [29,41] and/or vitamin
D3 at concentration 1 nM in the presence of 10 mmol/L sodium β-glycerophosphate to accelerate the
mineralization process. After 4, 8, 12, 16, and 20 days, cells were collected. Vitamin D3 was used in its
metabolically active form of 1,25(OH)2D3, which has previously been shown to regulate osteoblast
differentiation [42,43]. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric
assay was used to study the effect of vitamin D3 on cells and to determine the optimal concentration
of vitamin D following a procedure previously described in the literature [44]. The concentration of
vitamin K used for the MTT assay did not affect cell viability.
To examine the effects of vitamins D3, K1, K2 (MK-4 and MK-7), and hydroxyapatite on osteoblast
proliferation and differentiation, DNA content as well as alkaline phosphatase (ALP) and OC levels
were determined. Redox status was estimated for each group based on measured ROS, GSH,
and 4-hydroxynonenal (4-HNE) levels.
2.3. Determination of ROS Level
Electron spin resonance (ESR) spectrometer e-scans (Noxygen GmbH/Bruker Biospin
GmbH, Germany) were used to detect total ROS generation using spin probe CMH
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(1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetra-methylpyrrolidine, 200 μmol/L), which selectively
interacts with ROS to form a stable nitroxide CM-radical (carbamoyl radical) with a half-life of
4 h [43]. After 4, 8, 12, 16, and 20 days in culture, the cells were suspended in Krebs HEPES
buffer (2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid) (KHB) and the CMH spin probe
was added. Samples were incubated for 30 min at 37 ◦C in a mixture of N2 and 02 of 96:4 (02:N2) and
electron paramagnetic resonance (EPR) was performed on cell lysates using the following acquisition
parameters: field center 1.99 g, microwave power 20 mW, amplitude of modulation 2 G, sweep time
10 s, number of scans 10, range of deviation 60 G.
2.4. Determination of GSH Level
Non-enzymatic antioxidant—glutathione (GSH)—was quantified using capillary electrophoresis
(CE) method of Maeso et al. [45]. Cells were sonicated with a mixture containing acetonitrile/water
(ACN/H2O 62.5:37.5, v/v) and centrifuged at 30,000× g for 10 min. The separation of supernatant
components was performed on a capillary with 47 cm total length (40 cm effective length) and 50 μm
i.d. and was operated at 27 kV with UV detection at 200 ± 10 nm.
2.5. Determination of Glutathione Peroxidase Activity
Glutathione peroxidase (GSH-Px, EC 1.11.1.6) activity was estimated by spectrophotometry using
a microplate reader (Infinite M200, Tecan), according to the method of Paglia and Valentine [46].
Enzyme activity was measured using an indirect method involving two conjugated reactions:
glutathione oxidation reaction (catalyzed by glutathione peroxidase) and glutathione reduction reaction
with simultaneous oxidation of reduced nicotinamide adenine dinucleotide phosphate (NADPH) to
NADP. The cell lysate was combined with a mixture containing 1.5 mM ethylenediaminetetraacetic
acid (EDTA; in 0.2 mol/L Tris-HCl buffer; pH 7.6), 15 mmol/L sodium azide, and 0.72 mmol/L
NADPH in a 96-well plate and incubated for 5 min at 20 ◦C. Then glutathione reductase and 0.1 mL of
10 mmol/L H2O2 in 0.02 mmol/L Tris-HCl buffer (pH 7.6) were added to each sample. Absorbance
was measured at 340 nm for 1 min relative to Tris-HCl buffer. One unit of GSH-Px activity was defined
as the amount of enzyme catalyzing the oxidation of 1 μmol NADPH min−1 at 25 ◦C and pH 7.4.
Enzyme specific activity was expressed as micro-units per mg of protein.
2.6. Determination of Lipid Peroxidation
Lipid peroxidation was estimated based on the level of 4-hydroxynonenal (4-HNE)
as a derivative of O-pentafluorobenzyl-oxime-trimethyl silyl ether (O-PFB-oxime-TMS) [47],
assessed using gas chromatography-mass spectrometry (GC/MS) in selected ion monitoring
mode (SIM), according to a previously described method [48]. Briefly, aldehydes were
derivatized by the addition of O-(2,3,4,5,6-pentafluorobenzyl) hydroxylamine (PFB) in PIPES
buffer (piperazine-N,N′-bis(2-ethanesulfonic acid) in the presence of benzaldehyde-D6 as an
internal standard (IS). The O-PFB-oxime aldehyde derivative was extracted using hexane.
The hexane phase was evaporated under a stream of argon followed by the addition of
N,O-bis(trimethylsilyl)trifluoroacetamide in 1% trimethylchlorosilane to form TMS ether of the
hydroxyaldehyde group. A 1 μl aliquot was injected into the GC-MS. Derivatized aldehyde was
analyzed using a 7000 quadrupole MS/MS (7890A GC, Agilent Technologies, USA) equipped with
a HP-5 ms capillary column (0.25-mm internal diameter, 0.25-μm film thickness, 30-m length).
The column temperature was initially set to 50 ◦C for 1 min, increased at a rate of 10 ◦C/min to
200 ◦C, then at 3 ◦C/min to 220 ◦C, 20 ◦C/min to 310 ◦C, and finally, maintained at 310 ◦C for
5 min. The injector temperature was maintained at 250 ◦C, the transfer line was held constant at
280 ◦C, and the source temperature was set to 230 ◦C. Derivatized aldehyde was detected by selected
ion-monitoring GC/MS using the following ions: m/z 333.0 and 181.0 for 4-HNE-PFB-TMS and m/z
307.0 for nternal standard (IS) derivative.
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2.7. DNA Proliferation Assay
A DNA fluorometric assay for measuring osteoblasts proliferation was used [49]. Briefly,
medium was discarded, and cells were washed with a washing solution (0.8% NaCl, 0.04% KCl,
0.1% ethylenediaminetetraacetic acid EDTA, and 1% NaN3). The plates were then allowed to dry
at room temperature for 10 min, wrapped with parafilm, and frozen at −70 ◦ C until analysis.
After removal from the freezer, 0.01% dodecyl sodium sulfate (SDS) was added, and samples were
incubated at room temperature for 15 min. Cell lysates in the amount of 10 μL were put into a 96-well
plate with H33258 at a concentration of 2 μg/mL. The DNA level was measured under excitation
of 360 nm and emission at 460 nm and calculated from the calibration curve for Calf Thymus DNA
solution. The DNA level was expressed as ng of DNA per mg of protein.
2.8. Determination of ALP Activity
Alkaline phosphatase (ALP) activity was determined fluorometrically using the p-nitrophenyl
phosphate (p-NPP) according to Reference [50] at 405 nm. Briefly, a lysis buffer (10 mmol/L Tris-HCl,
pH 7.5, containing 0.5 mmol/L MgCl2, 0.1% Triton X-100) was added to cells, and after 10 min
incubation on ice, cells were collected in tubes and stored at −70 ◦C until analysis. After thawing,
samples were sonicated and centrifuged at 10,000× g for 15 min at 4 ◦C. Next, glycine buffer
(25 mmol/L, pH 10.4) containing 2 mmol/L MgCl2 and 10 mmol/L p-NPP was added to samples,
and then incubated at 37 ◦C for 25 min. The enzymatic reaction was stopped by the addition of 3 mol/L
NaOH. The activity of ALP was expressed as the amount of enzyme (nmol) that catalyzed the reaction
with substrate per minute per mg of protein.
2.9. Determination of OC Level
The osteocalcin (Gla-OC) concentration was determined in the culture medium. The osteocalcin
level was determined using a commercially available human-specific enzyme-linked immunosorbent
assay (ELISA) kit (Gla-type Osteocalcin (Gla-OC) EIA Kit, TaKaRa, Bio Inc.). The tests were performed
according to the manufacturer’s protocol. The OC level was expressed as ng of osteocalcin per ml of
culture media.
2.10. Statistical Analysis
Data were analyzed using standard statistical analyses, one-way/two-way analysis of variance
(ANOVA) to determine significant differences between different groups. All analyses on cells were
performed on the results obtained from three independent experiments. The results are expressed as
the mean ± standard deviation (SD) for n = 3. p-values less than 0.05 were considered significant.
3. Results
3.1. Biochemical Studies
The results obtained show that the growth of osteoblasts was associated with a gradual increase of
ROS levels, the largest increase being observed between the days 8 and 12 (Figure 1). While vitamin D3
did not affect such changes in ROS levels for cultured osteoblasts, the other vitamins attenuated
continuous increases of ROS. The most prominent reduction of ROS production was observed
in MK-7-treated osteoblasts at day 12 and day 16 (16% and 23%, respectively), whereas ROS
levels observed in the K1-treated osteoblasts decreased by 11–17% and in MK-4-treated osteoblasts,
by 14–15%.
Opposite to the vitamins, the hydroxyapatite-based biomaterials further enhanced production
of ROS by cultured osteoblasts, which was also shown to be significantly reduced by vitamins,
depending on the type of biomaterials and vitamins used (Figure 1b–e). Osteoblasts cultured on
hydroxyapatite in medium containing vitamin D3 with either vitamin K1 or K2 exhibited significantly
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lower ROS production, particularly at day 16 and 20, compared to controls (10–20%) or cells grown on
hydroxyapatite-based biomaterials alone (10–20%).
Figure 1. Reactive oxygen species (ROS) level in osteoblasts after incubation with hydroxyapatites and
treated with vitamins D3, K1, MK4, and MK7 after 8, 12, 16, and 20 days. The results are expressed as the
μM/min/mg of protein and are shown as the mean ± SD (n = 5). The values for the control cells and the
treated cells were significantly different according to unpaired Student’s t-test. * Statistically significant
differences versus control, p < 0.05; (a) statistically significant differences versus group hydroxyapatites
(Mx (Maxgraft), Cb (Cerabone), Ap (Apatos), Go (Gen-Os), respectively for graphs (b–e)); p < 0.05.
Levels of the main cytosolic antioxidant, GSH, gradually increased in osteoblast cultures until day
12; however, a decrease was observed at day 20 (Figure 2). The addition of vitamin D3 as well as K1
and K2 to culture medium significantly increased GSH concentrations compared to controls. Vitamin
K1 and K2 had slightly less of an effect than vitamin D3. The largest increases in GSH concentration
were observed between day 8 and 20. Furthermore, the combination of vitamin D3 and vitamin K1 or
K2 resulted in enhanced GSH levels compared to cultures treated with only the vitamin K variants.
Cells cultured with hydroxyapatite (Apatos and Gen-Os), exhibited lower GSH levels (Figure 2b–e);
moreover, the addition of vitamin D3 and a mixture of vitamins D3 and K1 or K2 led to a significant
increase in GSH levels compared to controls. The largest increase was observed between day 8 and day
20 in osteoblast cultures treated with vitamin D3 and K1 or K2 in the presence of Maxgraft (17–58%) or
Cerabone (28–54%).
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Figure 2. Glutathione (GSH) level in osteoblasts after incubation with hydroxyapatites and treated
with vitamins D3, K1, MK4, and MK7 after 8, 12, 16, and 20 days. The results are expressed as the
nmol/mg of protein and are shown as the mean ± SD (n = 5). The values for the control cells and the
treated cells were significantly different according to unpaired Student’s t-test. * Statistically significant
differences versus control, p < 0.05; (a) statistically significant differences versus group hydroxyapatites
(Mx (Maxgraft), Cb (Cerabone), Ap (Apatos), Go (Gen-Os), respectively for graphs (b–e)); p < 0.05.
Observed changes in GSH level were associated with changes in GSH-Px activity since GSH is its
co-substrate. Vitamin D3 as well as MK-4 and MK-7 significantly enhanced the activity of GSH-Px
by approximately 16–13% for vitamin D3 alone between 8 and 20 days and by approximately 14%
for D3+MK-4 and D3+MK-7 on day 8 and day 20, compared to controls (Figure 3a). Therefore,
the combination of D3+MK-4 or D3+MK-7 significantly enhanced GSH-Px activity. The most
effective treatment was D3+MK-7 which resulted in a 28% increase after 16 days. The presence
of hydroxyapatite-based biomaterials, in particular Apatos and Gen-Os, led to a decrease in GSH-Px
activity of approximately 11% (Figure 3b–e). Osteoblasts cultured in the presence of hydroxyapatite but
treated with vitamin D3 were characterized by significantly higher GSH-Px activity (9–12% and 11–19%
for Apatos and Gen-Os, respectively) compared to cells grown only in the presence of hydroxyapatite.
However, a combination of vitamins, D3+MK-4 or D3+MK-7, led to a significant increase in GSH-Px
activity even in the presence of hydroxyapatite. For Apatos, GSH-Px activity was enhanced by
approximately 11–17% and 20% with D3+MK-4 and D3+MK-7 treatment, respectively; for Cerabone,
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approximately 15–24% for D3+MK-4 and 18–24% for D3+MK-7, and for Gen-Os, 7–16% for D3+MK-4,
and 9–19% for D3+MK-7.
Figure 3. GSH-Px activity in osteoblasts after incubation with hydroxyapatites and treated with
vitamins D3, K1, MK4, and MK7 after 8, 12, 16, and 20 days. The results are expressed as the mU/mg
of protein and are shown as the mean ± SD (n = 5). The values for the control cells and the treated
cells were significantly different according to unpaired Student’s t-test. * Statistically significant
differences versus control, p < 0.05; (a) statistically significant differences versus group hydroxyapatites
(Mx (Maxgraft), Cb (Cerabone), Ap (Apatos), Go (Gen-Os), respectively for graphs (b–e)); p < 0.05.
Furthermore, biomaterials and vitamins affected redox balance in cultured osteoblasts by
modifying lipid metabolism, in the manner similar as observed for ROS levels. Namely, the growth of
osteoblasts was associated with continuous increase of 4-HNE levels (Figure 4). However, different
from the lack of influence of vitamin D3 on the ROS change, the most significant effects on the 4-HNE
production were observed in vitamin D3-treated cultures (Figure 4a), followed by MK-7, with a
reduction of approximately 12–19%. As was noticed in the case of the change of ROS (Figure 1),
the presence of hydroxyapatite biomaterials also caused a significant increase in lipid peroxidation,
i.e., enhanced production of 4-HNE, while vitamins attenuated lipid peroxidation induced by the
osteoblast growth also if cultured in the presence of hydroxyapatite.
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Figure 4. 4-HNE level in osteoblasts after incubation with hydroxyapatites and treated with vitamins
D3, K1, MK4, and MK7 after 8, 12, 16, and 20 days. The results are expressed as the nmol/mg of protein
and are shown as the mean ± SD (n = 5). The values for the control cells and the treated cells were
significantly different according to unpaired Student’s t-test. * Statistically significant differences versus
control. p < 0.05; (a) statistically significant differences versus group hydroxyapatites (Mx (Maxgraft),
Cb (Cerabone), Ap (Apatos), Go (Gen-Os), respectively for graphs (b–e)), p < 0.05.
3.2. Osteoblast Growth
Significant increase in the osteoblasts’ DNA levels were observed on day 12 and thereafter,
remaining constant until day 20 (Figure 5). Vitamin D3 did not affect DNA levels, whereas vitamin
K1 accelerated cell proliferation by 12–23%, MK-4 by 15–27%, and MK-7 by 16–51% (Figure 5A).
Addition of vitamin D3 to vitamin K1 and K2 did not change the rate of osteoblast proliferation.
All hydroxyapatites, with the exception of Maxgraft, inhibited osteoblast proliferation (Figure 5b–e).
The most notable changes were observed for Cerabone, Apatos, and Gen-Os on day 4 and 8 of culture,
with a decline in DNA levels of 23%, 24%, and 37% (day 4), and 12%, 15%, and 36% (day 8), compared
to controls. When vitamin D3 was present, osteoblast proliferation was not affected. In contrast,
the combinations D3+K1, D3+MK-4, and D3+MK-7 increased DNA levels in both controls with no
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hydroxyapatite (10–34%) and osteoblasts cultured in the presence of hydroxyapatite (10–50%); however,
D3+MK-7 was most effective.
Figure 5. DNA levels in osteoblasts after incubation with hydroxyapatites and treated with vitamins
D3, K1, MK4, and MK7 after 4, 8, 12, 16, and 20 days. The results are expressed as the ng/mg of
protein and are shown as the mean ± SD (n = 5). The values for the control cells and the treated cells
were significantly different according to unpaired Student’s t-test. * Statistically significant differences
versus control, p < 0.05; (a) statistically significant differences versus hydroxyapatites (Mx (Maxgraft),
Cb (Cerabone), Ap (Apatos), Go (Gen-Os), respectively for graphs (b–e)), p < 0.05;
The osteoblast differentiation process, characterized by increasing ALP activity over time, reached
a maximum after 16 days of culture, and thereafter, began to decrease (Figure 6). Vitamin D3
significantly enhanced ALP activity (40–150%) compared to the control (Figure 6a). Vitamin K1
and K2 did not affect ALP activity; however, the combination of vitamins D3+K1, D3+MK-4,
and D3+MK-7 significantly increased ALP activity. At day 20, the largest increase was observed
in MK-7-treated cultures, with a 2.5-fold increase. The presence of hydroxyapatite-based biomaterials
did not significantly affect ALP activity, with the exception of an increase observed with Maxgraft
(Figure 6b–e). Osteoblasts cultured with hydroxyapatite and treated with vitamin D3 exhibited
significantly higher ALP activity compared to cells grown with only hydroxyapatite and control
(no hydroxyapatite). Moreover, the addition of vitamin D3+K1, D3+MK-4 or D3+MK-7 led to a
significant increase in ALP activity in the presence of hydroxyapatite. The combination of vitamin
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D3 and MK-7 led to the largest increase in ALP activity, particularly evident on day 4 (a two-fold to
four-fold increase).
Figure 6. ALP activity in osteoblasts after incubation with hydroxyapatites and treated with vitamins
D3, K1, MK4, and MK7 after 4, 8, 12, 16, and 20 days. The results are expressed as the nmol/min/mg
of protein and are shown as the mean ± SD (n = 5). The values for the control cells and the treated cells
were significantly different according to unpaired Student’s t-test. * Statistically significant differences
versus control, p < 0.05; (a) statistically significant differences versus hydroxyapatites (Mx (Maxgraft),
Cb (Cerabone), Ap (Apatos), Go (Gen-Os), respectively for graphs (b–e)), p < 0.05.
Cell culture media was collected, and OC levels were estimated as a marker of mineralization.
The OC concentration gradually increased from day 8 to day 20 (Figure 7). Furthermore, synthesis
of OC was enhanced by vitamin D3 treatment compared to control (Figure 7a). Vitamin K1 did
not affect OC levels, whereas K2 caused an increase in OC production of 16–18% with MK-4 and
22–23% with MK-7, at day 16 and 20, respectively. The level of OC also increased in the cell culture
media of D3+K1 (41–66%), D3+MK-4 (47–82%), and D3+MK-7 (55–116%) groups compared to controls.
A decrease in OC concentration (approximately 10–26%) was observed in the media of osteoblasts
cultures in the presence of Apatos and Gen-Os, resulting in similar OC levels (Figure 7b–e). Vitamin
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D3-treated osteoblasts cultured in the presence of hydroxyapatite had enhanced OC levels compared
to controls and non-treated cells (hydroxyapatite only). Finally, exposing cells to D3+K1, D3+MK-4 or
D3+MK-7 resulted in higher OC levels compared to controls and non-treated cells (hydroxyapatite
only). The greatest enhancements were observed with vitamin D3 (55–120%) and MK-7 (40–120%).
Figure 7. OC levels in osteoblasts after incubation with hydroxyapatites and treated with vitamins D3,
K1, MK4, and MK7 after 8, 12, 16, and 20 days. The results are expressed as the ng/mL of medium
and are shown as the mean ± SD (n = 5). The values for the control cells and the treated cells were
significantly different according to unpaired Student’s t-test. * Statistically significant differences versus
control, p < 0.05; (a) statistically significant differences versus group hydroxyapatites (Mx (Maxgraft),
Cb (Cerabone), Ap (Apatos), Go (Gen-Os), respectively for graphs (b–e)), p < 0.05. (a) statistically
significant differences versus group vitamin D3 with hydroxyapatites (Mx (Maxgraft), Cb (Cerabone),
Ap (Apatos), Go (Gen-Os), respectively for graphs (b–e)), p < 0.05.
4. Discussion
Hydroxyapatite-based biomaterials are often implanted to support bone regeneration or are
used as a scaffold for culturing osteogenic cells, notably osteoblasts, which are essential for bone
regeneration producing protein and mineral components of bone [50]. During the bone regeneration
process, osteoblasts are recruited to the site of the bone defect, where they proliferate, differentiate,
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and contribute to extracellular matrix mineralization [51]. Biomaterials can cause inflammation and
prolong wound healing as a result of increased ROS generation [52]. Vitamin D3, as well as K1, MK-4,
and MK-7, possess osteoinductive, anti-inflammatory, and antioxidant properties, and may be able to
prevent oxidative stress to improve bone regeneration [18,33,53].
Redox homeostasis results from the balance between ROS generation and the activity of cellular
antioxidants [54]. Under physiological conditions, osteoblasts maintain redox homeostasis; however,
interaction between osteoblasts and biomaterials can disturb this balance leading to oxidative stress.
Results of this study showing that osteoblasts cultured in the presence of xenogeneic and allogeneic
biomaterials exhibit increased ROS generation and reduced antioxidant capacity. Increased ROS
production has been shown to directly affect the biological activity of osteoblasts via inhibition of
Runx2 phosphorylation, the process responsible for transcription of type I collagen, osteopontin,
osteoprotegin, sialoprotein, OC, and ALP [55].
Results of this study indicate that the presence of xenogeneic and allogeneic biomaterials can lead
to antioxidant-related disorders in osteoblasts, including those associated with the GSH-dependent
system. In addition to performing regulatory functions that ensure redox homeostasis, GSH tripeptide
is also a cofactor of glutathione peroxidase, the main enzyme involved in breaking down peroxides
including lipid peroxides. Thus, GSH is responsible for protecting cell membrane phospholipids and
as a consequence, its deficiency can affect the function of biological membranes [56]. Lower GSH
levels prevent glutathione peroxidase from performing its function; therefore, allogeneic biomaterials,
in particular Apatos and Gen-Os, which lower GSH levels, can affect the activity of glutathione
peroxidase, as observed in these studies. As a consequence, the GSH-dependent antioxidant system
cannot properly perform its protective role and increased peroxidation of unsaturated fatty acids
results in the formation of reactive aldehydes, such as 4-HNE, as confirmed by our study. Biomaterials
based on bioactive glass have also been shown to alter the redox homeostasis in osteoblasts’ cells,
manifested as increased 4-HNE production [57]. It should be mentioned that 4-HNE belongs
to the α,β-unsaturated aldehydes, which include carbonyl groups and unsaturated bonds, thus,
rendering them electrophilic and highly biologically reactive compounds mostly targeting nucleophilic
compounds, such as GSH or proteins, leading to a reduction in biological activity including reduced
GSH-Px phosphorylation [58,59]. This is also important because lipid peroxidation products decrease
the expression of genes encoding for bone morphogenetic proteins (BMPs), including BMP2, BMP7,
and BMP4, and therefore inhibit osteoblast maturation [55,60]. On the other hand, 4-HNE is known
to act as growth regulating factor, acting in the concentration dependent and cell-type-specific
manner influencing proliferation, differentiation, and apoptosis [61,62]. Mesenchymal cells, notably
osteoblast-like cells, are especially sensitive to the growth regulating effects of 4-HNE, which interfere
with complex bioactivities of numerous other growth-regulating factors (cytokines, hormones, etc.) and
might eventually be involved in pathophysiology of altered bone growth, as in case of hypertrophic
callus formation or otosclerosis [63,64]. Since 4-HNE was found to be produced by osteoblast-like
cells, the growth of which was enhanced in vitro by bioactive glass, we may assume that production
of 4-HNE by the osteoblasts observed in current study (also in the control cell cultures) supports
previously described growth regulating effects of 4-HNE for the bone cells, while hydroxyapatite
biomaterials resemble effects of bioactive glass [57,65]. However, to maintain functional growth of the
bone cells it is necessary to enhance not only their proliferation but also differentiation, while oxidative
stress and in particular 4-HNE were already proposed to be key mediators that might define the overall
bioactivities of the implantable bioactive materials that require maintenance of the redox balance and
the presence of supportive factors, like cytokines and vitamins [66,67].
Thus, the use of vitamins D3 and K to prevent redox imbalance could be beneficial for the
bone growth and regeneration. Vitamin D3 did not have any effect on ROS level in this study,
whereas ROS levels were significantly decreased with the addition of vitamin K to culture media,
particularly the MK-7 homologue. The mechanism of vitamin K action may be associated with the
inhibition of 12-LOX (lipoxygenase 12) activity [33], which can decrease ROS generation. Moreover,
213
Cells 2019, 8, 325
inhibiting ROS production may help maintain the metabolic activity of osteoblasts, but at the same
time, could increase osteoclast activity, resulting in increased bone resorption [60]. This could reduce
bone mineral density and the mechanical strength of newly formed and existing bone [68]. Therefore,
vitamin K treatment can have associated consequences including oxidation of reduced glutathione to
glutathione disulphide and reduced GSH-Px activity [69]. This is critical since GSH-Px activity protects
membrane phospholipids and prevents the formation of 4-HNE. At the cellular level, oxidative damage
disturbs cellular metabolism, thereby inhibiting osteoblast proliferation. This could be related to the
oxidative damage to fibronectin, a glycoprotein that regulates certain osteoblast activities including
adhesion, proliferation, migration, and cell morphology [70].
Here, we report decreased GSH levels in osteoblast cultures grown in the presence of allogeneic
and xenogenic bone derivatives and treated with vitamin D3 and/or K. The decrease in GSH levels
was particularly evident in cultures treated with the MK-7 homologue in combination with D3,
which could be related to the vitamin D3-mediated increase in cysteine glutamate ligase (GCLC)
activity which catalysis GSH biosynthesis [71]. Owing to the antioxidant properties of K vitamins,
they can also affect GSH concentration, as confirmed by previous studies on nerve cells [34].
Higher GSH levels are accompanied by elevated GSH-Px activity, which enhances antioxidant activity
in osteoblasts. Cells with enhanced antioxidant activity are less sensitive to oxidative damage and cell
membrane damage.
Our results suggest that vitamin D3 and vitamin K protect osteoblasts from oxidative stress and
have beneficial effects on proliferation, differentiation, and mineralization of osteoblasts cultured both
with and without hydroxyapatite-based biomaterials. This study suggests that vitamin K enhances the
proliferative activity of osteoblasts (measured by DNA concentration). The MK-7 homologue is the
most effective, either alone or combined with vitamin D3. Enhanced proliferation of MK-7-treated
osteoblasts has been confirmed by other authors [72,73]. However, in previous studies, osteoblasts were
not cultured in the presence of hydroxyapatite-based biomaterials. Osteoblast DNA levels have been
associated with OC expression, osteoprotegerin, NFκB ligand (RANKL), and RANK ligand promoter
genes facilitated by vitamin K [74,75]. Furthermore, the vitamin K family participates in sphingolipids
synthesis, in addition to their structural role, sphingolipids take part in proliferation, differentiation,
and intercellular recognition activities of neurons [76]. Vitamin D3 cannot affect proliferation on its
own, but does support osteoblast differentiation, as demonstrated by increased expression of typical
markers such as runt-related transcription factor 2 (RUNX2), type I collagen, alkaline phosphatase,
and OC [77–79]. Our results show that unlike vitamin D3, the K vitamins do not influence osteoblast
differentiation. However, the combination of vitamin K and D3 can significantly enhance osteoblast
differentiation with increasing efficiency: K1 < MK-4 < MK-7. This can clearly be observed when
osteoblasts are cultured in the presence of xenogeneic biomaterials (Maxgraft) and was previously
observed by others [79]. Results of this study confirm previous reports of the participation of vitamin
D3 and K vitamins in the bone regeneration process [75]. Human bone marrow stromal cells (hBMSC)
and 2T3 osteoblast lines treated with vitamin D3 showed a concentration-dependent increase in ALP
activity [80], whereas vitamin K did not affect ALP activity [42].
Osteocalcin is responsible for depositing calcium in bone tissue [81] and both vitamin D3 and
vitamin K participate in the OC biosynthesis and activation processes [82]. In our study, vitamin D3 was
shown to significantly affect OC levels in osteoblasts cultured without hydroxyapatite. A significant
increase in OC synthesis was observed on day 12, indicating the start of the mineralization process.
Other studies have confirmed the influence of vitamin D3 on OC production by osteoblasts [80].
However, we have shown that the presence of biomaterials, in particular, allogeneic bone-derived
biomaterials (Apatos and Gen-Os), significantly decreases OC levels in the medium of osteoblast
cultures. Furthermore, hydroxyapatite has been shown to bind 60–90% of OC [83]. Therefore, observed
differences in the effects of different biomaterials on OC levels may be the result of varying levels of
absorption related to the porosity and composition of the material. The lowest OC levels observed for
osteoblasts cultured in the presence of Gen-Os is most likely owing to the presence of collagen in the
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biomaterial structure. Collagen content favours the absorption of OC since OC binds to the surface of
collagen and further mediates the binding and accumulation of hydroxyapatite crystals on collagen
fibers [40].
The K vitamin family supports biosynthesis of OC by participating in post-translational
carboxylation of Gla residues of OC propeptides [26]. In contrast, carboxylated OC binds calcium to
bone hydroxyapatite, thus supporting bone metabolism [81]. The results of our study indicate the
effects of K vitamins are less significant than those of vitamin D3; however, the combination results in
synergistic effects, even in the presence of allogeneic biomaterials (Apatos and Gen-Os). This could
be because post-translational modification of OC depends on both vitamin D3 and vitamin K [37].
Vitamin D3 activates γ-glutamylcarboxylase for which vitamin K is a cofactor [26,84]. Moreover,
vitamin K intensifies the synthesis and accumulation of carboxylated OC [82], thereby supporting
hydroxyapatite deposition on collagen fibers. This process is regulated by the carboxylated form of
OC [85]. Since vitamins D3 and K have a high affinity for hydroxyapatite, they are absorbed onto
its surface and remain available to cells for a long time, despite the relatively short half-life of both
vitamins [79]. Our results show intensified biosynthesis of OC between day 16 and 20 of the culture.
Clinical studies have also confirmed that vitamin K (MK-4) and vitamin D3 treatments increase bone
mass [86].
5. Conclusions
This study suggests that proliferation and differentiation of human osteoblasts in vitro was
strongly influenced by redox balance, which might be altered in the presence of hydroxyapatite-based
biomaterials. While physiological ROS production-induced lipid peroxidation generating 4-HNE
might be important for the redox homeostasis of the growing osteoblasts, vitamins D3 and/or K
could prevent their excessive production through oxidative stress of the osteoblasts induced by
the biomaterials, thereby preventing their adverse effects on cellular proliferation and osteoblast
differentiation. The most desirable effects on the maintenance of redox homeostasis were in our
in vitro study observed for vitamins D3 and K2, especially the homologue MK-7.
It is suggested that proliferation and differentiation of human osteoblasts in vitro is strongly
influenced by redox balance, which is altered in the presence of hydroxyapatite-based biomaterials.
ROS production and thus induced lipid peroxidation with 4-HNE generation might be important
for the redox homeostasis of the growing osteoblasts, whereas vitamins D3 and/or K could prevent
oxidative stress of the osteoblasts induced by the biomaterials, thereby preventing their adverse effects
on proliferation and osteoblasts differentiation. The most desirable effects were in our in vitro study
observed for vitamins D3 and K2, especially the MK-7 homologue.
Author Contributions: Conceptualization, E.S. and G.G.; methodology, E.A.; validation, M.M.; formal analysis,
M.M.; investigation, E.A.; resources, G.T.; data curation, E.A.; writing—original draft preparation, E.A. and G.T.;
writing—review and editing, N.Z.; supervision, E.S.; project administration, E.S.; funding acquisition, G.G.
Funding: Cooperation between coauthors was financed by the Polish National Agency for Academic Exchange as
part of the International Academic Partnerships (PPI/APM/2018/00015/U/001).
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Ono, H.; Sase, T.; Tanaka, Y.; Takasuna, H. Histological assessment of porous custom-made hydroxyapatite
implants 6 months and 2.5 years after cranioplasty. Surg. Neurol. Int. 2017, 8, 8. [CrossRef]
2. Yamada, M.; Ueno, T.; Minamikawa, H.; Sato, N.; Iwasa, F.; Hori, N.; Ogawa, T. N-Acetyl cysteine alleviates
cytotoxicity of bone substitute. J. Dent. Res. 2010, 89, 411–416. [CrossRef] [PubMed]
3. Anusavice, K.J. Phillip’s Science of Dental Materials, 11th ed.; Elsevier: Saunders, FL, USA, 2003; pp. 170–190.
4. Anusavice, K.J.; Shen, C.; Rawls, H.R. Phillip’s Science of Dental Materials, 12th ed.; Elsevier: Saunders, FL,
USA, 2013; pp. 170–190.
215
Cells 2019, 8, 325
5. Yamada, M.; Kojima, N.; Att, W.; Minamikawa, H.; Sakurai, K.; Ogawa, T. Improvement in the osteoblastic
cellular response to a commercial collagen membrane and demineralized freeze-dried bone by an amino
acid derivative: An in vitro study. Clin. Oral Implants Res. 2011, 22, 165–172. [CrossRef] [PubMed]
6. Mouthuy, P.A.; Snelling, S.J.B.; Dakin, S.G.; Milković, L.; Gašparović, A.Č.; Carr, A.J.; Žarković, N.
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